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Abstract
The aim of this thesis was to develop a new module on pain and discomfort to be used 
in conjunction with the UK World Health Organisation Quality of Life Assessment 
(WHOQOL-lOO) that elaborates the experience of chronic pain (CP). Further aims 
were to elucidate its psychometric properties and assess the quality of life (QoL) of 
people with CP. The WHOQOL-lOO is a multilingual, generic instrument for the 
subjective assessment of QoL in adults. It contains 100 core items represented by 25 
specific facets covering six broad domains. The four items in the WHOQOL-lOO that 
address pain and discomfort have been found to under-represent the impact of pain on 
QoL, hence the need to develop a pain and discomfort module (PDM). Focus groups 
(FG’s) were conducted to generate data on how pain affects QoL. Ten new facets of 
QoL pertaining to CP were identified; flare-ups; pain relief; anger/ frustration; 
vulnerability/ fear/ worry; uncertainty; loss/ loneliness/ feeling alone; positive 
strategies; communication; guilt/ burdening others; relationship with health care 
providers. Concurrently, a web survey was conducted to provide confirmation and 
validation of the areas of QoL identified. A definition and items were written for each 
new facet of QoL. The resulting 108-item questionnaire was pre-piloted in a sample 
of people with CP using the technique of cognitive interviewing. Following deletion 
and modification of items, the 68-item PDM and 16 importance items were 
administered in a cross-sectional survey, where 4 facets remained in the PDM 
represented by 16 items. The WHOQOL and PDM were administered to low back 
pain patients having lumbar epidural steroid injections at baseline and 4-weeks 
following the intervention in a longitudinal survey to examine sensitivity to change. 
Patients not undergoing treatment also completed the WHOQOL and PDM at baseline 
and after 2 weeks to examine test-retest reliability. Pain relief, anger and frustration, 
vulnerability, fear and worry and uncertainty influence the QoL of people with pain. 
The PDM will be self-administered and must be used in conjunction with the UK 
WHOQOL-lOO for large-scale survey work, for evaluating the effectiveness of new 
and existing interventions designed to reduce the impact of pain on QoL and to 
identify the needs of sufferers.
1
Chapter one 
What is Chronic Pain?
1.1 Introduction
Everyone experiences pain at some point during their lives. Such experience is an 
inherently subjective experience and is associated with varied meanings. For some 
individuals, pain is perceived constantly through disease or ill health, sometimes even 
in the absence of pathology. Indeed, reports of pain are not highly associated with 
physical evidence of damage (Hunter, 2001). Given the inherent subjectivity, it is not 
possible to measure pain objectively by the extent of underlying pathology. 
Consequently, measuring or assessing a person’s pain must rely on verbal report or 
non-verbal behaviour. A person’s past experience, and the meaning and context of 
pain can influence such reports and lead to diverse consequences. This has led to the 
development of many different methods for measuring and assessing pain from simple 
visual analogue scales to multidimensional instruments assessing quality of life 
(QoL). The limitations of medical science to alleviate the suffering of persistent pain 
and the disability that may result from this has raised the question of how such 
experience may impact on the quality of people’s lives. This thesis addresses the 
impact that persistent pain has on the life quality of sufferers by developing an 
instrument to assess this.
1.2 Pain
Before going on to discuss the extent of the problem of pain, definitions of pain are 
introduced. In 1986, the international association for the study of pain (IASP) 
subcommittee on taxonomy defined pain as ‘an unpleasant sensory and emotional 
experience associated with actual or potential tissue damage, or described in terms of 
such damage’. That pain could be defined in this way, and as a consequence of 
important historical developments, such as the explication of the Gate Control Theory 
(GCT) (Melzack and Wall, 1965), the conceptualisation and understanding of pain has 
broadened to include the psychological and social aspects of a person’s experience. 
The application of psychology to the study of pain has become central to 
understanding its complexity, which is revealed in the burgeoning literature (e.g.
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Stembach, 1977; Skevington, 1995; Price, 1999; Gonzales, Martelli and Baker, 2000; 
Frischenschlager and Pucher, 2002, Turk and Okifuji, 2002).
1.2.1 Defining chronic pain
Defining chronic pain (CP) is conceptually necessary, useful in clinical practice and 
of paramount importance in empirical research. If CP is not adequately defined in 
studies investigating it, the reader is uncertain of which group of individuals are being 
referred to, or about whom the conclusions and recommendations are being made. CP 
has been defined as that which persists beyond the normal time of healing (Bonica, 
1953). In practice, this may be less than one month, but is more likely to be more 
than six months, indeed six months is often preferred for research purposes (IASP 
Task Force on taxonomy, 1994) to sufficiently distinguish between acute and chronic 
pain. In general, it is suggested that three months is the most convenient point to 
distinguish acute and CP where pain is non-malignant, for example as ‘pain that has 
persisted for longer than three months or past the expected time of healing’, which 
contrasts with the definition of acute pain as ‘pain associated with acute injury or 
disease’ (The Royal College of Anaesthetists and The Pain Society, Pain Management 
Services Good Practice, May 2003). Despite such definitions, it is suggested that the 
normal healing does not always occur and that the period of time will vary depending 
on the circumstances (IASP Task Force on taxonomy, 1994; Macrae and Davies, 
1999). Indeed, in some situations, repair may never be complete, for example, 
neuromata in an amputation stump represent a failure to heal and may be a site of 
persistent pain (Geraghty and Jones, 1996).
Advances in our understanding of CP have come about with research demonstrating 
the plasticity of the nervous system (Wall, 1989) where changes occur to its structure 
and function in response to the input it receives. Consequently, pain can be prolonged 
and maintained because of the response of the nervous system to injury. In view of 
this, it is suggested that CP may be viewed as “a persistent pain that is not amenable, 
as a rule, to treatments based upon specific remedies, or to the routine methods of pain 
control such as non-narcotic analgesics” (IASP Task Force on taxonomy, 1994). 
Consequently, the coding system developed by the IASP for classifying CP allows for 
durations of less than one month, one month to six months and more than six months 
(IASP Task force on Taxonomy, 1994). Although the differences between acute and
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CP are discussed, the IASP does not have a specific definition for ‘chronic pain’ 
(personal communication, October 2000). Moreover, although having a single 
definition of CP is a pragmatic one, the use of 'chronic pain' as an overarching term as 
a scientific construct has been questioned because it has been suggested that it is 
meaningless to compare different groups under this heading such as those with 
trigeminal neuralgia and low back pain (LBP) (Chapman and Donaldson, 1995). 
However, Novy and colleagues (1995) respond to this by suggesting that the term 
'chronic pain' has inherent clinical value. Anecdotally, this can be seen by the 
frequency with which health professionals refer to ‘chronic pain’ and the shared 
understanding of its meaning.
CP has also been defined as “pain which has continued for at least three months and is 
unlikely to resolve spontaneously” (Working Group of the National Medical Advisory 
committee, 1994). However, this may exclude some diagnostic groups, for example, 
recurrent headache, which may be experienced intermittently. A more inclusive 
definition is “pain or discomfort, that persists continuously or intermittently for 
longer than three months” (Elliott et al., 1999). For research purposes, this may be 
a better choice, since this allows for the inclusion of diagnostic groups characterised 
by intermittent pain or flare-ups, which are known to characterise some chronically 
painful conditions (Croft et al., 1998). In its operationalisation of CP, the series of 
studies reported in this thesis uses this definition as its main inclusion criterion. 
Furthermore, only patients with pain arising out of benign conditions such as chronic 
low back pain (CLBP) and rheumatoid arthritis (RA) are included, as opposed to 
malignant or life-threatening disease such as the persistent or breakthrough pain 
associated with certain types of cancer and its treatment.
1.2.2 Prevalence of chronic pain
Research reveals that estimating the prevalence of CP is problematic, given the lack 
of clarity in defining CP and the inherent subjectivity of the pain experience. 
Prevalence is defined as the number of persons with CP at a specific time divided by 
the total size of that population. Estimating prevalence is usually carried out through 
cross-sectional survey work. Researchers use different definitions, ranging from pain 
persisting for longer that one month (for example, Magni et al., 1993) to that 
persisting longer than six months (for example, Gureje et al., 1998). Despite
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numerous epidemiological studies on specific pain conditions or syndromes, there are 
few UK studies on CP across a wide range of diagnostic conditions. In order to select 
and recruit a representative sample for a research endeavour, it is necessary to have an 
accurate estimate of prevalence across the diversity of pain conditions, whilst being 
mindful of the fact that those presenting at primary care or beyond may represent the 
tip of the iceberg (Smith et al., 1996; Crombie and Davies, 1998).
In a review of 15 studies of the prevalence of benign CP, a median point prevalence of 
15% in the adult population, ranging from 2% to 40% was found (Veerhak et al., 
1998). People with CP tended to be women of lower socio-economic status and pain 
was most frequently present in the lower back, shoulder and neck and was often 
associated with depression or psychological distress. It is suggested that a 10% 
prevalence would be a very cautious estimate and that obtaining an accurate 
assessment of prevalence is problematic, given the inherent subjectivity of pain. 
Furthermore, it is suggested that it is more important to investigate the impact of pain 
on the lives of sufferers than to determine precisely how many people suffer (Veerhak 
et al., 1998). However, in order to carry out research on representative samples of 
people with CP, an important goal is to develop accurate ways of estimating 
prevalence to enable researchers to structure their samples in a way that can be said to 
represent people presenting with different types of CP. Large-scale epidemiological 
research is needed to quantify the extent of this distressing problem and to take 
account of the diversity of chronically painful conditions.
Three UK studies were included in the review (Veerhak et al., 1998). The first was a 
telephone survey of 2942 people of all ages in Great Britain (Bowsher et al., 1991). 
CP was defined as ‘pain which has lasted on and off for longer than the last three 
months’, allowing for the inclusion of recurrent pain. Taking into account location, 
temporal characteristics and social disability, the estimated prevalence was 7%. Pain 
was attributed to ‘arthritis’ (44%), ‘illness’ (8%), ‘injury’ (7%), ‘heart’ (6%) and 
‘surgery’ (4%). Pain was found to be most frequent in women of lower socio­
economic status and the bulk of people complained of musculoskeletal or articular 
disease, that is, pertaining to the joint. Although no significant differences in socio­
economic class were found for the prevalence of arthritis/ rheumatism, it was found to 
be significantly less common in the south of England (Greater London, south-east and
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south-west). The most common sites of pain were neck/back/spine, followed by, 
lower limb, upper limb, abdomen, chest and hips, and finally the head.
The second study was a postal survey of the registered population of two general 
practices in England of 1340 people between 18 and 85 years-of-age (Croft et al., 
1993). Pain was defined as ‘a report of any pain during the past month which has 
lasted for longer than 24 hours’. CP was defined as ‘pain as defined above, which 
started more than three months ago’. Widespread pain was defined as ‘along the axial 
skeleton (the skull and vertebral column) and in two contralateral quadrants of the 
body’. Finally, chronic widespread pain was defined as ‘widespread pain >3 months’. 
The prevalence of pain was 56%, widespread pain 16% and chronic widespread pain 
was 13%. Chronic widespread pain increased with age and was more common in 
women and a positive association was also found with somatic symptoms, tiredness 
and affective symptoms.
The third study by Potter and Jones (1992) was carried out with eight general 
practitioners for 10 months in England with people between the ages of 18 and 65. 
Pain was defined as a ‘new episode of musculoskeletal pain of 4 weeks’ duration’, CP 
as ‘still pain after 26 weeks’, otherwise ‘acute pain’. Taking into account the intensity 
and sensory/affective/evaluative aspects of pain and coping, they found 20 patients 
with CP, 25 with acute pain and three with pain but no follow up data. People with 
CP reported more intense pain than those with acute pain and more depressive 
symptoms were found amongst people with CP in addition to a greater use of passive 
coping strategies. This study is of limited value when considering the broad range of 
pain conditions across diagnostic groups, since only musculoskeletal conditions are 
investigated.
In a World Health Organisation Study in Primary Care on persistent pain and well­
being, Gureje and colleagues assessed the prevalence of persistent pain across 15 
different centres world-wide (Gureje et al., 1998). Pain was defined as 'pain present 
most of the time for a period of 6 months or more during the prior year'. They also 
assessed psychological illness, disability and activity limitation days in the previous 
month. Across the centres, persistent pain was found to be significantly more 
common among women than men, although in the UK sample taken from
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Manchester, England, 26% of men and 18% of women complained of persistent pain, 
giving an overall percentage of 21%. It was also found that back pain (BP), headache 
and joint pain were the three most commonly reported anatomical pain sites. This 
was followed by arm or leg pain, chest pain, abdominal pain and elsewhere. A large 
number of primary care patients also reported pain in at least two anatomical sites. In 
the UK sample, a relationship was found between depressive or anxiety disorder and 
persistent pain, rating health as fair to poor, work interference and three or more 
activity limitation days in the previous month.
Elliott and colleagues carried out a study to quantify and describe the distribution and 
prevalence of CP in the community (Elliott et al., 1999). A sample of 5036 patients 
was selected from 29 general practices and surveyed by postal self-completion 
questionnaire. As described above, CP was defined as ‘pain or discomfort, that 
persisted continuously or intermittently for longer than three months’. The estimated 
prevalence of CP in the general population was 46.5% (95% Cl 44.8-48.2). The most 
common complaints were BP and arthritis, which accounted for a third of all reported 
causes. In a subsequent study, Elliott and colleagues (2002) examined the course of 
CP in the community in a 4-year follow-up study in the Grampian region of Scotland. 
Participants were asked questions about whether they had CP, in addition to questions 
about severity, site, duration, and health care use. All participants gave socio­
demographic details and completed the chronic pain grade questionnaire and the SF- 
36. A response rate of 83.0% was achieved with 1608 returned questionnaires. The 
results indicate that there was no significant difference between the proportion of men 
and women reporting CP, in contrast to findings of previous studies (see above). The 
proportion reporting CP increased with age at both baseline and follow-up and the 
overall prevalence of pain increased over the 4-year period. The increase in 
prevalence was larger amongst women than men and for the youngest age group. Of 
those without pain at baseline, 33.3% had pain at follow up (annual incidence of 
8.3%). Of those with pain at baseline, 21.5% no longer had pain (annual recovery rate 
5.4%). When examining predictors of onset and recovery from CP, amongst those 
without CP at baseline, those with poorest physical and social functioning and more 
bodily pain (assessed by the SF-36) were most likely to develop CP in the next four 
years. Retired individuals at baseline were less likely than employed people to 
develop CP and individuals who had more bodily pain and poorer general health at
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baseline were least likely to recover. Furthermore, those aged between 45-74 at 
baseline were less likely to recover than the youngest people with CP. Generally, CP 
severity was found to be relatively static, that is, remain the same or change by one 
grade. Overall, health factors were better predictors of pain onset and recovery than 
socio-demographic factors. The authors conclude that pain is common and persistent, 
has high incidence, low recovery rates and its severity is relatively static over time.
In a systematic review on the prevalence of CP (Ospina and Harstall, 2003), each 
study was weighted according to its sample size to enable a single estimate of 
prevalence to be estimated. The prevalence rates varied widely according to how CP 
was defined, which population was being studied and the methods of data collection 
used. Of the 13 studies published between 1991 and 2002, 3 were carried out in the 
UK. The minimum criterion for defining CP was between three months and six 
months depending on the study. The weighted mean prevalence was 35.5%, with 
estimates ranging from 11.5% to 55.2% and for females it was 39.6% (range 13.4- 
55.5%) and for males it was 31.0% (range 9.1-54.9%). Although severity of pain was 
defined in quite different ways across the studies, the prevalence of severe CP in the 
general adult population was estimated to be 11%. Prevalence estimates ranged from 
10.1% to 55.2% and high prevalence rates among females were consistently reported. 
Given the variations observed in the data, including the use of different definitions 
and methods, the need for the conduction of concurrent, prospective epidemiological 
studies to estimate CP prevalence using clear, standardised case definitions and 
reliable and well-validated data collection tools, including QoL is recommended.
These studies illustrate the considerable variation in estimates of prevalence of CP in 
the community and diversity of diagnostic groups that constitute it, largely due to 
differing definitions and inclusion criteria, range of diagnoses included and the 
different methods determining prevalence. Consequently, elucidating the prevalence 
of the different types of pain as a proportion of all those presenting with CP is 
problematic. For many CP conditions, the pain is of unknown aetiology, and there is 
no apparent organic pathophysiological basis for its existence, which raises problems 
with accurate classification, particularly for patients reporting LBP, when there is no 
evidence of radiographic findings (van Tulder et al., 1997). Overall, prevalence of CP 
ranged from 10-20%, although some studies reported higher estimates. In general,
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there is agreement that the prevalence and consequent burden of musculoskeletal 
conditions is amongst the highest, in particular, pain pertaining to the bones and 
joints, such as back and neck pain and osteoarthritis. In general, prevalence rates 
were highest amongst women of lower socio-demographic status and increased with 
age. However, Elliott and colleagues (2002) found health to be a better predictor than 
socio-demographic status and comparable prevalence rates for men and women, 
although larger increases in prevalence were found for women over time. In contrast, 
the WHO study found that fewer females than males complained of chronic pain in 
their UK sample (Gureje et al., 1998). Many studies found co-morbidity, particularly 
with depressive symptomatology (Veerhak et al., 1998), which concurs with the 
strong association between pain and depression found amongst primary care patients 
(VonKorff and Simon, 1996). Taken together, these studies highlight the extent of the 
problem of pain in society, which necessitates further understanding of this complex, 
variable and prevalent experience.
1.3 Theories and models of pain
Having discussed definitions and prevalence CP, theoretical approaches to 
understanding pain are considered, before going on to discuss the importance of 
assessing its impact. There has been a proliferation of theories attempting to 
understand pain in recent decades and they reflect different levels of understanding, 
from biological theories explaining nociceptive processes to theories relating to higher 
order processes and outcomes such as QoL. The Gate Control Theory (Melzack & 
Wall, 1965) has revolutionised the understanding of pain with its acknowledgment 
and elucidation of the role of psychological processes, including descending control 
mechanisms (Melzack, 1982). Numerous theories have attempted to explain the 
aetiology, experience of and maintenance and treatment of CP and it is widely 
acknowledged by contemporary theories that pain is a multidimensional experience 
(Melzack, 2001; Martelli et al, 2004; Nicholson and Martelli, 2004). Consequently, 
any attempt to dichotomise pain into ‘physical’ and ‘psychogenic’ is not possible 
given that pain represents the complex interplay between numerous physical, 
psychological, social and cultural factors (Frischenschlager and Pucher, 2002). 
Models and theoretical approaches can be contrasted by whether they are broad 
conceptualisations, for example the biopsychosocial model, or derived specifically as
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a framework for the treatment and management of pain, for example cognitive 
behavioural approaches.
1.3.1 Biomedical model
The biomedical model conceptualises pain as a physical problem that arises from 
underlying disease processes or pathology, which can be treated by medical 
intervention. It focuses on elucidating the biological factors generating and 
maintaining disease processes, to the exclusion of psychological, social and cultural 
factors influencing the response to pain, which have been shown to be important (e.g. 
Coste et al., 2004). It has been argued that the biomedical approach is strongly 
dualistic in its epistemology because if no organic pathology is identifiable, pain is 
assumed to be of psychogenic origin (Spiegel, 1999). A study has shown that 80% of 
patients had no identifiable organic basis for their BP (Deyo, 1986); conversely, many 
people reporting no pain have identifiable abnormalities such as herniated discs 
(Jensen et al., 1994). Given these issues, and despite the massive advances of 
biomedicine, in terms of understanding the complexity of the genetic, neurochemical 
and pharmacological aspects of pain and its treatment, this model is limited in its 
ability to adequately account for the influence of intrapersonal, interpersonal and 
cultural mediators of pain or the complexity of human behaviour with respect to well­
being and health. The evidence for the biopsychosocial model discussed below 
supports such a conclusion.
1.3.2 Biopsychosocial model
The biopsychosocial model extends and broadens the narrow medicalised approach of 
the biomedical model and has arguably become the dominant paradigm within the 
field of health psychology. Engel was one of the first to propose such a model (Engel, 
1959; 1977) and more recently, others have been instrumental in developing the 
model in the field of pain (Waddell, 1992; Waddell et al., 1993; Turk, 1996; Gonzales 
et al., 2000). The model accounts for the biological, psychological and social aspects 
of health and its appeal derives from its all encompassing nature and applicability to 
numerous chronic health problems. The model conceptualises the multidimensional 
CP experience by accounting for the biological features of pain, perceptual awareness 
of nociceptive sensations by the sufferer, the psychological aspects including 
cognitions and emotions and the social environment in which individuals operate. It
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has been suggested that the movement towards the biopsychosocial approach, and 
away from the biomedical one, reflects the importance of psychological and 
environmental factors in pain (Garofalo, 2000). The model can be represented 
diagrammatically by three concentric circles, where social features encompass the 
psychological and biological, which is at the core. Within the model, the role of 
psychological processes has been drawn on extensively to elucidate the aetiology, 
maintenance, treatment and prevention of pain (Linton, 1995). Although the social 
dimension of the model is in need of elaboration, the advantage of this model is that it 
contextualises the individual and helps to account for the fact that CP is not just a 
consequence of underlying tissue damage (e.g. Ferrari and Schrader, 2001). The next 
two approaches discussed, based on behavioural and cognitive-behavioural theories, 
incorporate the biopsychosocial model in their treatment approach by acknowledging 
that social, behavioural and psychological factors influencing pain and its treatment.
1.3.3 Behavioural approach
One of the central tenets of the behavioural view is that behaviours arising from the 
pain experience, such as limping, grimacing and rubbing are subject to the influence 
of conditioning (Fordyce, 1996). Consequently, if such behaviours invoke reinforcing 
consequences, these behaviours are likely to persist beyond the time of healing 
(Sanders, 1996). Although the principles of the behavioural model have been applied 
widely to the treatment of pain for several decades (Fordyce, 1973), the approach has 
been subject to much criticism, including the assumption that such pain behaviours 
are maladaptive (Turk, 1996). Fundamentally, the lack of any cognitive constructs in 
the theory and the denial that a patient’s interpretation of environmental changes may 
be important (Sharp, 2001) limits its applicability and challenges common sense 
assumptions and the views of patients. Moreover, a large body of research has 
provided convincing evidence for the role of cognitive constructs such as 
catastrophising and fear avoidance in explaining, or mediating the response to pain 
(Main and Waddell, 1991; Vlaeyen and Linton, 2000; Swinkels-Meewisse et al., 
2003). Although treatment based on modifying behaviour through environmental 
contingencies has been shown to successfully reduce ‘pain behaviours’, Sharp (2001) 
challenges the interpretation that this provides support for the model, since it is not 
possible to rule out the importance of cognitive factors. The cognitive-behavioural
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approach described below integrates such factors with the more traditional 
behavioural views.
1.3.4 Cognitive-behavioural approach
The cognitive-behavioural approach to pain is the dominant paradigm in the treatment 
and management of pain. It was bom out of the operant behavioural approach 
espoused by Fordyce, and combined with the acknowledgement of the importance and 
contribution of cognitive constructs (Sharp, 2001). From this approach, pain is 
viewed as complex and multidimensional and it is influenced by the underlying tissue 
damage, thoughts (cognitions), feelings (emotions) and behaviour (Turk and Kems, 
1983; Bradley, 1996). Its central tenets are that it is the thoughts and feelings 
associated with pain and its consequent behaviour that can be modified to bring about 
important treatment gains. Systems theory is also integrated into this approach, as a 
change in one dimension of the pain experience influences other domains (Main, 
Keefe and Rollman, 2002). Treatment based on cognitive-behavioural principles is 
widely used and a comprehensive meta-analysis has demonstrated its efficacy 
compared to waiting list controls (Morley et al., 1999). This approach has the 
potential to be integrated with QoL theory given the broad aspects of a person’s 
experience that are covered.
1.3.5 Model of the psychosocial processes and social factors implicated in the 
generation and maintenance of a chronically painful illness
The models outlined above are limited by giving only tacit acknowledgement to the 
social factors that influence the response to pain. Consequently, the model proposed 
by Skevington (1995) presents four levels of understanding and provides a framework 
within which the social aspects of CP may be better appreciated. Level 1 defines the 
individual processes affected by social influences, such as perceived bodily 
sensations. In contrast, Level 2 characterises salient interpersonal behaviours, in 
particular, that person’s relationship with significant others. Level 3 defines group 
and intergroup behaviours such as group beliefs, experience and influences, while 
Level 4 encompasses some of the higher order factors that affect socio-psychological 
processing, such as health ideology and health politics. Although reductionist, this 
model aims to understand the processes within each level and the relationships 
between levels, rather than assuming that each level can be better explained by
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looking at the level below. Consequently the strength of the model lies within its 
broad conceptualisation of CP by removing the individual from their social and 
cultural ‘black box’ and through the inclusion of higher order factors such as QoL 
(Skevington, 1995, Skevington and Mason, 2004).
These theoretical approaches and models provide a framework to conceptualise the 
complex response to living with persistent pain. Given the limitations of the 
biomedical and behavioural approach in their narrow conceptualisation of pain and 
exclusion of other important factors, the biopsychosocial model and the model 
outlined by Skevington (1995) provide the most useful framework to understand the 
multidimensional experience of pain. Such models acknowledge that pain can be 
influenced by cognitive, social and cultural factors, in addition to the extent of 
underlying pathology, which is compatible with the holistic assessment of QoL. From 
the conceptualisation of pain, we turn to the ways in which pain has been measured 
and assessed.
1.4 Assessment of pain
1.4.1 Measurement of pain and disability
There has been considerable debate about the best way to measure pain, given the 
inherent subjectivity of the experience. Despite its apparent salience or intensity, 
finding words to describe the experience can be a challenge to the sufferer, although 
this has been aided by the seminal work of Melzack and Torgerson on verbal 
descriptors or adjectives describing the experience of pain (Melzack and Torgerson, 
1971). The instruments summarised in table 1.1, illustrate commonly used measures 
of pain, its intensity, severity, quality and physical and psychological consequences. 
Such instruments reflect the complexity and diversity of approaches to measuring pain 
and its concomitants and highlight the need for multidimensional assessment.
Table 1.1 Summary of commonly used instruments used to assess pain and its consequences
Instrument Authors Purpose of instrument Qualities of pain assessed Examples or issues






Consists of a pain drawing, a 5-point Visual rating 
scale & a list of 78 pain adjectives divided into 20 
subclasses that reflect four dimensions of 
experience. These are, sensory, affective, 
evaluative & miscellaneous. Patients indicate 
which word/s best describe their pain
The discriminant validity of the 
Pain Rating Index (PRI) is 
questioned because of high 
intercorrelations between the 3 
components. Use of the total score 









15 pain adjectives, 11 sensory & four affective Well validated & used extensively 
with people with CP





Grades the severity of 
pain
Seven-item instrument grading the severity of pain 
in two dimensions, namely, intensity & disability. 
Patients are classified into five hierarchical grades: 
Grade 0 (pain free), Grade I (low disability- low 
intensity), Grade II (low disability- moderately 
limiting), & Grade IV (high disability- severely 
limiting)
Developed in the USA, but 
validated in the UK. Acceptable, 
valid & reliable for use as a postal 
questionnaire (Smith et al., 1997)
The West Haven-Yale 
Multidimensional Pain 
Inventory (WHYMPI)
Kerns et al., 
1985
Assess clinical pain 
expressing psychosocial 
variables relevant to the 
pain experience
Self-report questionnaire, derived form the 
cognitive- behavioural model. Twelve scales make 
up 3 parts of the inventory that assess the impact of 
pain on the lives of patients, the responses of others 
to communications of pain & the extent to which 
patients engage in daily activities. Yields 3 profiles; 
dysfunctional, interpersonally distressed & adaptive 
copers
Good psychometric properties 
(Mikail et al., 1993) & it also 
contains a Pain Control Scale
Tampa Scale for 
Kinesiophobia (TSK)
Kori et al., 
1990
Measures fear of 
movement, pain & injury
A 10-item scale, 4-point rating scales are used for 
whether patients agree or disagree with statements
Reliability & validity is well 
documented (Crombez et al., 1999)





Measures the frequency 
with which people use 
six pain coping strategies
Coping self-statements, ignoring pain sensations, 
reinterpreting pain sensations, diverting attention, 
praying & hoping & increasing behavioural 
activities
Extensively used & well validated 
(Keefe et al., 1992)
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Instrument Authors Purpose of instrument Qualities of pain assessed Examples or issues




Perceived level of 
disability
A 10-item disability sub-scale measuring perceived 
level of disability
Change in pain cognitions assessed 
by the SOPA is associated with 
change in physical performance in 








questionnaire for the 
assessment & evaluation 
of treatments for neck 
pain
Six composite measures can be derived, which 
assess; pain severity, functional disability, 
psychological distress, physical symptoms, health 
care utilisation & satisfaction
Reliable, valid & responsive to 





Measures pain in adults 
with Rheumatoid 
Arthritis (RA)
A 24-item self-report scale consisting of 4 
subscales; physiological, affective, sensory- 
discriminative & cognitive to account for the 
multidimensional experience of pain
Scale has high internal consistency 
with a reliability coefficient of .92. 
Subscale a ranged from .65 to .86
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1.4.2 Why assess the impact of pain on QoL?
The variety of instruments to assess pain and its consequences highlight its 
multidimensional nature. Given the complexity of pain, assessing the broader impact, 
including QoL, is becoming increasing important. Indeed, according to Niv and 
Kreitler (2001), two major factors have contributed to the increasing interest in the 
QoL of people with pain. The first is an epidemiological or socio-economic factor, 
that is, the high prevalence of pain amongst the community, the extensive use of 
health and social care by people with CP and the increasing demand for evaluating the 
effectiveness of interventions in a culture of evidenced based practice and clinical 
governance. The second factor is the emphasis on the ‘whole person’ brought about 
by an increased understanding of the mechanisms underlying the experience of pain 
(Niv and Kreitler, 2001). Indeed the emphasis on QoL represents a move from the 
biomedical to the biopsychosocial model. More generally, research has shown that 
pain has a significant negative impact on QoL (Skevington, 1998) and Becker and 
colleagues have demonstrated that QoL amongst Danish pain patients is lower than 
that of any other condition (Becker et al., 1997). Similarly, Sprangers and co-workers 
ranked QoL scores from eight data sets from over 15,000 participants and found that 
musculoskeletal conditions impacted most severely on QoL; within this category, 
osteoarthritis had the most severe impact, followed by back problems and RA 
(Sprangers et al., 2000). More recently, people with spinal, neuropathic and somatic 
pain have been shown to have a lower QoL than healthy controls (Fanciullo et al., 
2003).
Such evidence supports the need for assessing QoL in addition to the other important 
outcomes summarised in table 1.1. Within such an assessment, instrument quality, 
such as the reliability, validity and sensitivity to change is important to demonstrate 
treatment success and to show improvements in traditional outcomes (reduction in 
pain, increased functioning and so on) in addition to well-being and QoL. Key 
outcomes incorporate different levels of functioning and include higher level factors 
such as QoL, health care utilisation and lifestyle behaviour; physical factors such as 
pain, activity restrictions, functional status, mobility and ADL; aspects of mental 
health such as depression, anxiety, knowledge about pain and other identified 
correlates of pain such as catastrophising, self-efficacy, health locus of control (HLC) 
and so on. One of the challenges to pain researchers and health professionals is to
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maximise, promote and retain positive gains following interventions, given that 
improvements are often not maintained at follow-up (for example, Hopman-Rock and 
Westhoff, 2000). This has both economic implications and consequences for 
individual sufferers. Consequently, identifying the important correlates of pain allows 
for more effective targeting of interventions. A systematic review of rehabilitation for 
CLBP found that few RCT’s report on the effects on QoL or global assessments 
(Guzman et al., 2001) and given the importance of evidenced based practice, 
developing, validating and standardising such outcome measures greatly assists the 
planning, implementing and interpretation of RCT’s (Cranney et al., 1999), 
highlighting the need for such instruments to be routinely included.
To conclude this section, it has been shown that assessing QoL in people with CP is 
important due to the high prevalence of pain, an increased understanding of its impact 
coupled with a more holistic approach to health care and evidence suggesting that the 
QoL of people with pain is more compromised than that found amongst other 
conditions. Furthermore, consideration must be given to the quality of instruments 
purporting to assess outcomes and the importance of incorporating QoL assessment 
into RCT’s due to the diverse impact of CP. Table 1.2 summaries instruments that 
have been designed specifically to measure the impact on QoL of particular diseases 
or conditions where pain is a major feature, such as cancer or RA. In the section that 
follows, studies investigating the QoL of people with CP are discussed, although QoL 
is introduced and discussed in more detail in chapter two.
1.4.3 Studies assessing the QoL of people with pain
The previous section highlighted the need for assessing QoL. Numerous studies have 
examined the relationship between CP and aspects QoL, for example, perceived 
support from a social network, self-esteem, sense of internal control over health and a 
negative attitude towards illness were found to be correlates of QoL in a study of 
arthritis patients (Burkhardt, 1985). At the time of the study, each of these concepts 
required a different scale. Consequently, it has been suggested that in addition to 
assessing health status, other measures should be included to account for the influence 
of other important mediating variables to enable a comprehensive assessment to be 
obtained (Deyo, 1993). Since that time, a number of comprehensive assessments have
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been developed, for example, in the work of the WHOQOL Group (detailed in chapter 
two) in order to capture the diverse consequences of health conditions on QoL.
Burton and colleagues (1998) investigated the relationship between QoL and health 
locus of control orientation in 219 patients with CP and also found an association 
between internal locus of control and physical, emotional and social well-being, 
where patients categorised as internally orientated had a better psychological profile, 
reported less pain and less pain interference and had better coping skills than 
externally orientated patients. It is suggested that CBT interventions designed to 
change locus of control orientation could improve QoL. However, the study used a 
cross-sectional design and thus it is not possible to establish the direction of causation, 
that is, whether internal control leads to positive well-being or whether positive well­
being brings about an internally orientated locus of control. Furthermore, although 
the authors claim to show a relationship between internal life orientation and 
increased QoL, they do not actually measure QoL per se because their instrumentation 
does not include an assessment of QoL.
Investigating the frequency of CP following inguinal hernia repair and its impact on 
QoL using the SF-36, Poobalan and colleagues found that compared to controls, those 
with CP had poorer social functioning and mental health and more pain (Poobalan et 
al., 2001). However, the SF-36 assesses health status rather than QoL per se and thus 
conclusions about the impact on QoL should be made with caution. Indeed, it has 
been argued that the conclusions can be misleading when a health-status measure is 
used to assess quality of life (Bradley, 2001). This is an important point given the 
large number of studies claiming to measure QoL using health status instruments such 
as the SF-36. Additionally, more ‘precision’ is needed when using the term QoL, 
particularly if clinicians are to be clear that health status measures assess whether a 
particular intervention changes perceived health, not whether or not it improves or 
decreases QoL (Bradley, 2001).
In a pilot study exploring the impact of stressors on the QoL of people with chronic 
non-malignant pain, Gerstle, All and Wallace (2001) used Neuman’s Systems Model 
as a framework. This model is based on the concept of stress and reaction to stress.
Table 1.2 Summary of commonly used specific QoL instruments relating to pain
Instrument Authors Purpose of instrument Aspects of QoL assessed Examples
The European Organisation 
for Research & Treatment of 
Cancer core quality of life 




Evaluates the QoL of 
people taking part in 
clinical trials for cancer
Incorporates 9 multi-item scales; 5 functional 
scales (physical, role, cognitive, emotional & 
social); 3 symptom scales (fatigue, pain, & 
nausea & vomiting); & a global health & QoL 
scale. Also contains several single-item 
symptom measures
Reliable, valid measure for use in 
clinical trial outcome 
measurement for cancer 
(Niezgoda & Pater, 1993)




Measures the subjective 
well being of people 
living with a life- 
threatening illness
20-item scale measuring QoL at the end of life Can distinguish between good & 
bad days of patients attending 
oncology outpatient clinics or 
receiving palliative care (Cohen & 
Mount, 2000)
The Rheumatoid Arthritis 




Assesses the QoL of 
people with rheumatoid 
arthritis
30-item questionnaire developed simultaneous 
in the UK & The Netherlands, derived from 
patient interviews. It has a yes/ no format & 
takes around 6 minutes to complete
High internal consistency & test- 
retest reliability & is sensitive to 
discriminating between groups 
with various disease severity (de 
Zong et a l, 1997)




Assesses the global 
subjective impact of 
migraine on QoL
20-items with 3 hypothesized scales, Role 
Function-Restrictive, Role Function- 
Preventive, & Emotional Function
Reliable & valid, with scale a=.93 







disability in patients 
with osteoporosis & BP 
due to vertebral 
fractures
Five domains; quantitative indices of pain, a 
standard 20-item depression scale, 26 items 
relating to functional abilities, a scale of social 
activities, & confidence in the ability of 
prescribed osteoporosis treatment to reverse 
disability
Reliable, valid & sensitive to 
change (Helmes et a l, 1995)
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They compared QoL in terms of health and functioning and variables such as age, 
gender and so on. In a descriptive correlational research design, of 36 people with 
CP, QoL was assessed with the Ferrans and Powers QoL Index (Ferrans and Powers, 
1985). Gerstle and colleagues found a higher QoL across broad domains amongst 
older, female, employed patients and those who were receiving workman’s 
compensation. In contrast, poor QoL was associated with low income, high treatment 
costs and an absence of workman’s compensation. They also found that, in general, 
QoL was low amongst this group compared to previously reported levels from other 
studies. It is likely that the stressors associated with living in the United States are 
different from those in the United Kingdom and thus caution should be used when 
applying these findings to UK populations who typically do not pay for health care or 
necessarily received compensation, which highlights the importance of accounting for 
contextual factors and cross-cultural issues when considering the assessment of QoL.
Other studies have also investigated the QoL of people from particular diagnostic 
groups with a variety of instruments purporting to measure QoL. For example, a 
study investigating which aspects of QoL were important to people with reflex 
sympathetic dystrophy (RSD) of the arm or leg used the Sickness Impact Profile 
(SIP), the Nottingham Health Profile (NHP) and the EuroQoL-5D (EQ-5D) (Kemler 
and de Vet, 2000). Although using generic instruments with highly scoring 
dimensions provided a responsive instrument to enable clinicians to focus on aspects 
of health-related QoL (HRQoL) affected by such a condition, focusing specifically on 
HRQoL does not account for the broader life domains affected by pain and its 
consequences.
In a pilot study using a non-experimental causal-comparative design to examine the 
perception of QoL of CP patients undergoing a multidisciplinary pain-management 
treatment programme in a rural community (All et al., 2000), QoL was measured 
using the Ferrans and Powers Quality of Life Index (Ferrans and Powers, 1985). 
Although it was hypothesised that those not receiving an intervention would report a 
lower QoL, the opposite was found to be the case, although this difference was not 
statistically significant. It was concluded that there were no differences between the 
intervention and non-intervention group in terms of perceptions of QoL. However, 
the study size was small (N=36) and conclusions based on such a small sample are
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difficult to draw. Furthermore, the instrumentation may not have been sensitive 
enough to detect important changes in QoL.
Although chapter two discusses QoL in more detail, this section has highlighted the 
diversity of instruments used to assess pain and QoL. A number of caveats have also 
been shown in studies purporting to measure QoL. For example, many studies use a 
cross-sectional design, which does not allow causal relationships be elucidated. 
Moreover, a considerable diversity of measures has been employed to assess QoL, 
which makes it difficult to draw comparisons across different cultural contexts, 
communities or diagnostic groups. Other studies assess the QoL of people from 
particular diagnostic groups where pain is a major symptom rather than examining the 
features that are common across groups, which was the goal of the research reported 
in this thesis. Furthermore, conclusions are frequently drawn about QoL when health 
status instruments have been used, which is problematic because such instruments do 
not account for the breadth of influences on QoL because they are specific to health 
and, relative to the holistic, multidimensional concept of QoL, are narrowly 
conceptualised.
1.5 Conclusion
This chapter began with an introduction to the extensive literature on CP, including 
how pain is defined, its prevalence in society and theoretical models and approaches 
to understanding pain and its consequences. Furthermore, it has argued that 
investigation of its impact on QoL is necessary because of its multidimensional 
impact and because of the lack of comprehensive instrumentation. Chapter two 
introduces, defines and discusses QoL in addition to outlining the rationale, aims and 
objectives, methodology and target population of the studies that follow. This work is 
set in the context of wider health psychological research and the fields of outcome 
measurement and psychometrics. The importance of understanding how living with 
persistent pain impacts on a person’s life quality is the common thread tying this 
thesis together and the following chapters report the development of a new instrument 




2.1 Defining Quality of Life
Reaching a consensus about what QoL is and how to define it is a more daunting task 
than the apparent ease with which people seem able to talk about their QoL. Despite 
recognition that QoL covers broad life domains (Rosenburg, 1995), it has been 
suggested that there is a lack of consensus in the meaning of QoL (Helmes, 2000) and 
a lack of agreement on the definition of QoL (Skevington, 1995). There is a relative 
dearth of literature on conceptualising QoL compared to research claiming to measure 
it and there appears to be some conceptual confusion between QoL and health-related 
QoL (HRQoL), indeed the two terms are often used interchangeably. However, QoL 
covers much broader life domains than HRQoL, which focuses on those areas of life 
pertaining to health. According to LePlege and Hunt, attempts to measure HRQoL 
are improbable because of the interconnectedness of health with other aspects of life; 
something that people cannot necessarily distinguish (LePlege and Hunt, 1997). Such 
lack of consensus and the consequent diversity of outcomes purporting to measure 
QoL present a challenge because of the difficulty of making meaningful comparisons 
across studies or contexts.
Table 2.1 summarises some of the definitions that have arisen over the last 25 years. 
Welch (1994) has pointed out that the term ‘quality of life’ was first used in Index 
Medicus in 1977. The examples shown here are not exhaustive, but have been chosen 
to represent the diverse ways in which QoL has been described and defined. 
Caiman’s (1984) view incorporates the notion that a person’s expectations relate to 
their QoL, in the perceived gap between these and their actual experience. Gill and 
Feinstein’s (1994) definition encompasses broader non-health areas such as 
employment, family, friends and life circumstances and the ways in which patients 
perceive and react to aspects of life. Shin and Johnson’s (1978) definition embodies 
social comparison theory (discussed in chapter three), as illustrated by the last 
sentence where QoL results in part from the perception that one benefits from 
downward social comparison, that is, one perceives oneself positively compared to
Chapter two 22
others. However, this definition fails to account for individuals who report a good 
QoL, despite not being able to fully participate in society, which presents a challenge 
to explaining the disability paradox, where despite considerable adversity, people are 
able to enjoy a relatively good QoL (Albrecht and Devlieger, 1999). Furthermore, 
this definition appears to reflect an ethno-centric position, with its focus on ‘wants’, 
‘desires’ and ‘self actualisation’, which arguably reflect and embody western values. 
However, to its credit, it encompasses resources and participation, which can be seen 
as broad aspects of QoL. The definition offered by Celia and Tulsky (1990) and 
Lutgendorf and colleagues (1995) also includes notions of comparison with internal 
standards or ideal states in making judgements about QoL. Cohen’s (1982) focus on 
achieving life ambitions also fails to account for the disability paradox, where people 
may have such aspirations dashed by illness or disease, yet still report a good QoL. 
Such counterintuitive reports have been explained by response shift, which is 
described below (Sprangers and Schwartz, 1999).
Other definitions, such as those offered by Le Mendola and Pellegrini’s (1979), 
Spilker (1990) and Jacobson, de Groot and Samson (1995) are restricted to health and 
do not account for or encompass other domains or aspects of life that might impact on 
QoL because of their focus on illness and its consequences. Although more 
comprehensive than definitions relating to health, the definition offered by Wenger 
and colleagues (1984) emphasises functioning and satisfaction with role performance, 
which precludes a more holistic assessment. However, the strength of Spilker’s 
definition is that it explicitly acknowledges the patient as the decider or assessor of his 
or her own QoL. The emphasis of these and many other definitions is the reliance on 
the subjective perception of the individual assessing their own QoL. Although this is 
a strength of such conceptualisations, there are clearly implications for measurement 
if an individual is unable to assess their own QoL because of cognitive or 
communication difficulties.
Such varied definitions reflect the challenge to develop a comprehensive definition 
accounting for the complexity of QoL. The World Health Organisation Quality of 
Life (WHOQOL) Group have addressed such a challenge by defining QoL as ‘an 
individual's perception of their position in life, in the context of the culture and 
value systems in which they live, and in relation to their goals, expectations, 
standards and concerns. It is a broad ranging concept, affected in a complex
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way by the person's physical health, psychological state, level of independence, 
social relationships and their relationship to salient features of their 
environment’ (The WHOQOL Group, 1995). The purpose of the definition is to 
provide conceptual clarity and to provide a framework within which to conceptualise 
and measure QoL. Its strengths are its breadth, its cross-cultural applicability and the 
notion that QoL is subjectively defined rather than being based on any objective 
indicators such as wealth. Furthermore, it embodies the notion that the perception of 
QoL takes place within the context of one’s culture and in relation to others. The 
WHOQOL definition and many of the definitions discussed above share a relativist 
position where QoL is subjectively defined in relation to one’s experience. 
Comparative themes are also shared by a number of these conceptualisations, where 
perceptions of QoL arise out of comparison of oneself with others (Shin and Johnson, 
1978) or with one’s own standards (WHOQOL Group, 1995) or ideal states (Celia 
and Tulsky, 1990; Lutgendorf et al., 1995).
2.2 Models of Quality of Life
From conceptualising QoL in a definition, models have been developed as a 
framework to understand and assess QoL. Quality-adjusted life years (QALYs) were 
developed in order to include an assessment of years of life saved and QoL in making 
resource allocation decisions, hence their importance in the rationing of health care. 
There are two components; remaining life years gained from carrying out a particular 
procedure, treatment or intervention and an adjustment for the QoL of years gained 
from that procedure (Baldwin et al., 1990). Despite criticism of the use of QALYs in 
priority setting in health care on ethical grounds, Williams (1996) concludes that 
given the alternatives, it should not be discarded because of its significant role.
Lindstrom (1992) contrasts different approaches to QoL, such as the sociological 
approach of Allardt (1981) which encompasses needs and satisfaction with material 
and immaterial resources or ‘being happy’ with, for example, ‘being rich’ in terms of 
Gross National Product (GNP). However, GNP takes no account of the distribution of 
wealth in a population, forms of social assistance lower GNP but are nonetheless 
ways of improving QoL of vulnerable groups and there is evidence that an increase in 
wealth does not lead to a corresponding increase in QoL (for example, Mastekassa, 
1988) (Lindstrom, 1992). In contrast to the ‘being happy’ and ‘being rich’ views is
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Table 2.1 Author and corresponding definition of QoL
Author Definition of QoL
Shin and Johnson, 
1978
The possession of resources necessary to the satisfaction of individual 
needs, wants and desires, participation in activities enabling personal 
self-development and self-actualisation and satisfactory comparison 
between oneself and others
Le Mendola and 
Pellegrini, 1979
The individual’s achievement of a satisfactory social situation within 
the limits of perceived physical capacity
Allardt, 1981 The immaterial resources and needs of people, or people’s 
relationships to other people, society and nature (loving and being), 
and the subjective perceptions of the same
Cohen, 1982 Achieving their life ambitions
Caiman, 1984 The extent to which our hopes and ambitions are matched by 
experience
Wenger et al., 1984 A multidimensional constmct that includes a wide range of 
capabilities, limitations, symptoms, and personal psychosocial 
characteristics that describe an individuals ability to function and 
derive satisfaction from a variety of roles
Wenger et al., 1984 The individual’s perceptions of his or her functioning and well-being in 
different domains of life
Spilker, 1990 The functional effect of an illness and its consequent therapy upon a 
patient, as perceived by the patient
Celia and Tulsky, 
1990; Lutgendorf et 
al., 1995
The importance of peoples subjective perception of current ability to 
function as compared with their own internalised standards of what is 
possible or ideal
Lindstrom, 1992 The essential characteristics of life which, in the general public, is 
often interpreted as the positive values of life or the good parts of life 
or the total existence of an individual, a group or society
Gill and Femstein, 
1994
The reflection of the way that patients’ perceive and react to their 
health status and to non-medical aspects of their lives
Jacobson, de Groot 
and Samson, 1995
The individual’s subjective perception of well-being, as it relates to 
health status
Leung, 2002 A global, lasting state of being, which comprises perceived life 
satisfaction, presence of positive affect, and absence of negative affect
‘staying normal’ which is a medical view where one sits on the continuum between 
disease and health. In Lindstrom’s examination o f different approaches to QoL, it is 
shown that philosophy focuses on the ‘good life’ and values o f life; sociology on 
nonmaterial welfare and well-being, human needs and wants; an economic approach 
focuses on economic standards and resources; behavioural science on well-being and 
mental well-being; and medicine on normality and medical interventions. This clearly 
demonstrates the inherent biases associated with approaching the problem of QoL 
from particular disciplines and further reveals the complexity o f the concept that can 
be articulated and understood from numerous positions.
In contrast to the models described above a system model o f QoL has been developed, 
which can be used to guide rehabilitation and psychosocial care (Leung, 2002). The
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model attempts to address the question of how QoL perceptions are formed, and is 
based upon the Gap model of QoL (Michalos, 1980). In this model, perceived QoL 
results from the appraisal of the gap between personal aspiration and reality, and is 
mediated by comparative frames such as the past, present and future status of the 
individual and by other factors such as peer group and sociocultural norms. The 
reality itself is seen as a result of the person-environment interaction, which generates 
different feelings towards various aspects of life. It is these feelings that are said to 
mediate the appraisal of QoL domains (Veenhoven, 1997). The advantage of this 
model is its dynamic nature, which accounts for changes in perception of QoL by 
shifting of comparative frames. Such a model also reflects the definitions discussed 
above that include reference to making comparisons or the gap between ones 
expectations and reality.
Such models offer competing approaches and conceptualisations of QoL. In contrast, 
the WHOQOL model of QoL embodies its multidimensional definition in 
conceptualising and measuring broad life domains and emphasising the subjective and 
relative aspects of QoL. Furthermore, given that comparative QoL research is 
difficult because of the lack of consensus over the definition (Lindstrom, 1992), the 
WHOQOL Group overcome this limitation by providing a way of measuring QoL 
cross-culturally, which it has been shown to do successfully (Bowden and Fox- 
Rushby, 2003). The WHOQOL model also contrasts with the disease-focused 
approach to QoL which has tended to leave out the positive aspects of a person’s life, 
precluding a truly comprehensive assessment.
In general, these models illustrate that it is possible to view QoL from different 
conceptual frameworks. From the narrow pragmatic and economic focus of QALYs 
in priority setting of health care, to the competing approaches described by Lindstrom, 
where according to Allardt (1981), QoL is seen as synonymous with subjective well­
being and happiness, which is contrasted with level of living or being wealthy and 
being healthy and free from disease. Further differences are reflected in Leung’s 
system model based on the gap between expectation and actual experience, which can 
be used to guide rehabilitation and care and the multidimensional, subjective, cross- 
cultural approach of the WHOQOL Group. All of these approaches confer 
advantages depending on the purpose of measurement. In the section that follows, 
assessment of QoL is introduced and discussed.
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2.3 Assessment of QoL
Having introduced and discussed definitions and models of QoL, this section 
examines the ways in which QoL is assessed. Although QoL is a concern of health 
professionals, it has been argued that it is rarely assessed in a systematic way 
(Skevington, 1995). Despite the increased use of QoL as an outcome in clinical trials, 
it does not necessarily influence clinical decision making or short-term changes in 
health status because physicians and trial designers are more likely to rely upon more 
objective, unidimensional measures such as observable behaviour, medication intake 
or work status and so on. It has been suggested that if the use of QoL information is 
to be increased, it must be integrated in an acceptable and useful manner (Fitzpatrick 
et al., 1992). Furthermore, outcomes are unhelpful if they are unnecessarily long or 
poorly defined or they do not allow clinicians to make sensible judgements based on 
known differences between scores on QoL instruments. The scoring must be easily 
translatable or interpretable in a clinical context if it is to be used for such situations, 
as opposed to those primarily designed for large-scale survey work or audit. The 
decision to select one instrument over another involves a trade-off between brief, 
clinically useful measures and multidimensional scales covering a broad 
comprehensive spectrum of dimensions.
There are numerous methods for assessing QoL and the last decade has seen an 
explosion of instruments purporting to measure this concept. However, a study of 
QoL measures found that very few research papers claiming to measure QoL provide 
a definition for the reader and they also make conceptual errors in defining QoL 
(Velanovich, 2001). Such issues lead to difficulty in making comparisons between 
studies and different patient groups because underlying concepts are not defined or 
made explicit. The need for international standards for conducting and reporting QoL 
in clinical trials has been proposed (Bottomley et al., 2002) given the failure of 
published trials to meet good standards of reporting (Lee and Chi, 2000). Despite the 
development of Consolidated Standards of Reporting Trials (CONSORT) which is a 
standardised evaluation of the quality of methodology reporting, to improve the 
reporting of randomised controlled trials (RCT’s) and to enable readers to understand 
the way a trial has been conducted and to assess the validity of its results (Begg et al., 
1996; Moher et al., 2003), it has been suggested that these guidelines fail to address 
the issue of QoL (Bottomley et al., 2002).
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QoL instruments can measure so-called objective indicators of QoL and subjective 
aspects. It is generally argued that the latter give a more realistic impression of a 
person’s QoL because it captures the perception of the individual rather than making 
assumptions about what should be important. This has become an increasingly 
important issue since the recognition that despite considerable ill health or disability, 
people may report a remarkably good QoL (Bury, 1991). The theory of response 
shift, defined as “changes to the meaning of one’s self-evaluation of a target 
construct”, describes the adaptation to illness where a re-calibration, re-prioritisation 
and reconceptualisation of internal standards occurs, a process that involves re­
evaluating priorities, standards and values (Sprangers and Schwartz, 1999; Schwartz 
and Sprangers, 1999). This theory has been employed to explain the apparent paradox 
that QoL can be rated as good despite objectively appearing to be poor, which 
challenges what it means to have a good QoL, that is, one free from ill health. Three 
points of reference for the measurement of QoL have been proposed. That QoL 
should be assessed against previous or best ever QoL, against the value seen in others 
suffering with the same disease and with the same background characteristics, or the 
platonic view, where QoL is assessed against the ideal self or imagined position 
(Sartorius, 1987). Each of these approaches requires that individuals make 
comparisons. Such processes are embodied in many of the definitions described 
earlier
Instruments can be self-administered, that is, completed by the person the instrument 
is claiming to measure, or proxy assessed, where the assessment is completed by 
another person on behalf of the person whose QoL is being measured, usually a 
significant other (SO) or health professional. The view of the individual has become 
increasingly more central given that historically, the patient perspective was rarely 
taken account of (Lindstrom, 1992). However, proxy assessment often occurs when, 
for cognitive or physical reasons, a person is unable to complete an assessment for 
themselves. Much controversy exists around the issue of proxy assessment of QoL 
given the apparent disparity between observer and self assessed QoL (Coen, 1999). In 
a review of the role of health care providers and SO’s in evaluating the QoL of people 
with chronic disease, Sprangers and Aaronson found a tendency to underestimate 
QoL, that both SO’s and health care provider’s evaluations were comparably 
(in)accurate and that health care providers underrated pain intensity. Furthermore, 
they found that proxy ratings are more accurate when assessing more observable or
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concrete aspects and that although SO’s ratings can be more accurate if they live 
closely with the patient, the role of caregiver can bias the ratings (Sprangers and 
Aaronson, 1992). More recently, Andresen and colleagues looked at the reliability of 
proxy measurement of people with disabilities (Andresen et al., 2001). To do this, 
they compared the HRQoL of people with disabilities (PWD) to that judged by 
proxies (a total of 131 pairs). They found that the highest reliability and agreement 
was between PWD and relatives, followed by friends and then health care proxies. 
Generally, proxies tended to underestimate HRQoL and overestimate impairment. 
However, for pain, this pattern was reversed and it was underestimated. They 
conclude that caution must be applied to using proxy assessments, particularly for the 
more subjective domains such as pain. This has implications for the delivery of health 
care if health care provider assessments are inaccurate and for the distress and 
behaviour of carers if there is a disparity between ratings.
The content of QoL instruments and coverage of scales differs widely, and as with the 
lack of consensus about defining QoL discussed above, there is also little agreement 
about what should be included in QoL instruments. Despite claims to be based on the 
concerns of patients, the content of QoL instruments are not always based on the 
views of patients. For example, Hunt (1997) gives the example of the epilepsy scale, 
which contains items that do not mirror the concerns of epilepsy sufferers as 
suggested by qualitative interviews with patients (Scrambler and Hopkins, 1991). 
This further reinforces the importance of developing questionnaire items based on the 
real concerns of the group of people the instrument is being applied to. User 
involvement in the development of measures is a way of overcoming the problems 
inherent in developing relevant and appropriate outcome measures for use with 
clinical populations and the WHOQOL Group have pioneered this approach in the 
development of the WHOQOL instruments (WHOQOL Group, 1994; Skevington, 
McArthur and Somerset, 1997, see below).
Assessing QoL presents a number of challenges, for example, the inclusion of aspects 
of QoL in a form and format that means the same thing to everyone in the target 
population, developing instruments that adequately reflect each domain of QoL and 
establishing how important each domain is to different individuals (Kane, 2001). 
Such criteria can be useful in critiquing QoL instruments. Similarly, it is assumed 
that when measuring QoL, we know what and why certain variables are being
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measured, and that the assessment provides a valid indicator of an individual's QoL 
(Lancet editorial, 1995). Such assumptions have been challenged by Gill and 
Feinstein (1994), who provide evidence to suggest that out of a sample of 75 papers 
with ‘quality of life’ in their titles, only 15% included a definition of QoL, only a third 
provided a rationale for inclusion of particular instruments, and patient rated QoL was 
only obtained in 13% of cases. This implies that QoL assessment is not satisfactorily 
operationalised in studies claiming to measure it. Given the longer survival of those 
with fatal diseases, the associated side effects of therapeutic interventions and the 
increase in chronic diseases in society due to the aging population (van den Bos and 
Limburg, 1995) QoL is an increasing important outcome (Lancet editorial, 1995). 
Furthermore, a wish amongst breast cancer patients for a greater emphasis on QoL has 
been found (Goodare and Smith, 1995), demonstrating a demand from patients to 
include assessments of their QoL. Although QoL assessment has become integral to 
outcome measurement in clinical research (Muldoon et al., 1998) and is now required 
as a secondary outcome measure in all clinical trials by the US Food and Drugs 
Administration (Apolone, 2003), fewer than 5% of RCT’s between 1980 and 1997 
reported on QoL, and of those who did, a variety of instruments were used and the 
standard of method and results reporting was poor (Saunders et al., 1998).
This section has highlighted some of the important considerations in the assessment of 
QoL, including the appropriateness and interpretability of instruments, the need for 
international standards in reporting of QoL in clinical trials, the issue of subjective 
assessment and problems associated with proxy assessment. Furthermore, the 
relevance of the content of instruments to the QoL of the people being assessed, the 
challenges of assessing QoL and the increasing importance of including QoL as an 
outcome have been discussed. When selecting appropriate outcome measures, 
instruments must be appropriate, reliable, valid, responsive, precise, interpretable, 
acceptable and feasible (Fitzpatrick et al., 1998). These criteria also apply to the 
development of QoL instruments and are addressed throughout this thesis.
2.3.1 Generic and disease specific measures
There is ongoing debate about the relative merits of using generic or disease specific 
measures of QoL. Generic instruments contain broad life domains and are applicable 
to any population (see table 2.2). In contrast, specific instruments tend to focus on the 
domains or aspects of life specific to a particular condition or disease state, for
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example the EORTC, designed to measure the QoL of people with cancer undergoing 
clinical trials (Aaronson et al., 1993; Sprangers et al., 1993) (see chapter one, table 
1.2). During longitudinal studies of treatment efficacy, specific instruments tend to 
produce bigger effect sizes compared to generic instruments. This is because specific 
measures are more sensitive to the nuances of any particular condition and are 
therefore likely to be more sensitive to change when an effective intervention is 
applied. This has important implications for assessing the subtle differences between 
individuals from relatively homogeneous groups undergoing the same intervention 
and for assessing change over time for particular individuals. In contrast, generic 
instruments assess the more global effects of a condition or intervention and this is 
important too, since the effects of a condition or intervention can be broad and far- 
reaching and are rarely specific to health (LePlege and Hunt, 1997). Furthermore, 
generic instruments allow people from different diagnostic groups or cultures to be 
compared, which provides important information about the QoL of different groups, 
can inform policy decision making about setting priorities and allow cross-cultural 
comparisons to be drawn and so on. Given the need to develop disease-specific 
models to assess the QoL of particular groups and to evaluate intervention efficacy 
(Guyatt et al., 1986) it has been suggested that combining specific and general models 
would increase usability (Flanagan, 1982). Consequently, appending instruments 
assessing condition specific aspects of QoL with generic instruments would offer 
distinct advantages.
2.3.2 Generic QoL instruments
Table 2.2 summarises a selection of widely used generic instruments for the 
assessment of QoL. Although the SF-36 assesses health status rather than QoL per se 
and dominates the literature (Bowden and Fox-Rushby, 2003), studies often report its 
use in assessing QoL. Similarly, the EQ-5D is a measure of health status and has 
been applied to a range of studies in Europe. Bradley (2001) has described the EQ- 
5D as a ‘blunt instrument’, because it was unable to detect differences between people 
with different diabetes complications in the UK Prospective Diabetes Study (UKPDS 
Group, 1998). Another study has showed that the EQ-5D was limited in its ability to 
detect changes in health of people with ankylosing spondylitis (Haywood et al., 2002). 
The Quality of Well-Being Scale (QWB) is used as part of a General Health Policy 
Model to estimate QALYs and is limited because it does not include a mental health 
component. However, the validity of the QWB in people with osteoarthritis has been
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shown as it has been found to correlate with the Arthritis Impact Measurement Scale 
over 1 year (Groessl, Kaplan and Cronan, 2003). The SEIQoL and PGI are both 
respondent generated measures designed to take into account individual preferences 
by allowing individuals to indicate which aspects of their lives are important. The 
PGI is advantageous because it gives an indication of how a person’s current reality 
compares with the expectations held about the areas of life that are most important. 
However, the symptoms and functions rated can vary between patients (Ward, 2004) 
making it difficult to make comparisons. Moreover, in a recent review of patient 
generated instruments, it has been argued that despite the utility of such instruments in 
complementing traditional instruments and guiding treatment decisions, their use in 
clinical trials is questionable (Patel et al., 2003).
Generic instruments have been used widely in the CP literature, particularly in 
rheumatology (Garratt et al, 2002). However, given some of the limitations discussed 
above, developing condition specific modules would enhance the responsiveness and 
sensitivity of generic instruments, whilst still enabling comparisons to be made across 
diverse diagnostic groups. Moreover, the specific instruments discussed in chapter 
one tend to pertain to specific conditions such as rheumatoid arthritis, migraine and so 
on and do not allow for comparisons between patients from different diagnostic 
groups. An instrument with a generic core and a specific module to assess the QoL of 
people with pain from broad diagnostic groups would fill this gap. This would 
provide added value both in research and in clinical settings with heterogeneous 
patient groups presenting with CP.
Table 2.2 Generic health status and QoL instruments validated for use with CPP’s





Ware & Sherboume, 
1992
Generic health status measure 
developed in the United 
States. Minor modifications 
have been used to adapt the 
instrument to a UK context 
(Jenkinson et al., 1999)
Measurement of subjective health status across 8 
domains; physical functioning (10 items), social 
functioning (2 items), role limitations due to 
physical problems (4 items), role limitations due 
to emotional problems (3 items), mental health (5 
items), energy/vitality (4 items), pain (2 items), 
general health perception (5 items) & another item 
asking about health change over the last year
Rheumatoid arthritis 
(Kosinski et al., 2002)
EuroQol (EQ-5D) Developed by an 
international 
multidisciplinary group 
since 1987 (Rabin & de 
Charro, 2001)
Health status Five dimensions; mobility, self-care, usual 
activity, pain/ discomfort & anxiety depression, 
which are divided into three levels; no problem, 
some problem & extreme problem, generating a 
single numeric index of health status
Complex regional pain 
syndrome type I 
(Kemler & deVet, 2000; 
Forouzanfar et al., 
2004); CLBP (Seitz et 
a l, 2001)
The Quality of 
Well-Being Scale 
(QWB)
Kaplan et al., 1998 Used as part of a General 
Health policy Model to 
estimate QALYs
Functional components, including mobility, 
physical activity & social activity & a list of 
symptoms & problems. The QWB places the 
individual on a continuum of wellness from dead 
(0) to asymptomatic (1.0) The QWB does not 
include a mental health component
Osteoarthritis (Groessl, 
Kaplan & Cronan, 
2003); Fibromyalgia 
(Kaplan, Schmidt & 
Cronan, 2000)
The Schedule for 
the Evaluation of 
Individual Quality 
of Life (SEIQoL)
McGee et al., 1991 Respondent generated 
measure of QoL
Measure patients' level of functioning in five self­
nominated facets of life & the relative weight or 
importance attached to these areas
Patients undergoing hip 
replacement (O’Boyle 
et a l, 1992)
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Ruta et al., 1994 Respondent generated 
instrument designed to 
measure HRQoL for postal & 
interview administration
List the five most important areas of life affected 
by the condition. Mark on a VAS how badly 
these areas are affected, from 0 (worst) to 100 
(best). Rate how much other aspects of life are 
affected by their condition. Imagine that they can 
improve these areas with a number of points, 
which they allocate to each area depending on 
their priorities. The index gives an indication of 
how current reality compares with the 
expectations held about important areas of life
Low back pain (Ruta et 
al., 1994); elderly 
people with arthritis 
(Tully & Cantrill, 2002)
Ferrans & Powers 
Quality of Life 
Index
Ferrans & Powers, 1985 QoL in healthy & sick 
populations
Satisfaction with & perceived importance of 
different domains of life, including, health care, 
relationships & family, employment, leisure, faith 
& life goals. There are 64 self-report items 
arranged with 6-point Likert scales. There are 
also subscales addressing health & functioning, 
socio-economic, psychological, spiritual & family 
factors




2.4 Review of development and validation of the WHOQOL-lOO
Having introduced and discussed definitions, models and methods of assessing QoL, 
this section reports the extensive literature on the development and validation of the 
WHOQOL instruments. Since 1991,15 collaborating countries worldwide have taken 
part in the development and piloting of the WHOQOL pilot form (The WHOQOL 
group, 1998). The WHOQOL-lOO is a generic, multilingual instrument for the 
assessment of QoL in adults. It contains 100 core items (and 2 additional national 
items) represented by 25 facets and six domains of QoL; physical, psychological, 
level of independence, social relationships, environment and spirituality, religion and 
personal beliefs (SRPB). In addition to the 102 items, there are 26 importance items 
relating to the facets of the WHOQOL that can be appended to the core instrument 
and these can be applied concurrently. To be considered important, facets must have 
a mean importance rating of 3.0 on a 5-point Likert scale (Skevington, MacArthur and 
Somerset, 1997). Subsequently, an abbreviated form, the WHOQOL-Bref has been 
derived from the WHOQOL-lOO, which contains 26 items; one per facet and one that 
asks about general QoL (see below) (The WHOQOL group, 1998). The WHOQOL 
was designed to assess subjective aspects of QoL and it was proposed to be used with 
four groups of individuals; those suffering with disease, health professionals and 
carers, those living in stressful situations and those unable to communicate their 
feelings (Orley and Kuyken, 1994).
At the core of the WHO project was that the instrument would be used in different 
cultural settings worldwide and that operational equivalence would be achieved, 
which refers to cross-culturally comparable reliability, validity and responsiveness 
(The WHOQOL Group, 1994). A position paper from the WHOQOL Group 
described the project to develop the WHOQOL instrument (WHOQOL Group, 1995). 
One major goal was to allow for the assessment of QoL cross-culturally by 
collaborating with different cultural centres. Another was to determine the extent to 
which the impact of disease on QoL is mediated by social and cultural factors. It was 
recognised that translating existing QoL instruments from one language to another 
was problematic given the lack of conceptual and semantic equivalence between 
language and cultures. The method involves simultaneous development in different 
cultures (The WHOQOL Group, 1994; Bullinger, 1994) and is known as spoke wheel 
methodology where the items were generated simultaneously in the collaborating 
centres and then fed back to the centre in Geneva. The methodology is characterised
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by its translation method of forward and back translation to achieve conceptual, 
semantic and technical equivalence in different language versions. Field centres 
based in cultures with different levels of industrialisation, health service availability 
and other relevant factors were selected. In a review of generic QoL measures, 
Bowden and Fox Rushby (2003) evaluated the WHOQOL and some of the other 
generic instruments discussed above, according to conceptual, item, semantic, 
operational, measurement and functional equivalence cross-culturally, with a 
particular focus on translating and adapting such measures. The WHOQOL was 
found to have evaluated equivalence most rigorously, although it is suggested that 
further testing is needed because of the imposed definition of health and that an index 
is not calculated in the scoring.
The development of the WHOQOL was based on the execution of several stages 
(WHOQOL Group, 1994), concept clarification, qualitative pilot, development of the 
pilot instrument and field-testing. Concept clarification was achieved by international 
expert review, which created a QoL definition and a protocol for the study. The 
qualitative pilot determined the domains and facets of QoL, drafted and selected items 
to create a global item pool and generated response scales. This was achieved 
through expert review, focus groups (FG’s), and expert and lay item writing panels. 
Views of patients and health professionals are represented in the development of the 
WHOQOL, and FG’s were conducted with sick and well people to generate the 
important facets of QoL and the items for the instrument (Skevington, MacArthur and 
Somerset, 1997). Although the items in the instrument are culturally specific, cross- 
cultural comparisons are possible.
The pilot test reported by the WHOQOL Group describes the international 
development and psychometric properties of the WHOQOL (The WHOQOL Group, 
1998). The aims were to look at the construct validity of the WHOQOL domain and 
facet structure, select the best items to produce a version to be used in the field trials 
and to establish its psychometric properties. The 15 participating centres were each 
requested to administer the instrument to a minimum of 300 participants (250 health 
care users and 50 healthy respondents). The pilot instrument consisted of 236 items, 
covering six domains and 29 facets, approximately 8 items per facet. Other items 
were also included addressing overall QoL and health perceptions and there were 41 
importance items. The total number of participants across the centres was 4802.
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Correlations between perceived objective and self-report subjective QoL were at 
r>0.8 which led to the distinction between these two levels being dropped in the field 
trial. Five of the 29 facets were dropped; activities as provider/ supporter, sensory 
functions, dependence on non-medicinal substances, communication capacity and 
work satisfaction, leaving 24 facets. Four items per facet were selected because four 
is the minimum required for scale reliability analyses (Kline, 1983). At this point, the 
field trial became known as the WHOQOL-100 and facets were calculated by 
summing the item scores, therefore ranging from 4 -20. Using Cronbach’s alpha (a), 
the internal consistency was shown to be good, ranging from 0.65 (physical 
environment) to 0.93 (working capacity). Higher scores represent higher QoL and 
consequently, where it is not possible to phrase an item in a positive way (for 
example, items relating to pain and discomfort, negative feelings and dependence on 
medication), the scoring for that item is reversed.
The results suggested that contrary to expectation, it was possible to develop an 
instrument with the same facet and domain structure for each of the 15 centres taking 
part in the field trial. A number of the centres had additional ‘national items’ (see 
below), which were found not to perform any better than the core items. Following 
exploratory factor analysis, a four-factor structure was yielded, consisting of the 
physical, environment, psychological and social relationships domains. Confirmatory 
factor analysis confirmed that the four-factor structure was a better fit than either a 
six-domain or single domain structure (The WHOQOL group, 1998).
In contrast to the international development described above, Skevington, MacArthur 
and Somerset (1997) investigated contemporary beliefs about QoL in Britain as part 
of the process of developing items for the WHOQOL. Their three aims were; to 
investigate whether the proposed facets were relevant to people in Britain, to see if 
there were any areas that were not covered by the proposed facets, that is, that were 
specific to people in Britain and thirdly to ascertain the importance of the core facets. 
To do this, 7 focus groups were conducted with 46 individuals. The groups discussed 
the proposed facets and definitions, which were provided in a manual. The group 
were then invited to generate items for each of the facets, rate the importance of each 
of the facets on 5-point Likert scales and add anything else that had not been covered. 
The groups were found largely to confirm the relevance of the proposed facets. 
Although happiness was found to be most important, religion and dependence on
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substances were neither important nor unimportant, but since these two facets were 
important to subsections of the population, they were retained. Omissions were 
identified in four areas; need for the intimacy of loving relationships, job security and 
fear of losing employment, fears of bereavement or the loss of loved ones and 
concerns about the environment.
In a paper introducing the UK WHOQOL, Skevington presents the psychometric 
properties of the instrument (Skevington, 1999). A total of 320 sick and well people 
completed the WHOQOL. The best predictor of QoL in Britain was found to be the 
presence or absence of positive feelings. This was improved with the addition of 
information about mobility and energy. The scores were found to discriminate well 
between sick and well people and the instrument showed excellent internal 
consistency reliability (a=.97). In a subsequent study, Skevington and colleagues 
examined the properties of the national items to be appended to the WHOQOL, using 
data from 3740 participants from 10 of the WHOQOL centres (Skevington, Bradshaw 
and Saxena, 1999). Five statistical criteria were applied to 144 national items; 
hierarchical multiple regression analysis, item-national facet correlations, item-facet 
and item-total correlations, Cronbach’s a, hierarchical cluster analysis and 
multidimensional scaling. Multidimensional scaling and cluster analysis allowed an 
examination of the structural relationship of the national items within their own facet. 
This led to the selection of 29% or 40 of the national items, including ‘How fed up do 
you feel?’ and ‘To what extent are you satisfied with your level of happiness?’ in the 
UK.
Skevington and Tucker report on the development of response scales designed in the 
UK for use with the UK WHOQOL (Skevington and Tucker, 1999). To do this, they 
asked 20 sick and well people to assign 60 descriptions to separate 100 mm lines. 
There were 15 descriptions for each of 4 types of response scale and the anchor points 
had already been agreed as internationally meaningful by the WHOQOL. Means and 
standard deviations were calculated for each label at the 25%, 50% and 75% interval 
and those with the closest means and smallest standard deviations were selected. The 
study resulted in a set of 5-point interval response scales relating to how much, how 
completely, how satisfied, happy or good and how often a person has experienced an 
aspect of QoL, where 1 represents poor QoL and 5 good QoL.
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Since the development of the WHOQOL instruments, extensive validation work has 
been conducted in diverse patient groups, confirming the broad applicability of the 
core generic instruments to a range of health conditions. For example, the 
relationship between pain and discomfort and QoL was investigated by Skevington, 
using the WHOQOL-100 (Skevington, 1998). A total of 320 well people and people 
from different diagnostic groups completed the 276 item WHOQOL (29 facets, 
grouped under 6 domains). Pain and discomfort was found to make a significant 
impact on perceptions of general QoL related to health. The presence of pain affected 
five domains of QoL, but did not affect SRPB. Negative feelings were most closely 
associated with reports of pain than any other facet of QoL. QoL relating to pain was 
better explained by the addition of six other facets. These were; the availability of 
social care, mobility, ADL, positive mood, less relevant, but nonetheless important 
were; sleep and dependence on medication. Other findings include; those without 
pain reported significantly better QoL than those with pain, pain of a longer duration 
is associated with poorer QoL, intense affective pain has an adverse effect on QoL. 
The pain and discomfort facet was found to have good internal consistency, 
discriminant and criterion/ concurrent validity.
In another study, Skevington, Carse and Williams (2001) examined the impact of a 
pain management programme (PMP) on the QoL of CP patients. The QoL of 106 CP 
patients was assessed before and one month after taking part in a PMP with the 
WHOQOL-100. The MOS SF-36, the Beck Depression Inventory and measures of 
pain intensity, duration, disruption and distress were also applied concurrently. 
Following the PMP, QoL improved generally and in the physical, psychological and 
independence domains and in ten facets of QoL, including pain and discomfort. Low 
levels of pain distress, severity and disruption were associated with good QoL, where 
each domain was significantly negatively correlated with pain severity, pain and 
distress, disrupted activities and Beck Depression Inventory (BDI) scores at <0.01, 
with the exception of SRPB. The WHOQOL demonstrated good psychometric 
properties, although the internal consistency reliability was marginal for the pain and 
discomfort facet (a =.67). The study shows that for chronic pain patients (CPP’s) 
taking part in a PMP, QoL is improved on several dimensions and that the 
WHOQOL-100 is a valid and reliable tool for use with CPP’s. However, the authors 
suggest that the inclusion of more items pertaining to CP would improve its
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sensitivity to clinical change and would also allow for the exploration of more aspects 
of QoL within the framework of the WHOQOL.
Given the generic nature of the core instrument, it was proposed that add-on modules 
would be developed for assessing the QoL of people with particular diseases (The 
WHOQOL Group, 1994). Of the five priority areas, persons suffering from chronic 
diseases are the first and CP fits this category. The protocol for developing these 
modules is outlined in a WHO study protocol (WHO, 1993). However, although the 
protocol states that modules must be developed simultaneously in at least three 
culturally diverse centres, at the time of commencing the present study it was not 
possible to obtain funding to achieve this, or to find at least two other centres world­
wide with sufficient interest in CP and QoL to conduct such a study. However, this 
does not preclude such a study in the future. This thesis describes the development of 
a pain and discomfort module (PDM), in order for it to be more sensitive to the needs 
and issues pertinent to people with CP
2.4.1 Review of the development and validation of the WHOQOL-Bref
In 1998, the WHOQOL Group described the derivation of the WHOQOL Bref, an 
abbreviated version of the WHOQOL-100 (The WHOQOL Group, 1998). The Bref 
is scored in four domains and includes a facet on overall QoL and health. The Bref 
consists of 26 items that were selected from the WHOQOL-100 on the basis of those 
items that correlated most highly with the mean of all facets. The domain scores of 
the Bref were found to correlate highly with the domains scores of the WHOQOL- 
100. The Bref show good discriminant validity (significant differences between ill 
and well people in all domains), internal consistency (domain a ranged from 0.66 to 
0.84) and test-retest reliability (domain correlations between time 1 and 2 ranged from 
0.66 to 0.87). The Bref is advantageous when quick assessments of QoL are required, 
for example when evaluating the impact of treatment on QoL. In a study of the 
importance of WHOQOL Bref items for cross-cultural research, data from 4804 
respondents from 15 centres world-wide was examined (Saxena et al., 2001). All 
items representing the 24 facets had a mean rating of between 3.29 and 4.29, 
suggesting that they were all considered to be at least moderately important. The 
results also suggest that no single domain was seen to be more important than any 
other, rather different aspects or facets of the domains were. Gender differences were 
observed, where women rated the majority of items as more important than men, with
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the exception o f sexual life. Differences were also found between younger and older 
adults, where younger adults rated more items as more important to them than older 
adults. In general, the results reaffirm the importance o f the 24 facets o f QoL selected 
to be applicable cross-culturally.
2.4.2 Domain and facet structure of the core WHOQOL
Table 2.3 lists the domains and facets o f QoL covered by the WHOQOL assessment. 
As described above, the WHOQOL inquires into six broad domains and 24 specific 
facets o f  QoL. Four items address each facet, including a facet enquiring into overall 
QoL and general health.
Table 2.3 Core WHOQOL facets and dom ains
Overall quality of life and general health_______________
Domain I - Physical_______________________________
1. Pain and discomfort_____________________________
2. Energy and fatigue______________________________
3. Sleep and rest__________________________________
Domain II -  Psychological domain___________________
4. Positive feelings________________________________
5. Thinking, learning, memory and concentration_______
6. Self-esteem____________________________________
7. Bodily image and appearance_____________________
8. Negative feelings_______________________________
Domain III -  Level of independence_________________
9. Mobility______________________________________
10. Activities of daily living_________________________
11. Dependence on medication or treatments____________
12. Working capacity_______________________________




Domain V - Environment___________________________
16. Physical safety and security_______________________
17. Home environment______________________________
18. Financial resources______________________________
19. Health and social care: availability and quality_______
20. Opportunities for acquiring new information or skills
21. Participating in and opportunities for recreation/ leisure
22. Physical environment (pollution/ noise/ traffic/ climate)
23. Transport______________________
Domain VI -  Spirituality/ religion/ personal beliefs_____
24. Spirituality/ religion/ personal beliefs
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2.5 Rationale
The extensive literature on CP and QoL has been introduced in the first two chapters 
to provide a context within which to illustrate why this research was timely. The 
prominence of CP derives from its increasing prevalence, its consequent economic 
burden and the inability of traditional biomedicine to adequately manage it without 
the aid of psychology and related disciplines. Elucidating, understanding and 
measuring its impact on QoL become central because of the persistence of pain. 
Moreover, given the complexity of understanding pain and its management, assessing 
its impact goes far beyond pain severity or intensity alone, hence the need to measure 
the broader sequelae, within the context of a culture of evidenced based health care. 
Given the heterogeneous diagnostic groups that experience pain as a major symptom, 
the need for assessments that are reliable, valid and able to discriminate between these 
groups are warranted to enable comparisons to be made across time and in different 
contexts.
2.6 Aims and objectives
■ To develop a new module (set of specific items [questions]) to be added to the 
WHOQOL-100 that elaborates the experience of CP.
■ To develop an instrument that is acceptable and applicable to the main CP groups, 
regardless of clinical condition using WHOQOL methodology with the addition of 
innovative methods and techniques.
■ To explore the relationship between the new PDM and the core facets and 
domains of QoL measured.
■ To determine whether the new PDM is reliable, valid and sensitive to changes in 
clinical condition.
■ To make a preliminary assessment of the QoL of people with CP.
■ To propose ways of incorporating the WHOQOL and the PDM into the 
management of pain, as an outcome measure and as part of large scale survey 
work and studies designed to measure the efficacy of interventions designed to 
decrease pain and increase functioning and well-being.
2.7 Methodology
Following the WHOQOL procedure, there are three key methodological stages to the 
development of the module, which are outlined below and summarised in table 2.4.
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2.7.1 Stage one - qualitative studies
The aim of the first stage is to identify facets of QoL and to develop items pertaining 
to these facets in the vernacular, which are most salient for all major CP groups. The 
FG’s will consist of individuals from one of three categories, health professionals, 
informal carers and people with CP from different diagnostic groups. Items raised in 
the FG’s will be pooled and assessed to derive a set of items asking about the new 
aspects of QoL identified by the FG participants. Concurrently, results from a web 
survey will provide validation for these new facets by ensuring that the results from 
the FG’s are not idiosyncratic to the participating patients.
2.7.2 Stage two - cross-sectional quantitative development
The PDM will be administered with the WHOQOL-100 in a pre-pilot study using the 
technique of cognitive interviewing, a cognitive aspect of survey methodology 
(CASM). The WHOQOL-100 and a selection of items will then be administered to a 
representative sample of CP patients from a range of diagnostic groups in a cross- 
sectional survey to enable the relationship between the new module and core facets to 
be examined. During analysis, the items in the PDM will be reduced in number using 
traditional psychometric procedures. Following an examination of the psychometric 
properties of the pilot data, a small number of items will be selected from the item- 
pool to form the PDM, which can be used in conjunction with the WHOQOL-100.
2.7.3 Stage three - longitudinal quantitative study
The final stage will be a field test to determine how the WHOQOL and PDM behave 
when applied to a clinical population. This will be a longitudinal study over a period 
of 4 weeks, assessing the QoL of patient with chronic low back pain (CLBP) 
undergoing a lumbar epidural steroid injection. Other instruments will be completed 
concurrently, to test the validity of the PDM. Analysis of the data will elucidate the 
psychometric properties of the PDM and determine whether the measure is sensitive 
to changes in clinical condition. Concurrently, test-retest reliability will be examined 
in a population not undergoing treatment over a 2-week period.
2.7.4 Ethical issues
Ethical approval for the entire study was granted from the Bath Local Research Ethics 
Committee and from the Swindon Local Research Ethics Committee, through their 
reciprocal agreement with Bath.
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2.7.5 Participating centres
All the work reported in this thesis was conducted from the UK Field Centre for the 
study of Quality of Life in Bath. Patients from the following places took part; Royal 
United Hospital (RUH) (Pain Clinic, orthopaedics, maxillo-facial surgery, genito­
urinary medicine, physiotherapy and gynaecology); Royal National Hospital for 
Rheumatic Diseases (Rheumatology); Salisbury District General Hospital; Combe 
Down General Practice Surgery; Box General Practice Surgery; The Wiltshire Back 
Pain Network; Pain Concern, East Lothian (registered pain charity); Local Support 
Groups (Fibromyalgia and Positive Living - former patients of the Pain Management 
Programme at the RUH).
2.7.6 Target population
The goal of this research was to represent all CP groups to ensure that the results can 
be said to apply to people from across diagnostic categories. However, a clear 
distinction is made between chronic benign pain, such as pain deriving from the 
lumbar spine or from osteoarthritis and pain experienced as a result of malignant 
conditions such as some cancers. This distinction is made because of the different 
psychosocial consequences of having a life limiting versus a life threatening disease 
or condition. Furthermore, those working in the field of cancer have worked hard to 
develop generic and specific instruments to assess its impact and aid in the reduction 
of pain and suffering (for example, the EORTC). The main focus is adults over the 
age of 18 who have pain persisting continuously or intermittently for longer than three 
months. Participants will have a good literacy level and language ability, with 
English as the first language (with the exception of the web survey). The presence of 
other illness that might impact on QoL such as depression or another medical 
condition will be noted, however it is unrealistic to exclude such people since some 
co-morbidity is inevitable. Developing an instrument for too specific a population 
will limit its use and thus the aim is to focus on conditions where pain is the major 
symptom to ensure that the instrument will be applicable to all patient groups with 
CP.
Table 2.4 Summary of stages in the development of the pain and discomfort module
Stage Method Products Objectives
Conceptual and 
methodological work
Review of the literature and history of 
the work of the WHOQOL Group
Development of protocol based on the 
work of WHOQOL Group
Establishing a need for a pain specific module to 
increase specificity and sensitivity
Empirical I: 
Qualitative pilot
Focus groups (11 groups, N=59) 10 new facets pertaining to pain and 
discomfort
To elucidate the impact of pain on QoL and 
identifying new facets of QoL through systematic 
qualitative analysis of focus group transcripts
Empirical II: Web 
survey
Technology based survey using the 
Internet (N-234). A combination of 
quantitative descriptive analysis and 
qualitative analysis
International data set providing 
confirmation of the 10 new facets 
identified by the FG’s
To gather data on how pain effects QoL from an 
international, geographically dispersed sample by 
allowing people with pain to express their views 
about how pain impacts on their QoL
Consolidation: 
Definition and item 
construction
Definitions and items constructed for 
each of the new facets
Multidimensional definitions and 
items to represent the facets of QoL
To explore and conceptualise the facets relating to 
pain related QoL and to write items based on 
contextual material from the FG’s
Questionnaire
development
Construction of the pilot PDM The pilot PDM consisting of 108 
items attached to appropriate 
response scales and arranged in 
response scale blocks
To form the PDM by putting the items together, 
attaching response scales and arranging in a 
suitable format in preparation for preliminary 
pilot work.
Empirical III: Pre-pilot 
testing and module 
refinement
Cognitive interviewing (N=9) and 
expert reading of the PDM
Modified and reduced pilot PDM 
consisting of 84 items
To reduce the number of items and to ensure that 
items are comprehensive and meaningful
Empirical IV: Field 
test I
Cross sectional survey design (N=216) Reduced number of items to 16, 
representing 4 facets of QoL relating 
to pain and discomfort
To establish the psychometric properties of the 
WHOQOL-100 with the addition of the PDM
Empirical V: Field test 
II
Longitudinal survey design (N=133), 
consisting of a trial of steroidal 
epidurals for low back pain (N=57) 
and test re-test reliability (N=30)
Further elucidation of the 
psychometric properties of the 
WHOQOL and new PDM
To establish whether the PDM is reliable, valid 





These two chapters have explored how pain has been defined, discussed studies 
estimating the prevalence of CP in the general population, introduced recent models 
of pain and reviewed the relevant literature on QoL and its assessment. The core 
objectives, methodology of the study, ethical issues, participating centres and the 
target population of the research have also been described. Lack of consensus over 
defining QoL has led to problems with, and different approaches to measurement. 
Given that relatively few attempts have been made to find a way of adequately 
measuring the impact of a chronically painful condition on the QoL of the sufferer, 
this provides the rationale for developing an instrument for the subjective assessment 
of QoL in people with CP. It highlights the importance of adequately defining the 
concepts that one purports to measure and in adopting rigorous methods for 
developing these instruments, by combining traditional and novel methodologies. 
Accurate assessments of QoL from the perspective of the patient will lead to 
improved design and implementation of interventions to improve the QoL of people 
with pain and will assist the work of health professionals who are engaged in this task.
2.9 Outline of remaining chapters
This thesis consists of two introductory chapters (one and two), five pieces of 
empirical work (three, four, six, seven and eight), one process and consolidatory 
chapter (five), a preliminary assessment of the QoL of people with CP (nine) and a 
final discussion (ten). Specifically, chapter three presents the first empirical data, 
using FG methodology to identify facets of QoL relating to pain. Chapter four 
describes a web survey that was set up to obtain a larger international data set about 
the QoL of people with CP. Chapter five outlines the process of questionnaire 
development, including definition construction and item writing. Chapter six reports 
the preliminary pilot work using cognitive interviewing. In chapter seven, the 
preliminary psychometric properties of the new module are explored through data 
derived from a cross-sectional survey of heterogeneous sample of people with CP. 
Chapter eight further explores the validity and reliability of the new module through a 
longitudinal field test and summarises its psychometric properties. Chapter nine 
presents a preliminary assessment of the QoL of people with CP. Finally, chapter ten 





The Quality of Life of People with Chronic Pain
3.1 Introduction
The previous two chapters reviewed the literature on chronic pain (CP) and quality of 
life (QoL) and presented the rationale for this research. This chapter explores the 
QoL of people with CP from a qualitative perspective. In doing this, it outlines the 
preliminary work to develop a pain and discomfort module (PDM) to be used in 
conjunction with the UK World Health Organisation Quality of Life Assessment 
(WHOQOL-100). The goal of this qualitative study was to investigate CP and its 
affect on QoL and to identify new facets of QoL pertaining to pain and discomfort.
3.1.1 Chronic pain and quality of life
Pain is one of the primary reasons for seeking help from a general practitioner 
(Schappert, 1992) and has a complex, multi-factorial aetiology, which is often 
unknown. Moreover, it has been argued that disability associated with CP is reaching 
epidemic proportions (Aronoff, 1991; Loeser, 1991). As measures of disease status 
alone are not sufficient to capture the wide impact of living with a chronic condition, 
it is therefore necessary to measure the multidimensional experience of CP by 
assessing QoL. This is important for two reasons, firstly because of the non-linear 
relationship between pain and disability (Waddell, 1987) and the erroneous 
assumption that improvements in pain or disability necessarily correlate with 
substantial improvements in QoL. Secondly, because chronic benign pain rarely 
causes death and cure is unlikely, alternative outcomes are necessary to measure the 
efficacy of treatments in meaningful and accurate way.
As discussed in chapter two, the WHOQOL-100 was designed to allow the 
development of specific modules addressing particular disease groups or conditions 
that could be appended to the core instrument (The WHOQOL Group, 1998). Focus 
groups (FG’s) were used in the development of questionnaire items for the 
WHOQOL-100 and can also be used in the development of additional modules (see
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below). It was necessary to develop a PDM because the existing pain and discomfort 
facet in the WHOQOL-100 may under-represent the impact of pain on QoL 
(Skevington, 1998; Skevington, Carse and Williams, 2001) and pain has often been 
considered in isolation from other aspects of a patient’s life. It has also been noted 
that a more holistic approach to pain is necessary (Dunn, 2000). Furthermore, 
previous measures of pain have tended to focus on the measurement of the severity or 
intensity of pain alone, for example in the widespread use of the visual analogue 
scale, despite the recognition that pain is a multidimensional phenomenon (Turk and 
Okifuji, 1999). Gaining a greater understanding about the way pain can affect a 
person’s QoL is a necessary step to bridging the gap between the needs of patients and 
the way that health care is delivered to this group, who are avid users of health care 
resources (Maniadakis and Gray, 2000).
In addition to issues around measurement, theoretically it is useful to ask what beliefs 
or psychological processes affect the decisions people make about their QoL, above 
the immediate impact of a particular health condition or adverse situation. First 
elaborated by Festinger (1954), social comparison theory holds that when people are 
under threat from health problems, the consequent uncertainty increases the need for 
information and hence the desire for comparison (Taylor et al., 1990). Festinger 
(1954) originally assumed that upward comparison would almost always occur 
because it would provide information, however Brickman and Bulman (1977) 
recognised that this failed to account for the potential stress generated for the person 
doing the comparing. Consequently, the importance of downward comparisons was 
acknowledged (Wills, 1981). Gibbons argues that when people are faced with 
significant life events, social comparison increases and that the level of social 
comparison decreases and that these cognitive alterations impact on the success of 
coping (Gibbons, 1999). Evidence suggests that the importance attributed to different 
life domains is adjusted, for example, in a study of reactions to significant negative 
health events, greater emphasis was put on mental abilities (Bulman and Wortman, 
1977). A number of correlational studies of people with CP have found a relationship 
between engaging in downward comparison and positive affect and well-being 
(Jensen and Karoly, 1992; Tennen and Affleck, 1997).
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Skevington also found that people with arthritic diseases use social comparison when 
they think about and make decisions about their QoL (Skevington, 1994). In a 
qualitative study of 6 FG’s with 31 people with rheumatological conditions, support 
was found for the use of three levels of analysis, intrapersonal, interpersonal and 
sociocultural. Intrapersonal comparison involves comparing one’s current state with a 
past or imagined future one. Interpersonal comparison occurs when people compare 
themselves upwardly, downwardly or horizontally with other individuals. 
Sociocultural comparison occurs when people compare themselves to society’s 
expectation of how they should be. Interpersonal comparisons were used most 
frequently, particularly regarding age. Downward comparisons were used more 
frequently than upward comparisons, although the consequences of these comparisons 
were mixed. Downward comparisons did not always produce a positive effect 
because the behaviour of others sometimes provided a model of how not to behave; 
similarly these comparisons could also be threatening. At the sociocultural level, the 
perception of a lack of understanding or caring about the person with chronic illness 
and a stigmatisation of the condition also impacted on QoL. Social comparison is 
important because it has been encapsulated in many of the definitions of QoL 
discussed above and provides an important theoretical contribution to the way that 
people make decisions about their QoL.
3.1.2 Focus groups
Numerous qualitative methods can be employed to elucidate factors pertaining to 
health, and FG’s are one such method. FG’s are a form of group interview; however, 
unlike interviews the important data comes from the interaction between group 
members, rather than the answers to individual questions from the researcher, who 
acts as a facilitator. Morgan suggests that the hallmark of FG’s is “the explicit use of 
the group interaction to produce data and insights that would be less accessible 
without the interaction found in the group” (Morgan, 1988; 1998). In other words, the 
richness of data would not be found in individual interviews. Morgan has also 
emphasised the use of FG’s as a qualitative research tool and as part of a larger 
research program, such as the development of questionnaires in the present study.
The WHOQOL Group has used FG’s as a bottom up approach to the development of 
items in the development of the WHOQOL (WHOQOL Group, 1993), enabling the
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use of standardised protocols whilst generating rich data. The aim of using FG’s is to 
develop items in the vernacular, capturing the ways in which people discuss issues, 
the idiosyncratic use of language and conversation, and the use of humour and 
anecdotes in particular populations during group interaction. Thus, FG’s have been 
used to develop the international core and can also be used in the development of 
additional disease specific modules.
The aim of this research was to develop a module to measure subjective QoL related 
to CP. The work presented here details the preliminary stage of the research and the 
chapters that follow detail the subsequent stages. The specific aim of the FG’s was to 
generate facets pertaining to the impact of pain on QoL. Three different groups of 
participants (described below) were asked about CP related QoL, and this chapter 
draws on the key themes discussed in the FG’s and attempts to understand their views 




Eleven FG’s were conducted with 59 voluntary participants between December 2000 
and March 2001. A purposive sampling strategy (Mays and Pope, 1995) was adopted 
to ensure that FG’s were conducted with people representing a heterogeneous cross- 
section of diagnostic groups to reflect the diversity of people with CP (Kuzel, 1992). 
FG’s were also conducted with health professionals working with people in CP and 
informal carers of people with CP. Each FG consisted of 4 to 9 participants.
3.2.2 Patient groups
Six FG’s were conducted with 32 people with CP recruited from the Pain Clinic, 
Rheumatology, Oral surgery and Orthopaedic services of a District General Hospital 
(Royal United Hospital (RUH)), a specialist centre for rheumatic diseases (Royal 
National Hospital for Rheumatic Diseases (RNHRD)), and from primary care through 
a local General Practice in Bath. One hundred and twenty four letters were sent 
inviting people to attend a group on a given day, accompanied by a full explanation of 
the purpose of the study and an assurance of confidentiality. Known reasons for 
refusing to take part were transport difficulties, having prior arrangements, being too
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tired, having other responsibilities, being unable to leave work on time, illness, being 
advised to rest before joint replacement surgery and receiving information too late 
because o f being on holiday. The mean age o f patient participants was 49.41, (range 
28-69) and 69% were female. Participants came from a range o f diagnostic categories 
(as described by participants) and these are shown in table 3.1. The duration o f 
groups was between 1 hour 30 minutes and 2 hours.












Diagnostic composition of 
group
1 4 33-56 3 F, 1 M 125.5 (range 
64- 264, SD 
94.0)
Neck pain; rheumatoid 
arthritis (RA), arthritis in hip; 
RA; left hip soft tissue 
damage, sciatica
2 4 29-53 2 F, 2 M 120.0 (range 
36- 240, SD 
89.3)
Back pain (BP); 
temporomandibular j oint 
disorder; fibromyalgia (FMS), 
osteoarthritis (OA); chronic 
pancreatitis
3 4 29-63 2 F, 2 M 195.0 (range 
36- 552, SD 
241.5)
Spinal injury; rib muscle and 
chest pain, BP; BP, arthritis; 
OA, neuropathic foot
4 5 39-69 2 F, 3 M 77.0 (range 
5-180, SD 
84.4)
OA, ankylosing Spondylitis; 
BP, arthritis; frozen shoulder; 
BP; RA
5 6 28-69 4 F, 2 M 187.6 (range 
96- 384, SD 
114.3)
Pain in stomach; Neck pain; 
BP; BP, arm pain, lumbar 
canal stenosis; BP
6 9 37-69 9 F, 0 M 175.3 (range 
32- 456, SD 
168.6)
FMS; FMS; FMS; FMS; FMS; 
FMS, BP; OA, ruptured 
tendons, carpal tunnel; FMS, 
OA; FMS, viral arthritis
* Standard Deviation
3.2.3 Health professional groups
Three FG’s were conducted with a total o f 17 health professionals who were 
experienced in working with people with CP, recruited from the RUH in Bath, 
Frenchay Hospital in Bristol and the Gloucester Royal Hospital in Gloucester (Health 
professional groups from 4 hospitals were approached, 3 agreed to take part). The 
composition o f the groups is shown in table 3.2. Group members had a range o f 
experience o f working with people with CP on an individual and group basis, in the 
assessment o f people with CP and in the delivery o f various treatments and pain
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management programs. The duration o f groups was between 1 hour 15 minutes and 1 
hour 45 minutes. The rationale for including health professionals was that this group 
are experienced in talking to their patients about issues pertinent to their QoL, and 
consequently, would understand something about the nature o f  its impact.








Health professions Hospital 
recruited from










2 6 31-49 4 F, 2 M Consultant Clinical 
Psychologist, 
















3.2.4 Informal carer groups
Two FG’s were conducted with a total o f 10 informal carers who were recruited 
through contacting local CP support groups (of the 4 groups approached, 2 agreed to 
take part). The composition o f the groups is shown in table 3.3. The duration o f 
groups was between 1 hour 35 minutes and 1 hour 45 minutes. The inclusion o f 
carers was seen as an important step to elucidate their perception o f the QoL o f the 
people with pain that they care for, and how this compares to patients’ perceptions o f 
their own QoL.













1 6 29-63 3 F, 3 M 3 husbands, 2 
wives, 1 mother
3-18 years
2 4 38-74 2 F, 2 M 2 mothers, 2 
husbands
14 months -  13 years
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3.2.5 Procedure
Participants were provided with an information sheet about the WHOQOL project, a 
consent form, a map, confirmation of the meeting and a WHOQOL-100 with 
importance items to complete in advance of FG the meeting, to familiarise themselves 
with the content. This also provided data on demographic factors such as age, gender, 
educational level, marital status, occupation, patient status, nature of health problem, 
provision of care for others (for carers only) and professional status (for health 
professionals only). Supplementary information was obtained from patients and 
carers on the site/ nature/ diagnostic condition and the duration of pain that they/ their 
family member had experienced. Patient and carer FG’s were conducted in a hospital 
setting in Bath. Health professional groups were conducted in a hospital setting in 
Bath, Bristol and Gloucester. Seats were arranged in a U-shape to facilitate group 
interaction. All FG’s were audiotaped and ideas and questions elicited by participants 
were summarised on a flip chart.
Two moderators, a lead moderator and a co-moderator facilitated each group. The 
role of the lead moderator was to introduce the project and the task, emphasising that 
all participants’ views were equally valid, that there were no correct answers, that 
each individual’s viewpoint should be listened to and respected and that all 
information was strictly confidential. The role of the co-moderator was to assist the 
lead moderator and take detailed notes of the session to supplement the audiotapes. 
Both moderators ensured that all participants were focused on the task and probed 
participants about their experience to avoid the exchange of anecdotes.
The moderators and participants introduced themselves to the group (all members, 
including moderators wore a name badge). Participants were provided with a pen and 
paper and asked to free-list how pain had affected their QoL in the last two weeks. 
Participants were asked if there were any aspects of their/ their patients/ their family 
members’ QoL specific to living with CP that were not included in the core 
WHOQOL. The task of the group was firstly, to consider how having CP affects QoL 
and whether there were any aspects that were not covered by the core WHOQOL 
facets. Secondly, to consider how important these new aspects were, and thirdly, to 
generate suitable questions in their own words that could be used to ask others in CP 
about these aspects of QoL.
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At the end of each group, participants were thanked and provided with a telephone 
number for any post-session counselling (this was not taken up by anybody). After 
the group, the moderators conducted a debriefing session to discuss impressions of, 
and issues raised during the group, any unexpected findings and commented on group 
dynamics.
Although the FG procedure was standardised from the outset (see figure 3.1), the 
process of conducting groups evolved and was refined each time to ensure that data 
collection was maximised. For example, a list of the three goals of the group was 
introduced and put up after several groups, to help focus the group on the task. A list 
of the four core items addressing pain and discomfort was also introduced and put up 
after several groups to further stimulate discussion and highlight any possible gaps in 
these items addressing pain.
FG’s were run until saturation was reached, that is, no new themes or areas of QoL
were emerging from the groups and the data from each new group provided further
confirmation of data derived from the previous groups.
Figure 3.1 Focus group interview schedule adapted from the WHOQOL User 
Manual, appendix six (WHOQOL Group, 1998)
Participants should have completed the WHOQOL prior to the session.
Welcome
■ Opportunity for the participants to get to know one another.
■ Moderators hand out name badges.
■ Participants complete participant forms and consent forms (for patients only) to provide 
demographic information e.g. name, gender, age, educational level, occupation, marital 
status, length of time in pain/ length of time caring for somebody with pain/ professional 
status (for health professionals only) and diagnostic group or painful area/s.
Orientation and Instructions
The following points were covered before beginning the discussion.
■ What is a FG? A type of “group interview” to generate ideas about an issue and involves 
doing a task i.e. thinking about generating questions that relate to the areas brought up in 
the discussion.
■ FG’s are a “different” and “new” way of collecting information.
■ Outline briefly the WHOQOL project and the place of FG’s within it. Describe the 
definition of quality of life in lay terms.
■ Describe the purpose of this group. To generate additional items/ questions for a 
questionnaire for use with people who have CP.
■ The FG is “time out” from normal cultural and social rules about what is said and what is 
acceptable to discuss.
■ Emphasise that there are no right or wrong answers, just different points of view.________
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■ All participants’ ideas and views are equally valuable.
■ Participants should try to say as honestly as they can, what they think, rather than what
they think they should or are expected to say.
■ The session will be recorded, but all data is confidential.
■ The session will be expected to take 1.5 hours, with a break for refreshments.
■ Opportunity for participants to ask questions.
Warm-up
■ A warm-up exercise is given to familiarise participants with what is expected of them and 
facilitate subsequent discussion. Participants are asked to free-list areas of their/ the 
person they care for/ their patients life that are affected by having CP and to think about 
the ways in which pain affects quality of life.
■ To help focus the group, the aims of the session are put up on the board. These are as 
follows;
1. To identify and discuss how CP affects your/ the person you care for/ your patients 
QoL.
2. To establish how important each of these areas are to you/ them.
3. To think about how you would ask about these areas, i.e. try and generate questions 
asking about these areas of your/ the person you care for/ your patients life.
Main session
■ Participants are asked to think about the WHOQOL-100 that they have completed and say 
if  there is anything that they think might be missing, that is specific to CP.
■ Participants are invited to begin discussing some of the issues that they have written
down, pertaining to CP and quality of life. It is explained that if  an area arises that is
already covered by the WHOQOL-100, the moderators will ask the participants to move 
on to a new area that has not already been covered. The aim was for the group to discuss 
new areas that are specific to having pain.
■ The co-moderator uses a flip chart to record issues raised by participants.
■ As a prompt for further discussion, the moderator asks:
“Are there any issues important to your/ the person you care for/ your patients quality of life 
that have been missed out of this (facet) list?”
■ After an opinion has been stated, the moderator should enquire of the group if this opinion 
is consensually held.
■ The questions addressing pain and discomfort are put up and the moderator also asks:
“Do the questions for pain and discomfort fully address pain-related quality of life?”
■ If an issue is consensually felt to be inadequately covered:
“How would you ask about how CP affects QoL?”
■ Any new areas or questions are written up on the flipchart as they arise.
■ The moderator then summarises the group discussion by going through the list of areas
written up by the co-moderator. This helps to highlight if anything else has been missed 
by giving participants to elaborate on particular areas if necessary and insures that each of 
the areas is important to everyone, not just particular individuals.
Closure, Debriefing and thank you!
Debrief with co-moderator 
Consider the following questions:
■ What are the most important themes or ideas discussed?
■ How did these differ from what we expected?
■ How did these differ from what occurred in earlier FG’s?
■ What points need to be included in the report?
■ What quotes should be remembered and possible included in the report?
■ Were there any unexpected or anticipated findings?
■ Should we do anything differently for the next FG?
Compare notes and check on whether there is agreement of key points.____________________
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3.3 Analysis
3.3.1 Identification of themes
All audiotaped FG’s were fully transcribed and systematically coded for themes (see 
appendix 1 for a sample of coded transcript). First, general themes were identified 
and the WHOQOL domain and facet structure provided a theoretical framework for 
this analysis (The WHOQOL Group, 1998), although additional attention was paid to 
narrative supporting social comparison theory. Particular attention was paid to 
identifying new areas of QoL, not covered by the WHOQOL-100. Themes from each 
FG were first arranged under the most appropriate headings based broadly on the six- 
domain structure of the WHOQOL. Subsequently, a matrix was formed of themes, 
plotted against each FG, allowing the similarities and differences between the groups 
to become apparent. From this, it was clear which themes had emerged consistently 
across all groups and which were idiosyncratic to particular groups. Criteria for 
inclusion as a facet were a.) themes not already covered by the core WHOQOL, b.) 
themes specific to people with CP and c.) themes represented in each of the 
transcripts. The themes were further refined and clustered according to their 
conceptual and semantic attributes. During this refinement process, conceptually 
similar themes were merged together to allow for a more parsimonious account of the 
important areas identified by the FG’s, to give facets of QoL.
3.3.2 Inter-rater reliability
To ensure that the themes identified were a reliable representation of the FG narrative, 
inter-rater reliability assessed the extent of agreement between 2 independent raters 
(the author and a Health Psychology Masters student). Both raters coded the data 
using the core WHOQOL facet and domain structure as a coding frame to aid their 
interpretation of the text, with the additional task of identifying themes relating to 
chronic pain (CP) that were not covered by this core structure. Both raters were 
familiar with the structure of the WHOQOL. An adequate level of agreement 
between raters for the identification of additional themes pertaining to CP was 
achieved in a 17% sample of the total patient focus group (FG) transcripts. This 





Although participants were requested to discuss areas not covered by the core 
instrument, evidence for the 25 core WHOQOL facets was found in the FG 
transcripts. Table 3.4 shows the 31 themes identified in the transcripts organised as 
described above. The 31 themes were then reduced to 10 facets pertaining to pain and 
discomfort, arranged under three domain headings; physical, psychological and social 
relationships. Table 3.5 shows the final list of 10 facets of QoL and how these were 
incorporated into the domain structure of the WHOQOL. The contraction from 31 
themes to 10 facets was based on an examination of their semantic proximity, taking 
into account the contextual material from the transcripts. To achieve this, the location 
of themes was changed until they were placed where the domain heading best fitted 
with their conceptual and semantic qualities. Reference to the contextual material 
from the transcripts also ensured that facets were allocated to the most appropriate 
domain.
The process of refining and re-working the themes was an evolving process involving 
the deletion of, and movement of themes between domains following discussion with 
the Principal Investigator. For example, ‘adapting the environment’ was deleted 
because there was not enough supporting evidence across the transcripts. ‘Feeling 
alone’ was moved from the social to the psychological domain because of its 
association with loss. In addition, ‘guilt’ was moved from the psychological to the 
social domain because of the contextual nature of guilt, i.e. being firmly rooted in 
social relations where guilt is experienced as a result of a person’s increasing 
dependence on others.
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Table 3.4 List of 31 themes arranged under headings based broadly on the six- 





4. Ability to do what once could___________________________
5. Ability to obtain relief_________________________________











14. Sense of humour_____________________________________
15. Hope______________________________________________
Issues around treatment_________________________________
16. Side effects of treatment/ medication____________________
17. Complimentary therapies/ medicine_____________________
18. Information_________________________________________
19. Worry about medication / treatment_____________________
20. Hope of cure/ relief__________________________________
Social/ personal relationships____________________________






Relationships with health care providers__________________
27. Relationship with doctor/s_____________________________
Environment _____________________________________
28. Adapting the environment_____________________________
Relationship with system________________________________
29. Support from system__________________________________
30. Dependency_________________________________________
31. Societal attitude towards pain and use of health or social care
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Table 3.5 Ten new facets pertaining to CP and QoL derived from the FG work
Physical domain_____________________________
I Changes in pain*____________________________
II Pain relief_________________________________
Psychological domain_____________________
III Anger and Frustration_______________________
IV Vulnerability, fear and worry________________
V Uncertainty________________________________




IX Guilt and burdening others___________________
X Relationship with health care providers_________
*Changed at a later stage to ‘flare-ups’.
3.4.2 Importance of WHOQOL facets
FG participants completed the WHOQOL importance items prior to attending the 
group and table 3.6 shows the mean importance ratings for each o f the 25 facets. 
Each item is scored on a 5-point Likert scale where 1= not important, 2= a little 
important, 3= moderately important, 4= very important, 5= extremely important. All 
facets received an importance rating >3, reflecting their perceived importance to 
people with CP. The most important facet was activities o f daily living (ADL) and 
the least important was body image and appearance.
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Table 3.6 Mean importance ratings for the core WHOQOL facets (N=31)
Importance items Mean (SD)
Overall QoL and general health
Overall QoL
4.29 (.74)
Overall health 4.35 (.61)
Domain I -  Physical health
1. Pain and discomfort
4.32 (.75)
2. Energy and fatigue 4.26 (.63)
3. Sleep and rest 4.42 (.72)
Domain II -  Psychological
4. Positive feelings
4.03 (.71)
5. Thinking, learning, memory and concentration 4.26 (.68)
6. Self-esteem 4.10 (.75)
7. Body image and appearance 3.52** (.89)
8. Negative feelings 4.23 (.62)
Domain III -  Level of independence
9. Mobility
4.42 (.62)
10. Activities of daily living 4.68* (.48)
11. Dependence on medication or treatments 4.16 (.86)
12. Work capacity 3.84 (.90)
Domain IV -  Social relationships
13. Personal relationships
4.10 (.94)
14. Social support 3.94 (.89)
15. Sexual activity 3.58 (1.03)
Domain V - Environment
16. Physical safety and security
4.10 (.60)
17. Home environment 4.42 (.56)
18. Financial resources 4.10 (.75)
19. Health and social care: availability and quality 4.39 (.62)
20. Opportunities for acquiring new information or skills 3.97 (.60)
21. Participation in and opportunities for recreation and leisure 4.10 (.54)
22. Physical environment (pollution, noise, traffic, climate) 4.23 (.72)
23. Transport 4.19 (.60)
Domain VI -  Spirituality/ religion/ personal beliefs
24. Spirituality, religion and personal beliefs
3.71 (.94)
* Most important facet. 
** Least important facet.
The results presented here are divided into two sections, evidence o f facets from the 
transcripts, and evidence o f the use o f  social comparison in thinking about and 
describing pain related QoL.
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3.4.3 Evidence of facets from the transcripts
The following quotes have been extracted from the FG transcripts to demonstrate how 
the discourse reveals the multidimensional nature of the new facets, their conceptual 
complexity and their impact on QoL. The letters at the start of each quote represent 
the identity of the participant making the statement.
3.4.4 DOMAIN 1: PHYSICAL DOMAIN
3.4.5 I Flare-ups are defined as the changing nature of a person’s pain or condition 
characterised by temporary and acute worsening of pain. Flare-ups include the notion 
of pain increasing with activity; of the unexpectedness and unexplained nature of 
flare-ups and of the adaptations made to live with and try and avoid these flare-ups.
C It's little things really. The frustrations ’ there because you feel that you're just 
about coping within it, and then all o f a sudden you think 'what did I  do to cause 
that?' And you think, I  should be able to sit on the floor and wrap up Christmas 
presents, without causing the pain to flare up (FG3).
3.4.6 II Pain relief is a facet that reflects the importance of being able to achieve 
pain relief through the means available to a person, and how this impacts on QoL. 
For example, in terms of being physically comfortable, obtaining relief and 
controlling pain. As the text illustrates, achieving pain relief is an important goal that 
brings with it a sense of control, however, this relief offers no certainty about pain 
relief in the future.
D  I'm lucky that I  can plan ahead because I've got some control for my pain
at the moment with the medications. I'm getting lots o f breaks, which is wonderful, 
but I'm always wary that i t ’s there, sitting in the background, and it could get you at 
anytime. And so, I  think it restricts me, it restricts me as a person too (FG2).
The following quote represents the use of broader sociocultural comparison where it 
is assumed that people in North America are using Cannabis for pain relief.
B but you don ’t do it because it's illegal and because it's obviously hard to get 
hold of, um, I  don’t know why we don't do it really i f  I'm being honest, I  think we 
should LAUGHS.
A Well Americans are issuing it so why, can’t we?
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3.4.8 III Anger and frustration is reported as loss of patience, being irritable and 
short tempered and experiencing mood changes, which impact on a person’s QoL. 
Anger and frustration has consequences for the self, for ones relationship with others 
and for QoL.
C I  was actually suspended from my job because I  did actually lose my temper,
I ’m afraid to say. A very stressful job anyway, and I  was actually suspended from 
work last October because o f the very fact that I  was trying to cover the pain. I  was 
suffering in silence. Pain is invisible, other people don’t know. And you try and work 
through it and push through it, and pushing through pain is really the worse thing 
that you can do. Because you just become a very angry person (FG2).
The following quote is evidence of the frustration experienced by people with pain.
D I  can tell you the most normal thing is sitting here in this chair, or sitting down 
at home, and it's so frustrating when you've got to get up, like getting up to move over 
there, cause it hurts and you think ’why is it all the time?’ and I  mean you’ve got to sit 
down at some point in your life (FG4).
The following quote represents the use of upward intrapersonal comparison and the 
mood changes that come about from being dependent on others.
G Can’t do anything, can’t do nearly as much now as I  could two years ago, and
it all gets on the next person which is my husband and he is over protective, he tries to 
do more than I  want him to do, and I  say 'leave it, I'll do it', and that upsets him then, 
because I  lose my temper because he's trying to help.
The anger described in the next account is an example of the use of downward 
intrapersonal comparison and that living with and adapting to pain is an ongoing 
process.
F When I  first was in pain, I  used to think 'why me?’, 'why me?', 'why does it
have to be me?' and I  was so angry with the world you know, thinking well, I
haven't hurt anybody, I  don’t deserve this, but you just get used to it, it's a part o f your 
life, and you can't be angry about it all the time, you've just got to get on with your life 
the best you can.
3.4.9 IV Vulnerability, fear and worry were reported in terms of physical 
vulnerability from pain and its associated disability, fear and worry over high doses of 
medication, and concern from the apparent decreasing efficacy of medications over
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long periods of time. The following reveals how use of a walking stick helped to 
reduce feelings of physical vulnerability experienced because of the fear of being 
knocked over.
B Before my legs were sorted out, I  used to feel very vulnerable like you about 
falling over, and I  was frightened o f being bumped into, because i f  someone knocked 
me and I  was on the floor, I  wouldn't be able to get up. I  still wouldn't be able to get 
up now. With a stick there, people do just give you a bit more o f a wide berth or open 
a door or something, and it helps (FG1).
The next extract reveals the fear associated with taking large quantities of medication. 
B When you're on that drug in your 40's, I  try very hard not to up it (medication)
and obviously I  wouldn't do it without my doctors’ advice, but what's going to 
happen? I'm going to get to that stage where it's not going to do any good, that 
frightens me more than anything (FG4).
3.4.10 V Uncertainty describes situations where the outcome is not known or is 
outside a person’s control and includes problems associated with making plans for the 
future, lack of a definitive diagnosis (in some cases), and general uncertainty of the 
future, all of which impact on a persons’ QoL. Uncertainty may lead to catastrophic 
thoughts about a potentially more negative future. The consequences of uncertainty 
include having to live moment by moment, having to cancel plans and not wanting to 
commit to anything in case of not being able to honour that commitment. Here, an 
uncertain future is considered, along with the potential impact of this on others.
A The other thing I  think o f is, i f  it is like this now, what am I  going to be like in 
thirty years time? I f  I ’m limited to things I  can do now, am I  going to be more reliant 
on people to help me in thirty years time? (FG1).
The following discussion shows that even planning daily life can be problematic 
because of the possibility of pain or immobility.
A You've got to try and plan your day, or whatever the things you do, but
unfortunately, you're very often overtaken by pain or whatever, or immobility.
F Really, you've just got to plan one day at a time (FG5).
In an example of upward interpersonal comparison use, this participant makes a 
comparison with people who are able to make plans for the future.
B So you have nothing, it's not just that the future looks like a void, but also, it's
very depressing, it's very negative, and then the anger kicks in again because other
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people know that in six months time they're doing this or they're doing that. We don't 
know i f  next week we can actually attend a dental appointment that we made three 
months ago.
3.4.11 VI Loss, loneliness and feeling alone describe the emotional reaction to loss 
of function and role. Loneliness and feeling alone are related to loss in that they are 
concerned with feeling the absence of others or feeling alone in ones suffering. These 
feelings of isolation reveal a loss of identity and sense of bereavement for the person 
one could have been in the absence of a painful condition.
B You sometimes think, i f  I  didn’t have this I'd be a completely different person, 
and I  would have lived a different life, and you almost sort o f grieve. ‘Cos mine 
started when I  was 22, I  was just starting in life, just sort o f blossoming, and I  feel 
that I  have grieved for that person that I  should have been really (FG1).
The following shows how becoming a member of a support group alleviated feelings 
of loneliness and aloneness and can, therefore, be a positive aspect of QoL. This is 
also evidence of lateral interpersonal comparison because comparing oneself with 
similar others confirms that one is not alone in ones suffering.
B The only thing we got out o f it (being a member of a support group), well the 
only thing I  got out o f it, which is wonderful, is I  know I'm not alone and all o f a 
sudden that was the one thing that came out, that you're not alone (FG5).
3.4.12 VII Positive strategies include the ability to see the humorous side of events, 
and experiences, hope and optimism for the future. Humour may be an active attempt 
to be positive or to diffuse potentially embarrassing situations. Hope of a magic 
treatment or cure offers a distant, but nonetheless imaginable possibility of a pain free 
future.
B I  don't talk to my husband about it because he knows when I  am bad...and we 
don’t treat it as a precious thing. We sort o f  joke a lot about it in our house. A lot o f 
people might be quite offended but, there is nothing he can do to help, and I  know how 
helpless he feels, so when it's my worse times, I  don't talk to him about it. That is 
when I  do find the medical profession very good. I f  they can increase my drugs to just 
get me through that phase, or often it's because my knees or something are really bad 
and I  can only have a replacement. When you’ve had a replacement, then you can go 
on again. It's like walking along a road really, and it bashes you down, and when you
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are having a bad time and it bashes you down to the floor. I f  someone mends you, 
you just get up walking again, ‘cos well what else do you do, you've just got to keep 
going haven't you? (FG1).
The importance of hope and optimism that there will be a treatment or a cure for pain 
is revealed here.
C I  always hoped that the next treatment is going to be the one. Against this 
frustration is hope that somebody will give me this magic potion or whatever 
(LAUGHS) to rub on it, or make it better and it's quite upsetting when you discover 
that that treatment hasn't had that magical affect you've pinned all your hopes on, 
especially as you get further down and you've tried more things (FG3).
The following quote shows how self-esteem can be boosted and perceived severity 
can be minimised by comparison with others demonstrating the use of downward 
interpersonal comparison as a positive strategy. This also demonstrates willingness to 
engage in life despite the pain.
A You've just got to take a positive approach, but sometimes you can't. I  mean, I  
know I've got other things wrong with me, but I  consider myself lucky, because there 
are millions that are far worse than what I  am. My problems are not life threatening. 
They disrupt your everyday activities, um, but I  consider myself lucky, I  could have 
something far, far worse.
3.4.13 DOMAIN 3: SOCIAL RELATIONSHIPS DOMAIN
3.4.14 VIII Communication concerns living with an invisible condition and its 
consequences. Looking well despite the pain makes it difficult for others to see that 
something is wrong. People living with CP question whether they are believed and 
understood by others, including how they are viewed and whether they are able to 
communicate their feelings. These questions affect QoL through their effect on ones 
relationships and subsequently on ones identity.
D The problem I  have is that you cannot see anything wrong with me, people say
‘you look absolutely fine ’, but the chronic pain is continuing and you 're trying to look 
through it really. That's what I'm trying to do, although I  will say to people i f  I'm on 
the telephone, ‘we won't be tabng long because it actually really aggravates the ear', 
they forget that and carry on talbng, because they can't see anything wrong, so that's 
a problem for me. It's only when I'm holding my face or rubbing my ear that they say
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‘oh, your ears bad today isn’t it? ’ so yeah, you can’t physically see anything wrong 
(FG2).
Another consequence of the lack of understanding from others is withdrawal and the 
cessation of communication.
C I  walk very slowly and I ’ve had people brush past me and nearly knock me
down and I  think that is outrageous. Before I  had difficulty with my walking, I  used to 
hide it, and i f  you were at work and a colleague might say ‘oh what’s wrong?’ ‘Oh, 
I ’ve got really bad pain in my legs ’, ‘oh well we ’ve all got something wrong with us ’ 
and all this kind o f attitude, when I  know that I ’ve got a recognised chronic illness 
and I ’m not even discussing it with colleagues anymore...you don’t want to look for 
the sympathy vote -  that’s not what I ’m about, you just need a bit o f understanding 
sometimes (FG2).
3.4.15 IX Guilt and burdening others describes feelings of blame for one’s 
increasing dependence and reliance on others. Guilt is an important social experience 
associated with feelings of being a burden on others, of inadequacy, of not 
contributing equally to relationships, and of letting people down, all of which impact 
QoL. The following illustrates the perceived unequal contribution to relationships 
that results in feelings of guilt.
B I  think you feel inadequate, don’t you? In a relationship, you don ’t feel you ’re 
pulling your weight and you feel you ’re leaving them to do too much.
C Yeah, absolutely. Oh, I  know I  am, and my husband works hard, very hard, 
and I ’m putting on him all the time (FG1).
B I  think your partners suffer, which makes you feel very guilty, and because you
feel guilty, you then get depressed and it's a vicious circle, it really, really is. (FG5).
3.4.16 X Relationship with health care providers addresses interpersonal 
interactions with doctors and other health professionals involving perceptions of 
support, being believed and listened to, perceived adequacy of available information, 
and the use and benefits gained from complementary therapies and new treatments. 
The quality of interactions with health care providers impacts QoL.
C I  think communication and being felt like you've been listened to is quite
important for your QoL, not just from your family but also from medical agencies 
(FG3).
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B I f  there's some new drug out and it's supposed to be some miracle drug and
you read about it in the paper or someone brings it up on the Internet and tells you 
about it. Well really, it's not very good to the specialist; they're so busy, which is only 
natural, so you don't like to take up their time. But it would be nice to have somebody 
to discuss with, whether you'd be able to have the new drug or is it available yet, or is 
it just for younger people - and stuff like that? (FG4).
This participant, who considers herself to be more fortunate than others because she 
has a good relationship with her doctor, shows evidence of downward interpersonal 
comparison.
F  I  must admit, I've got a good doctor, he does listen and he is very supportive,
you know so, I  suppose I'm lucky really compared to some people.
In summary, the 10 new facets supported by FG excerpts illustrate how living with 
pain impacts on QoL. The narrative also illustrates the use of social comparison by 
FG participants and provides preliminary evidence of the importance of acceptance of 
pain. This reveals the variety of strategies used to talk about QoL amongst 
individuals with CP, illuminating the comparative processes that are embodied in the 
WHOQOL Groups’ definition of QoL discussed in chapter two.
3.5 Discussion
3.5.1 New facets of QoL
The FG data supports the notion that pain-related QoL is influenced by numerous 
facets from broad life domains. The data also suggest that in addition to the core 
facets of QoL, other facets are important to people with CP which can be used to 
elaborate the WHOQOL core. The emergent themes concerned the consequences of 
specific symptoms which characterise particular conditions such as living with a 
fluctuating condition, issues surrounding treatment, the difficulty with which people 
find communicating their feelings and the fact of their pain to others and their 
relationship with their health care provider, particularly the interpersonal context of 
these interactions. Ten new facets emerged in addition to the WHOQOL core, which 
were divided into the most appropriate categories (domains of QoL), based on the 
contextual information accompanying the themes. These were changes in pain (later 
changed to flare-ups) and pain relief (physical domain); anger and frustration, 
vulnerability/fear/worry, uncertainty, loss/loneliness/feeling alone, and positive
Chapter three 67
strategies (psychological domain); and communication, guilt and burdening others, 
and relationships with health care providers (social relationships domain). These 
findings illustrate the salience of psychosocial variables. No new facets arose for the 
level of independence, environment or spirituality/ religion/ personal beliefs (SRPB) 
domains, suggesting that these are sufficiently elaborate to account for the impact of 
pain on QoL. However, it is possible that facets will shift following further 
development and testing of the instrument reported in subsequent chapters.
People with pain derived the new facets from FG discussions and although these 
issues are not original to the literature, this is the first time that such concepts have 
been brought together to specifically identify a holistic group of QoL issues, for the 
purpose of developing an outcome measure. The facets also reveal the 
multidimensional nature of the pain experience, underscore the importance of the 
biopsychosocial approach to pain management, and support a broader approach to 
outcome measurement. Furthermore, the results support the need for a theoretical 
base in QoL research and the discussion also illustrates how it might be possible to 
modify these areas of QoL with appropriate interventions since there is an ethical 
question about whether one should include or assess a variable or facet that is not 
potentially amenable to change.
In the physical domain, living with a fluctuating condition, the presence of flare-ups 
and the physical side effects of treatment were important in addition to issues covered 
by the core WHOQOL -100. These were reduced to flare-ups and pain relief. The 
occurrence of flare-ups are common to clinical experience (Whitney and VonKorff, 
1992; Hammond and Freeman, 2001), however this research shows explicitly that 
people from wide diagnostic groups experience and are affected by flare-ups, and that 
these flares of pain impact on QoL. Although it is possible to argue that ‘flare-ups’ 
are a symptom of a condition, they are also a consequence or effect of living with a 
painful condition. Flare-ups are an important target for therapeutic intervention by 
decreasing their frequency and severity and Pain Management Programmes (PMP’s) 
and other approaches already target these by introducing pacing and relaxation 
strategies to prevent their occurrence. In other conditions such as RA, a more 
pharmacological approach might be necessary to prevent or relieve the fluctuations 
that characterise the condition (Skevington, 1994).
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It may be intuitively obvious that obtaining pain relief is important to a person’s QoL, 
nonetheless, this facet has been elaborated upon. Pain relief itself may be affected by 
numerous physical and psychological variables and actions taken by the person with 
pain. Theoretically, obtaining relief from unremitting pain may be associated with a 
person’s sense of control. Indeed we know that greater control of pain is associated 
with improved outcomes (Jensen, Karoly and Huger, 1987; Harkapaa, 1991). Pain 
relief is not a unidimensional phenomenon since often there is a trade off between 
effective pain relief, adverse medication side effects and beliefs about the safety of a 
particular drug. It is also simplistic to see pain relief in isolation as a purely physical 
occurrence, demonstrated by the multidisciplinary nature of pain management 
interventions emphasising the importance of a more holistic approach to pain relief. 
Although pain relief and a reduction in pain are important outcomes, where this is 
difficult to obtain, other outcomes such as improved management rather than pain 
reliefper se tend to be more important.
In the psychological domain, a number of key themes emerged over and above the 
core WHOQOL content which provides evidence for an elaboration of the 
psychological domain, particularly for the presence of the specific range of negative 
feelings that accompany being in pain, for example, the presence of anger, frustration, 
guilt, vulnerability and fear. Furthermore, confidence, acceptance of pain, the 
inability to make future plans, uncertainty and worry about the future, role loss, hope 
and issues around control (life control, control of pain, control within relationships, 
control around treatment and medications) were well represented in the transcripts and 
seem to characterise the experience of pain. Many of these concepts are complex and 
are composed of different levels of meaning and specificity. For example, hope, 
which appears to be a remarkably robust characteristic, was expressed as a general 
hope for the future and a more specific hope for a cure or relief of pain. These 
psychological aspects were subsumed into five facets of QoL, anger and frustration, 
vulnerability/ fear/ worry, uncertainty, loss/ loneliness/ feeling alone and positive 
strategies. Although originally placed in the psychological domain, guilt was moved 
to the social relationships domain because of the contextual information regarding 
relationships, that is, participants experienced guilt because of what they could no
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longer do and the consequent impact of their increasing dependence on significant 
others (SO’s).
FG participants talked extensively about how anger and frustration affected their QoL. 
Given that pain is associated with considerable negative affect, including depression 
and anxiety, it is not surprising that other negative emotions would need to be 
elaborated to fully grasp the impact of pain on QoL. It has been argued that anger is 
one of the most salient emotional correlates of pain and given that pain has affective 
as well as sensory qualities and is often associated with depression and negative 
affect, this is not surprising (Fernandez and Turk, 1995). This concurs with the IASP 
definition of pain describing pain as an emotional as well as a sensory experience. In 
a recent review, Suinn provides evidence to show how anger can exacerbate pain 
(Suinn, 2001). Furthermore, patient anger (assessed with the anger/hostility subscale 
of the Profile of Mood States) has also been shown to have a role in the depression of 
patient spouses, along with average pain and the spouses level of marital satisfaction 
(Schwartz et al., 1991), reflecting the social and personal consequences of the 
expression of anger and hostility. In a more recent study, Bruehl and colleagues 
looked at the different effects of ‘anger in’ and ‘anger out’ on pain intensity in 
patients with and without complex regional pain syndrome (CRPS) (Bruehl, Chung 
and Bums, 2003). ‘Anger in’ is characterised by suppression of anger and ‘anger out’ 
by a direct verbal or physical expression of anger and can be measured with the Anger 
Expression Inventory. Given the reported relationship between the outward 
expression of anger and elevated physiological response to stress, it appears that in 
conditions that reflect catecholamine-sensitive pain mechanisms such as CRPS, anger 
out has a greater negative impact on pain intensity, thus demonstrating that 
differential expression of anger can influence the reported pain intensity of different 
conditions in different ways. A reduction in, or increased control of, anger and 
frustration can be considered important goals of therapy considering the prevalence 
and consequence of these emotions on the person with pain and their relationship with 
other people. Indeed, given the role of anger in mediating spousal distress, Schwartz 
and colleagues argue that assessment of spouses should be routine in the evaluation of 
patients with CP, including a focus on marital issues and anger management 
(Schwartz et al., 1991).
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The literature on vulnerability, fear and worry has burgeoned in the last decade or so, 
particularly around the issue of fear avoidance, where individuals avoid activity for 
fear of imagined or real damage. Fear avoidance is seen as a psychosocial variable 
involved in the development of disability (Symonds et al., 1995; Cohen and Rainville, 
2002). Fear avoidance has been examined in relation to lumbar and cervical spine 
pain and a weaker relationship was found between fear avoidance and disability in 
cervical spine pain patients than lumbar spine pain patients. Differences were also 
found between sub groups of patients (George, Fritz and Erhard, 2001), which 
suggests that this represents a variable concept. Feeling physically vulnerable to 
damage is also tied up with this concept, in addition to psychological vulnerability. 
For example in a recent study, Davis and colleagues found that women with FMS 
were more vulnerable to stress than women with OA (Davis et al, 2001). Both of 
these studies reflect the heterogeneity of chronic pain patients (CPP’s). Eccleston and 
colleagues have recently looked at pain and worry and found that worry was related to 
awareness of somatic sensations and that compared to non-pain worry, pain worry 
was more difficult to dismiss, more distracting, more attention grabbing, more 
intrusive, more distressing and less pleasant (Eccleston et al, 2001). Taken together, 
this evidence suggests that vulnerability, fear and worry are significant psychological 
variables and the evidence provided by the FG work highlights their importance for 
QoL. Furthermore, the narrative describing vulnerability fear and worry demonstrates 
the salience of treatment beliefs, including worry about the decreasing efficacy of pain 
medications and so on. The lay referral network might perpetuate such worries that 
are specific to living with and managing long-term pain in the absence of satisfactory 
medical advice. Vulnerability, fear and worry can all be targets of intervention for 
people with pain and discomfort, particularly by using cognitive-behavioural 
techniques to challenge thoughts that mediate these variables and to provide 
information to extinguish worry and fear about the future.
Uncertainty was expressed throughout and is another example of a complex theme 
and was expressed as uncertainty about the trajectory of a person’s pain and disability, 
the uncertainty of the future in general, the daily uncertainty of not being able to make 
plans because of the fluctuating nature of the condition and the uncertainty of the 
efficacy of new treatments. It is possible to assess uncertainty with the Mishel 
Uncertainty in Illness Scale (MUIS) (Mishel and Epstein, 1990). The MUIS assesses
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difficulty in understanding the meaning of illness-related events. Four subscales 
address the patients' perceptions of the ambiguity, complexity, and inconsistency of 
information given to them and the unpredictability of their illness. It has been shown 
to have high internal consistency reliability (a = 0.93) and convergent validity 
(Mishel and Epstein, 1990). A recent phenomenologic study sheds some light on the 
area of uncertainty. In describing the lived experience of people with pain, Thomas 
suggests that for people with chronic non-malignant pain it appeared that time stopped 
and the future seems unfathomable (Thomas, 2000), which echoes the uncertain future 
found amongst participants in the present study. A more recent qualitative study of 
the narrative accounts of 30 Finnish women with BP described the stigmatising 
consequences of medical uncertainty in the absence of a diagnosis (Lillrank, 2003). 
Such medical uncertainty has been shown previously with the scant evidence of a 
causal relationship between spinal radiographic findings and reports of back pain (van 
Tulder et al., 1997). Therapeutically, if may be possible to reduce uncertainty by 
providing people with information about a condition and its course and by providing 
cognitive strategies to manage uncertainty more effectively and to reduce feelings of 
uncontrollability associated with an uncertain future, and hence improve QoL.
The loneliness and isolation experienced by FG participants has also been shown by 
Thomas (2000), who found that the pain was a barrier that separated them from other 
people. Similarly, a study by Snelling shows that CP can cause social isolation, 
although from the grounded theory approach taken, it is not possible to make causal 
inference about the direction of this relationship (Snelling, 1994). It may be possible 
to reduce feelings of loneliness and isolation through educating and involving SO’s 
and family members in pain management. Improving the social skills needed to feel 
part of a group and group work may also act to reduce feelings that one is alone in 
ones suffering, for example in PMP’s or lay led support groups.
The literature on loss has been closely aligned to bereavement, loss of a limb and the 
subsequent changes to body image and loss of identity. Echoing this, Katz and 
Florian have distinguished three different types of loss, interpersonal loss, loss of a 
limb or function, and environmental loss or loss of peace of mind (Katz and Florian, 
1986). Others have focused on the importance of addressing the grief that might be 
experienced following loss of function, which may be mistaken for depression
Chapter three 72
(Stewart and Shields, 1985). The accounts of FG participants demonstrated loss of 
function, loss of peace of mind through an uncertain future and loss of social role, and 
there was some evidence of grieving for the person that they could have been in the 
absence of chronic disease and pain. Loss represents a complex feature of the 
experience of living with a chronic condition and it may an important target for 
therapy. Depending on the nature of the loss experienced by the individual, providing 
information and skills about alternative roles and coping strategies might be useful in 
moderating its influence on QoL.
The use of humour and hope were found to be important to the QoL of participants in 
this study. Less is known about the positive aspects of adverse experience, despite 
these being important to individuals. Stevensen has looked at non-pharmacological 
pain management techniques for acute pain and found inconclusive evidence of the 
efficacy of humour therapy (Stevensen, 1995). Whether this is applicable to CP is not 
known, although Skevington and White (1998) found the use of humour to defuse 
embarrassment amongst a group of RA patients. More recently, Boyle and Joss-Reid 
(2004) conducted a psychometric investigation of the relationship of humour to health 
using the Multidimensional Sense of Humour Scale (Thorson and Powell, 1993) and 
found humour to be a multidimensional construct comprising humour production, 
attitudes towards humour, coping humour and humour to cope with life. Moreover, in 
the medical patients in the study, worse pain was associated with an increase in 
humour scores, which suggested that humour might be used as a coping mechanism to 
relieve pain. In the present study, humour was also used as a strategy to defuse the 
embarrassment of others, which is contrary to traditional notions of the function of 
humour. However, this concurs with the coping humour found by Boyle and Joss- 
Reid, which is described as the production of humour to cope with difficult situations 
which in the present study was found to be important to a person’s interaction with 
others and hence their QoL and happiness.
The concept of hope receives limited attention in the literature; often it is in the 
context of hope for relief from pain. For example, Shannon and Baranowski discuss 
the use of opioids in non-malignant pain representing the only hope for relief from 
pain for some CP sufferers (Shannon and Baranowski, 1997). Tennen and Affleck 
summarise the prevalence and adaptive significance of construing benefits from
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adversity, for example, in CP. They utilise stress and coping theories to explain how 
people may find benefits from their experience and refer to particular dispositions 
such as hope and optimism (Affleck and Tennen, 1996). This work is of particular 
relevance to the current research because it highlights the importance of positive 
psychological strategies in adapting to, and managing CP, an area that has been given 
limited attention in previous research. Less is known about the positive aspects of 
adverse experience, and research tends to focus on the negative consequences of 
chronic illness or disease, although there are some notable exceptions (for example, 
Sodegren and Hyland, 2000; Sodergren et al., 2002; Folkman, 1997). This represents 
a broader approach to QoL and highlights the importance of positive psychological 
strategies in adapting to, and managing CP without focusing exclusively on negative 
affect and physical disability, which has too often been the case in outcome research. 
It also reflects the possibility that negative and positive affect can co-occur, despite 
adversity (Folkman, 1997). Promoting the use of humour, where appropriate, and 
realistic hope might be important strategies and coping mechanisms to manage pain 
and its sequalae more effectively.
Hope and optimism share some commonalities, and optimism is therefore relevant to 
the present study because of its semantic proximity to hope. Moreover, research on 
the elaboration of the SRPB facet has shown that both hope and optimism are 
important to QoL (O’Connell, PhD thesis, 2002). Garofalo, in a review of the role of 
optimism in pain, introduces optimism as a personality dimension and a mediator of 
stress, although it has been described and conceptualised in numerous ways (Garofalo, 
2000). Due to the extensive focus on the importance of psychological variables in 
response to pain, optimism has been hypothesised to have health promoting effects. 
This is set within the context of an area that is poorly understood and elaborated 
because of the dominance of investigations into negative affect and pain. Indeed Turk 
and Holzman (1986) show how patients report despair and feelings of hopelessness 
for the future because of the limited success of treatments. Numerous researchers 
have shown a potential relationship between an optimistic disposition and successful 
treatment of people with pain (for example, Gruen, 1972; Haerkaepaeae and 
Jaervikoski, 1996; Jamison et al., 1993; Novy et al., 1998). This evidence reflects a 
potentially important area for intervention, in decreasing feelings of hopelessness and 
despair and promoting or maintaining optimistic beliefs about the future.
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Initially, in the level of independence domain, specific issues around treatment 
emerged as being important to participants living with pain. For example, the diverse 
nature of medication side effects (physical, cognitive and social), the constant search 
and hope for a cure or relief, the importance of having adequate information regarding 
available treatments and the side effects of medication and a person’s journey through 
the health care system. Participants often felt compelled to seek their own 
information about their condition through use of the Internet and libraries. Issues 
around the use of, and availability of complementary therapies and treatments were 
important. It appears that for this group of patients living with persistent pain, 
conventional medicine often did not provide adequate relief and thus complementary 
therapies where seen as an important way of obtaining some relief, or at least 
provided some hope of relief. Participants also expressed general beliefs about 
medication and treatment. These issues around treatment were subsumed into other 
facets to allow for a more parsimonious account, for example pain relief. Moreover, 
the core WHOQOL facets already account for some of these issues.
A number of themes arose for personal and social relationships. All groups talked 
about living with an invisible condition and its implications for relationships and 
general social interaction. Tied up with this, was the importance of being believed 
and understood by others and the difficulty participants had expressing their emotions 
and pain related information to SO’s. This was often accompanied by a sense of guilt 
over the effect this had on the carer. Participants were also very aware and concerned 
about how they were perceived by others and the extent to which they made 
legitimate complaints reflecting the extent of their suffering. These issues have 
implications for the identity of CPP’s and were subsumed into communication and 
guilt and burdening others.
Communication is a complex feature of CP and the key issues include communication 
of pain verbally and non-verbally and communication to SO’s, health professionals 
and wider society. Ineffective communication with physicians is seen as a barrier to 
pain relief and Glajchen suggests communication should be part of patient education 
to reduce these barriers (Glajchen, 2001). Difficulty communicating with others, 
including communicating the fact of ones pain to others and communicating how one
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is feeling has been shown to impact on a person's QoL. It is possible that 
communication can be improved through specific intervention to give people the 
skills to communicate more effectively with the important people in their lives, 
including family, SO’s and health care professionals. This raises the issue of 
empowerment given that CPP’s are a vulnerable group in terms of traditional power 
relations with health professionals, particularly physicians.
Examining the literature on CP and guilt, two early studies are particularly relevant. 
Johansson and colleagues looked at the relationship between personality traits and 
endorphin levels in the cerebrospinal fluid, they found that CP patients were 
characterised by guilty feelings, need for order, low need for autonomy, and low 
tendency toward sensation seeking (Johansson et al., 1979). This provides early 
empirical support for the presence of guilt amongst pain patients. Stein and 
colleagues found a relationship between guilt and illness behaviour in the depression 
of people with intractable pain (Stein, Fruchter and Trief, 1983). More recently, 
Skevington (1994) found that guilt was associated with the intrapersonal comparisons 
that people use in making decisions about their QoL because of feelings that they had 
not appreciated the things that they had been able to do in the past. Perceptions of 
burdening others, whether real or imagined are genuine concerns of people with CP. 
The literature tends to focus on the economic and or societal burden of CP and the 
extensive health care utilisation of CP patients (Maniadakis and Gray, 2000; Loeser, 
1999; Maetzel and Li, 2002). Literature on perceptions of burden by patients 
themselves is less common. Challenging feelings of guilt and addressing anxiety 
about burdening others might be important areas of clinical intervention to improve 
the QoL and perhaps the quality of relationships of people with pain and their SO’s.
Participants also discussed their relationship with health care providers. The 
importance of the patient-doctor relationship and being listened to understood and 
supported. Trust and consistency was expressed as being important and there was 
some evidence of a conflict of beliefs between patient and doctor, for example in the 
perceived cause of the pain and the most suitable treatment options. Within this 
theme was a person’s relationship to the system as a whole including perceived 
support, feeling caught up within the system in a stream of unexplained referrals and 
the extent to which a person receives adequate information about their health
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condition. Relationship with health care providers was also placed within the social 
relationships domain, because of its interpersonal nature. This is distinct from what is 
already covered in the WHOQOL because it highlights the interpersonal aspect of a 
person's relationship with health care providers as opposed to perceptions of the 
availability and quality of health and social care.
A person’s relationship with their health care providers, including the quality of the 
patient-doctor relationship, perceptions of support and so on have been shown to be 
important to the QoL of people with pain, particularly because of their dependence on 
health care for continued management and relief from pain. There is empirical 
evidence of the importance of the patient-doctor relationship, for example, it has been 
shown that the quality of the patient-doctor relationship can affect treatment 
adherence in post-surgical pain (Moskowitz, 1996). Stembach suggests that 
agreement on the features of the patient-doctor relationship is essential for the 
successful management of CP patients (Stembach, 1977). However, it is not just this 
relationship, but also a patient’s relationship with other health care professional such 
as nurses, occupational therapist and physiotherapists that may also have a bearing on 
their QoL and are increasingly important given the multidisciplinary management of 
CP. Less is known about the quality and nature of these relationships, which might 
prove to be important for understanding the experience of patients.
A recurring theme was the patient's relationships with their General Practitioner and 
their Consultant and how this affected their QoL. Past research has shown that 
medical encounters are largely social interactions (Vonbaeyer, 1994). Research has 
also shown that the judgements of physicians are influenced by the properties of the 
patient, the situation, and the valence of the patient-doctor interaction (Tait and 
Chibnall, 1997). This allows for greater sense to be made of the experience of the 
patient, by examining the perspective of the physician. From the perspective of the 
patient, this relationship may be tied up with the concept of support and the need to be 
listened to and believed. It became apparent that for those with troubled relationships 
with their doctors, this was a very salient narrative for discussion about their QoL. 
Although a causal relationship cannot be established between adjustment and 
relationship with doctor, it is certainly a factor influencing QoL.
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There is an apparent paradox in the need for patients to feel supported by the medical 
profession and the need for the medical profession to reduce patient demands to utilise 
resources. CP presents a challenge to physicians and health professional groups 
talked about their own frustration at not being able to relieve the pain of their patients. 
Thus, feelings of being let down by the medical profession are wholly justified. 
Interventions in this area might be problematic and politically sensitive. However, 
increasing the knowledge of health professionals about psychosocial variables is an 
important goal, including listening and other communications skills. From the 
perspective of the patient, it is possible to improve their ability to communicate with 
their physician by providing them with effective skills to do so.
In the environment domain, reliance on aids and having to adapt the environment to 
reduce disability emerged, however there was not sufficient evidence of this to 
support its status as a new facet. Furthermore, there is a core facet addressing 
dependence on medication and treatment, which asks about reliance on medical aids, 
which is sufficient to capture this aspect of QoL. Other themes that emerged less 
consistently were anecdotes about the weather influencing pain levels (this might be 
quite important for people with RA) and mood. Indeed there is an existing item in the 
WHOQOL-100 that asks about climate, although this does not account for the 
fluctuating, unpredictable nature of British weather and its alleged affect on mood and 
health!
3.5.2 Theoretical observations
The results suggest that when talking about pain and its affect on QoL, people use a 
‘language of loss’ and this is reflected by many of the emergent themes. The concepts 
of independence and dependence are also used to describe different aspects of a 
person’s life with pain and such concepts are already a core part of the WHOQOL 
structure embodied in the level of independence domain. Participants talked about a 
loss of physical strength, control of pain, sleep, activities, abilities to carry out tasks of 
daily living, control over and loss of options for the future (loss of what the future 
might have been), mind, enjoyment of life, relationships, role, and so on. A degree of 
loss had been experienced with all these physical, psychological and social 
experiences and was shared by members of each group. Tied up with the concept of 
loss, was the apparent consequence of dependency that these losses engendered.
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Independence was described as being very important to participants and these losses 
represented a threat to their independence. Physical independence was described in 
terms of being able to wash or bath oneself, psychological independence as freedom 
from medication and social independence as engaging in a social life without reliance 
on the carer, illustrating the complexity of independence. The level of independence 
domain of the existing WHOQOL-100 covers these aspects of a person's QoL, 
although these are specific examples relating to the QoL of people who live with pain 
and discomfort.
Furthermore, the transcripts provided evidence of the processes used by people to 
describe their QoL in a group setting. Considerable evidence from the transcripts 
emerged in support of social comparison theory. Each patient transcript provided a 
rich source of quotes demonstrating its use in talking about QoL, including the use of 
intrapersonal, interpersonal and sociocultural level comparisons. For example, 
participants often compared themselves to how they had been before the onset of their 
pain and associated disability. This intrapersonal comparison was described in terms 
of what they were no longer able to do, which may also be characterised by a sense of 
loss. This process acted to remind the patient of what they are unable to do because 
of the pain and associated disability and that fact that activities now take longer and 
require greater effort. An idealised past was used as a reference point to compare 
different aspects of experience and further highlights the changes to self and the 
increasing dependence on others, which have implications for ones relationships with 
others. Although such processes do not provide benefits to the individual, there is 
some evidence of an appreciation of what one was able to do in the past and an 
acceptance of the changes that have come about because of living with CP. 
Participant narrative also provided preliminary evidence of acceptance of pain, shown 
by such acceptance of changes and by the willingness to engage in activity despite the 
pain, which has been shown to be important in adjusting to CP (Geiser, 1992; 
McCracken, 1998, McCracken et al., 1999; McCracken, Vowles and Eccleston, 2004) 
and this is investigated further in chapter eight. In contrast to upward intrapersonal 
comparison, downward intrapersonal comparison occurs when people compare their 
current selves favourably with a less favourable point in the past so that an 
improvement is perceived, consequently, a sense of benefit is derived from the
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perception that they have changed for the better or have made a successful adaptation 
to adversity.
Interpersonal comparison, such as describing others who are perceived to be worse 
off, was another strategy employed by participants to boost their own self-regard. For 
example, downward interpersonal comparison was shown when comparisons were 
made with others who are worse off than oneself, including hypothetical comparisons, 
for example, believing that one could have a more severe condition, but does not. 
Consequently, this type of comparison can bring about psychological advantages for 
the person doing the comparing. Comparisons are also made with others perceived to 
be worse off, which can serve to minimise ones own problem, but also bring about 
shame for thinking about oneself. Downward interpersonal comparison is important 
because of the perceived benefits that can be construed from believing that ones 
situation is better, or less severe than that of other people. In contrast, upward 
interpersonal comparison is characterised by comparing oneself with someone who is 
perceived to be better off, which can have negative consequences for the individual. 
The acknowledgment that other people can do the activities that one is unable to do or 
that others appear to be complaining unjustly seem to impact on decision making 
about QoL.
Making comparisons with similar others, an example of lateral interpersonal 
comparison, allowed people to conclude that they were not alone in their suffering. 
Although FG participants used this type of comparison infrequently, benefit was 
derived from knowing that one is not the only person suffering with CP. A broader 
sociocultural level of comparison was also described in terms of methods of pain 
relief such as the perception that in the USA, cannabis is widely available and so on, 
which suggests that people make comparisons with other cultures when thinking 
about methods of relief that might be available to them. The use of sociocultural 
comparison is important because it locates individuals in their broader social and 
historical context and illustrates the complexity of QoL decision-making, including 
the diversity of issues that are considered by individuals when thinking about their 
QoL. Although this type of comparison was used, it is not clear that this impacts on 
individual QoL life decisions, rather more global statements about perceptions of the 
society that a person interacts with. The quotes demonstrating social comparison also
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provide narrative evidence of acceptance and of the possibility that response shift 
(discussed in chapter two) occurs in people living with, and adjusting to, a life with 
pain, for example through shifting priorities and altering internal standards and values 
as part of the process of adjusting to life with pain and disability.
3.5.3 A critique of the focus group method
In general, group members interacted well and despite attempts by some group 
members to dominate, this did not appear to create any discord. This was successfully 
resolved by ensuring that quieter members felt comfortable to be drawn into the 
discussion. Efforts were also made to obviate the contribution of idiosyncratic views, 
by focusing participants on the goals of the group. It is possible that a number of 
group processes were operating to potentially alter the comments and behaviour of 
individual members. A notable example is the possibility of social desirability bias, 
where people are influenced by the behaviour and comments of others and wish to 
appear in a certain way, for example, by agreeing with what another person is saying, 
despite their contrary opinion or belief. However, efforts were made during the 
groups to emphasise that all opinions were valuable and that participants were to 
respect the views of others and so on. Furthermore, awareness and sensitivity to the 
possible inhibiting influence of a wide range of age groups contributing to each group 
was considered. In the carer groups, care was taken to allow them to discuss the 
perspective of the patient rather than the effect it had on themselves. Recruitment of 
these two groups was challenging and the group consisted of a fairly homogenous 
sample, that is, carers of people from similar diagnostic groups. Consequently, results 
from the carer groups were not presented and primacy was given to the views of 
patients. Generally, the groups found the task of item generation quite difficult and 
FG participants were too fatigued to give their full attention to the task of generating 
items pertaining to the facets of QoL they had identified at the end of the FG. In 
retrospect, it would have been beneficial to ask them to do this after each new facet 
had been identified and discussed. However, it is also possible that this would have 
disrupted the flow and dynamics of the group.
FG’s have been used in all stages of the WHOQOL development to identify facets of 
QoL cross-culturally and this has proved to be a successful method to do so 
(Skevington, MacArthur and Somerset, 1997). Despite their utility and feasibility,
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there are a number of drawbacks. Firstly in the present work, the number of 
participants was relatively small and were all taken from the southwest region, 
however, the goal was not to produce statistically generalisable results but to reach 
saturation where no further pertinent issues arise from subsequent groups. 
Furthermore, the UK WHOQOL was designed for native English speakers and its use 
has not been widely documented with members from British ethnic minority groups 
and the sampling reflects this. The sampling broadly represents the proportion of 
people presenting with particular conditions, however, it was not possible to include 
people from very specific groups such as sickle cell anaemia and amputees because of 
difficulty in gaining access to these groups. As anticipated, a large percentage of 
participants had musculoskeletal conditions and this is borne out in national statistics 
(for example, Elliott et al., 1999). The method also represents a departure from the 
collaborative procedure used for the development of the core WHOQOL instruments 
and other modules, which included at least three other centres internationally. 
Although FG’s generate information rich data, in common with other qualitative 
approaches, limitations include the generalisability of results to the target population, 
determining validity and potential problems associated with group interaction. 
However, every attempt was made to overcome these potential drawbacks through the 
inclusion of a broad sample and through the effective moderation of groups. 
Furthermore, the systematic analysis ensured the identification and comprehensive 
coverage of facets pertaining to QoL.
Despite the cross-sectional nature of the study, the FG method provided some fruitful 
data, which confirms what is known about the process of adapting to, and managing 
pain in terms of the verbal reports of group members. In addition, it provided novel 
evidence of the impact of pain on QoL, including the importance of positive strategies 
such as hope and humour.
3.5.4 Conclusions
This preliminary qualitative study captures the essence of how QoL is affected by the 
pain experience. The 10 new facets represent new features of the physical, 
psychological and social relationships domains, which will form the basis of the PDM 
to be used in conjunction with the UK WHOQOL-100. For the physical domain, 
flare-ups and pain relief were found to be important to QoL. For the psychological
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domain, anger and frustration, vulnerability/ fear/ worry, uncertainty and loss/ 
loneliness/ feeling alone were elicited by FG members and are known to be salient 
emotional correlates of pain. Furthermore, the positive strategies of hope and humour 
were found to be central to QoL, which is important because of the tendency to focus 
on the negative consequences of illness. Finally, in the social relationships domain, 
communication of pain and the perception of burdening others were important 
features of QoL, contrasting with the focus on the economic or societal burden of CP. 
A person’s relationship with their health care providers was also found to be a key 
aspect of QoL. Although the WHOQOL-100 is a reliable and valid generic measure 
of QoL, this chapter has shown that there are specific life domains influenced by 
living with CP that must also be taken account of when measuring QoL. Taken 
together, these new facets should improve the sensitivity and accuracy of the 
instrument to measure the physical, psychological and social aspects of QoL. 
Evidence was also found for the use of social comparison judgements and acceptance 
as processes involved in describing how pain and discomfort impacted on QoL.
3.5.5 Further work
In the next chapter, the results from a web survey are reported to complement and 
provide validation for the data derived from the FG’s given the sampling limitations. 
In chapter five, definitions that elaborate on the concept represented by each facet title 
and items pertaining to these facets that address that aspect of a person’s QoL are 




Further Exploration of the Quality of Life of People with
Chronic Pain
4.1 Introduction
Chapter three reported on the quality of life (QoL) of people with chronic pain (CP) 
using focus group (FG) methodology. This chapter reports data from an international 
web survey with English speaking respondents to further strengthen the conclusions 
drawn from the FG work. Data derived from these two sources provides the basis of a 
pain and discomfort module (PDM) to be used in conjunction with the UK World 
Health Organisation Quality of Life Assessment (WHOQOL-100). Given that few 
measures have taken account of cross-cultural diversity in assessing the QoL of 
people with CP, the Internet provides an opportunity to address this issue.
4.1.1 The World Wide Web
The Internet or World Wide Web (www) has grown rapidly over the last decade and 
its use has increased dramatically. It is estimated that 33 million people or 55% of the 
population have access to the Internet in the UK (Jupiter MMXI, 2001). This 
compares to the USA, which has 115 million or 62% of the population using the 
Internet (Chan et al., 2001). The numbers are substantially smaller in developing 
countries such as Africa, which has an estimated 6 million Internet users (NUA, 
2002), although this varies considerably across different African countries. There has 
been a proliferation of sites dedicated to specific or particular health conditions, 
including online support groups for individuals to derive solace from others and to 
obtain advice and support from fellow sufferers. The Internet has become a widely 
used source of information to supplement other mediums of information delivery. For 
example, Taylor and colleagues found widespread use of the Internet amongst 
families using genetics clinics, although the accuracy and clarity of the information 
was questioned (Taylor et al., 2001). However, its use as a tool for research is less 
developed and relatively new. Robinson argues that unsolicited narratives from the 
Internet are a rich source of qualitative data (Robinson, 2001). He discusses sources
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of data and the ethical issues associated with using information from this potential 
data source. However, this only has implications for those who are unaware that their 
narrative or Internet use is the subject of research.
More recently, there has been debate in the literature on QoL about computer-assisted 
technology, including the comparison of traditional paper and pencil questionnaire 
administration and computer-assisted interfaces (CASI) such as touch screen or web- 
based administration (Litaker, 2003). Litaker found that different modes of 
administration have different effects on the reliability of instruments and highlights 
the need for studies to explore this issue. In a pilot study Bliven and colleagues 
collected health related QoL information using software operated over the www 
(Bliven et al., 2001). Compared to paper administration, they found a preference for 
computer-assisted administration and conclude that health related QoL (HRQoL) 
measures using software operating over the www is a reliable method for collecting 
data. Allenby and colleagues conducted a study of patients attending an ambulatory 
cancer clinic and found that the administration of the Cancer Needs Questionnaire 
(CNQ), European Organization for the Research and Treatment of Cancer quality of 
life questionnaire (EORTC QLQ-C30) and the short-form Beck Depression Inventory 
(BDI) using a touch-screen computer to assess self-reported psychosocial functioning 
to be an acceptable and efficient way to obtain such information (Allenby et al., 
2002). Studies such as this underline the importance and benefits of utilising current 
technology to advance survey methods and to promote efficient and reliable modes of 
data collection.
The rationale for setting up a web survey was to gather data from an international 
heterogeneous sample of people with CP, to validate the data derived from the FG 
work. There was no pre-determined sampling strategy, since the goal was to reach a 
large number of English speaking people internationally. It was decided that since 
previous WHOQOL work had been firmly routed in cross-cultural research, obtaining 
data from an international sample via the www would be a useful way of providing 
validation for the data derived from FG work. Thus, the web survey provided 
additional data on how CP affects QoL, to confirm the data obtained from the FG’s 
described in chapter three and to provide additional contextual material for the
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definition and item (question) writing stage of the PDM to be used in conjunction 
with the UK WHOQOL-lOO, which is detailed in chapter five.
4.2 Method
4.2.1 Procedure
The CP web survey was set up in December 2000 using a questionnaire template (see 
appendix 2 and http://www.bath.ac.uk/~pspvm/painqol.htmlT A configuration file 
was established to transfer directly into an EXCEL database, to be viewed and 
manipulated. The web site was advertised through web based CP support group 
message boards to obtain the widest possible interest. Potential respondents were 
invited to complete the short questionnaire about how CP affected their QoL. The 
questionnaire consisted of 19 questions requesting socio-demographic information, 
nature of medical condition, location of pain, duration of pain, temporal 
characteristics, intensity of pain, types of treatment utilised and how pain affected 
their QoL. The questionnaire took approximately 10 minutes to complete depending 
on the willingness of the respondents to write about their QoL. Although there is no 
way of checking the legitimacy of the web survey respondents, the questionnaire was 
structured in a way that would make it difficult for a ‘hoax’ respondent to complete it 
without knowing a considerable amount about pain, its treatment and its consequences 
for QoL.
4.3 Results
The web-based survey was available online between December 2000 until August 
2003 and the data presented here derives from this period. The results largely confirm 
the existing WHOQOL domain and facet structure and provide evidence to support 
the 10 new CP specific facets derived from the FG work. The results report the 
quantitative statistics from the web survey describing the sample, and present the 
content analysis of the comments pertaining to the QoL of respondents, arranged 
under the domain and facet headings or the core WHOQOL facet and domain 
structure already described.
4.3.1 Socio-demographic composition
Between December 2000 and August 2003, 234 people with CP completed the online 
web survey. The mean age of respondents was 44.15 years (range 14-85, SD 11.66).
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Of the respondents, 78.2% were female (n=183), 60.7% were married (n=142), 16.2% 
were single (n=38), 12.8% living as married (n=30), 6.8% divorced (n=16), 2.1% 
separated (n=5) and 0.9% widowed (n=2). A higher education level was achieved by 
38.9% (n=91), followed by 29.1% with further education (n=68), 17.5% secondary 
education (n=41), 11.5% postgraduate (n=27) and 2.1% in primary education (n=5). 
Of the sample, 55.1% were working (n=129) and of these 28.6% were engaged in 
full-time work (n=67), followed by 14.1% part-time paid work (n=33), 13.7% looked 
after the home (n=32), 10.7% voluntary work (n=25), 8.5% looked after a child or 
children (n=20), 3.0% part-time unpaid work (n=7), 3.4% part-time study (n=8), 2.6% 
full-time study (n=6) and 0.4% full-time unpaid work (n=l). The majority of 
respondents came from the UK (50.9%, n=l 19), followed by the USA (29.1%, n=68), 
Canada (2.6%, n=6) and one from each of the following countries (4.7%, n=ll); 
Australia, Bahamas, France, Ireland, Italy, Malta, New Zealand, Pakistan, Singapore, 
Sweden, Thailand; 30 (12.8%) respondents did not state which county they were 
from. All questions were answered in English.
4.3.2 Characteristics relating to pain
Most of the sample had current pain (96.6%, n=226) and had their diagnosis 
confirmed by a doctor (92.7%, n=217). The mean duration of pain was 105.4 months 
(range 3-564, SD 91.05). Of the sample, 42.3% (n=99) had some form of surgery for 
their pain, 84.2% (n=197) used prescribed medicine, 42.7% (n=100) used other 
medication (e.g. ‘over the counter’ medication) and 42.7% (n=100) used alternative 
treatment/ medicine for their pain.
4.3.3 Intensity and temporal characteristics of pain
Based on items derived from the McGill Pain Questionnaire (Melzack, 1975) and 
included in the questionnaire, pain intensity was distressing for 32.9% (n=77), 
horrible for 21.4% (n=50), discomforting for 20.5% (n=48), excruciating for 17.5% 
(n=41), mild for 5.6% (n=13), and 2.1% (n=5) had no pain. For the temporal 
characteristics, 74.4% (n=174) described their pain as continuous, 23.9% (n=56) as 
intermittent, 1.3% (n=3) as brief and 0.4% (n=l) did not reply.
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4.3.4 Location of pain and diagnosis
Respondents reported pain in numerous bodily locations, often reporting a 
constellation of other symptoms. A total of 41 specific pain regions were identified. 
The most common site of pain was the back and spine (124), followed by the legs 
(97), neck (71), shoulders (58), head (44), hips (40), feet (37), arms (35), knees (31), 
hands (28), abdomen (26), ankles (16), all over (14), elbows (14), buttocks (13), 
wrists (12), sciatic nerve (12) and chest/breasts/pericardium (12). A total of 97 
diagnoses or conditions were identified, as defined by the respondents, and substantial 
co-morbidity was recorded. The most common diagnoses reported were chronic back 
pain (n=58, 24.8%), degenerative discs and sequalae (n=54, 23.1%), arthritis (all 
types) (n=47, 20.1%), fibromyalgia (n=41, 17.5%), facial pain (n=26, 11.1%), 
endometriosis (n=25, 10.7%), headaches and migraines (n=20, 8.5%) and spondylosis 
or spondylolistthesis (n=15, 6.4%).
4.3.5 Medication and treatment utilisation and alternative medicine/ therapy use
Opioid-based drugs where used extensively for the relief of pain (206), followed by 
non-opioid analgesics (147), non-steroidal anti-inflammatory drugs (NSAIDs) (133), 
anticonvulsants (67), antidepressants (64), other drugs (25), sedatives (21), drugs for 
the treatment of arthritis (17), co-analgesics (8) and local anaesthetics (5). A variety 
of complementary/alternative therapies were also used to relieve pain, or as an 
adjuvant to pain relief. The most widely used were nutritional supplements (57), 
transcutaneous electrical nerve stimulation (TENS) (22), acupuncture (21), relaxation 
and meditation in its many forms (18), the use of hot and cold (16), massage therapy 
(14), chiropractic (11), external creams (11) and reflexology (11).
4.3.6 The QoL of web survey respondents
The content analysis is presented in table 4.1 and summarises aspects of QoL affected 
by pain from the perspective of web survey respondents and illustrates the frequency 
of individual aspects of QoL. The core domain and facet structure provided a way of 
coding the analysis. The first column of table 4.1 contains the domain and facet title 
with some examples, drawn from the qualitative data, of what this facet represents. 
The second column gives an example taken from the written narrative of the 
respondent to illustrate the relevance of the particular facet to their QoL. The 
frequencies shown in the third column give a sense of the relative salience or
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importance of particular aspects to a person's QoL and the percentages quantify the 
frequency with which facets were expressed in the narrative accounts. The length of 
the contributions made by each respondent varied and their comments representing 
each facet were only counted once. The facets highlighted in grey are the new facets 
of QoL derived from the FG work, but confirmed here, relating to pain.
The results validate the core WHOQOL facets and support the 10 new pain and 
discomfort facets derived from the FG work. Comments reflecting all core facets of 
QoL were elicited, with the exception of physical safety and security, home 
environment and physical environments. Of the core facets, the most frequently 
mentioned were activities of daily living (ADL) and the least frequent was 
opportunities for requiring new skills and information. Of the 10 new pain and 
discomfort facets, loss/ loneliness and feeling alone were the most frequently elicited 
and positive strategies were the least frequent. A small number of miscellaneous 
themes were elicited including eating and appetite, the accessibility of the 
environment and weather affecting pain, however, these were mentioned infrequently 
(<7, 3.0%).
Table 4.1 The PDM facets incorporated into the core WHOQOL domain and facet structure and the content analysis of the web survey
results (frequency refers to the number of times elicited by web survey respondents (N=234, new facets (60-69) are highlighted in grey)
Domain, facet and examples Supporting quotations Frequency
(%)
OVERALL QUALITY OF LIFE AND GENERAL HEALTH
Affects general outlook on life/ entire QoL affected
“My pain affects my whole quality of life”
“My entire life has been affected substantially”
“I have no quality of life any longer”
“My whole life seems to centre or be focused on this horrible 
pain”
“This chronic pain has taken over my whole life”
“Pain affects my entire quality of life. There isn’t a single waking 
moment that I’m always aware of this insidious creature called 
pain. Whether I’m reading, entertaining, making love, dressing or 
just trying to see the humour in all this; pain is there to steal my 
life’s moments”
43(18.4)
DOMAIN I - PHYSICAL
1. Pain and discomfort Sitting or standing for long periods painful, 
preoccupation with pain
“I cannot sit or stand for a long period of time; even minutes are 
painful”
“Sometimes all I can think about is how much I hurt”
61 (26.1)
2. Energy and fatigue Slowed down/ loss of energy/ saps energy/ get 
tired/ fatigue/ draining
“Pain of this sort saps a person of all strength”
“Constant pain drains me”
“It seems that when I am undergoing the worst of the pain I feel 
completely and totally exhausted and robbed of my strength”
58 (24.8)
3. Sleep and rest Sleep problems/ unable to rest and relax “I do not have a regular sleeping pattern because of the pain” 
“I have major problems with sleeping, it takes me hours to fall 
asleep and then the pain wakes me up continually during the 
night”
37 (15.8)
60. Flare-ups Overdoing it leads to flare-ups/ pain increases with 
activity/ activity leads to flare-ups/ pain can worsen from lack of activity/ 
pain varies/ fluctuates/ good days and bad days
“Constant pain is just unpleasant at the best of times. Flare-ups 
are beyond describing”
“I can’t keep up my housework because it causes my back to flare- 
up”
“I have to plan my life around my pain (or anticipation of pain)!”
23 (9.8)
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Domain, facet and examples Supporting quotations Frequency
(%)
61. Pain relief No comfort/ getting comfortable/ obtaining relief ‘a 
holiday away from pain’/ control of pain/ pain can control the person/ 
successful PMP can give more control over life/ ability to find relief/ 
managing pain is time consuming/ side effects of medication/ the success 
of treatment/ nervous about surgery (treatment)/ preoccupation with cure 
or feelings that it is too late to do anything
“Spend most free hours trying to relieve the pain with hot baths, 
heating pads, massage, exercise; you name it”
“I feel very frustrated and depressed all the time at not being able 
to find long-term relief’
71 (30.3)
Miscellaneous new theme Eating/ appetite “Even eating a meal can be a chore because of the pain” 6 (2.6)
DOMAIN n  - PSYCHOLOGICAL 
4. Positive feelings Happiness
“I am happy at times but I should always be happy because as a 
human being I deserve better”
3(1.3)
5. Thinking, learning, memory and concentration Cannot concentrate 
or think clearly which affects work and distracts/ affects memory
“I am unable to concentrate or to think properly”
“Pain is constant which makes it very difficult to concentrate on 
activities, which is ironic as I feel that if I could concentrate better 
it may help take my mind off the pain.”
29(12.4)
6. Self esteem Self esteem/ loss of confidence/ self image/ self worth/ 
feeling inadequate/ self-motivation/ tired of keeping going
“For years, worry about being able to work and hold down a job 
was stressing and lowered self esteem”
15(6.4)
7. Body image and appearance Weight gain due to inactivity/ body 
image/ appearance
“Weight gain affects self-esteem (and intimacy with spouse and do 
not think that because I am 70 years old this is not important or 
distressing)”
6 (2.6)
8. Negative feelings Depressed/ decreased enjoyment of life/ unhappy/ 
anxiety/ feeling downhearted and miserable/ feel low/ suicide ideation/ 
helplessness
“It often makes me feel miserable, downhearted even depressed 
sometimes”
“It is depressing to wake up to pain everyday”
“I have felt suicidal at times”
66 (28.2)
62. Anger and frustration Anger/ frustration/ loss of patience/ irritable/ 
mood changes/ mood swings/ short tempered/ annoyance
“The effects chronic pain has on my life is it makes me angry that 
I have to live this way”
“Physical activity limitations causes frustration and anger”
“I have had years of frustration over my health problems”
34 (14.5)
63. Vulnerability, fear and worry Avoidance of activities that will 
generate pain/ fear/ fear of activity/ wary of movement/ fear of losing job/ 
worry/ fear of pain/ worry and fear about the future and about treatment/ 
vulnerability/ preoccupation with pain/ suffering
“I’m so afraid I’m going to break and hurt myself’
“By far the strongest emotion is fear...fear of it getting worse, fear 
of not being able to cope, fear of my husband getting fed up, fear 
of my daughter inheriting the condition and suffering like me”
“I’m afraid to lift anything”
24(10.3)
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Domain, facet and examples Supporting quotations Frequency
(%)
64. Uncertainty Uncertainty of diagnosis/ no diagnosis/ no explanation 
for cause/ changed life and course of future/ narrowed career options/ 
unable to make plans/ plan activities around pain/ restrictions/ uncertainty 
of future and day-to-day living/ never know when the pain will come
“I can’t plan ahead as I can’t foresee how bad the pain is going to 
be next day”
“The NHS has taken nearly 14 years to come up with a diagnosis”
43(18.4)
65. Loss, loneliness and feeling alone Not able to do what once could/ 
cannot do what want or need to do/ role loss/ life will never be what it 
once was/ wasting my life/ mourn for lost life/ feel lonely/ alone/ feelings 
of isolation/ loss of self (not the person I was)/ loss of life/ struggle to 
accept new self/ lonely because of the invisibility of pain/ isolation/ 
lonely and silent condition/ reduced social life because difficult to make 
new friends/ losing old ones/ withdrawn/ feel ‘old’/ life is on hold/ 
prematurely standing still/ do not get out and do things with others/ lose 
friends because you are ‘sick’
“I’m lonely because all my body parts are present but pain is 
invisible”
“I feel very isolated”
“I miss my old life”
“Above all I have felt this is not 'ME'. I want to find the 'ME' I 
used to be again. Being trapped in a body that does not work 
properly feels like being in jail, it feels like being an alien - it does 
not feel 'right'. The person I have become is not the person I see 
myself as and trying to make peace with the 'new' person I have 
become, is terribly difficult because I do not WANT to be this new 
person at all”
“I lost my job and school scholarship as well as my normal 
lifestyle”
102 (43.6)
66. Positive strategies Hope/ hope for a cure or relief/ coping self 
statements/ acceptance
“I only hope that someday I can be free from pain”
“I am far too young to let this get me down”
“I have learned a lot about managing my pain over the last decade, 
and attitude, perceptions, beliefs and acceptance is everything” 
“My life won’t be the same ever again. I have learned to accept 
that and now look for ways to rebuild my life”
“Though pain has hindered me in many ways, I try to balance it 
out with other activities that are fulfilling”
“I find it very difficult to accept the way I am now although I try 
hard to keep a positive attitude and do as much as I can for myself 
as possible”
“Though I suffer much, I know there are others out there who’re 
much worse than I am”
15 (6.4)
Sense of humour/ use of humour to diffuse embarrassment “My prayer through all of this is that I do not lose by sense of 
humour or who I am to this pain. I have not”
2 (0.9)
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Domain, facet and examples Supporting quotations Frequency
(%)
DOMAIN III - LEVEL OF INDEPENDENCE
9. Mobility Reduced mobility/ having to think before engaging in
activity, something once taken for granted
“It prevents me from having the level of mobility I desire” 55 (23.5)
10. Activities of daily living Reduced functioning/ problems with ADL/ 
no longer enjoy or engage in physical activity/ cannot do ‘normal’ things/ 
no longer able to take care of the home/ unable to do share of chores/ 
having to pace activity/ not wanting to ask others for help with basic 
things/ do not want partner to have to compensate for them e.g. do things 
they cannot/ reliance on others
“Limits normal daily activities that ‘normal’ people enjoy”
“I was previously VERY active and self-sufficient and I can no 
longer stand in one spot long enough to even do the dishes”
89 (38.0)
11. Dependence on medication or treatments Reliance on medication/ 
dependence on pain management techniques/ use of narcotics for pain 
relief/ constantly trying different treatments/ concern about amount of 
medication needed/ attitudes towards medication (e.g. stigma associated 
with the use of opiates)/ the expense/ cost of chasing a cure or relief/ 
issues around the legalisation of cannabis and use of cannabis
“I have had to depend on pain medications for the last three years” 5 (2.1)
12. Working capacity The ability to work/ feels better when able to work 
(mentally and physically)
“I had to give up a job that I loved doing”
“My pain has forced me to stop working totally outside the home” 
“My pain keeps me from working as well as finishing my degree”
89 (38.0)
DOMAIN IV - SOCIAL RELATIONSHIPS
13. Personal relationships Personal relationships with family and
friends/ unable to get involved in family life/ family do not understand
“My family doesn’t always understand why I am unable to be 
there for them in the ways I used to be”
“I am irritable with my family”
“Pain affects the relationships I have with other people”
51 (21.8)
14. Social support Loss of independence/ having a supportive carer/ 
support from family
“My husband is wonderful, we have a college freshman daughter, 
she is also very supportive”
“It has also affected my family although they have been extremely 
supportive”
16(6.8)
15. Sexual activity Sexual activity is reduced and painful/ intimacy with 
partner
“I have no sex life (this is too painful)” 19(8.1)
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67. Communication Being understood/ believed/ listened too/ talking 
about pain/ avoidance of telling others/ hard to explain pain to others/ 
pain is ‘invisible’/ embarrassment because not able to do things/ 
perception of others, perceived as malingering/ stigma of being a 'slacker' 
when not functioning well/ trying to appear 'normal' in social situations/ 
hide feelings from others to be accepted as 'normal'/ being treated 
differently/ chronic pain is over looked and misunderstood/ others do not 
understand the inconsistency of behaviour, i.e. being able to do something 
one day, but not the next/ avoid groups in case they annoy/ anger one/ 
others acceptance of methods of pain relief
“Everyone says I look fine, and they don’t seem to understand the 
state I am constantly in”
“Sometimes feel that my pain is not believed by others”
“You try to make yourself presentable to go out into public and 
people look at you as if to say ‘what is your problem? You look 
just fine to me’. Chronic pain is a silent demon”
51 (21.8)
68. Guilt and burdening others Guilt/ worry about the effects on others/ 
worry about burdening others/ value in relationships/ affects the ability to 
care for/ help others/ unable to support/ be there for others/ family suffer 
because cannot do what I once could/ strain on family/ affect on partner/ 
grumpy and irritable with others/ more information needed for society to 
prevent them making pain patients feel they are a burden on society
“I feel I have struggled with this injury and feel very guilty toward 
my family for not being able to always join them”
34(14.5)
69. Relationship with health care providers Passed around from doctor 
to doctor/ belief that chronic pain is not recognised by the Government 
(UK)/ relationship with doctor/ dealing with doctors and health 
professionals/ support from health professionals/ loss of confidence in 
doctors/ struggle to get pain relief from doctors because of their fears of 
addiction/ reluctance to give pain relief/ being listened too, understood 
and believed/ lack of knowledge about specific conditions/ incompetent 
health professionals/ treated poorly by doctors and health professionals/ 
compassionate doctor/ doctors confuse pain with depression/ the need for 
information about cause of pain/ doctors in the US reluctant to give a 
diagnosis/ the medical profession ignores chronic pain/ anxiety about 
health professionals thinking ‘it’s all in your head’/ labelled as drug 
addict or malingerer by health professionals/ blame e.g. medical system
“I am really strong willed but the constant battle I have with the 
medical profession to be given better pain control is shocking” 
“If I am in pain I have to go without pain killers the next day 
because doctors are afraid to give proper pain control to chronic 
pain sufferers in case they get addicted to the medication”
“It saddened, then enraged me to find that so many doctors will 
readily label a person as anything from a malingerer to a drug 
addict without a second thought!”
57 (24.4)
DOMAIN V - ENVIRONMENT 
16. Physical safety and security
None None (0)
17. Home environment None None (0)
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Domain, facet and examples Supporting quotations Frequency
(%)
18. Financial resources Financial problems “I am uninsured and have no money to pursue further treatment” 
“I am financially destitute”
12(5.1)
19. Health and social care: availability and quality Difficulty getting 
benefits/ disability pensions/ feeling 'let down' by the system/ perceived 
support from the health and benefits system
“I am continuing to fight for the social security disability benefits I 
paid into for 25 years”
“The medical profession have just left me to more or less get on 
with it”
13(5.6)
20. Opportunities for requiring new skills and information Lack of 
information available on treatment and other issues/ active information 
seeking/ need for information generally/ informed self about condition to 
improve sense of control
“I also became very well informed about the condition and 
educated myself on the causes, symptoms and treatment options. 
This helped tremendously and gave me some measure of control 
over the situation”
3(1.3)
21. Participation and opportunities for recreation and leisure Life 
limiting
“I am unable to do the things that I once did; I cannot participate in 
sports any longer”
“Work induced pain restricts my ability to pursue personal 
interests”
“Can’t enjoy normal leisure activities”
94 (40.2)
22. Physical environments None None (0)
23. Transport Driving problems “I am no longer able to drive” 18(7.7)
Miscellaneous new themes Physical environment not geared up to deal 
with disability/ accessibility of the environment
“There are very few shops I can go into, most are access un­
friendly”
1 (0.4)
Weather (facial pain and rheumatic conditions) “It is worsened in cold weather, and in damp weather I have 
trouble with my lower back and hands due to arthritis” 
“When weather is cold or stormy I have pain more often”
7 (3.0)
DOMAIN VI -  SPIRITUALITY/ RELIGION/ PERSONAL 
BELIEFS
24. Spirituality/ religion/ personal beliefs Personal beliefs/ faith/ inner 
strength/ will/ the positive side/ positive thinking, learning experience, 
personal growth/ prayer and coping/ spirituality/ pray that will cope that 
day/ prayer/ emotional and spiritual needs/ self-determination
“My faith in God kept me going and gave me the confidence that I 





Respondents of the web survey elaborated upon a complex set of interrelated issues 
for each of the facets of QoL pertaining to pain. The responses covered diverse 
aspects of QoL and there was a high degree of concurrence between the views of 
those taking part. In general, support was found for the core WHOQOL facets and the 
10 new facets of QoL. Although there was evidence for a small number of additional 
themes including eating and appetite, the accessibility of the environment being a 
barrier to mobility and the weather affecting pain, these were infrequently elicited. 
The theme about the weather was described by those with rheumatic conditions such 
as RA and facial pain conditions such as trigeminal neuralgia and thus can be said to 
be idiosyncratic to particular diagnostic groups, rather than people with CP in general. 
The areas of QoL identified by respondents provided further evidence of the 
multidimensional nature of each of the new facets of QoL pertaining to pain and 
discomfort. Given that no new areas of QoL pertaining to CP emerged from 
subsequent respondent completions, it was decided that data saturation was reached.
Generally, the spontaneous elicitations of respondents gave the sense of the global 
impact of the pain on a person’s life, illustrated by the quotes supporting the general 
quality of life and health facet. Moreover, many comments seemed to capture the 
essence of the experience of living with CP by reflecting its all-encompassing nature. 
Furthermore, the narrative often illustrated the complexity and elaborateness of the 
new facets of QoL identified. For example, feelings of irritability, being short- 
tempered, a loss of patience and mood swings provided support for the different 
aspects of anger and frustration and the way in which this can impact on QoL.
The web survey results provided validation for the core WHOQOL facets of QoL. 
For example, for domain I, issues around pain and discomfort, energy and fatigue and 
sleep and rest were elicited by 16-26% of respondents, where pain and discomfort was 
most frequently mentioned. These physical health facets were expected and 
confirmed to be salient for people with pain, in addition to the two extra facets 
identified in the physical domain, flare-ups and pain relief. Flare-ups occur with 
varying frequency and this is reflected by its low frequency compared to pain relief. 
However, the experience or threat of a flare-up or temporary worsening of pain 
appears to impact on QoL. Echoing the findings reported in chapter three, the ability
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or inability to obtain pain relief have also been shown to be important to an 
individual’s QoL, in addition to issues around the side effects of medication and the 
ability to find a physically comfortable position to be in.
The evidence suggests that the psychological domain requires the most elaboration in 
order to explain the effect of pain and discomfort on QoL, with the addition of five 
new facets which are anger and frustration, vulnerability/ fear/ worry, uncertainty, 
loss/ loneliness/ feeling alone and positive strategies. The content analysis revealed 
that all of these areas were represented in the web survey results. The most frequent 
of these were feelings of loss, loneliness and feeling alone. Respondents described 
the isolation and loneliness of living with pain and the losses associated with their 
experience. Feelings of uncertainty were also common and respondents described the 
difficulty of making plans because of not knowing how they will feel. Consequently, 
uncertainty does not describe a cognitive deficit, but a logistical practical one 
reflecting an uncertain future. Anger and frustration were also commonly reported by 
respondents and were often described as a loss of patience, feeling annoyed and short 
tempered. The vulnerability, fear and worry expressed by respondents covered a wide 
range of fears and anxieties specific to pain such as fear avoidance, that is, the fear of 
movement, worry about treatment and so on. Positive strategies, which include hope 
and humour, were the least frequently reported of the new facets. Hope was elicited 
more frequently than the use of humour and on the basis of this relatively low 
frequency, particular attention will be paid to the items addressing this facet and how 
they behave during further testing. Possible explanations for the relative low 
frequency of positive strategies are that depressed respondents might be less likely to 
express positive thoughts or emotions, and that given limited time and space to 
describe how pain affects their QoL, individuals taking part in research over the 
Internet might be less likely to talk about their positive experiences.
The third domain to be elaborated was social relationships. Three new facets were 
identified and are supported by the web survey data. These are communication, guilt 
and burdening others and relationship with health care providers. Reports of the 
increasing dependence on others was associated with the experience of guilt and 
perceptions of being a burden to others and of the new facets in this domain, this was 
mentioned the least. Communication relates to being understood, believed and
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listened to, ones ability to communicate ones feelings to others and to the notion of 
the invisibility of pain. Communication represents a heterogeneous facet and later 
stages of questionnaire development will determine whether it is conceptually sound, 
or whether it might be possible to integrate aspects of this facet into core WHOQOL 
facets. Of the new facets in this domain, a person’s relationship with health care 
providers was mentioned most frequently. For example a belief that the medical 
profession ignores pain because they do not like to deal with things that they do not 
understand or know how to treat properly was evident. Related to this was the 
constant struggle to be understood and believed by health professionals in order to 
obtain the most effective treatment. There was evidence of a perception of a 
reluctance to prescribe opioid-based medications for fears of addiction, which has 
been demonstrated to be an erroneous perception (Schug, Merry and Aclanc, 1991; 
Passik and Weinreb, 2000). These issues support the notion that a person’s 
interaction with health care appears to impact considerable on their QoL.
Evidence of the importance of these additional facets to people with CP may provide 
a basis for interventions designed to modify and improve QoL in these domains. In 
the physical domain, minimising flares and providing pain relief are already central 
goals of pharmacological and pain management interventions. However, in the 
psychological domain, five new facets provide additional targets and a structure for 
minimising the impact of pain on QoL. Moreover, the social domain provides a 
forum in which to explore the role of the interaction between patients and their social 
environment, particularly the importance of communication with significant others 
and health care professionals, and how all of these issues contribute to QoL.
The web survey results also provide evidence of the psychological processes used by 
people with pain and these are illustrated by the quotes representing the facets. For 
example, the use of positive strategies included hope for relief from pain, coping self­
statements, a sense of mastery or control and acceptance of pain. Evidence of 
acceptance of pain was found in the positive strategies facet, which highlights an 
important process that might influence QoL outcomes. Given that acceptance was 
also found in the FG work reported chapter three, which concurs with evidence for the 
relationship between acceptance and adjustment to CP (McCracken, 1998), the 
relationship between acceptance and QoL is tested further in chapter eight. Educating
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oneself about the condition could be seen as a form of problem focused coping which 
enhanced a sense of life control and control over pain and its consequences and this is 
evidence of the importance of opportunities for acquiring new information and skills. 
There was also evidence for the perception of self-determination and strength in 
promoting faith in finding a solution, which can be seen as an aspect of the SRPB 
domain.
Processes identified in the discourse of the respondents also reflected the use of social 
comparison (discussed in chapter three), for example upward intrapersonal 
comparison where comparisons were made with a previous ‘able’ self. This is shown 
clearly by quotes supporting a number of facets including loss, loneliness and feeling 
alone, ADL and participation in and opportunities for recreation and leisure. These 
reveal the extent to which respondents were unable to engage in former activity levels 
and also a sense of loss of self, articulated as not being the person one once was. 
There was very little evidence of upward interpersonal comparison although support 
for the ADL facets shows use of comparison with what ‘normal’ people are expected 
to be able to do. The evidence for downward interpersonal comparisons was also 
scant, although there was an example of comparison with worse off others, which 
could be seen as a positive strategy to boost self-regard and QoL and to put one’s 
situation in perspective. Web survey respondents did not use downward intrapersonal 
comparison by comparing their current self with a time in the past when they were 
more affected by their pain. This seemed to suggest a general dissatisfaction with 
their current pain relief and control, because they did not express a time when it had 
been worse.
4.4.1 Variation amongst respondents
Although a global sense of the domination and centrality of pain and its sequalae was 
expressed and the resulting inability to pursue or attain life goals because of the 
perception that pain ‘ruled’ a person’s existence, there was variation in the 
contribution made by each respondent. This ranged from minimal comments about 
the global impact of their pain on QoL to long narratives describing its impact. There 
was tentative evidence that respondents with musculoskeletal conditions such as back 
pain tended to express more anger and frustration than other groups such as women 
with endometriosis, however, this requires further exploration. Legitimacy of
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‘invisible’ or stigmatised conditions such as endometriosis or fibromyalgia was 
consistently expressed which reflects the social consequences of pain and the complex 
interplay between a person in pain and their social world. Specifically, anxiety was 
expressed around being treated seriously and not being dismissed by health 
professionals and others. For those without a definitive diagnosis or who have a 
condition labelled by society as having a strong psychological component, a struggle 
to establish legitimacy is conveyed. Another general observation was that some 
respondents appeared to give psychologically literate accounts providing explanatory 
theories of their experience. However, this was not typical, but could perhaps be part 
of a coping repertoire characterised by coping self statements and information 
seeking, or indeed be gleaned from extensive interaction with health care resources or 
attendance at a Pain Management Programme and so on. In light of these 
observations, elucidating the important emotional correlates of pain for different 
diagnostic groups could be useful in targeting psychosocial interventions.
There was some suggestion of cross-cultural differences in the data. An example of 
this was the difference between the National Health Service in the UK and the system 
of health care in the USA. Specifically, the health care system in the UK is free at the 
point of access, which contrasts with respondents from the USA who elicited 
comments about the difficulty obtaining narcotics and other medications for pain 
relief, which was accompanied by a degree of frustration. This was not a prevalent 
view held by UK respondents. Although respondents from both countries described 
their relationship with health care providers as important, the nature of this 
relationship was different. Related to this issue, comments made by respondents 
pertaining to financial resources differed, in that the cost of obtaining satisfactory 
treatment was an issue for people from the USA, but not for those in the UK. 
Although the sample does not allow for robust conclusions about cross-cultural 
differences to be drawn, this highlights the importance of contextual factors when 
considering a persons’ QoL and of developing culturally appropriate items for 
outcome measures.
4.4.2 Contrasting the FG and web survey
The aim of this investigation was to provide evidence to support the facets identified 
by the FG work, to ensure that other important facets had not been overlooked. This
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is a novel and innovative approach to collecting data about the QoL of people with 
pain and provides an international data set. Moreover, the web survey provided 
anonymity and individuality of response in contrast to the face-to-face dynamic 
interaction and consensus of the FG’s. Unlike FG participants, web survey 
respondents were more geographically dispersed and had no prior knowledge of the 
core WHOQOL domains and facets, which meant that comments were elicited 
spontaneously. In contrasting the sample, the web survey respondents were younger 
(44.15) than the FG participants (49.41) and a greater proportion were female. People 
with musculoskeletal conditions, such as LBP comprised the largest proportion of 
both samples although the FG participants had pain of longer duration. The main 
differences to emerge in comments addressing the question about QoL were those 
relating to the cross-cultural issues discussed above. Additionally, the frequency with 
which loss, loneliness and feeling alone was elicited amongst web survey respondents 
was greater than the extent of its coverage by FG participants. This could be 
explained by the characteristics of Internet users, but is nonetheless an important 
difference to emerge from the use of these diverse methods. Web survey respondents 
and FG participants used comparative strategies when articulating aspects of their 
QoL, although there was less evidence of upward interpersonal comparison, 
downward interpersonal comparisons and no evidence of downward intrapersonal 
comparison in the web survey data. Both samples used upward intrapersonal 
comparison frequently when describing what they were longer able to do, which has 
emerged as an important aspect of decision making about QoL. The group context of 
the FG may have promoted the use of comparative strategies such as downward 
interpersonal comparisons to boost self-regard and to show others in the group that 
they were coping. The need to express such strategies may have been less important 
for the individualised and anonymous nature of the web survey.
4.4.3 Critique
Potential drawbacks and assumptions relating to the qualitative data derived from this 
methodology must be considered. Firstly, the respondents were self-selected, that is, 
there was no control over who accessed the web survey and which individuals 
completed it. There is sufficient complexity in the questionnaire structure to make it 
difficult for any potential hoax respondents to complete it. Furthermore, although an 
increase in Internet use has been observed in many countries worldwide, there may be
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biases associated with the types of individuals who have access to, use and explore the 
Internet. Respondents were asked an open-ended question about how their pain 
affected their QoL and the response to this question was variable and the extent to 
which individuals elaborated on this concept varied, highlighting the drawbacks of 
unstructured methods. Consequently, if an aspect of QoL was not expressed, it cannot 
be assumed that this was not important, or indeed affected by a person’s pain. For 
example, positive emotions were infrequently articulated, which does not demonstrate 
an absence of these emotions, but that these emotions were not salient at the time of 
completion. Additionally, it might reflect the tendency of people to describe the 
consequences of health conditions in negative ways. Several respondent narratives 
expressed suicidal thoughts, which are likely to represent a subset of depressed 
respondents who were able to express these thoughts and feelings through the 
relatively anonymous medium of the Internet. Given the anonymity of the responses 
it was not possible to give responses to people expressing such thoughts. Respondent 
generated approaches such as this have clinical value, given that patient priorities are 
reflected and this is a similar approach to the respondent-generated instruments 
discussed in chapter two, such as the SEIQoL, which asks people to state the five 
most important aspects of their QoL (McGee et al., 1991).
The order of questions may also have influenced responses since respondents had 
been primed with questions about their pain, which may have generated negative 
feelings and thus produced negative responses to the question about their QoL. There 
are a disproportionately large number of US and UK respondents in the sample, which 
will have introduced bias because there are well known cross-cultural differences in 
the experience and expression of pain (Sanders et al., 1992; Bates et al., 1995; Nelson 
et al., 1996) and consequently limits the extent to which cross-cultural conclusions 
can be drawn. Given the size of the sample representing other countries (n=17, 
7.3%), making reliable comparisons or generalising to other cultures is not possible. 
Exploring the potential differences in QoL cross-culturally is a central aim of the 
WHOQOL work and exploring differences in the impact of pain on QoL is an 
important goal of future studies. As with any cross-sectional study, the data was only 
collected at one time point and provides a snap shot of one group of individuals’ QoL. 
In general, these issues highlight some of the methodological challenges involved in 
conducting research using the Internet.
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4.4.4 Conclusions
This work reinforces the notion of QoL as a multidimensional concept and 
complements and validates the FG work outlined in chapter three, by confirming the 
10 new facets of QoL. Furthermore, data saturation improved confidence that nothing 
of importance had been missed during the FG’s. The web survey reveals the way in 
which people from diverse cultural contexts with a wide range of conditions describe 
the impact of pain on their lives. The qualitative data can be used as contextual 
material to elaborate the definitions of the 10 new facets pertaining to the QoL of 
people with pain and discomfort. Using the Internet is a novel method for collecting 
data from people with health conditions from countries worldwide. Future work 
could expand the debate about computer-assisted technology and explore further the 
use of the Internet as a research tool for reaching a broad sample of people cross- 
culturally, withstanding the inherent drawbacks of using this type of sampling and 
methodology. Future research might therefore focus on minimising the limitations 
inherent in using the Internet to collect data and further explore cross-cultural 
differences in QoL relating to pain both within and between cultures. Given that there 
are now more than 30 language versions of the WHOQOL-100, replicating this work 
in other languages this is an important goal. The research reported in this and the 
previous chapter represents the preliminary stages of developing a PDM to be used in 
conjunction with the WHOQOL-100. Chapter five details the process of 
questionnaire development, including the construction of facet definitions and items.
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Chapter five 
Stages of Questionnaire Development I:
Definition Construction and Item Writing
5.1 Introduction
Chapters three and four provided the empirical and conceptual foundations to the 
development of the pain and discomfort module (PDM) and provided evidence for the 
clustering of issues to become new facets of quality of life (QoL). The purpose of this 
chapter is to build on and expand the pain and discomfort focus group (FG) work and 
the web survey by describing the process of developing definitions pertaining to the 
10 new facets and the construction of items (questions) relating to these definitions.
5.2 Methodology
5.2.1 Writing definitions for the new pain and discomfort facets
Each of the 24 WHOQOL facets is accompanied by a definition to describe and 
elaborate its meaning. The process of writing definitions to address the new facets 
followed the same basic structure as the core facets (an example is given in figure 
5.1), which were developed through meetings of WHO consultants and field centre 
investigators, and through the FG work previously described (WHO, 1992; WHO, 
1993). The WHOQOL facets were originally conceptualised as ‘a description of a 
behaviour, a state of being, a capacity or potential, or a subjective perception or 
experience’ (WHOQOL Group, 1995). Each facet was given a conceptual definition, 
a description of various indicators or dimensions along which a rating can be made, 
and a list of situations or conditions, at various levels of intensity, that might affect 
that facet (WHOQOL Group, 1995). Figure 5.1 gives the facet definition, examples 
and items for the pain and discomfort facet to illustrate this. The goal was to use the 
core definitions as a guide to conceptualise each new facet in a narrative description, 
to clarify its meaning and coverage, including what the items will attempt to address, 
what it relates to in terms of the subjective experience of the target group and to say 
something about why it was conceptually distinct from the core facets. Thus, the 
format of the new definitions is consistent with the core definitions. The contextual 
material from the FG work and the web survey informed the content and nature of the 
definitions.
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5.2.2 Writing items for the new pain and discomfort facets
Items for the core WHOQOL were derived from the suggestions o f health 
professionals and patients who took part in the FG’s held in each o f the field centres 
(WHO, 1993). Consistent with the WHOQOL Group protocol, following analysis o f 
the transcribed FG’s and construction o f a definition for each o f the 10 facets, the 
process o f item writing was undertaken. The goal o f this process was to write items 
pertaining to pain related QoL, based on the evidence provided by the FG transcripts. 
The phrasing o f items used by FG members was used as far as possible to ensure that 
items were framed in a comprehensive way and are understandable by the user 
population. The criteria used for the development o f the original W HOQOL-100 
items used by the writing panel are detailed in table 5.1 (WHO, 1993). Based on this, 
items pertaining to the QoL o f people with chronic pain (CP) should adhere to these 
criteria. Consequently, each facet definition is accompanied by a set o f  items 
generated with consideration o f the criteria. Four items address each facet in the core 
WHOQOL.
Table 5.1 Criteria for the development of WHOQOL items
Be based as far as possible on the suggestions of patients and health personnel participating in
the FG’s_______________________________________________________________________
Give rise to answers that are illuminating about the respondents’ pain and discomfort
related QoL, as defined in this project______________________________________________
Reflect the meaning conveyed in the facet definition___________________________________
Cover, in combination with other items for a given facet, the key aspects of the facet as
described in the facet definition____________________________________________________
Use simple language, avoiding ambiguity in terms of either wording or phraseology_________
Be shorter rather than longer______________________________________________________
Avoid double negatives__________________________________________________________
Be amenable to a rating scale______________________________________________________
Enquire about a single issue_______________________________________________________
Avoid any explicit reference point either in terms of time or in terms of some comparison
point (for example, the ideal or before I was ill)_______________________________________
Be applicable to individuals from the main diagnostic groups who have CP and with a
range of impairment_____________________________________________________________
Be phrased as questions and not as statements________________________________________
Reflect the typology of questions adopted for the project_______________________________
Where possible items must be framed in a positive way________________________________
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5.2.3 Derivation of items
FG participants found the task of generating questions pertaining to the new areas of 
QoL they had identified a challenge. Consequently, the process of item writing 
departed from the WHOQOL procedure and instead items were generated by using 
the language of participants and by using the core WHOQOL items as a guide to 
structure, length and so on. Furthermore, a form of triangulation was used, by 
utilising the items pertaining to pain and chronic illness from the original international 
pool of items (WHOQOL, 1993). Some of these items were similar to the items 
derived through the work reported here and thus provided a way of validating and 
improving the items generated. Those items that were most relevant to pain and 
discomfort where selected and items were excluded if they were repetitions of other 
items, the response scales did not match the items, they were too general or that they 
asked about Tiow often' a person experienced something. This latter question type 
makes the assumption that the frequency of something affects a person's QoL, without 
enquiring as to whether a person is bothered by something. This assumption can only 
be made with aspects that are unambiguously problematic, for example, the presence 
of negative feelings such as anxiety or depression. This provided a rationale for 
excluding certain items and retaining others from the original WHOQOL work. Each 
new facet included at least five items to begin with in order to identify the best items 
from this pool during subsequent stages of development.
5.2.4 Likert scales
Each WHOQOL item is answered on five-point Likert response scale, where each 
scale point has a verbal descriptor. There are five such response scales that address; 
how much and how completely a person has experienced something, how satisfied, 
happy or good they have felt about a particular aspect of their life, how often they 
have experienced something, how poor or good something is and how important 
various aspects of their life are. The response scale type and anchor points are shown 
in table 5.2 (Szabo, Orley and Saxena, 1997). Work in each of the WHOQOL centres 
established the most suitable verbal descriptors corresponding to the ‘2’, ‘3’ and ‘4’ 
scale points, which correspond to 25mm, 50mm and 75mm between the lower anchor 
point (0mm) and the upper anchor point (100mm) (Skevington and Tucker, 1999). 
Skevington and Tucker asked a quota sample of 20 people in Britain to assign 15 
verbal descriptions to 100mm lines for each of the 4 types of response scale. The
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anchor points representing ‘1’ and ‘5’ had been agreed internationally by the 
WHOQOL Group. After mean and standard deviations (SD) had been calculated for 
each label, the label with the closest mean and smallest SD were selected for each 
scale point, that is, those words whose average ratings were closest to the scale points. 
This provided a set o f 5-point interval response scales where the scale points are 
equidistant (Skevington and Tucker, 1999). Consistent with this item-scale format, 
appropriate response scales were added to the items pertaining to each new facet. 
This was done by selecting the scale that best fitted the nature o f  the question being 
asked, for example whether they were asking about the degree or extent to which an 
aspect o f QoL is experienced, their capacity to experience something, the frequency 
o f something or a person’s appraisal or evaluation o f  an aspect o f their QoL.
Table 5.2 Response scales used in the WHOQOL instruments (Szabo, Orley and 
Saxena, 1997)
Type Anchor points
Intensity Not at all Extremely
Capacity Not at all Completely
Frequency Never Always
Evaluation Very dissatisfied Very satisfied
Evaluation Very poor Very good
Evaluation Very unhappy Very happy
Importance Not important Extremely important
5.2.5 Importance items
It has been demonstrated (Skevington, O'Connell and the WHOQOL Group, 2004) 
that establishing the importance o f an area o f QoL to a person is an invaluable way o f 
understanding a person’s QoL in terms o f the observed discrepancy between how a 
person rates a core item o f QoL and the importance that individual attributes to it. 
Facets, rated by their corresponding importance item, must be rated at 3.0 o f above on 
a five-point Likert scale to be considered for inclusion in a QoL instrument o f this 
kind (Skevington et al., 1997). Despite inevitable individual variation, all facets in a 
generic QoL instrument such as the WHOQOL should be important to all potential 
respondents and not idiosyncratic to particular groups and Saxena and colleagues 
(2001) have demonstrated that all o f the core facets are important to sick and well 
people. Consequently, in addition to writing items representing the new facets, a set 
o f importance items were also written corresponding to each new facet as a way o f 
ensuring that each facet is important to people with CP. As with the items 
representing the facets, the structure o f the importance items was based on the
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phrasing and format of the core importance items. The importance items 
corresponding to each facet are shown in the results below. In subsequent stages of 
development, these importance items will be used to assess the importance of each 
new facet and to explore the discrepancy between the importance of an area of QoL 
and the extent to which it is compromised by living with persistent pain.
5.2.6 The pain and discomfort facet, an example
The definition describing the pain and discomfort facet in the core WHOQOL is 
shown in figure 5.1 (WHOQOL Group, 1995). Two examples and four items follow 
the definition. These items are comprehensive and are applicable to all individuals 
regardless of whether or not they have pain, consistent with the generic nature of the 
core WHOQOL. They address how often a person suffers pain, how much they worry 
about it, whether or not they can ‘handle’ pain and whether their pain prevents them 
from doing what they need to do. The item asking about whether a person can 
‘handle’ pain is a good example of how items reflect the vernacular, however, it also 
shows the potential problems involved in translating instruments into different 
language versions, a problem that the WHOQOL Group has overcome by the method 
of simultaneous development in different cultural centres (The WHOQOL Group, 
1994; Bullinger, 1994).
5.2.7 Refinement of the items
Following the process of item writing described above, the list of items was further 
refined based on the readability and face value of the items. Consideration was given 
to whether an item asked about an aspect of QoL in an unambiguous way and which 
items best asked about that particular aspect, and this was done by assessing the face 
validity and clarity of the items. It was also necessary to establish whether items 
would require reverse scoring depending on the valance of the item, that is, whether it 
was phrased positively or negatively. It is not always possible to ask about pain in a 
positive way, and thus for negatively phrased items, scores need to be reversed. 
Indeed, all the items representing the pain and discomfort, negative feelings and 
dependence on medication or treatments facets in the core WHOQOL require reverse 
scoring, as do a number of other items representing other facets. Eliminating any 
ambiguity at this stage was essential to prevent problems with scoring at subsequent 
stages.
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Figure 5.1 Facet definition, examples and items for the pain and discomfort facet 
(WHO, 1995)
Facet 1. Pain and discomfort
This facet explores unpleasant physical sensations experienced by a person and, the 
extent to which these sensations are distressing and interfere with life. Questions within 
the facet include the control the person has over the pain and the ease with which relief 
from pain can be achieved. The assumption is made that the easier the relief from pain, 
the less the fear of pain and its resulting affect on QoL. Similarly changes in levels of 
pain may be more distressing than pain itself. Even when a person is not actually in 
pain; either through taking drugs or because the pain itself is by its very nature on and 
off e.g. migraine, his/ her QoL may be affected by the constant threat of pain. It is 
acknowledged that people respond to pain differently, and differing tolerance and 
acceptance of pain is likely to affect its impact on QoL.
Unpleasant physical sensations such as stiffness, aches, long-term or short-term pain, or 
itches are included. Pain is judged to be present if a person reports it to be so, even if 
there is no medical reason to account for it.
Examples
• A person with intermittent severe migraine with possible threat of severe pain as the 
major feature
• A person with rheumatoid arthritis.
Items
How often do you suffer pain?
How much do you worry about pain and discomfort?
How difficult is it for you to handle pain or discomfort?
How much do you feel that pain prevents you from doing what you need to do?
Importance item
How important to you is it to be free of any pain?
5.3 Results
5.3.1 Definitions, examples and items
In order to ensure consistency, the definitions, examples and items presented for each 
of the new facets follows the format of the core WHOQOL facets shown by the 
example of pain and discomfort in figure 5.1. The definitions are longer and more 
detailed than the core WHOQOL definitions in order to provide sufficient depth and 
to detail their conceptual distinctiveness. For each new facet, 2 or 3 examples are 
given to illustrate what the facet represents and these were based on the experiences 
of FG participants. The items pertaining to each facet and their response scales are 
tabulated below each definition and set of examples (tables 5.3- 5.12). The item code
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is given in the column on the right. When followed by an T  this indicates that the 
item was taken from the original item pool, but did not form part of the final core 
instrument (WHOQOL Group, 1993). All definition, example and item blocks are 
arranged under their parent domain. The facets have been allocated the numbers 60- 
69 to distinguish them from ongoing WHOQOL work on the development of other 
modules.
5.3.2 Domain I -  Physical domain 
Facet 60. Flare-ups definition
This facet describes the temporary worsening or exacerbation in condition that 
characterises living with long-term pain, and the extent to which these flare-ups are 
distressing and interfere with life. Items ask about the extent to which a person 
worries about, or is bothered by these flare-ups. It is assumed, but may not always be 
the case, that a flare-up will have a negative affect upon QoL. Fear of a flare-up may 
be as distressing as the pain experienced during a flare-up. Flare-ups may follow 
over-activity, an increase in psychological distress or may be experienced without any 
obvious aetiology and be quite spontaneous in presentation. Flare-ups are also 
characterised by living from one day to the next without knowing how much pain one 
will be experiencing, what one will be feeling or what one will or will not be able to 
do because of the pain. These flare-ups have implications for a person’s QoL directly 
and more broadly, for example, through uncertainty, which is dealt with in 
'Uncertainty' (facet 64).
The opposite of experiencing flare-ups would be a condition that does not have the 
temporary or severe worsening which characterises flare-ups, for example, living with 
a painful condition that is relatively stable or unchanging. This facet is conceptually 
different from the core pain and discomfort facet because it addresses a specific 
consequence of living with long-term pain, not the actual pain and discomfort per se.
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Examples
■ A person with chronic lower back pain who experiences a temporary worsening or 
flare-up following light exertion or lack o f sleep.
■ A person with chronic rheumatoid arthritis who experiences a flare-up following 
emotional distress, illness such as a cold or flu, in response to the changing 
seasons or without any apparent precipitating event.
Table 5.3 Items and response scales for flare-ups
How much Code
1. To what extent do flare-ups affect your QoL? (F60.1)
2. To what extent do you worry about experiencing a flare-up? (F60.2)
3. How much are you bothered by flare-ups? (F60.3)
4. To what extent does your pain vary over time? (F60.4)
5. How much do changes in pain bother you? (F60.5)
How important
1. How important is it to you to be free from flares in your pain? (Imp60.1)
2. How important is it for you to be free from changes in your pain? (Imp60.2)
Facet 61. Pain relief definition
This facet is concerned with whether a person living with long-term pain is able to 
experience a reduction in perceived pain through the means that are available to them. 
Items ask about the extent to which a person is able to obtain relief from, or control 
pain and discomfort and the extent to which this contributes to a person’s QoL, for 
example, through the use o f medication, treatments, psychological techniques or any 
other available strategy, conventional or otherwise. This also includes a person’s 
ability to find a physically comfortable position to be in, regardless o f whether they 
are sitting, standing, lying down or engaging in activity. It is acknowledged that 
finding and remaining in a comfortable position is problematic for those with pain 
(particularly musculoskeletal in origin), who often have to keep adjusting their 
position. A person may still be in considerable pain, but a comfortable position is one 
that reduces any further discomfort and does not exacerbate existing discomfort. This 
facet also covers the broad range o f side effects experienced by those taking 
medication or having treatment to control, reduce or assist management o f pain. It 
includes any adverse physical, cognitive or psychological consequences o f taking 
medication or having treatment and their relationship to a person’s QoL. Items ask 
about the extent to which these side effects are bothersome, worrying or cause 
physical or psychological distress.
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The key issue is whether a person perceives a reduction in, or feels able to control 
pain, and its relationship to QoL. Whether a person is able to obtain relief from pain 
is not covered by the core WHOQOL since it is specific to those who are experiencing 
pain and it would not be appropriate to ask a person not in pain this type o f question. 
Similarly, it is distinct the core pain and discomfort item asking about whether a 
person is able to 'handle' pain because this implies coping with pain rather than pain 
control and relief specifically. This facet does not address a person’s dependence on 
medication as the core WHOQOL covers this aspect o f QoL.
Examples
■ A person who has tried a new treatment, medication or strategy for the first time 
and experiences a degree o f relief and enhanced control, regardless o f the level o f 
relief experienced.
■ A person who is able to find a comfortable position by sitting in a particular chair, 
resting on an orthopaedic bed or using a particular type o f pillow.
Table 5.4 Items and response scales for pain relief
How much Code
6. To what extent do the treatments available to you offer you relief from pain? (F61.1)
7. How much control do you have over your pain? (F61.4i)
8. To what extent has having treatment improved your QoL? (F61.6i)
9. How easy is it for you to get into a comfortable position? (F61.7)
10. How much are you bothered by taking medication? (F61.8)
11. How much are you bothered about the side effects of medication? (F61.9)
How completely
57. How well do you cope with your level of pain? (F61.3i)
How satisfied
63. How satisfied are you with your ability to obtain relief from pain? (F61.2)
64. How satisfied are you with the control of your pain? (F61.5i)
How important
3. How important is it for you to be able to obtain relief from pain? (Imp61.1)
4. How important is it to be able to control your pain? (Imp61.2)
5. How important is it for you to be able to find a comfortable position? (Imp61.4)
6. How important is it for you to be free from the side effects of treatment? (Imp61.5)
5.3.3 Domain II -  Psychological domain 
Facet 62. Anger and Frustration definition
This facet describes the emotional responses to living with pain. Anger is usually 
experienced as extreme displeasure and may be a feeling or an expression. Anger 
may be an emotional reaction to the pain itself or more broadly, a reaction to the 
consequences o f pain. It may be directed or expressed inwardly to the self, or
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outwardly to others, and may itself generate distress. Frustration is characterised by 
feelings o f irritation, agitation and annoyance and may be a consequence o f the pain 
itself or the consequences o f what the pain prevents one from doing, that is, the pain 
may prevent one from achieving a desired or necessary goal. Frustration may result 
from being unable to control the pain, being unable to carry out activities o f daily 
living (ADL) or by ones relationship with other people and so on. O f central 
importance is the presence or experience o f  anger and frustration and the 
consequences o f this for the individual.
Questions are framed so as to address the extent to which anger and frustration are 
bothersome and interfere with everyday life. Anger and frustration are distinct from 
the item asking about the presence o f  negative feelings since they are the specific 
emotional consequences o f living with pain. Consequently, they are not synonymous 
with depression, blue mood or sadness and may be experienced transiently or 
intermittently.
Examples
■ A person with chronic low back pain may experience or express anger and 
frustration because they do not have a definitive diagnosis.
■ A person with pain may be frustrated by unsuccessful attempts to achieve 
satisfactory pain relief.
Table 5.5 Items and response scales for anger and frustration
How much Code
12. How much are you bothered by feelings of anger? (F62.1)
13. How much do feelings of anger interfere with your every day life? (F62.2)
14. To what extent do feelings of anger affect your relationships with other 
people?
(F62.4)
15. How much do feelings of frustration bother you? (F62.6)
16. How much do feelings of frustration interfere with your everyday life? (F62.7)
How often
74. How often does your pain make you feel angry? (F62.3)
75. How often does your pain make you feel irritable? (F62.5)
How important
7. How important is it for you to be free from anger? (Imp62.1)
8. How important is it for you to be free from frustration? (Imp62.2)
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Facet 63. Vulnerability/ fear/ worry definition
This facet describes how people living with pain may feel vulnerable, fearful and 
worried. This may relate to physical or psychological aspects of a persons experience. 
For example, people may feel physically vulnerable in particular situations because 
their problems with mobility generate fear of further damage or injury. Similarly, fear 
of further pain or exacerbations of pain from engaging in activity may be experienced. 
Furthermore, a perception that others might criticise or challenge them may bring 
about feelings of vulnerability. This facet also addresses worries associated with 
living with CP. Worry might be quite specific or general depending on the context. 
For example, a person may have worries regarding the need to take medication. This 
may include the worry about the potentially adverse long-term affects of taking 
medication, the concern that medication may lose its efficacy over time or the concern 
about the social stigma attached to taking medication. Treatment beliefs and the lay 
referral network may be an important aspect of this facet, since they may serve to 
perpetuate any worries a person is having in the absence of professional advice.
The worries a person has about their pain and discomfort and its consequences are 
distinct from the presence of negative feelings. Vulnerability and fear are distinct 
from physical safety and security, mobility and negative feelings since they deal 
specifically with the emotional consequences and experience that characterises living 
with long-term pain, which these core facets do not capture.
Examples
■ A person with rheumatoid arthritis who goes out shopping may feel vulnerable in a 
crowd of people where they could be knocked or bumped.
■ A person with chronic lower back pain who fears certain movement such as 
bending or reaching.
■ A person without a definitive diagnosis who worries about having a malignancy.
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Table 5.6 Items and response scales for vulnerability/ fear/ worry
How much Code
17. How much are you bothered by feelings of vulnerability? (F63.1)
18. How much do feelings of fear bother you? (F63.2)
19. How much do feelings of vulnerability interfere with your everyday life? (F63.3)
20. To what extent do you feel threatened by the possibility of pain? (F63.4i)
21. How afraid are you of experiencing pain? (F63.5i)
22. Are you distressed by the fear of pain? (F63.6i)
23. How much are you bothered by feelings of worry? (F63.7)
24. How much do you worry about having treatment? (F63.8)
How important
9. How important is it for you to be free from feelings of vulnerability? (Imp63.1)
10. How important is it for you to be free from fear? (Imp63.2)
11. How important is it for you to be free from worry? (Imp63.3)
Facet 64. Uncertainty definition
This facet is a higher order or cognitive process that is affected by living with CP, 
describing the uncertainty associated with living with a chronically painful condition. 
Uncertainty is a psychological construct to describe situations where the outcome is 
either not known or is outside o f  a persons control. For example, a person may be 
uncertain about whether they will always be in pain, about the efficacy o f treatments 
or about whether they will be able to carry out a particular activity from one day to the 
next. More specifically, the future is uncertain. To make plans for the future a person 
must have a certain amount o f control over whether it will be possible for them to 
carry out the planned activity when the time comes. It is not the process o f making 
plans per se that is affected, but the ability to execute the plans at the time that one 
had intended. This uncertainty has an affect on a person’s QoL through its personal 
and social consequences. As part o f the adjustment process, it might be possible that 
the ability to make future plans becomes less important since it is not possible to do 
this any longer, for example, as a result o f re-conceptualising inner standards and 
priorities through a response shift (discussed in chapter two).
Items addressing this facet ask about the extent to which uncertainty interferes with 
everyday life and satisfaction with the ability to make plans for the future. Although 
uncertainty is conceptualised as a negative experience, it is distinct from negative 
feelings because it is concerned with the awareness o f an uncertain or less certain 
future and the extent to which this is bothersome and interferes with life.
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Examples
■ A person with a recent diagnosis is uncertain o f their future, how quickly their 
condition will deteriorate and how their pain and disability will change their 
lifestyle.
■ A person with pain may be reluctant to make plans to meet a friend in case they are 
not able to honour the arrangement.
Table 5.7 Items and response scales for uncertainty
How much Code
25. How much does uncertainty about the future interfere with your everyday 
life?
(F64.2)
26. To what extent do difficulties with planning affect your everyday life? (F64.4)
27. Does pain prevent you from doing what you want to do? (F64.6i)
28. Does pain or discomfort limit your life? (F64.7)
How completely
58. To what extent does your pain prevent you from making plans? (F64.3)
How satisfied
65. How satisfied are you with your ability to make future plans? (F64.5)
How often
76. How often do feelings of uncertainty bother you? (F64.1)
How important
12. How important is it for you to be free from uncertainty? (Imp64.1)
13. How important is it to you to be able to make plans for the future? (Imp64.2)
Facet 65. Loss/ loneliness/ feeling alone definition
The facet is a psychological construct used to describe the emotional reaction to the 
absence o f something that formerly belonged to somebody, for example, the loss o f 
function, loss o f mobility, loss o f role, loss o f social relationships. The emotional 
reaction to the absence o f these is loss and the consequent disadvantages associated 
with this loss. It is the perceived negative consequences o f this that may have an 
effect on QoL, including associated disability and being unable to carry out the 
activities that one once could.
This facet also describes the feeling o f being lonely rather than being alone per se. 
Being alone assumes the absence o f others, whereas being lonely or isolated implies 
an emotional reaction toward being alone. A person living with pain may feel that 
they are the only one suffering from pain or their particular condition and as a 
consequence feel isolated and lonely regardless o f whether they perceive that they 
have good social support. It concerns feelings about ones emotional isolation from 
others and that one might be alone in ones suffering.
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Items include the extent to which a person is bothered by not being able to carry out 
the tasks they were previously able to do. This can range from simple ADL to more 
complex activities such as playing sport or going to the theatre. This may be a form 
o f intrapersonal social comparison (discussed in chapter three), that is, what one was 
able to do in the past acts as a reference point to what one is able to do now. This is 
often accompanied by thoughts about the repertoire o f activities that one will not be 
able to do in the future (including catastrophic thoughts), although this facet does not 
specifically address the future. Other items address the extent to which a person feels 
lonely.
This facet is distinct from the ability to carry out ADL, mobility and so on because it 
addresses the sense o f loss associated with the changes brought about by living with 
persistent pain. Furthermore, it is distinct from personal relationships and social 
support because it describes the social and or emotional isolation or loneliness that 
might be a consequence o f living with pain, as it should not be assumed that 'being 
alone' per se has a negative affect on QoL.
Examples
■ A person may no longer be able to fulfil their social or occupational role and may 
experience loss and isolation as a result o f this.
■ A person with rheumatoid arthritis feels that they are alone in their suffering.
Table 5.8 Items and response scales for loss/ loneliness/ feeling alone
How much Code
29. How much are you bothered by feelings of loss? (F65.1)
30. How much do feelings of loss interfere with your everyday life? (F65.2)
31. To what extent are you bothered by not being able to carry out the activities 
that you used to do?
(F65.3)
32. How much are you able to carry out the activities that you once could? (F65.4
33. To what extent do feelings of loneliness bother you? (F65.6)
34. How much does being alone bother you? (F65.7)
How completely
59. How lonely do you feel? (F65.5)
How important
14. How important is it for you to be free from feelings of loss? (Imp65.1)
15. How important is it for you to be able to continue carrying out the activities 
that you once could?
(Imp65.2)
16. How important to you is it to feel that you are not alone? (Imp65.3)
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Facet 66. Positive strategies definition
This facet is characterised by the ability to see the humorous side of events or 
experiences and also describes a form of optimism or expectation for the future that a 
person’s situation will improve. These strategies may represent dispositional 
tendencies or, if they are effortful, coping strategies or processes. A sense of humour 
may be more characteristic of those who perceive themselves to be coping well or 
those who are at later stages of the illness trajectory or who have had a long ‘pain 
career’. It incorporates those people whose QoL is enhanced by the ability to see the 
humorous side of their adverse experience. The concept of hope addresses the belief 
that, at some point in the future, there will be a possible cure or possibility of pain 
relief and it is a form of optimism that the future may be pain free. This might take 
the form of a new drug, therapy or novel approach that has not yet been tried by the 
person with pain. For example, a person might hope that there will be a cure for their 
condition, a pill that will take their pain a way or that they will not continue to lose 
their function or mobility. In the absence of hope an individual might experience 
hopelessness. It is possible that this would occur in a subset of clinically or sub 
clinically depressed patients and people experiencing suicide ideation. The opposite 
of hope is resigned acceptance that the person will always be in pain.
Items address how much hope and humour helps people to deal with their problems 
and how hopeful and optimistic people feel about the future. Although it is not 
assumed that these represent adjustment or adaptation, hope and humour are 
conceptualised as positively valanced strategies. Positive strategies are distinct from 
the core positive feelings facet because they represent specific beliefs and strategies 
held and used be people with pain rather than the general experience of positive 
feelings.
Examples
■ A person may be able to find humour in what they are unable to do for themselves.
■ A person with rheumatoid arthritis might hope that the current advances in medical 
technology and research will bring about a cure for their condition.
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Table 5.9 Items and response scales for positive strategies
How much Code
35. How much does humour help you to deal with your problems? (F66.2)
36. How much do you hope for relief from pain? (F66.3)
37. How much does hope for relief from pain improve your QoL? (F66.4)
38. How much do you experience feelings of hope? (F66.5)
39. How hopeful and optimistic do you feel about the future? (F66.6i)
40. How much does hope and optimism help you to deal with your problems? (F66.7)
How often
77. How often are you able to see the humorous side of things? (F66.1)
How important
17. How important to you are feelings of hope? (Imp66.1)
18. How important to you is having a sense of humour? (Imp66.2)
5.3.4 Domain IV -  Personal/ social relationships domain 
Facet 67. Communication definition
This facet concerns living with an invisible condition and the consequences this has 
for people living with pain. As pain is not visible to others, communication 
encompasses the extent to which a person feels that the people around them 
understand them, and the extent to which this affects their QoL. It includes whether a 
person feels that others understand the nature o f their condition and the extent to 
which it impacts on their lives. This is also concerned with whether the person with 
pain feels that others listen to them in order to facilitate that understanding. Related 
to this is the ability o f somebody to communicate their feelings and needs to other 
people and the extent to which any difficulties affect a person’s QoL. This might 
include whether somebody feels able to talk about their pain to others, whether 
somebody is able to convey to another person how they are feeling as a consequence 
o f having pain, whether a person feels comfortable to do so, and whether they have 
the psychological or cognitive resources to do so. This facet also covers whether a 
person is able to communicate their needs to the significant people around them. 
However, no assumption is made about whether or not communicating feelings is 
beneficial or not. Integral to this facet is the value the person with pain places on how 
other people see them and how this affects their QoL. The perceived views o f others 
towards self are an integral part o f identity and can have an impact on a person’s QoL.
The opposite o f aspects o f communication and identity, would be having an illness or 
condition that others can see clearly and where the physical signs 'speak for 
themselves' or a situation where a person feels that the significant people in their life 
understand and respect the consequences that pain has on their lives. For example, it
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would be clear to people that a person with a leg in plaster, would have a broken leg, 
and people would react accordingly. This facet also highlights the limited public 
understanding o f chronically painful illness, which is in conflict with the acute 
medical model o f curing non-malignant disease or relieving pain. The distinctiveness 
o f this facet derives from its specific focus on the invisibility and communicative 
aspects o f pain and not just on personal relationships or perceptions o f support.
Examples
■ A person with Fibromyalgia does not appear to have any external physical signs o f 
illness that communicate to others that they are in pain.
■ A person may feel that a significant other (SO) or employer or work colleague is 
not listening to them or understanding the nature o f their condition or the issues 
that relate to living with persistent pain.
■ A person living with pain may find it difficult to communicate to their partner that 
they are suffering or find the right words to convey how they are feeling and what 
their pain is like.
Table 5.10 Items and response scales for communication
How much Code
41. How much are you bothered by the fact that other people cannot see the extent 
of your pain and suffering?
(F67.1)
42. To what extent does your pain affect your relationships with other people? (F67.2)
43. How much do you feel that other people recognise your condition and the 
consequences it has for you?
(F67.5)
44. To what extent are you bothered by any difficulties in communicating your 
feelings to others?
(F67.8)
45. How much are you concerned about how other people see your condition? (F67.10)
46. How much do you feel that your health interferes with your personal 
relationships?
(F67.1 li)
47. How much are you concerned about society's attitude toward how you use 
health and social care?
(F67.12)
How completely
60. To what extent do you feel that other people appreciate the nature of your 
condition?
(F67.3)




66. How satisfied are you that other people recognise your condition? (F67.6)
67. How satisfied are you with your ability to communicate your needs to other 
people?
(F67.7)
68. How satisfied are you with your ability to express your feelings? (F67.9i)
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How important
19. How important is it to you that people cannot see your pain? (Imp67.1)
20. How important is it to you to feel that other people understand your pain? (Imp67.2)
21. How important is how other people see your condition? (Imp67.3)
22. How important is it to be able to communicate your feelings to others? (Imp67.4)
23. How important are the attitudes of others to your use of health and social 
services?
(Imp67.5)
Facet 68. Guilt and burdening others definition
This facet describes a higher order psychological feeling or process associated with a 
social awareness. Generally, a person who experiences guilt may feel that they are to 
blame or have done something wrong. A person may experience guilt for numerous 
reasons because o f their pain, although in this context, it is the guilt generated by 
having pain and the awareness o f ones relationship to and with others. For example, 
guilty feelings may result from becoming increasingly dependent on a SO or because 
o f the inability to fulfil the expectations o f others. Guilt might be experienced 
because the person with pain may feel responsible for the changes to the lifestyle o f 
the SO or because they feel that they have let somebody down. Consequently, people 
with pain may become concerned about their increasing dependency on SO’s and 
perceive that they have become a burden on others. This perceived burden emerges as 
a consequence o f no longer being able to do certain tasks for oneself or feeling that 
one has become emotionally dependent and so on, regardless o f whether the carer 
actually perceives that they are a burden. This facet incorporates how a person 
perceives their condition or changed health status has affected the significant people 
in their life.
Guilt is distinct from the presence o f negative feelings because for the person with 
pain, the guilt experienced by them is in the context o f their personal relationships and 
an awareness o f the effect their pain has on others. For this reason, guilt and 
burdening others is placed within the social relationships domain.
Examples
■ A person with lower back pain may feel guilty that they are unable to go on 
holiday with their partner or spouse because they are not well enough.
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■ A person with rheumatoid arthritis may feel guilty about their increasing 
dependency on their carer because o f concern that their reliance is becoming a 
burden.
Table 5.11 Items and response scales for guilt and burdening others
How much Code
48. To what extent are you concerned about burdening others? (F68.1)
49. How much do you worry about the effect your pain has on others? (F68.2)
50. How much are you bothered by feelings of guilt? (F68.3)




69. How satisfied are you with your ability to support others? (F68.4i)
How important
24. How important is it to be free from feelings of guilt? (Imp68.1)
25. How important is it to feel that you are not a burden to others? (Imp68.2)
Facet 69. Relationship with health care providers definition
This facet deals with a person’s relationship with their doctor/s, the other health care 
professionals that a person with pain has regular contact with and their relationship 
and perceived support from the health care system as a whole. This is concerned with 
the interpersonal relationship between a person and their health care providers, 
including whether a person feels supported, listened to and understood by their 
doctor/s and other health care professionals. Also included is whether a person has 
access to, or feel that they are given enough information about their specific condition 
and the available treatments. This need for information is distinguished from general 
everyday information because it asks specifically about the extent to which a person 
feels that they have enough information about their condition or pain. This 
information may be delivered from health care professionals or, if  this is lacking, 
through self-teaching and use o f libraries and new technology such as the Internet. It 
is the person’s perception o f whether or not they have enough information regardless 
o f the fact that this might be a function o f  individual differences such as being a 
blunter or a monitor, that is, they may desire more or less information.
A persons relationship with health care providers is specific is people with pain 
because they are a group that utilise extensive resources through the investigation o f 
their condition and subsequent use o f different treatments, because o f the nature o f 
their ongoing condition. Related to this, people with pain may also be dependent on
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the health and social care systems for the continual management of their pain and may 
feel that they are caught up in a stream of referrals leading to continual reliance on the 
system, including the associated waiting involved for appointments and treatments. 
This facet also concerns a person’s access to, and use of, complementary or 
alternative therapies or medicine and the extent to which this contributes to a person’s 
QoL. This includes any thing outside of the conventional medicine remit and any 
non-prescribed therapy or medication, for example, Reiki, homeopathy, chiropractic, 
Chinese medicine and may also cover the use of alcohol or illegal substances such as 
cannabis to bring about relief and so on (non-medicinal substances).
Items ask about the extent to which a person feels supported by their doctor/s and 
other health care professionals and the extent to which they are satisfied with these 
relationships. This is contrary to the aim of some treatments, for example PMP’s, 
whose aim it is to foster self-care, independence and self-management through 
effective health care interactions in order to prevent further dependence.
Examples
■ A person with chronic musculoskeletal pain feels that they have a good, supportive 
and understanding relationship with their doctor.
■ A person with chronic lower back pain feels that they have been dismissed by the 
system and that their problem has not been investigated thoroughly.
■ A person feels that they are caught up in the medical system waiting for 
appointments and passed through a stream of referrals.
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Table 5.12 Items and response scales for relationship with health care providers
How much Code
52. To what extent do you feel supported by the health service? (F69.3)
53. To what extent do you feel that you are dependent on health and social 
services?
(F69.4)
54. How much do you benefit from the use of complimentary therapies? (F69.6)
55. To what extent does the use of complimentary therapy contribute to your 
QoL?
(F69.7)








70. To what extent are you satisfied with your relationship with your doctor/s? (F69.1)
71. To what extent are you satisfied with your relationship with those health 
professionals that you have regular contact with?
(F69.2)
72. How satisfied are you with the support you receive from the medical service? (F69.5)




26. How important is it to you to have a good relationship with your doctor/s? (Imp69.1)
27. How important is it to you to have a good relationship with your health care 
professionals?
(Imp69.2)
28. How important is it to you to feel supported by the health service? (Imp69.3)
29. How important is it for you to be free from dependency on the health service? (Imp69.4)
30. How important to you is the availability of non-prescribed and 
complimentary therapy?
(Imp69.5)
31. How important is it to have adequate information regarding your condition 
and the availability of treatment for it?
(Imp69.6)
5.3.5 Pilot pain and discomfort module
The items generated during this stage formed the pilot PDM. Items were presented in 
response scale blocks to avoid potential confusion and appropriate instructions were 
added to each section, corresponding to the W HOQOL-100 instrument. Table 5.13 
shows the number o f items by response scale type, giving a total o f 108 items.
Table 5.13 Number of items in the PDM by response scale block










Table 5.14 outlines the hypothesised relationships between the new and core 
WHOQOL-100 facets. These a priori predictions will be tested during the cross- 
sectional survey reported in chapter seven, where the analysis will explore the 
correlations between the new and core facets. It is hypothesised that each o f the new 
facets are distinctive and sufficiently multidimensional to stand alone within the 
domain to which they have been allocated. However, if  during subsequent analysis 
any o f the new facets correlate highly with the core facets (>.70), they will be deleted, 
as this is evidence o f a conceptual overlap suggesting that the core facets already 
account for that particular aspect o f QoL.
Table 5.14 Hypothesised relationships between new and core facets
Facet Core facet hypothesised to be highly correlated with
Flare-ups 1. Pain and discomfort, 9. Mobility, 10. ADL
Pain relief 1. Pain and discomfort, 9. Mobility, 10. ADL and 11. Dependence on 
medication or treatments, 19. Health and social care: availability and 
quality
Anger and frustration 8. Negative feelings and 13. Personal relationships
Vulnerability/ fear/ 
worry
8. Negative feelings, 9. Mobility, 16. Physical safety and security
Uncertainty 2. Energy and fatigue, 8. Negative feelings, 9. Mobility, 13. Personal 
relationships, 19. Health and social care: availability and quality, 21. 
Participation in and opportunities for recreation and leisure
Loss/ loneliness/ 
feeling alone
8. Negative feelings, 9. Mobility, 10. ADL, 13. Personal 
relationships, 14 Practical social support
Positive strategies 4. Positive feelings, 24. Spirituality, religion, personal beliefs (SRPB)
Communication 13. Personal relationships, 14. Practical social support
Guilt and burdening 
others
8. Negative feelings, 9. Mobility, 10. ADL, 12. Working capacity, 




5. Thinking, learning, memory and concentration, 11. Dependence on 
medication or treatments, 18. Financial resources, 19. Health and 
social care: availability and quality, 20. Opportunities for acquiring 
information and skills
5.4 Discussion
This chapter reported the process o f constructing definitions and writing items for the 
10 facets o f QoL identified by the FG’s and presented each o f these facets with their 
corresponding definition, examples and items. Data derived from people with pain 
was used to inform the content o f the definitions, provided specific examples 
illustrating the definitions and was used to construct items pertaining to the QoL o f 
people with pain. The development work aimed to be as true to the language used by 
FG’s participants as possible, to ensure that items adequately and appropriately
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addressed the underlying concepts, whilst taking account of the WHOQOL criteria for 
developing items. The definitions elaborate each facet concept and provide a 
foundation from which to further conceptualise and operationalise their meaning. The 
items reveal the complexity of the concepts underlying the 10 new facets by tapping 
into the semantic attributes of the definitions. This process derived 77 items and 31 
importance items, giving a total of 108 items, which represents an item pool to be 
reduced in subsequent stages. This formed the pilot PDM, which was prepared for the 
preliminary pilot work described in chapter six.
Each new definition addressed how that facet differed from the core facets of QoL, as 
part of justifying its conceptual distinctiveness, although it is anticipated that some of 
the new and core facets will be highly associated either due to their conceptual 
similarity or because these variables covary to a high degree (Melzack and Katz,
1994). For example, flare-ups are hypothesised to correlate with pain and discomfort 
because of the semantic proximity of the underlying concepts and because flare-ups 
have been shown to be an integral part of the physical experience of pain and 
discomfort. In addition to pain and discomfort, this facet is likely to correlate with 
mobility and ADL because severe flare-ups are likely to affect these facets of Tevel of 
independence’ and vice versa. Pain relief is also likely to be closely associated with 
pain and discomfort because achieving pain relief is hypothesised to be an important 
component of the physical domain. The extent to which pain relief is achieved may 
be highly associated with mobility, ADL, dependence on medication or treatments 
and availability and quality of health and social care. Furthermore, pain relief is also 
closely related to a person’s relationship with the health care system and their 
dependency on pain relieving drugs.
Anger and frustration may be most closely associated with negative feelings. Anger 
is one of the five basic emotions and both anger and frustration were negative 
experiences for the study participants. This facet may also correlate with personal 
relationships because of the interpersonal consequences of anger. Indeed one of the 
items addressing anger and frustration asks about the affect of anger on relationships. 
The vulnerability/ fear/ worry facet is predicted to be associated highly with 
negative feelings. Fear is also a basic emotion and vulnerability and worry are better 
conceptualised as higher order negative affectivity. Given the consequences of fear
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and vulnerability, including the avoidance of movement, this may also correlate with 
the mobility facet and physical safety and security. Uncertainty has been 
conceptualised broadly because of its diverse consequences for a person’s QoL and 
consequently is hypothesised to be strongly associated with energy and fatigue, 
negative feelings, mobility, personal relationships, availability and quality of health 
and social care and participation in and opportunities for recreation and leisure.
Loss/ loneliness/ feeling alone have been conceptualised as negative experiences and 
so are predicted to be highly associated with negative feelings. Given the social 
aspect of loneliness, it could also be related to personal relationships and practical 
social support because this facet is related to the presence or absence of meaningful 
social interaction. Moreover, given the loss that living with CP engenders, it could 
also be associated with mobility and ADL because of its impact on level of 
independence. Positive strategies are predicted to be closely associated with positive 
feelings and may also be viewed as coping strategies by people with pain and 
discomfort. Hope and optimism are also likely to be related to the spiritual dimension 
of QoL and consequently, are predicted to correlate with SRPB.
Communication addresses a person’s relationship with other people and is therefore 
likely to correlate with personal relationships and social support, although the items 
addressing communication address the invisibility of pain and the extent to which 
people feel able to communicate their feelings to others which is distinct from asking 
about the extent to which people feel supported by others. Guilt and burdening 
others is hypothesised to correlate with personal relationships because of the social 
context of this type of guilt. However, it may also be associated with negative 
feelings because both guilt and perceptions of burden can be seen as negative 
experiences, although they are higher order, more complex emotions than those 
already covered by negative feelings. This facet may correlate with facets in the level 
of independence domain such as mobility, ADL and working capacity because a 
reduction in mobility and limited working capacity may lead to an increased reliance 
on others. Practical social support and financial resources may also be highly 
associated with guilt and burdening others because of having to rely upon others.
Chapter five 127
Relationship with health care providers may be closely related to the availability 
and quality of health and social care because it addresses the relationship of people 
with CP to health care providers in greater detail. This facet may also correlate with 
thinking, learning, memory and concentration because of the need and receipt of 
health care information, dependence on medication or treatments because of the 
provision of these by the health service, financial resources where individuals have to 
pay for treatment, for example, alternative therapies and opportunities for acquiring 
information and skills because of the availability of information about a person’s 
health condition.
Although relationships between the new and core facets have been hypothesised, the 
new facets have distinct conceptual qualities and are not synonymous with the core 
facets that they are predicted to correlate highly with because they represent specific 
consequences of living with persistent pain. This was demonstrated through the 
elaborate definitions which address how each facet differs from the core WHOQOL 
facets. Consequently, each PDM facet definition is longer than the core definitions to 
ensure that the facets were adequately elaborated and distinguished from core facets. 
Subsequent testing will elucidate the relationship between new and core facets. Each 
facet should correlate more highly with the domain within which it is placed and with 
the core facets that comprise that domain than with other domains and the facets 
within them.
This chapter has consolidated and defined the concepts identified and discussed in 
chapters three and four and the PDM facet definitions will provide a useful addition to 
the items that represent them to allow researchers using the PDM to have a detailed 
account of the way each facet has been conceptualised. Given that the definitions 
elaborate the impact of CP of QoL, they may also provide a useful framework for 
conducting interviews with people with CP, although this was not the intended 
purpose. In general, such methods of developing definitions and items are 
advantageous because they derive from the experience of patients and consequently 
this increases the acceptability, comprehensibility and face validity of the items 
representing these facets, which will be tested in the next stage. Chapter six reports 
the use of a relatively new technique in health care research based on cognitive 
aspects of survey methodology, to modify and eliminate items in preparation for the
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cross-sectional survey to pilot the new PDM (chapter seven) and the longitudinal 




Stages of Questionnaire Development II: 
Preliminary Pilot Work using Cognitive Interviewing
6.1 Introduction
The previous chapters reported on the preliminary stages of developing facets of 
quality of life (QoL) for a pain and discomfort module (PDM) for the WHOQOL-100 
(chapters three and four), including the construction of definitions and questions 
(items) addressing these facets (chapter five). This chapter reports on the preliminary 
pilot work to determine the initial appropriateness and feasibility of the PDM in 
patients with chronic pain (CP).
6.1.1 Cognitive aspects of survey methodology
There are now many questionnaires assessing QoL and one of the challenges to 
instrument development is that respondents bring many varied and different meanings 
to the questions derived from their experiences, personal history, culture and so on. 
For this reason, those who administer questionnaires do not always appreciate or 
monitor the processes and influences that contribute to the decision to choose a 
particular score or response. Given the need for instruments that are relevant, 
comprehensive and meaningful to the intended users, cognitive aspects of survey 
methods (CASM) (Jobe and Mingay, 1991; Tanur, 1992; Schwartz and Sudman, 
1996; Greenhalgh, 2001) are a relatively new addition to the field of outcome 
measurement. Cognitive interviewing (Cl) represents collaboration between cognitive 
psychology and survey researchers. It provides a way of pre-testing new survey 
instruments and has been used in the development of health status and QoL scales and 
measures (Meadows et al, 1998; Barofsky, 1996), particularly in the generation of 
disease or condition specific QoL scales (for example, Niero et al., 2002; Rouland et 
al., 2002).
Methods such as these are necessary because the data obtained from a given 
questionnaire is only as good as the instrument itself (Collins, 2000). Moreover, it
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allows us to find out how people make judgements about their QoL. QoL instruments 
must be reliable, valid and sensitive to changes in condition for them to have full 
practical or clinical value and such methods enable us to collect high quality data, 
which is a necessary feature of any research or clinical trial.
Cognitive interviews or verbal protocols were first used by cognitive psychologists 
such as Ericsson and Simon (1980) to develop tests of information processing. These 
methods rely heavily on the ability of respondent to be introspective and verbalise 
their thoughts. Loftus proposed that an examination of the verbal reports about 
thought processes or protocol analysis would be a way of looking at how people 
answer survey questions (Loftus, 1984). In such an examination, participants are 
asked to ‘think aloud’ whilst completing a survey instrument. Probes can be used to 
encourage participants to articulate their thoughts such as asking them to tell the 
researcher what is going through their mind (Ericsson and Simon, 1980) or what a 
question means to them (Willis, 1993; Belson, 1981). Such probes allow the 
researcher to test comprehension and meaning of questions.
The procedures used by CASM are underpinned by the question and answer model 
from cognitive psychology, which represents a four-step process that gives us greater 
access to how respondents answer questions (Tourangeau, 1984, 1987; Tourangeau 
and Rasinski, 1988). The first stage is comprehending the question, secondly 
retrieving the relevant information, thirdly making a judgement about the information 
and fourthly responding to the question (Tourangeau, 1984, 1987; Tourangeau and 
Rasinski, 1988). Although these stages can occur in seconds and without much 
conscious thought, they nonetheless help us to conceptualise the process of 
responding to questionnaire items.
Cl allows respondents to talk through how they answer questions, thus offering a 
distinct advantage over traditional methods, which only allow us to quantify any 
changes to the instrument. This qualitative method also provides a rigorous way to 
pre-test instruments before they are subject to traditional methods espoused by survey 
researchers and provides greater detail on the strengths and weaknesses of individual 
questions (Collins, 2003). As Bjomer and colleagues point out, cognitive assessments 
and traditional psychometric techniques are compatible with, and can offer benefits to,
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each other (Bjomer, Ware and Kosinski, 2003), as this method compliments 
traditional psychometric techniques to ensure that questions are measuring what they 
intend to measure.
There are numerous methods and techniques for applying CASM's (Jobe and Mingay, 
1989). The research reported here adopts concurrent ‘think alouds’, which allow 
respondents to verbalise their thoughts whilst answering questions, and paraphrasing, 
which allows respondents to restate the question in their own words. Concurrent 
‘think alouds’ benefit from being a more complete report of cognitive processes, 
although this simultaneous process itself may influence cognitive processes. 
Conversely, retrospective ‘think alouds’ or cognitive debriefing asks participants to 
recall what they were thinking after the task and do not have the problem of 
influencing the process itself, but the report itself is more subject to memory biases 
and so on.
Cl has been used extensively to develop health or QoL measures (Shaw et al, 2001; 
Jacoby et al, 2000), for example in the development of a symptom and impact diary 
for people with multiple sclerosis, which allowed problematic questions to be 
identified and modified (Greenhalgh et al., 2000). Respondent quotes also supported 
the notion that individuals reconceptualise their inner standards when thinking about 
their current health in a response shift (Sprangers and Schwartz, 1999) and provided 
insight into how this occurred ‘through reframing or reordering ones expectations of 
what one wanted to do to be consistent with what one was capable of doing’. Given 
that validity can be compromised if respondents are unable to comprehend the 
meaning of questions and because people change their inner standards during 
treatment, complimenting Cl with traditional psychometric evaluation can enhance 
the validity of measures (Greenhalgh et al., 2000).
Despite the utility of CASM’s, such methods have been criticised because there are 
not shared standards for carrying out cognitive interviews (Willis, DeMaio and 
Harris-Kojetin, 1999). Consequently, if different protocols and techniques are being 
used, researchers may be deriving different results. However, there are clear 
advantages of selecting the techniques that are most appropriate for the type of 
instrument being developed. The issue of standardisation is also relevant to how data
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from cognitive interviews is coded. Numerous coding procedures and frames have 
been developed to allow researchers to make sense of the types of problems emerging 
and to quantify the data, although there is little consensus about how best to code the 
information derived from these methods (Tourangeau, Rips and Rasinski, 2000). 
Where verbatim transcription can be laborious and unproductive, one approach has 
been to summarise the information in a ‘gist’ transcript and then to provide a 
summary of problems for each question, although this may generate a potentially non- 
quantitative, impressionist analysis of the results (Tourangeau, Rips and Rasinski, 
2000). Conrad and Blair (1996) defend the approach by developing coding frames 
that allow for rigorous analysis of results. Coding frames tend to distinguish between 
problems with different components of the response process, for example, 
comprehending the question, memory, judgment and response formulation. Different 
methods may also identify different problems (Presser and Blair, 1994), whilst not 
necessarily providing solutions (Tourangeau, Rips and Rasinski, 2000). A further 
criticism is the low reliability based on a small number of interviews (Tourangeau, 
Rips and Rasinski, 2000), however it has been suggested that Cl is usually carried out 
with small samples, selected not for representativeness, but to account for the ways in 
which different characteristics can influence cognitive processes (Campanelli, 1995).
It is also possible that the process of measuring the cognitive strategies of respondents 
changes them, known as the Heisenberg effect, and caution should be applied in the 
use of probes facilitating the verbal responses of respondents, to avoid putting words 
into their mouths (Sudman et al, 1996). Avoiding such probes may reduce any 
possible artefacts although this may prove to be difficult when respondents are less 
educated or less verbally articulate. However, inclusion of such individuals in the 
process is essential if the instrument is to be used by a wide range of people. Other 
possible sources of measurement error include prestige bias, where respondents are 
keen to show them selves in a positive light or where they are reluctant to give 
answers they believe are socially undesirable. Questions may also be seen as 
threatening (Bradbum et al, 1979, Sudman et al, 1996). These possible sources of 
measurement error and bias remind us that the process of completing a questionnaire 
takes place and is affected by contextual factors. In general, the use of CASM’s 
improves the face validity of instruments and gives access to otherwise inaccessible 
information.
Chapter six 133
The WHOQOL was designed to allow the development of modules pertaining to 
specific conditions such as CP, to increase the instruments’ specificity and sensitivity. 
To date, the technique of Cl has not been used in its fullest sense in the development 
of the WHOQOL, although during the process of item design, the WHOQOL Group 
used expert panels, including lay people, to select items (The WHOQOL Group,
1995), and therefore carried out this process in a limited way. Such methods have not 
yet been widely applied to the development of instruments assessing the impact of 
pain, highlighting the importance of applying such methods to new patient 
populations. However, these methods are being used more frequently in the 
development of instruments purporting to assess QoL, providing an important 
justification for applying such methodology to the WHOQOL, given the value of 
utilising and integrating the most current approaches into its protocol. Having 
introduced and discussed CASM’s, this chapter describes the preliminary pilot work 
using Cl, where patients are asked to 'think aloud' whilst completing the PDM to 
enable items to be selected for further piloting using more traditional psychometric 
methods.
6.2 Aims of cognitive interviewing
■ To establish whether people with CP are able to complete the PDM without 
guidance.
■ To carry out concurrent ‘think alouds’ allowing participants to verbalise their 
thoughts whilst they answer items.
■ To highlight if there are particular items that are difficult to comprehend or answer 
and the reasons why this is the case.
■ To examine how items are interpreted to check for consistency between 
participants by asking them to paraphrase, that is, restate the question in their own 
words, allowing us to determine if an item has a shared meaning.
■ To determine whether items address the underlying concepts (facets of QoL).
■ To select items for further pilot testing.
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6.3 Method
6.3.1 The pilot PDM
As described in chapter five, the pilot PDM consisted of 108 items, which were 
presented in response scale blocks with appropriate instructions, corresponding to the 
layout and structure of the core WHOQOL-100. The items pertaining to pain-related 
QoL were based on the evidence provided by the FG transcripts reported in chapter 
three. The phrasing of items was based on the accounts of FG members and the 
criteria used for the development of the original WHOQOL-100 items was utilised to 
ensure that items were framed in a comprehensive way (WHOQOL Group, 1993). 
Items should also be applicable to the main diagnostic groups who have CP and with a 
range of impairment, such as people with chronic low back pain (CLBP) or 
rheumatoid arthritis (RA) and so on. As described in detail in chapter five, 
appropriate five-point Likert response scales were added to the items pertaining to 
each facet, corresponding to intensity, capacity, frequency, evaluation and importance 
(Szabo, Orley and Saxena, 1997). Each new facet was represented by a minimum of 
five items to begin with, in order to identify and select the best items from this pool 
(detailed in chapter five). In addition to the items representing the new facets, 
importance items were also written corresponding to each facet.
6.3.2 Sample
Nine people with chronic musculoskeletal pain were recruited from two hospitals in 
southwest England (7 people from the Pain Clinic at the Royal United Hospital 
(RUH) and 2 from the Royal National Hospital for Rheumatic Diseases (RNHRD)). 
Such sample sizes are sufficient for this methodology providing that saturation is 
reached, that is, a degree of confidence that no new issues are emerging from 
subsequent participants. Five males and four females between the ages of 29 and 53 
with a range of pain conditions and locations with mean pain duration of 5.3 years 
(range 2 years to 14 years, SD 4.39). Of the 11 patients that were approached, two 
were unable to take part because they lived too far away or they declined to be 
involved due to caring responsibilities. Table 6.1 summarises characteristics of the 
participants taking part in the CL
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Table 6.1 Gender, age, condition/ diagnosis, location and pain duration (years
and months) of participants (N=9)
Gender Age Condition/ diagnosis Location of pain Pain duration
Female 29 CP Back, neck, hips, ribs 
and legs
3.6
Female 46 Soft tissue and nerve damage Back, legs and feet 2.7
Female 46 RA Hands 14.0
Female 49 Chronic obstructive pulmonary 
disease and chronic back pain 
(CBP)
Back and leg 3.0
Male 36 CBP due to tom disc Lower back 2.3
Male 39 CP Back, legs and shoulders 7.0
Male 51 Back problem L3 irritated nerve Back, groin, lower 
stomach, legs and right 
foot
2.0
Male 53 Ankylosing Spondylitis Right ankle, knee, thigh, 
elbow and ribs and neck
11.0
Male 53 Disc problem Back and legs 2.4
6.3.3 Setting
Seven participants were interviewed in a quiet consulting room and two participants 
were interviewed in their own homes because they were unable to visit the research 
centre. Interviews lasted for between 1 hour and 1 hour 45 minutes.
6.3.4 Procedure
Patients were given a letter and information sheet inviting them to complete the new 
PDM. The task o f the participant was to complete the 108 items o f the PDM whilst 
simultaneously 'thinking aloud', to enable the poor items to be identified and 
discarded and the meaningful and comprehensive items to be selected for further 
testing. Specifically, participants were asked to say what they thought o f the items 
they were responding to, and to try to say everything that ‘came to mind’. 
Participants were encouraged to talk about their thoughts and were asked questions 
about the meaning o f items, and the degree o f certainty about their response. A 
protocol was established to ensure that each interview was standardised (see figure 
6.1). Interviews were audiotaped and detailed notes o f respondent comments were 
recorded. The recorded interviews were not fully transcribed but were used to support 
and add to the detailed notes taken by the researcher during the interview.
If  participants asked questions during the task, the researcher reflected the question 
back to the participant to avoid influencing their response, for example, by saying
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‘what does 'x' mean to you? or ‘how did you go about answering that question? 
Appropriate prompts were used where participants were less forthcoming with 
speaking their thoughts. Where possible, attempts were made to ask participants to 
offer a solution to the problem that they identified unless it was irreconcilable, for 
example, when a participant did not understand the meaning of a word. Following 
completion of the task, participants were asked to comment on their overall 
impressions of the questionnaire in order to determine overall acceptability. 
Questions included; ‘tell me what you thought about the new questionnaire in 
general?’, ‘was there anything you did not understand?’, ‘what did you think about the 
layout?’ and ‘what did you think about the instructions?’.
Figure 6.1 Cognitive interviewing protocol
Introduction
■ Thank you for giving up your time today and taking part in the study.
■ We have developed a questionnaire to measure the QoL of people with CP to be added to a 
general QoL questionnaire developed by the WHO. To do this we conducted FG’s and 
asked people to tell us how pain affected their QoL. The purpose of the study is to find out 
which are the best questions for our final questionnaire. To do this we would like you to 
complete our new questionnaire and to ‘think aloud’ whilst you are doing this so that we 
know which are the best questions.
■ We would like you to tell us what you think of the questions you are responding to and to 
try to say everything that comes to mind.
■ This session will be recorded to enable us to capture all your comments to ensure that we 
select the best questions for the final questionnaire.
■ You may stop or withdraw from the study at any time without having to give a reason.
■ Everything you say or complete today is strictly confidential.
Task (record the start time)
■ Please remember that there are no right or wrong answers and that it is the questionnaire 
that is being tested, not you.
■ I am here to answer questions if you need me to, but I may not answer them until the end if 
I believe that it will affect your responses.
■ Are there any questions before we begin?
■ We are interested in your answers, but also how you reach your decisions. I’d like to ask 
you to ‘think aloud’ as you answer each question and tell me everything that comes to your 
mind in answering the question. The more you can tell us, the more useful it will be to us 
as we try to develop better questions. Okay?
■ Please begin completing the new module, as you do so, try and tell me everything that 
comes to mind.
■ Try and talk about your thoughts as you answer the questions. I may ask you questions 
about what you are doing and thinking during this task and I will be taking notes.
Ask the participant the following questions about each of the questions:
■ What does this mean to you?
■ How sure are you about your answer (say in %)?
■ How do you feel about answering this question?
Also think about asking these questions if the participant does not say very much
■ What time period were you thinking about when you answered that question?
■ How did you calculate your answer?




■ Tell me what you are thinking?
■ I am not interested in your secret thoughts, only what you are thinking about the task.
■ The questionnaire is being tested, not you.
■ Tell me about any questions that arise while you are working? This will help us 
understand your answers.
■ You may not get an answer because these unanswered questions may help us to see where 
there are problems with the way a question is being asked and highlight any difficulty 
people are having with the format of the questions.
If participants ask a question about, for example, the meaning of a question, apply the 
following:
■ How did you go about answering that question?
■ What does 'x' mean to you?
■ How did you feel about answering this/ that question?
■ Questions sometimes have different kinds of effects on people. We’d like your opinion 
about that question. Perhaps tell me whether you think that question would make most 
people very uneasy, moderately uneasy, slightly uneasy, or not at all uneasy?
Overall impressions of the questionnaire
■ Tell me what you thought about the new questionnaire in general?
■ Would you like to expand on that more?
■ Was there anything you didn’t understand?
■ What did you think about the layout?
■ What did you think about the instructions?
Record the end time
6.4 Analysis and results
6.4.1 Coding of participant responses
The coding frame, based on the four-stage question and answer model (Tourangeau, 
1984, 1987; Tourangeau and Rasinski, 1988), provided a structure for the response to 
items and the codes and their corresponding meaning are illustrated in Table 6.2. The 
qualitative response to each item was coded according to the type of problem or issue 
encountered and broad difficulties were identified. Items to be included were those 
with fewer than three identifiable problems, low hesitation, high certainty of response 
and high importance (assessed by the importance items corresponding to each facet). 
Excluded items were those with low importance, substantial difficulty with 
comprehending the meaning of the question and those that did not appear to be 
measuring a component of QoL. Question wording was altered when the meaning 
was misinterpreted or when changes would give greater clarity and readability.
In general, good items were those that adequately address the underlying concept and 
that are easy to comprehend, retrieve information on, judge and respond to without 
difficulty. In addition, they are items that might prove to be sensitive to change or
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that might distinguish between people with different conditions or with different pain 
severities. Problematic items are those whose meaning is not clear or are ambiguous, 
where retrieval of appropriate information is inaccessible, where there is difficulty 
making a judgement with that information and where a response is either absent or 
uncertain. Table 6.2 also summarises the frequency of difficulties and issues 
encountered by participants completing the PDM.
The least frequent problem was semantic difficulties, which gives a degree of 
confidence that the participants were able to comprehend the meaning of the words 
used in the items. Hesitation prior to responding to the question was the most 
frequent issue, followed by missed items. Hesitation (a pause before answering) is 
not in itself a problem, since participants are asked to think about and respond to 
questions that they have not been asked before and therefore hesitation to a novel task 
is not unexpected or surprising. Missing a question may seem problematic, and some 
of these items have been deleted or modified. However, this was also due to the 
perceived repetition of a previous question in the item pool, and thus helps in the 
selection of the ‘best’ items relating to particular facets, as participants were asked to 
express a preference for one item over another.
6.4.2 Specific problems with items
Having identified the frequency of problems or issues corresponding to each stage of 
the model, table 6.3 outlines the nature of the problem, the number of items where 
that problem occurred, examples of such items and a possible solution to the problem. 
Attention is paid to the problems or difficulties rather than those items that were 
considered to be ‘good’ because the goal was to use this information to exclude or 
modify problematic items and to retain the ‘good’ items. Low frequency issues 
included semantic difficulties, misinterpretation, poorly worded, time frame, response 
scale confusion, omission, preference and items not addressing QoL. Issues that were 
moderately problematic included incomprehension, multiple interpretations, 
repetition, relevance and good questions. High frequency issues were need for 
clarification, difficult questions, hesitation in comprehension and retrieval, missed 
question, response hesitation and responsive to change.
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Table 6.2 Coding frame for the analysis of the Cl and the overall frequency of 
problem types (total number of items =108)





The meaning of a word is not understood 2
Incomprehension The meaning of a question is not understood 17
Need for 
clarification
Clarification of the questions’ meaning is sought 42
Misinterpretation The question is not interpreted as it was intended 11
Multiple
interpretations
There are two or more possible interpretations 19
Poorly worded It is suggested that the question be reworded 11
Difficult items Delay in comprehending question meaning and difficultly 
answering
36




Time frame The 2-week time frame is disregarded due to difficulty 
generalising over a 2-week period because of the variability 
of the issue in question
7
Repetition A question has the same meaning as a previous one 25




Response certainty The extent to which a participant is sure about their response 




Difficulty with the response scale 4
Missed question Refusal to answer or missed question 44
Hesitation Any excessive pausing or hesitation 84
Positive attributes of items
Responsive to 
change
Items that participants have suggested are responsive to 
change
27
Preference A preference is expressed for one question over another 
(where items have a similar content)
7
Good question The participant believes that the question is a good one 23
Table 6.3 Problem type, frequency of problem, examples and possible solutions
Problem type Items Frequency Examples Solution
Comprehension difficulties
Semantic difficulties 17, 19 Low (2) 17. How much are you bothered by 
feelings of vulnerability? 19. How much 
do feelings of vulnerability interfere with 
your everyday life?
Modification of question by shortening 
‘vulnerability’ to ‘vulnerable’
Incomprehension 4, 17, 19, 26, 47,51,54, 
56, 68, 69, 72, 76. 




47. How concerned are you about 
society’s attitude toward how you use 
health and social care? 54. How much do 
you benefit from the use of 
complimentary therapies?
Deletion of 4, 47 and importance 2, 23 because of 
frequency of problems. Modification of 17, 19, 
54, 72 and importance 9, 27 and 30 to ensure that 
the meanings of the items are clear
Need for clarification 6, 8, 10, 18, 20, 22, 23-25, 
32, 37, 42-44, 47, 52-55, 
57,61,64, 66-69,71,72, 
75, 76. Importance; 2, 3, 
6, 10, 15, 19-22, 25,27,
30
High (42) 25. How much do feelings of uncertainty 
interfere with your everyday life? 54.
How much do you benefit from the use of 
complementary therapies?
Deletion of 32, 37, 47, 55, 71 and importance 2 
because of frequency of problems or difficulty 
scoring. Modification of 18, 20, 22, 24, 25, 53,
54, 72 and importance 27, 30 to ensure that items 
are clearer. Participant responses showed that it 
was possible to interpret the question in numerous 
ways. This is deliberate to ensure that the question 
is not too specific
Misinterpretation 25, 47, 49, 54, 56, 67, 69, 
71. Importance 19, 30, 31
Low (11) 54. How much do you benefit from the 
use of complementary therapies? 71. To 
what extent are you satisfied with your 
relationship with those health care 
professionals that you have regular 
contact with? Imp 19. How important is it 
to you that other people cannot see your 
pain?
Deletion of 47, 71. Modification of 25, 54 and 
importance 30. Such responses are not necessarily 
problematic, but reflect the broad inclusiveness of 
the items. Those that were particularly 
problematic were deleted or made clearer to avoid 
misinterpretation
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Problem type Items Frequency Examples Solution
Multiple interpretations 3, 17, 18, 23,25, 35,43, 
46, 47, 50, 53, 56, 57, 64. 




17. How much are you bothered by 
feelings of vulnerability? 53. To what 
extent do you feel that you are dependent 
on health and social services?
Deletion of 47. Modification of 17, 18, 25, 35, 53. 
Reflects the broad coverage of items with a 
deliberate degree of ambiguity, allowing for the 
full range of interpretations and responses, which 
may confer advantages
Poorly worded 17, 18,21-23, 25, 28,47, 
54. Importance 15, 29
Low (11) 22. Are you distressed by the fear of 
pain? 25. How much do feelings of 
uncertainty interfere with your everyday 
life?
Deletion of 47. Modification of 17, 18, 21, 22, 25, 
54. The majority of items were modified or 
removed
Difficult items 2, 4 ,5 ,8 , 9,13,16,17,19, 
21,22, 25,33,35,37, 39, 
41-45, 47, 54, 56, 65, 67, 
71, 72. Importance 1, 5, 
14, 19,21,23,27, 29
High (36) 4. To what extent does your pain vary 
over time? 5. How much do changes in 
pain bother you? 17. How much are you 
bothered by feelings of vulnerability? 22. 
Are you distressed by the fear of pain?
Deletion of 4, 5, 37, 47, 71 and importance 23, 27. 
Modification of 9, 17, 19, 21, 22, 25, 35, 54, 72.
A question could be difficult for numerous reasons 
and was only deleted or modified if there was 
consensus about this
Hesitation in comprehension 
and retrieval
2-5, 8, 9, 16-20, 22, 25, 
26, 28, 32-34, 37, 40, 47, 
51-53, 55, 56, 64, 72, 73. 
Importance 2, 19, 21, 23, 
30
High (34) 47. How much are you concerned about 
society’s attitude toward how you use 
health and social care? 72. How satisfied 
are you with the support you receive from 
the medical service?
Deletion of 4, 5, 32, 37,47, 55 and importance 2, 
23. Modification of 9, 17-20, 22, 25, 53, 72 and 
importance 30. Hesitation itself is not sufficient 
grounds for exclusion given that participants were 
responding to novel questions and the consequent 
delay in retrieving appropriate information
Judgement difficulties
Time frame 4, 8, 15, 37, 57, 63, 73 Low (7) 4. To what extent does your pain vary 
over time? 37. How much does hope for 
relief from pain improve your quality of 
life?
Deletion of 4, 37. Reiterating the 2-week time 
frame and asking participants to give the nearest 
approximation to their experience in the last 2 
weeks
Repetition 15, 20,21,25,26, 28, 30, 
32, 37-40, 42, 46-48, 55, 
58, 62, 65, 66. 
Importance 3, 4, 28, 29
Moderate
(25)
32. How much are you able to carry out 
the activities that you once could? 37. 
How much does hope for relief from pain 
improve your quality of life?
Deletion of 32, 37, 47, 55. Modification of 20, 21, 
25. These items were considered to be repetitions 
of previous items, however this not a problem 
since the goal was to use this process to select the 
best items asking about similar aspects of QoL. 
Preferences for one question over another were 
considered
Chapter six 141
Problem type Items Frequency Examples Solution
Relevance 9, 17, 18, 20,21,24, 33, 
34, 37, 44, 49, 53-55, 66, 
73, 77. Importance 2, 3, 
9, 10, 13, 14, 23,25
Moderate
(25)
55. To what extent does the use of 
complimentary therapy contribute to your 
quality of life? 77. How often are you 
able to see the humorous side of things?
Deletion of 37, 55, 77 and importance 2, 23. 
Modification of 9,17,18, 20, 21, 24, 53, 54 and 
importance 9. Despite questioning the relevance, 
the option to circle ‘not at all’ is still available. 
Such questions might be important in 
discriminating between people known to differ on 
certain characteristics
Responding
Response certainty All items were answered with low, moderate or 
high certainty and this varied across items and 
depended on the previous three stages of the 
model occurring
Response scale confusion 5, 9, 58. Importance 29 Low (4) 5. How much do changes in pain bother 
you? 9. How easy is if for you to get into 
a comfortable position?
Deletion of 5. Modification of 9
Missed question 4, 5, 8, 10,17-21,23,25, 
26, 28, 30, 32, 33, 37-40, 
42-44, 47, 49,51,55-57, 
62, 66, 70-73, 76. 
Importance 2, 4, 6, 9, 10, 
12, 23,30
High (44) 4. To what extent does your pain vary 
over time? Importance 23. How important 
are the attitudes of others to your use of 
health and social services?
Deletion of 4, 5, 32, 37, 47, 55, 71 and importance 
2, 23. Modification of 17-21, 25, 70, 72 and 
importance 9 and 30.
Hesitation 1,2, 4-6, 8, 9, 12-14, 16, 
18-26, 28, 30, 32-35,38- 
46, 49-52, 54, 56-64, 66- 
69,71,74-76. Importance 
1-16, 18-23, 25-27, 29, 30
High (84) 5. How much do changes in pain bother 
you? Importance 27. How important is it 
to you to have good relationships with 
your health care professionals (excluding 
doctor/s)
Deletion of 4, 5, 32, 71 and importance 2, 23, 26. 
Modification of 9,18,19-22, 24, 25, 35, 54 and 
importance 9, 27, 30. Hesitation in responding is 
only a problem if there are other difficulties
Miscellaneous
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Problem type Items Frequency Examples Solution
Omission Not relating to specific 
items but whether there 
was a question on exercise 
and another on depression 
or sadness (already 
covered by the core 
WHOQOL-lOO)
Low (2) N/A Already addressed in the WHOQOL-lOO
Positive attributes of items
Responsive to change 3, 6-8, 12, 14, 20, 26, 32- 
34, 36, 42, 44, 46, 56, 62, 
65, 67-69, 73. Importance
4, 16, 20, 22, 29
High (27) 8. To what extent has treatment improved 
your quality of life? 56. How much 
access do you have to the information 
you require about your health?
Due to other problems with the above items, 32 
was deleted and 20 was modified
Preference 3, 13, 16, 19,31,37, 46 Low (7) 3. How much are you bothered by flare- 
ups? 31. To what extent are you bothered 
by not being able to carry out the 
activities that you used to do?
Deletion of 37. Modification of 19. Preferred 
items were retained
Good question 1-3, 5, 12, 14, 16, 17, 27, 




1. To what extent do flare-ups affect your 
quality of life? 12. How much are you 
bothered by feelings of anger?
Deletion of 71. Modification of 17
Additional category -  
deletion because question 
does not tell us about a 
persons QoL (e.g. difficult to 
score with out making an 
assumption).
4, 5, 32, 47, 53, 77. 
Importance 23
Low (7) 4. To what extent does your pain vary 
over time? 32. How much are you able to 
carry out the activities that you once 
could?
Deletion of 4, 5, 32, 47, 77 and importance 23
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Following this analysis o f the response to the 108 items, approximately 57 items were 
considered to be good questions and 28 items were found to be eligible for exclusion 
or modification. Table 6.4 summarises problems encountered by the participants 
during the cognitive interviews, which stage o f the model these occurred at and 
possible solutions to these.
Table 6.4 Summary of problems encountered during Cl and corresponding
model stage and solutions
Problem or issue Model stage Possible solution or action taken
The term ‘other people’ was 
considered to be ambiguous and the 
response would vary according to 
whom that referred
Comprehension This deliberate ambiguity is 
necessary to prevent the most 
appropriate significant others of 
each individual being excluded. 
Respondents may be more likely 
to consider SO's when answering 
questions of this nature
Participants report that the question is 
ambiguous in some way
Comprehension Deliberate to ensure that all 
potential respondents are able to 
fill each question in. The more 
specific the items are, the less 
scope for responding to them. A 
balance has to be struck between 
openness and ambiguity
Thinking generally rather than about 
the last 2 weeks
Judgment Emphasise or repeat that 
respondents should think only 
about the last 2 weeks given that 
memory for longer than two 
weeks is less accurate
Difficulty generalising experience to 
give a definite response if something 
is variable (e.g. a mood state such as 
frustration)
Judgement Participants could be encouraged 
to give the first answer that they 
think of
The relevance of some items was 
thrown into doubt
Judgement This type of response may be 
idiosyncratic to a particular 
individual and is not strong 
enough evidence for exclusion. 
There is an opportunity to 
respond with ‘not much’ or ‘not at 
all’
Items regarding use of health service 
and perceptions of support etc are 
more likely to be susceptible to 
various social biases, for example, 
social desirability, and the need not to 




Careful attention at later stages of 
testing for ceiling or floor effects. 
Not sufficient grounds for 
exclusion if the item is important
Some participants appear to be 
generally hesitant in responding to 
items. This could be due to the fact 
that the task is novel and extra 
retrieval and subsequent judgement
All stages This type of individual difference 
will inevitably arise when in 
large-scale survey work and 
should not necessarily be seen as 
a problem with the instrument but
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Problem or issue Model stage Possible solution or action taken
time is needed. Equally, it could be a 
side effect of medications and the 
fatigue associated with CP
rather the participant’s interaction 
with, or response to it
A small number of participants picked 
up on every issue and potential 
problem
All stages Although account should be taken 
of there comments, this is not 
particularly useful
An item is assessed as having low 
importance
N/A This may be attributable to 
idiosyncratic aspects of 
individuals, for example, in terms 
of relevance or salience and may 
even distinguish between people 
with different conditions or with 
different severity
A question may not actually tell us 
much about a person's QoL
N/A Careful attention needs to be paid 
to this both for theoretical and 
scoring purposes. The question 
must have a clear scoring 
direction
A facet addressed by a particular 
question or set of items may not be 
amenable to change through 
intervention.
N/A This is only a problem for 
measures designed specifically to 
pick up changes over time and not 
necessarily for those comparing 
or distinguishing between 
different individuals
6.4.3 Importance ratings
Importance items were also included in the Cl to make a preliminary assessment o f 
the importance o f the new facets. However, given that it is not possible to make any 
definitive conclusions because o f the sample size (n=9), the importance ratings for 
each o f  the 31 importance items corresponding to the PDM facets are not shown. 
Each facet should be represented by one importance item, however, at this 
preliminary stage, facets had between 2 and 6 importance items corresponding to 
them. These addressed different aspects o f each multidimensional definition to enable 
the most appropriate importance item to be selected to represent it during subsequent 
stages. O f these importance items, ‘How important is it to be able to control your 
pain?’, which represents the pain relief facet, obtained the highest importance rating 
o f 5.0 across the nine participants. ‘How important are the attitudes o f others to your 
use o f health and social services?’, representing communication, received the lowest 
importance rating o f  2.8 and was therefore considered to be the least important. All 
other importance items were rated above 3.4. Overall, the facet ‘pain re lie f was 
considered most important (4.5) and ‘communication’ the least (3.5). This 
information provides a useful indication o f  the relative importance attributed to the 
new facets o f QoL to be further tested in chapter seven.
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6.4.4 Performance of items
Each item was categorised following coding of responses and identification of 
problems based on the qualitative responses to items during Cl and the importance 
attributed to assessed aspects of QoL into items to be retained in the PDM, removed 
from the PDM, or modified to be more comprehensive and coherent. Retained items 
those with less than 3 identified problems, low hesitation in both comprehension and 
judgement stages, high certainty of response and high importance (>3.0). Removed 
items were those with low importance (<3.0), substantial difficulty with 
comprehending the meaning of the question, the same difficulty raised by at least 
three participants, items that were not likely to be sensitive to change or amenable to 
intervention and items that were difficult to score or did not tell us about a persons 
QoL. With modified items, there had to be consensus that the question would be 
clearer with a change in wording or with the addition of a small number of examples 
in brackets and were those items that were not interpreted as intended by at least three 
participants.
6.4.5 Expert reading of the PDM
Following the Cl with people with CP, the PDM was given to three independent 
experts in outcome measurement and questionnaire design with expertise in pain and 
one layperson. The aim was to identify any potential problems and thus consolidate 
the findings from the Cl. As shown in table 6.5, comments related to the 
identification of and wording of problematic questions and offered potential solutions 
to these. Any identified issues were taken into account in the light of evidence from 
the patient participants and modifications made where necessary. Including an expert 
reading highlights the importance of the instrument being acceptable to both the users 
and the people that administer it.
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Table 6.5 Summary of expert and lay comments (organised by facet)
Item Comment Solution
To what extent has 
having treatment 
improved your QoL?
The applicability of this item to all people 
with pain was questioned including the 
possibility of those not having treatment
Retained for 
further testing due 
to its potential for 
being sensitive to 
change
How much are you 
bothered by feelings of 
vulnerability?
Ambiguous, could be interpreted in a number 
of ways
Some ambiguity 
is intentional to 
avoid narrow 
concepts
To what extent do you 
feel threatened by the 
possibility of pain?
Not an easy concept to grasp This item was 




Does pain or discomfort 
limit your life?
The words ‘restrict’ or ‘inhibit’ were 
suggested as possible alternatives to ‘limit’
There was no 
evidence that 
people use the 
word ‘inhibit’
How frequently do 
feelings of uncertainty 
bother you?
Simplify to ‘how often’ ‘How frequently 
replaced with 
‘how often’
To what extent do 
difficulties with 
planning affect your 
quality of life?
It might be easier for participants to evaluate 
the effect this has on their everyday life than 
on their overall QoL
Replace with 
‘everyday life’
How much are you 
bothered by feelings of 
loss?
Ambiguous, could be interpreted in a number
of ways
Some ambiguity 
is intentional to 
avoid narrow 
concepts
How much does humour 
help you to deal with 
your problems?
The question cannot be scored without 
making the assumption that there is a 
unidirectional relationship between having a 
sense of humour and QoL
Changed to ‘how 
much does the 
use of humour 
improve your 
quality of life’
How much does hope 
and optimism help you 
to deal with your 
problems
Although hope and optimism may help a 
person to cope with adversity, they do not 
eliminate a problem. It might be that there is 
a value judgment in this question as it is 
currently worded because one has to make 
the assumption that if they do not help at all 
we would have to assume that this was 
negative, whereas it might be that they adopt 




How satisfied are you 
that other people 
recognise your 
condition?
‘Acknowledge’ could replace ‘recognise’, 
potential problem with scoring
Item deleted
To what extent are you 








How important is it to 
you that people cannot 
see your pain?
Suggested change to ‘How important is the 
fact that people cannot see your pain?’
Item deleted
How important is it to 
you to feel that other 
people understand your 
pain?
It was suggested that this could be modified 
to ‘how important is it for you to feel that 
other people understand your pain?’ i.e. 
replacing ‘to’ with ‘for’
Item deleted
How important are other 
people’s views about 
your condition?
Suggested change to ‘How important to you 
are other people’s views about your 
condition?’
Item deleted
How concerned are you 
that you do not have 
enough resources to 
provide for others?
Ambiguous i.e. what kind of resources Some ambiguity 
is intentional to 
avoid narrow 
concepts
How important is it for 
you to be free from 
worry about burdening 
others?
Suggested change to ‘how important is it for 
you not to feel that you are a burden to 
others?’
Changed to ‘How 
important is it to 
feel that you are 
not a burden to 
others?’
How important is it to be 
free from feelings of 
guilt?
The addition o f ‘to you’ was suggested Retained for 
further testing
To what extent are you 
satisfied with your 
relationship with those 
health professionals that 
you have regular contact 
with?
Too cumbersome Replaced with 
‘how satisfied are 
you’
How important to you is 
being able to use 
alternative therapies (for 
example, acupuncture 
and osteopathy etc.)?
Examples of acupuncture and osteopathy 
might exclude people thinking about herbal 
medicines for example
Item deleted
How important is it to 
have adequate 
information regarding 
your condition and the 
availability of treatment 
for it?
Asks two questions; about information 
regarding a persons condition and about the 
availability of treatment for it
Item deleted
How satisfied are you 
with the information that 
is made available to you 
about your health?




How important to you is 
being able to use 
alternative therapies (for 
example, acupuncture 
and osteopathy etc.)?
Modifications to the wording was suggested 
with replacing ‘is being able to use’ with 
‘are’. For example, ‘how important to you 
are alternative therapies.....?’ etc.
Item deleted
How important is it to 
have adequate 
information regarding 
your condition and the 
availability of treatment 
for it?
Suggested change to ‘how important is it to 
have adequate information regarding the 
availability of treatment for your condition? 
However, this changes the meaning of the 
question and reduces its breadth.
Item deleted
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Following the process of Cl and expert reading, 11 items were eliminated and 17 were 
modified. Question numbers 4, 5, 32, 37, 47, 55, 71, 77 and importance items 2, 23 
and 27 were deleted from the pilot PDM. Question numbers 9, 17, 18, 19, 20, 21, 22, 
24, 25, 35, 54, 70, 72 and importance items 9, 21, 26 and 30 were modified based on 
the suggestions of patients and health professionals, to ensure that they were 
comprehensive to potential respondents. Appendix 3 details the item and code for the 
PDM facets and whether they were retained, deleted or whether the wording had 
changed to improve its clarity or if a more appropriate response scale had been 
attached.
6.4.6 Format and content of PDM
Following the processes reported here, the pilot instrument consisted of the 102 core 
items of the WHOQOL-lOO, the 68 pain and discomfort items, the 26 WHOQOL 
importance items and the 16 pain and discomfort importance items. Of the 68 items, 
25 items were phrased positively and the remaining 43 items required reverse scoring 
because of the difficulty of asking about pain and its consequences in a positive way. 
The facet title ‘changes in pain’ was changed to ‘flare-ups’ because the items 
addressing changes in pain were removed from the PDM following the Cl described 
in this chapter and there was a tendency for people to describe exacerbations or flares 
in their pain rather than decreases. Four new items have been inserted into the socio­
demographic question page asking respondents about the duration and location of 
pain, perceived cause, the temporal characteristics (adapted from the McGill Pain 
Questionnaire, MPQ, Melzack, 1975) and the severity of pain (adapted from the 
MPQ). This will enable a greater understanding of the context of a persons pain 
related QoL. Table 6.6 shows the number of items by response scale type and per 
facet in the PDM before and following Cl and expert reading.
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Table 6.6 Number of items before and after C l and expert reading (ER) by 
response scale type and per facet (number of importance items corresponding to
each facet are shown in brackets)








How much 56 49 49 -7
How completely 6 7 7 +1
How satisfied 11 10 9 -2
How often 4 3 3 -1
Importance 31 28 16 -15
Facet
Flare-ups 5(2) 3(1) 3(1) -2 (-1)
Pain relief 9(4) 9 (4 ) 4 ( 2 ) 0 (-2)
Anger and frustration 7(2) 7(2) 7(2) 0(0)
Vulnerability/ fear/ worry 8 (3) 8 ( 3 ) 8 (-) 0(-D
Uncertainty 7(2) 7(2) 7(1) 0 (-1)
Loss/ loneliness/ feeling alone 7 ( 3 ) 6 ( 3 ) 6 ( 2 ) - l ( - l )
Positive strategies 7(2) 5(2) 5(2) -2 (0)
Communication 12(5) 11(4) 10(1) -2 (-4)
Guilt and burdening others 5(2) 5 ( 2 ) 5 ( 2 ) 0(0)
Relationship with health care 
providers
10(6) 8(5) 8(1) -2 (-5)
Total 77 69 68 -9
Overall total 108 97 84 -24
6.5 Discussion
This chapter described the use o f Cl to reduce and modify the items o f the PDM to 
assess the impact o f  CP on QoL. This preliminary pilot work was conducted with the 
108-item pilot PDM, which represented 10 new facets o f QoL derived from FG’s and 
a web survey. During completion o f  the items forming a PDM, Cl with 9 participants 
revealed which items were comprehensive enough to retain and subsequently, health 
professional views were elicited, to further determine the comprehensibility o f the 
items. Items were included, excluded or modified on the basis o f participant 
comments. O f 77 items and 31 importance items (total 108), 24 were eliminated 
during this process, leaving 68 items and 16 importance items in the pilot PDM. This 
method provided a way o f ensuring that items were relevant, comprehensive and 
acceptable to the users, and that the items tapped concepts that they purported to 
measure. This preliminary work demonstrates that it is possible to ask people about 
their QoL and to use this information to develop items that are relevant and 
comprehensive. The very notion o f  including patient preferences ensures a high 
content validity since participants were asked what was important to them.
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In general, there was a moderate to high degree of consensus between participants on 
which items were ‘good" and which where ‘problematic’. Saturation was reached by 
the ninth interview, where no new issues or problems were arising that had not been 
identified from a previous interview. The results show that there were very few 
problems with misinterpreting or understanding the meaning of items, which offers 
further support for the method of questionnaire development where primacy is given 
to using the words and phrases that people with pain use when talking about their 
QoL, ensuring that items adequately and appropriately address the underlying 
concepts. The Cl provided a systematic method for weeding out problematic items 
and identifying possible alterations to these, in addition to providing a verbal 
reinforcement of the relevance of the items.
During the Cl itself, the speed with which participants answer items might be an 
important indicator of whether or not items are ‘good’ or not. An item answered 
relatively rapidly reflects ease of comprehension and that the four stages of the 
question and answer model occur in rapid succession. For other items, hesitation or 
excessive pausing might be due to poor wording or the fluency of the item (i.e. a 
problem with the item), or difficulties with how to respond to an item (i.e. the 
response). Hesitation can therefore occur at the comprehension, retrieval, judgement 
or response stage of the model. It might be that there is a higher degree of certainty 
about which response to give for items regarding feelings because the question 
content is familiar, however, other items regarding more practical matters may require 
a greater degree of thought. In general, hesitation in itself is not grounds for 
excluding a question as participants may hesitate at different stages of the process for 
numerous reasons. For example, hesitation may be due to speed of retrieval if a 
person has not been asked that type of question before and consequently, more time 
may be needed to consider the information and make a judgement based on that 
information. Hesitation may also be due to a type of prestige bias whereby more time 
is needed to respond to a question because a person is concerned to appear in a good 
light. These provide plausible explanations accounting for hesitancy that do not 
warrant excluding the question.
Where participants asked a question regarding the meaning of an item, careful 
attention was paid to changing, clarifying or excluding those items. For example, 
questions were asked when there were two or more possible interpretations of the
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intended meaning of an item. A noticeable problem was that participants indicated 
that their answer depends on the day or time that they are completing the instrument 
due to the fluctuations that characterise living with CP. This has implications for the 
two-week time frame since participants found it hard to generalise their experience. 
This might be a particularly salient issue for people with CP since it is associated with 
frequent changes and fluctuations, which impacts on the ability to make a general 
statement about a two-week period. The presence and consequences of such flare-ups 
have been shown in previous chapters and have been reported by Mason, Skevington 
and Osborn (2004). However, as the timeframe of the WHOQOL instruments is two 
weeks, it is important that this model is adopted for the PDM.
Developing items in the vernacular has been central to the WHOQOL project 
(WHOQOL Group, 1995) and this illustrates the importance of developing items from 
the perspective of individuals with pain. The bottom up approach was confirmed by 
the Cl, which reinforced the relevance of the 10 new facets of QoL. Patient 
involvement in the development of outcome measures is seen as a way of highlighting 
the subjective perspective of the patient and putting their views in a more prominent 
position than has traditionally been the case and researchers are placing greater value 
on this approach (Greene, 1995). Obtaining ‘user views’ is a key objective of 
outcome measurement and, more broadly, clinical governance. This underpins the 
importance of creating relevant and appropriate instruments for measuring theoretical, 
empirical or experiential constructs such as QoL. Cl strengthens the quality of items 
and eliminates multiple meanings, which can compromise the validity of an 
instrument. Moreover, given the fundamental assumptions underpinning the 
reliability of self-report instruments, for example, that they accurately reflect a 
person’s view of their experience, this method provides a way of improving these 
self-report measures (Jobe, 2003) by ensuring that the perceived meaning of items 
corresponds to the intended meaning.
The process of development also facilitates the process of conceptualising QoL, 
relating to pain and discomfort. A relative absence of conceptual clarity in research to 
date has been problematic to understanding the rational for inclusion of particular 
items in QoL instruments. Indeed, subjective assessment is emphasised here rather 
than health status, which although is an important outcome, has erroneously become 
synonymous with the measurement of QoL, which is reflected in the large number of
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studies claiming to assess QoL using health status measures such as the SF-36. 
Consolidation of the concept of QoL is a laudable and necessary aim given the 
increasing importance of measuring QoL in assessing outcome.
6.5.1 Critique
An advantage of using Cl was that it allowed the interviewer to ask the participants 
for possible solutions to the problems that were identified. This overcomes the 
criticism that although the method of Cl highlights problems, it does not offer neat 
solutions. Allowing participants to contribute to this is an essential part of the process 
of developing a good measure. Whilst it is acknowledged that the number of 
participants who completed the Cl task was relatively small, it is generally thought to 
be acceptable providing saturation has been reached, where no new problems or issues 
are being identified with each new participant. Moreover, the goal is not to derive 
statistically generalisable results, but to reflect the cognitive processes that might be 
influenced by a range of respondent characteristics (Campanelli, 1995). It is argued 
that Cl should become a necessary and integral way of pre-testing survey instruments, 
echoing the view of Collins (2003) who proposes that cognitive testing should be a 
standard part of the development process.
This study has shown how cognitive methods can be applied to the development of a 
PDM to be used in conjunction with the core WHOQOL instrument to ensure that 
items are relevant, comprehensive and acceptable to the potential users. Furthermore, 
the methodology provides evidence that the meaning of items is shared between users 
so that ambiguity or misinterpretation of meaning is reduced or eliminated, increasing 
certainty that items are measuring what they purport to measure and consequently, 
that the instrument fulfils its purpose (Collins, 2003). Following subsequent testing of 
the PDM using the complementary traditional psychometric approach, its 
psychometric properties will be elucidated and the number of items will be further 
reduced during this process to create an instrument that is psychometrically sound and 
that can be applied across a range of research and clinical contexts to assess subjective 
QoL relating to CP. The new items will increase the specificity of the core instrument 
to account for the impact of pain on QoL. This work is important because although 
CASM are now being used in QoL research (for example, Niero et al., 2002; Rouland 
et al., 2002), to date, such methods have not been applied to CP populations. More 
generally, further work should focus on deepening the understanding of the cognitive
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processes involved in responding to self-report instruments, whilst developing 
systematic protocols for implementing cognitive methods in the creation of QoL, pain 
and other health related questionnaires to provide rigorous and meaningful outcome 
measures in a world of evidenced based health care.
6.5.2 Further work
This chapter has reported the use of Cl to modify and eliminate items to derive the 
pilot PDM to be used in conjunction with the WHOQOL-lOO. This methodology 
ensures that the items included in the pilot PDM have face and content validity, that 
is, are acceptable to the users and that items adequately and appropriately address the 
underlying concepts, to be further tested in the cross-sectional pilot survey described 
in chapter seven. This and the subsequent longitudinal field-test reported in chapter 
eight aim to elucidate the psychometric properties of the new PDM.
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Chapter seven 
The Cross-sectional Pilot Study:
Validation of the Pain and Discomfort Module
7.1 Introduction
In chapter six, the preliminary pilot work using cognitive interviewing was described, 
providing confidence in the face validity, meaningfulness and relevance of the items 
selected to represent the 10 new facets of QoL identified by the focus group (FG) and 
web survey participants in chapters three and four. Consequently, it is argued that the 
content of the items being tested in the pilot instrument represent aspects of QoL that 
are important to people with chronic pain (CP), which is evidence of the content 
validity (Streiner and Norman, 1995) or content relevance (Messick, 1980) of items. 
This chapter reports a cross-sectional survey to test the preliminary psychometric 
properties of the new pain and discomfort module (PDM) to be used in conjunction 
with the UK WHOQOL-lOO, and to reduce the number of items in the PDM in order 
to make a preliminary assessment of the Quality of life (QoL) of people with CP.
Depending on the goals of measurement, instruments may be designed for different 
purposes; for example, Juniper and colleagues describe discriminative, predictive or 
evaluative instruments (Juniper, Guyatt and Jaeschke 1996). Discriminative 
instruments should be sensitive to distinguish between different patient groups, such 
as those with differing diagnoses. Predictive measures should be able to predict 
outcomes to a criterion standard, that is, to a predefined outcome or gold standard. 
Evaluative instruments must be able to detect within-patient change over time by 
containing items that are responsive to change with response options that have 
sufficient gradations to register such change (Juniper, Guyatt and Jaeschke 1996). 
Any new instrument purporting to measure a specified outcome must be tested in the 
field by applying it to the populations in which its use was intended. Subsequent 
analysis should involve the application of numerous psychometric tests to the data 
derived from its use, in order to ensure that the instrument is reliable, valid and 
sensitive to changes in clinical condition. This traditional approach, incorporating
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classical test theory, has more recently been complemented by new methodologies, 
such as the cognitive interviewing described in chapter six. Substantial validation 
work has been conducted on the core WHOQOL-lOO in numerous populations, such 
as people with CP (Skevington, Carse, Williams, 2001), HIV (O’Connell, Skevington 
and Saxena, 2003) and depression (Skevington and Wright, 2001) and so on. As 
described in detail in chapter two, its general psychometric properties have been well 
documented (The WHOQOL Group, 1998).
The purpose of this investigation was to conduct a cross-sectional postal survey in 
order to elucidate the psychometric properties of the PDM by seeing how it behaves 
when applied to a clinical population. Specifically, to examine its validity in order 
reduce the 10 new facets and 68 items representing the PDM, to allow for a 
parsimonious, yet elaborate conceptualisation of the impact of pain on QoL. This 
chapter also explores the relationship between core WHOQOL-lOO facets and 
domains of QoL and the 10 new facets of QoL pertaining to pain and discomfort.
7.1.1 Item pool
One of the principle ideas behind this approach is that a small number of items will be 
derived from an item pool (Juniper, Guyatt and Jaeschke 1996). This enables the 
‘best’ items, based on their psychometric properties, to be selected. A number of 
broad criteria are applied to the performance of individual items within the context of 
the instrument as a whole, and these are used to decide whether or not an item should 
be retained or rejected. An item can be rejected based on its performance alone. For 
example, it might produce skewed data, which could lead to ceiling or floor effects. It 
may also perform badly within the instrument by not correlating very highly with its 
parent facet, suggesting that the item does not have a strong conceptual relationship 
with that facet or that the item does not tap into the concept in an adequate way. 
Furthermore, it might have an unacceptably low item-total correlation (Pearson’s r) of 
less than 0.20 (Kline, 1986) and so on. The following section discusses each of the 




Individual items should correlate highly with other items in the same facet, and with 
the summed score of the total of items in the same facet, as this ensures that each item 
is representing a different aspect of the same concept. Very high internal consistency 
is not necessarily desirable because the resulting scale would contain items of a very 
similar nature and content. This can be measured using Cronbach’s alpha, which is a 
model of internal consistency, which assesses the average inter-item correlation 
(Cronbach, 1951). High correlations represent high internal consistency and a perfect 
correlation of 1.0 would mean that items are measuring the same concept and 
consequently, such items would be redundant. Given the importance of capturing the 
multidimensional nature of QoL, facets addressing a narrow or unidimensional aspect 
of QoL are undesirable. It has been suggested that 0.70 is an acceptable reliability co­
efficient (Nunnaly, 1978) and Streiner and Norman (1995) suggest that Cronbach’s 
alpha should be between 0.70 and 0.90 to demonstrate acceptable internal consistency 
reliability. The correlation between individual items and the scale as a whole must 
also be examined, excluding the contribution of that item. Kline suggests that items 
should correlate a minimum of 0.20 with the scale (Kline, 1986). It is also important 
to examine the effect of each item on the overall scale, by systematically removing 
and replacing each item in order to assess its contribution to the overall scale. 
Consequently, if an item makes less contribution than other items representing that 
facet, it should be considered for deletion.
7.1.4 Validity
Validity is the extent to which an instrument measures what it claims to measure. 
More specifically, the important issue is whether the measure is validated with the 
particular population it claims to assess. Assessing the validity of an instrument is an 
ongoing process, beginning with the data derived from the cross-sectional survey, and 
followed by a longitudinal survey to examine test-retest reliability and sensitivity to 
change. Different types of validity must be assessed during testing of a new 
instrument; these are outlined below.
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7.1.5 Face validity
High face validity is when an instrument appears to measure the concepts identified 
and Ware defines this as ‘what an item appears to measure based on its manifest 
content’ (Ware et al., 1981). This is not a test per se, but can be carried out by 
examining the items in a non-statistical way, that is, based on the match between the 
facet concept and the semantic attributes of the question at face value. This was 
confirmed through the cognitive interviewing in the previous chapter, to ascertain if 
the PDM is applicable, appropriate and relevant to the group under study.
7.1.6 Content validity
Ware defines content validity as ‘how well a measurement battery covers important 
parts of the health components to be measured (Ware et al., 1981). That is, how well 
items cover the aspects being measured and whether these aspects are covered 
adequately. Guyatt and Cook (1994) ask about the involvement of people with 
relevant health status in developing the content. The FG work in chapter three 
addresses this qualitatively and confirms that this was done. Lomas and colleagues 
(1987) ask about the role of patients in generating and confirming the content of the 
instrument. Again, in the present study, patients were asked to think about ways of 
asking about how a particular aspect of pain impacted in their QoL and patients were 
also asked to confirm the content of the PDM through the process of cognitive 
interviewing. Despite the non-statistical nature of face and content validity tests, they 
are nonetheless essential to the process of developing a new measure and complement 
other more rigorous statistical testing. Quantitative tests provide further empirical 
demonstration.
7.1.7 Criterion validity
Criterion validity is concerned with whether a new measure correlates with an 
existing instrument known to measure the same or similar concepts, for example, the 
PDM should correlate with a well-validated or gold standard instrument known to 
assess QoL (Streiner and Norman, 1995; Juniper, Guyatt and Jaeschke 1996). Such 
validity can also be conducted by examining the correlations between the core 
WHOQOL items and the PDM items, as there is strong evidence that the core UK 
WHOQOL instrument assesses QoL (Skevington, 1998; Skevington, Carse and 
Williams, 2001), and therefore the new items should also be able to distinguish
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between poor and good QoL in a similar, but more sensitive way. Validity can be 
strengthened by making a priori predictions about which items are most likely to 
correlate, for example that new psychological or physical facets will correlate more 
highly with core facets housed under these domains, than with facets housed under 
different domains.
7.1.8 Construct validity
Construct validity looks at the relationship between a particular construct and a set of 
other variables in the absence of a gold standard measure (Juniper, Guyatt and 
Jaeschke 1996). Convergent and discriminant validity are types of construct validity 
(Campbell and Frisk, 1959), where predictions are made about the strength of the 
relationship between different variables. Related constructs will be stronger and 
unrelated or less related will be weaker. Patterns of items that are hypothesised to 
assess single underlying constructs are analysed and it is possible to check whether 
items correlate more with the scale in which they belong than with other scales, to 
ensure that items from different facets are not overlapping conceptually. Furthermore, 
it is important to check that items addressing one facet are measuring different aspects 
of the same aspect of QoL. Items in a facet should therefore correlate more highly 
with other items in that facet than with items in other facets. McDowell and Newell 
(1996) propose that a correlation coefficient of 0.60 may provide evidence of 
construct validity. It has been suggested that an a priori prediction should be made 
before this test is done, to ensure that it is possible to falsify validity, for example by 
making a prediction about the strength of the relationship between two items. Given 
that the PDM is multidimensional, covering facets from different QoL domains, a 
relationship is assumed between the different facets. For example, psychological 
facets should correlate more highly with each other than with physical facets.
7.1.9 Discriminant validity
Discriminant validity is whether an instrument is able to distinguish between groups 
known to vary on a particular characteristic, such as diagnostic group, condition, 
severity of symptoms, age, and gender and so on. Another way to test discriminant 
validity is to divide the sample into groups based on different pain severities or pain 
duration. This can be examined by conducting an a priori paired comparison analysis 
of variance (ANOVA) to see if there are significant differences in QoL between
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people who rate their pain at different intensities. Discriminant validity will be tested 
and reported in chapter eight on the longitudinal data and in chapter nine where 
further analysis will be conducted on the reduced set of PDM items from the cross- 
sectional data reported here. Analysis will explore the ability of the PDM to 
distinguish between patients who are known to differ on certain variables, for 
example, those defining themselves as ill or well, or those with different pain 
intensities or qualities.
7.1.10 Score distribution and floor and ceiling effects
Examining the score distribution of a scale allows us to see if all points on a scale are 
utilised by participants and whether scores tend to cluster around one or two points on 
the scale. It is important that all scale points are used or this will decrease the 
instruments ability to distinguish between different types of patients, or between the 
same patients at different time points. Floor and ceiling effects are related to score 
distribution because if the questions cannot distinguish between a good or excellent 
QoL in a particular aspect of life, it is not sufficiently sensitive and therefore is unable 
to detect varying magnitudes of change. Ceiling and floor effects occur when the 
questions and the response scales are presented in such a way that does not allow for 
further improvement of deterioration to be picked up and is a consequence of skew 
(Streiner and Norman, 1995). For example, if a person reports the poorest QoL, and 
then is asked 3 months later the same set of questions with the addition of a question 
asking about their health status relative to the baseline assessment, if they report a 
decline, the QoL assessment will not detect this deterioration, because the baseline 
reflected the poorest QoL. Decisions need to be taken about items that show floor or 
ceiling effects, once this has been established, and once their individual contribution 
has been elucidated. This can be done by tabulating the percentage of participants 
who responded with each of the points on the 5-point Likert scale (i.e. 1-5). There 
must be 10% in each category (each item should add up to 100%) or this might 
suggest floor or ceiling effects.
7.1.11 Item redundancy
An item is said to be redundant if it does not add anything to the instruments ability to 
assess QoL. Specifically, if an item is tapping into the same construct as another item 
and is essentially asking the same question, that item would be removed. An
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important goal is to achieve parsimony by avoiding the inclusion of superfluous items, 
which would add to patient burden, which can be tested by looking at the correlations 
between items. For example, if inter-item correlations or Cronbach’s alpha is 
unacceptably high (> 0.9), this suggests that those items are conceptually similar or 
too homogeneous where items may be asking the same question in different ways 
(Boyle, 1991; Hattie, 1985). Consequently, one of the items should be discarded 
based on its performance on other tests. Careful judgment is required when selecting 
one item over another and the performance of each item on others tests informs the 
decision about which one should be discarded.
The psychometric tests for conducting item reduction have been introduced and 
described. It is common practice to conduct cross-sectional postal survey as part of 
the process of validating a new instrument to measure a specified outcome and this 
chapter describes such a study.
7.2 Method
7.2.1 Construction of the quota sample
The quota sample for this study was structured using data from a community 
prevalence study of CP using broad categories based on epidemiological data (Elliott 
et al, 1999). The rationale for using this, as opposed to a sample based on the 
prevalence of CP types amongst pain clinic populations, was to ensure that the 
population represented a realistic cross-section of those seeking help for their pain, 
since only 1% of those with CP in the UK reach speciality clinics (Smith et al., 1996). 
Further estimates of the prevalence of conditions not defined by Elliot and colleagues 
were based on data from studies of the epidemiology of pain (Crombie et al., 1999; 
Scher, Stewart and Lipton, 1999; Macrae and Oakley Davies, 1999; MacFarlane, 
1999; Zakrzewska and Hamlyn, 1999). The known and estimated percentage 
prevalence of different CP types was multiplied by 2, to give the approximate number 
within each category to approach to achieve a sample approximating the prevalence of 
each pain type. Table 7.1 shows how the sample was divided into diagnostic groups 
by age and gender.
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Table 7.1 Diagnostic group, prevalence and target number (prevalence doubled)











Musculoskeletal (back pain (BP) and 
sciatica)
23.5* 47 14 15 14 18
Rheumatology (arthritis) 23.2* 46 3 18 3 25
Spinal chord/ injury 8.7* 17 9 7 4 5
Cardiology (angina) 6.6* 13 0 7 0 6
Gynaecology 5.7* 11 - - 7 3
Oncology 0.7* 1 0 1 0 1
Other, composed of 31.71* 64 8 13 8 11
Migraine io t 20 - - - -
Post-surgical 9f 18 - - - -
Neuropathic 6 t 12 - - - -
Fibromyalgia (FMS) 4 t 8 - - - -
Facial 3f 6 - - - -
Total 100.4 200 34 61 36 69
* Estimates based on data from Elliott et al., 1999
f  Estimates based on data from Crombie et al., 1999; Scher, Stewart and Lipton, 
1999; Macrae and Oakley Davies, 1999; MacFarlane, 1999; Zakrzewska and Hamlyn, 
1999.
7.2.2 Inclusion and exclusion criteria
Male and female patients over the age o f 16 (no upper limit), with pain persisting 
continuously or intermittently for longer than 3 months (Elliot et al., 1999) were 
included in the sample. Exclusion criteria were patients with a known psychological 
diagnosis with a referral to a Clinical Psychologist or Psychiatrist, those involved in 
any o f the previous stages o f research reported in this thesis or known to be involved 
in a concurrent study.
7.2.3 Procedure
Regional and national contacts were established and invited to assist in data collection 
by distributing the WHOQOL-lOO and PDM to their patients. A total o f 469 
questionnaires were sent out to patients from the pain clinic, departments o f 
orthopaedics, physiotherapy, maxillo-facial surgery, genito-urinary medicine (GUM) 
and gynaecology at the Royal United Hospital (RUH); the Wiltshire Back Pain 
Network (BPN); Royal National Hospital for Rheumatic Diseases (RNHRD) and Box 
Surgery General Practice in Bath and Pain Concern East Lothian (registered charity, 
Scotland) and a local FMS support group.
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Table 7.2 details the number of patients recruited from each centre or department, the 
patient type, mode of administration of the questionnaire and response rate. Potential 
participants were either sent a questionnaire pack in the mail or were given their 
questionnaire pack by hand. Packs consisted of a cover letter inviting them to 
complete the new assessment of QoL, an information sheet giving further details 
about the study and explaining the ethical considerations and the questionnaire 
consisting of the UK WHOQOL-lOO (102 items), the additional pain and discomfort 
items (68 items), importance items for both the international core (26 items) and the 
PDM (16 items). Socio-demographic and health status details were obtained from the 
extended ‘About you’ page at the back of the WHOQOL-lOO, which asks questions 
about gender, date of birth, educational level, marital status, current health problems 
and whether the respondent is in paid work and for their occupation. Additional 
questions, selected from the McGill Pain questionnaire asked about duration, location, 
severity and intensity of pain (Melzack, 1975). Respondents completed the 
questionnaire and returned it in the stamped addressed envelope provided. Based on 
the approximate length of time taken to complete the WHOQOL-lOO (30 minutes, 
The WHOQOL Group, 1998), this was estimated to take around 45-50 minutes, 
depending on level of disability, concentration and tiredness.
7.2.4 Reminders
Reminder letters were sent to 76 of the sample, that is, those that were traceable 
through records, in order to boost the response rate of the survey. This was done by 
sending letters inviting people to complete the questionnaire if they wished to and 
emphasising that they still had time to do so. Those who could not be traced were 
from specific clinics or organisations that did not keep precise records of study 
participants and were not able to divulge the names and addresses of patients to 
respect confidentiality. As packs were sent out in batches, reminders were not sent 
when there was a considerable interval between first receiving the questionnaire.
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Table 7.2 Centre or department, mode of administration, patient type, number





Patient type No. of 
patients
Response
Pain Clinic, RUH Mail Musculoskeletal conditions 199 91
Orthopaedics,
RUH





Hand and mail Mixed diagnoses 15 9
Maxillo-facial 
surgery, RUH
Hand Facial pain 11 5
GUM, RUH Hand and mail Mixed diagnoses 5 4
Gynaecology,
RUH
Mail Pelvic pain 3 2
BPN Mail BP 33 12
RNHRD Hand Rheumatoid arthritis (RA), 











Mail Mixed diagnoses 50 25
FMS support 
group
Mail FMS 3 2
Total - - 469 216
7.3 Analysis
7.3.1 Data cleaning
Data cleaning involved checking that data had been entered correctly and that all item 
data was a numerical value between 1 and 5. Each variable was systematically 
examined to ensure that no incorrect entries had been made. Box plots were 
examined to view the spread o f data for each item and check for any outliers 
(Tabachnick and Fidell, 1996). Means, frequencies and distributions were inspected 
to ensure that errors have not been made. A missing value analysis was also 
conducted because it is recommended that an assessment should be discarded if  20% 
o f an assessment is missing (The WHOQOL Group, 1998). All data was retained for 
analysis.
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7.3.2 Item reversal and scoring of domains
On receipt of the returned and completed questionnaires the data was entered into a 
SPSS data editor. Of the WHOQOL-lOO core items, 18 required reverse scoring and 
43 items from the PDM, due to the essentially negative valence of pain and its 
consequences. The WHOQOL-lOO syntax file was adapted to include the PDM items 
and the necessary items were reversed and facet and domain scores were calculated. 
Facet scores are calculated by summing the items within each facet and domain scores 
are calculated by computing the mean of the facet scores (domain scores excluded the 
new items) (WHOQOL Group, 1998).
7.3.3 Psychometric analysis
Consistent with the development of the international core (The WHOQOL Group, 
1998), the specific aims of the analysis were to examine the construct validity of the 
PDM facets, to select the best items to represent each new facet of QoL and to 
determine reliability (internal consistency) and validity. Table 7.3 summarises the 
criteria that apply to the selection of items, which is based on the application of the 
tests detailed in the introduction above.
Table 7.3 Summary of criteria that apply to the selection of items
Test Criteria
Missing value analysis No more than 10% missing data for each item
Normality -  skew and 
kurtosis
Response to each item should be normally distributed (see below)
Distribution of scores Minimum of 10% of responses at each point in scale




Pearson’s r should be higher for parent domain than other domains
Cronbach’s alpha Inclusion of each item should increase the Cronbach’s alpha o f the 
total scale reflecting its contribution
Stepwise multiple 
regression by facet
Items, as independent variables (IV’s), should contribute to 
explaining the variance in overall QoL and health (G) as the 
dependent variable (DV)





Of the 469 questionnaires sent out, 216 (46%) completed questionnaires were 
returned. The highest response rates were achieved from the community samples, that 
is the General Practitioner (54%) and the Pain Concern charity (50%) samples, 
possibly explained by a higher perceived obligation or older age. Known reasons for 
non-response included not suffering from CP, emigration, not known at address, 
questionnaire undelivered and deceased. Reasons for refusal included being unhappy 
about inclusion in the study because of being on the waiting list, being too ill to 
complete, caring for ill spouse and being unhappy with the way treated by health 
service.
7.4.2 Socio-demographic composition
The sample consisted of 132 (61.1%) females and 84 (38.9%) males. Of the male 
participants, 27 were aged 16-44, 48 were 45-65 and 8 were over 66. Of the females, 
41 were aged 16-44, 73 were 45-65 and 18 were over 66. The mean age was 51.32 
(SD 13.63, range 20-90). Of the sample, most were married (n=133, 61.6%), 
followed by divorced (n=29, 13.4%), single (n=26, 12.0%), living as married (n=14, 
6.5%), widowed (n=ll, 5.1%) and separated (n=3, 1.4%). Participants were mostly 
educated to secondary level (n=106, 49.1%), followed by further education such as 
technical/ clerical (n=71, 32.9%), university education (n=27, 12.5%), primary school 
education (n=6, 2.8%) and no education (n=4, 1.9%). One participant stated that their 
education had been ‘private’, without indicating level. Of the sample, 83 (38.4%) 
were currently employed.
7.4.3 Health characteristics
Of the sample, most described their health as neither poor nor good (n=77, 35.6%), 
followed by poor (n=67, 31.0%), good (n=43, 19.9%), very poor (n=19, 8.8%) and 
very good (n=6, 2.8%). One hundred and twenty three (56.9%) described themselves 
as currently ill, 79 (36.6%) as not currently ill and 14 (6.5%) did not state.
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7.4.4 Characteristics relating to pain
Mean duration of pain in months was 108.50 (SD 124.70, range 1-660 months) (10 
participants did not report their pain duration). Most patients described their pain as 
continuous (n=143, 66.2%), followed by intermittent (n=68, 31.5%) and brief (n=4, 
1.9%). Most patients described their pain as discomforting (n=77, 35.6%), followed 
by distressing (n=59, 27.3%), horrible (n=48, 22.2%), excruciating (n=18, 8.3%), 
mild (n=9, 4.2%) and no current pain (n=4, 1.9%). In general, substantial co­
morbidity was apparent. The most common condition was BP and sciatica (n=67, 
31.0%), followed by, arthritis (n=45, 20.8%), injury (n=19, 8.8%), gynaecological in 
origin (n=6, 2.8%), angina (n=4, 1.9%), cancer (n=2, 0.9%), other (n=53, 24.5%) and 
no condition specified (n=20, 9.3%). The most common site of pain was the legs 
(n=146, 67.6%), followed by the lower back and spine (n=140, 64.8%), upper 
shoulders and arms (n=96, 44.4%), pelvis (n=61, 28.2%), middle back and chest 
(n=54, 25.0%), upper back (n=51, 23.6%), head, face and mouth (46, 21.3%), 
abdomen (n=38, 17.6%) and other body regions (n=84, 38.9%). Respondents 
identified 14 more specific pain locations; ankles, elbows, feet, fingers, genitals/groin, 
hands, hips, knees, lungs, neck, rib cage/ chest, thigh, toes and wrists.
7.4.5 Missing value analysis for the PDM items
A missing data analysis was conducted to examine whether there are consistent 
patterns of items not being completed. None of the PDM items were systematically 
missed as items had fewer than 4 (1.9%) missing responses, which is well below the 
10% maximum criteria allowed for each item and provides further support for the 
comprehensibility, acceptability and face validity of the items representing the PDM. 
The 9 items with 4 missing responses came from the vulnerability/ fear/ worry, loss/ 
loneliness/ feeling alone, positive strategies and relationship with HCP facets. For the 
importance items, 9 of the 216 participants failed to complete any of the items. There 
were fewer than 10% missing responses for the 16 PDM importance items, although 
the most frequently missed was the importance of feeling that you are not alone (n=6) 
(due to an initial error in printing the item), followed by the importance of sense of 
humour and loss (n=2). Although the small number of missing responses supports the 
comprehensibility and face validity of the PDM and corresponding importance items, 
most missing responses occurred for the loss/ loneliness/ feeling alone, positive 
strategies and relationship with health care provider facets.
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7.4.6 Psychometric properties of the pain and discomfort items
Each of the 68 items was systematically tested in order to select the best items and 
discard the poorly performing items, based on the criteria discussed above. The 
penultimate table of the results section (table 7.13) summarises the results from each 
test, the aim being to derive a reduced number of 4-item facets. Each section that 
follows describes the performance of the items on each test.
7.4.7 Normality -  skew and kurtosis
Table 7.4 shows the mean, SD, skew, standard error and kurtosis of the PDM items. 
Of the 68 items, 18 had problems with skewness, because a skewness value of more 
than twice its standard error is taken to indicate a departure from symmetry (Howell, 
1997). Each of these cases will be examined in conjunction with other statistical tests 
to see if the item should be retained or removed.
7.4.8 Distribution of scores
At least 10% of participants must have used each of the 5 scale points corresponding 
to each item (WHOQOL Group, 1997). This demonstrates that the whole range of 
scores are being used, ensuring that ceiling or floor effects are not occurring. Table
7.5 shows the distribution of responses for each item, illustrating the way in which 
questionnaire respondents use the scales. Where there is a low percentage for 5 
(<10%) (good QoL), this suggests a floor effect, that is, respondents are treating the 
scale as a 4-point scale where the verbal label for the 5-anchor point may be perceived 
to be too extreme. Consequently, the scale will not be sensitive to a perceived 
improvement. The reverse is true for items where 1 (poor QoL) has not been used 
(<10%) and the scale will not be sensitive enough to detect a perceived deterioration. 
Given that substantial work has gone into the layout and format of the core response 
scales (Szabo, Orley and Saxena, 1997), changing the verbal label given to the 1 or 5 
anchor points to have a less extreme meaning is not a suitable solution. 
Consequently, items with skewed distributions can either be removed or item wording 
can be modified.
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Table 7.4 Frequencies for the 68 PDM items (Standard error of skewness .17 for
all items)
Item no. Item Mean SD Skew Kurtosis
F60.1 Flare-ups 2.17 .92 .55* .04
F60.2 Worry about flare-ups 2.67 1.07 .25 -.53
F60.3 Bothered by flare-ups 2.33 1.01 .45* -.20
F61.1 Treatments offer relief 2.61 .96 -.02 -.40
F61.4i Control over pain 2.48 .81 .35* .37
F61.6i Treatment imp QoL 2.64 1.03 -.012 -.79
F61.8 Bothered by medication 3.08 1.23 .09 1.0
F61.9 Side effects of medication 2.56 1.08 .45* -.62
F62.1 Bothered by anger 3.20 1.13 -.09 -.83
F62.2 Anger interfere 3.68 1.04 -.55* -.41
F62.4 Anger affect relationships 3.67 1.06 -.50* -.46
F62.6 Bothered by frustration 2.53 1.06 .42* -.35
F62.7 Frustration interferes 2.96 1.07 .01 -.68
F63.1 Bothered by vulnerable 3.31 1.05 -.17 -.61
F63.2 Fear bother 3.45 1.02 -.28 -.54
F63.3 Vulnerable interfere 3.69 .93 i "0 * .02
F63.4i Pain a threat 2.84 1.11 .36* -.65
F63.5i Concerned about pain 2.53 .91 .30 .04
F63.6i Distressed by pain 2.40 .92 .32 -.38
F63.7 Feelings of worry 2.86 1.06 .08 -.71
F63.8 Treatment worry 3.25 1.08 -.03 -.91
F64.2 Uncertainty interfere 2.86 1.09 .11 -.64
F64.4 Difficulty planning 2.94 1.11 -.01 -.80
F64.6i Pain prevent 2.15 1.09 .79* -.11
F64.7 Pain limit life 2.18 1.03 .77* .08
F65.1 Bothered by loss 2.69 1.16 .34 -.71
F65.2 Loss interfere 3.16 1.15 -.07 -.83
F65.3 Carry out activities 2.14 1.04 .83* .23
F65.6 Bothered by loneliness 3.42 1.15 -.32 -.72
F65.7 Alone bother 3.49 1.16 -.34 -.68
F66.2 Humour 3.70 .84 -.21 -.51
F66.3 Hope for relief 4.08 .91 -.84* .31
F66.5 Feelings of hope 2.99 .98 .12 -.37
F66.6i Hopeful optimistic 2.87 .96 .30 -.12
F66.7 Hope and problems 3.02 .93 -.04 -.28
F67.1 Others cannot see pain 2.78 1.15 .24 -.72
F67.2 Pain affect relationships 2.99 .99 -.07 -.50
F67.5 Pain invisible 2.92 1.22 .08 -.98
F67.8 Communicate feelings to others 3.19 1.12 -.17 -.56
F67.10 How others see condition 3.19 1.16 -.24 -.76
F67.1 li Health interferes with relationships 2.97 1.16 -.03 -.77
F68.1 Burden others 2.25 1.01 .69* .16
F68.2 Worry about effect on others 2.57 1.01 .22 -.36
F68.3 Guilt 3.09 1.27 -.01 -1.00
F68.5i Resources for others 2.91 1.28 .20 -.97
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Item no. Item Mean SD Skew Kurtosis
F69.3 Supported by health service 2.87 .94 .01 -.40
F69.4 Dependent on health service 3.13 1.17 -.00 -.90
F69.6 Benefit from cm 2.06 1.21 .84* -.50
F69.9 Access to information 2.84 .97 .15 -.27
F61.3i Cope with pain level 3.07 .82 -.04 .48
F61.7 Comfortable 2.50 .99 .38* -.03
F64.3 Prevent plans 2.67 1.02 .70* .14
F65.5 Lonely 3.57 1.15 -.31 -.83
F67.3 Others appreciate condition 2.73 .89 .01 -.39
F67.4 Others understand 2.69 .87 .09 -.10
F69.8 Access to treatment information 2.65 .96 .10 -.40
F61.2 Satisfied with relief 2.69 1.02 .19 -.64
F61.5i Satisfied with control 2.61 .98 .20 -.62
F64.5 Satisfied with future plans 2.69 1.04 .06 -.84
F67.7 Satisfied with communication 3.26 .95 -.34 -.52
F67.9i Satisfied with express feelings 3.23 1.06 -.23 -.73
F68.4i Satisfied with support others 3.00 1.13 -.15 -.97
F69.1 Satisfied with relationship with HCP 3.43 .98 -.40* -.25
F69.5 Satisfied with supp from HCP 3.17 1.07 -.12 -.66
F69.10 Satisfied with information 3.07 1.04 -.16 -.64
F62.3 Pain angry 2.98 1.11 .14 -.75
F62.5 Pain irritable 2.56 .93 .11 -.42
F64.1 Uncertainty 2.86 1.01 -.07 -.59
* Indicates where skew o f item is a problem
In only 4 o f the 68 items have at least 10% o f respondents used each o f the scale 
points. These 4 items come from the communication and guilt and burdening other 
facets and relate to how much a person is bothered that their pain is invisible to others, 
how much a person feels that their health interferes with their personal relationships, 
how much a person is bothered by feelings o f guilt and how concerned a person is that 
they do not have enough resources to provide for others. On inspection o f the 
distributions, this suggests that for the majority o f items, respondents are not using the 
anchor points representing either a very poor (1) or very good QoL (5). Although this 
will be taken into account in the selection o f items, such items might prove to be 
sensitive to change following further testing.
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Table 7.5 Frequency distribution for the PDM items (% scores for scale point)
Item Scale pointsf
1 2 3 4 5
Flare-ups
Flare-ups 25.0 41.7 25.9 6.0 1.4
Worry about flare-ups 13.9 31.9 32.4 16.7 5.1
Bothered by flare-ups 22.7 35.2 31.0 8.3 2.8
Pain relief
Treatments offer relief 14.4 27.4 42.8 13.5 1.9
Control over pain 00 00 43.7 39.1 7.0 1.4
Treatment improve QoL 15.8 27.9 34.4 20.0 1.9
Bothered by medication 9.3 27.0 27.0 20.0 16.7
Side effects of medication 14.5 42.1 20.6 18.7 4.2
Cope with pain level 3.2 16.2 54.6 21.8 4.2
Comfortable 15.8 34.9 36.7 8.8 3.7
Satisfied with relief 11.6 34.7 30.6 19.9 3.2
Satisfied with control 12.0 37.0 31.0 18.1 1.9
Anger & frustration
Bothered by anger 6.0 23.3 28.4 28.8 13.5
Anger interfere 2.3 13.5 20.9 40.5 22.8
Anger affect relationships 2.8 12.6 24.2 36.3 24.2
Bothered by frustration 16.3 36.3 29.8 13.0 4.7
Frustration interferes 8.4 26.5 32.6 25.6 7.0
Pain angry 7.9 28.8 30.7 22.3 10.2
Pain irritable 13.0 34.4 37.7 13.5 1.4
Vulnerability/ fear/ worry
Bothered by vulnerable 4.2 18.6 32.6 31.2 13.5
Fear bother 2.8 15.9 29.9 36.0 15.4
Vulnerable interfere 1.9 7.4 29.8 41.4 19.5
Pain a threat 8.4 35.8 28.4 18.1 9.3
Concerned about pain 11.6 37.7 38.6 9.8 2.3
Distressed by pain 15.3 42.3 29.8 11.6 0.9
Feelings of worry 9.8 29.8 31.2 23.7 5.6
Treatment worry 3.3 25.5 27.4 30.7 13.2
Uncertainty
Uncertainty interfere 10.8 27.7 33.3 21.1 7.0
Difficulty planning 10.3 26.3 29.6 26.3 7.5
Pain prevent 32.9 36.2 17.4 10.3 3.3
Pain limit life 27.7 41.3 18.8 9.4 2.8
Prevent plans 7.9 42.1 33.2 8.9 7.9
Satisfied with future plans 13.4 31.9 29.6 22.7 2.3
Uncertainty 9.8 26.0 36.3 24.2 3.7
Loss/ loneliness/ feeling alone
Bothered by loss 15.6 33.0 26.4 17.0 8.0
Loss interfere 7.5 23.0 29.1 26.8 13.6
Carry out activities 30.5 39.0 19.7 7.5 3.3
Bothered by loneliness 5.7 16.5 27.4 30.7 19.8
Alone bother 5.7 13.7 30.2 26.9 23.6
Lonely 3.7 14.8 29.2 25.0 27.3
Positive strategies
Humour 0 8.0 30.7 44.8 16.5
Hope for relief 0.9 4.7 17.9 38.2 38.2
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Item Scale pointsf
1 2 3 4 5
Feelings of hope 5.2 26.3 39.9 22.1 6.6
Hopeful optimistic 5.7 29.7 42.5 16.0 6.1
Hope and problems 4.7 23.3 42.3 25.1 4.7
Communication
Others cannot see pain 13.4 30.6 29.2 18.5 8.3
Pain affect relationships 6.5 24.7 37.2 26.5 5.1
*Pain invisible 13.6 27.1 24.8 23.4 11.2
Communicate feelings to others 8.3 16.7 36.1 25.9 13.0
How others see condition 8.9 19.2 28.2 31.0 12.7
*Health interferes with relationships 12.2 22.1 32.4 23.5 9.9
Others appreciate condition 7.9 31.9 41.2 17.6 1.4
Others understand 7.9 32.4 44.0 13.9 1.9
Satisfied with communication 3.3 20.0 30.7 40.0 6.0
Satisfied with express feelings 5.1 22.3 27.0 35.8 9.8
Satisfied with support others 9.8 27.0 22.8 34.0 6.5
Guilt & burdening others
Burden others 24.2 40.5 24.7 7.4 3.3
Worry about effect on others 15.3 31.6 36.7 13.0 3.3
*Guilt 12.1 22.0 28.0 20.6 17.3
*Resources for others 15.0 26.2 28.0 15.0 15.9
Relationship with HCP
Supported by health service 7.0 27.9 40.0 21.9 3.3
Dependent on health service 7.9 24.8 28.5 24.3 14.5
Benefit from cm 46.7 21.2 15.6 12.7 3.8
Access to information 7.5 29.0 40.7 18.2 4.7
Access to treatment information 11.6 31.9 38.4 15.7 2.3
Satisfied with relationship with HCP 3.3 14.0 31.2 40.0 11.6
Satisfied with support from HCP 5.6 22.1 31.9 30.0 10.3
Satisfied with information 7.1 23.1 32.5 30.7 6.6
f  1 is poorest QoL and 5 is good QoL (see appendix 3
corresponding to items)
* Indicates where each point o f the scale has been used by at least
'or response scales 
10% of the sample.
7.4.9 Reliability analyses for the 68 PDM items
Table 7.6 illustrates the reliability analyses for the 68 items in the PDM. Correlations 
between each item and their facet mean with that items contribution excluded are 
shown (range -.01- .80). The item-facet correlation must be > +0.4 to ensure that it 
has been placed in the most appropriate facet and the higher the correlation, the more 
the item contributes to the facet. For internally consistent facets, Cronbach’s alpha 
should be between 0.7 and 0.9. For 9 o f the 10 facets, standardised Cronbach’s alphas 
ranged .75-.91, demonstrating good internal reliability. The lowest, for positive 
strategies (a .67) suggests that this facet is not internally consistent, reflecting that 
items address two different underlying constructs; humour and hope. This is further 
supported by the low inter-item correlation between two items addressing these
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different concepts. The highest Cronbach’s alpha was found for anger and frustration 
(a .91) and uncertainty (a .91) suggesting that the items addressing these facets are 
highly homogenous, that is they appear to be addressing relatively unidimensional 
concepts. The remaining facets ranged between .73 and .89, reflecting more 
acceptable alpha levels. The lowest of these was relationship with HCP, and the 
highest was vulnerability/ fear/ worry. These results are not definitive given that 
alpha levels will change following item reduction. Consequently the next section 
further explores the performance of individual items within each facet.
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Table 7.6 Reliability analyses for the 68 PDM items and 10 facets
Item Item-facet a if item Item-total
correlation deleted correlation
Flare-ups - facet a .85, facet-total correlation .60, a if facet deleted .90
Flare-ups .68 .82 .50
Worry about flare-ups .68 .83 .59
Bothered by flare-ups .80 .71 .54
Pain relief - facet a .81, facet-total correlation .64, a if facet deleted .89
Treatments offer relief .57 .77 .32
Control over pain .53 .77 .41
Treatment improve QoL .58 .76 .37
Bothered by medication .15* .83 .28
Side effects of medication .35* .80 .36
Cope with pain level .46 .78 .51
Comfortable .52 .77 .53
Satisfied with relief .68 .75 .56
Satisfied with control .70 .75 .57
Anger & frustration - facet a .91*, facet-total correlation .82, a if facet deleted .88
Bothered by anger .76 .89 .72
Anger interfere .80 .89 .70
Anger affect relationships .77 .89 .66
Bothered by frustration .70 .90 .69
Frustration interferes .73 .90 .70
Pain angry .69 .90 .67
Pain irritable .68 .90 .59
Vulnerability/ fear/ worry - facet a .90, facet-total correlation .76, a if facet deleted .89
Bothered by vulnerable .73 .87 .64
Fear bother .72 .88 .56
Vulnerable interfere .73 .88 .66
Pain a threat .64 .88 .58
Concerned about pain .70 .88 .56
Distressed by pain .63 .88 .62
Feelings of worry .66 .88 .66
Treatment worry .59 .89 .61
Uncertainty - facet a .91*, facet-total correlation .80, a if 1facet deleted .8? j
Uncertainty interfere .66 .90 .70
Difficulty planning .78 .89 .71
Pain prevent .76 .89 .64
Pain limit life .77 .89 .65
Prevent plans .75 .89 .60
Satisfied with future plans .74 .89 .69
Uncertainty .64 .90 .69
Loss/ loneliness/ feeling alone - facet a .8 8, facet-total correlation .75, a if facet deleted .89
Bothered by loss .69 .86 .64
Loss interfere .70 .86 .71
Carry out activities .54 .88 .67
Bothered by loneliness .78 .84 .57
Alone bother .66 .86 .52
Lonely .75 .85 .63
Positive strategies - facet a .67*, facet-total correlation .3(>, a if facet deleted .91
Humour .38* .65 .26
Hope for relief .06* .77 -.27








Hopeful optimistic .56 .57 .44
Hope and problems .64 .53 .47
Communication - facet a .88, facet-total correlation .74, a if facet deleted .89
Others cannot see pain .69 .87 .58
Pain affect relationships .64 .87 .69
Pain invisible .71 .87 .53
Communicate feelings to others .76 .87 .62
How others see condition .68 .87 .59
Health interferes with relationships .59 .88 .73
Others appreciate condition .48 .88 .35
Others understand .42 .89 .27
Satisfied with communication .66 .87 .55
Satisfied with express feelings .56 .88 .56
Guilt & burdening others - facet a .81, facet-total correlation .73, a if facet deleted .89
Burden others .68 .74 .55
Worry about effect on others .65 .75 .50
Guilt .65 .74 .65
Satisfied with support others .35* .83 .51
Resources for others .64 .75 .58
Relationship with HCP - facet a .75, facet-total correlation .52, a if facet deleted .90
Supported by health service .44 .69 .26
Dependent on health service -.10* .80 .27
Benefit from complementary medicine .10* .77 .05
Access to information .62 .66 .42
Access to treatment information .56 .67 .36
Satisfied with relationship with HCP .60 .66 .42
Sat with support from HCP .66 .64 .42
Satisfied with information .75 .63 .54
* Unacceptable (< .40)
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7.4.10 Item-facet correlations
To ensure that an item is placed in the correct facet and to check for redundancy with 
the core WHOQOL-facets, each item must correlate more highly with its own facet 
(excluding that items contribution) than with other core or PDM facets. Eighteen 
items were problematic due to higher correlations with other facets than the parent 
facet. If the correlation with core facets is higher than with the parent facet, this 
suggests redundancy and conceptual overlap. Moreover, if  the correlation with other 
new facets is higher than with its own facet, this might result in that item being moved 
to another facet, or deleted as a consequence o f redundancy. Due to the large number 
o f items, only the problematic items are shown in table 7.7. This has implications for 
the conceptual integrity o f  facets.
Table 7.7 Item-facet correlations for items correlating more highly with other
facets
Item and no. Item-facet
correlation
Facet item correlates more highly with
618 Bothered by medication .15 19 other facets, most with vulnerability, .32
619 Side effects of medication .35 Vulnerability, .43
613 Cope with pain level .46 Uncertainty, .47, pain, .47, vulnerability, .50
617 Comfortable .52 Uncertainty, .54
636 Distressed by pain .64 Pain, .68
637 Feelings of worry .66 Loss, .68, negative feelings, .76
642 Uncertainty interfere .66 Negative feelings, .66, vulnerability, .67, loss, 
.68
641 Uncertainty .65 Loss, .66, negative feelings, .69
653 Carry out activities .54 7 other facets, most with pain, .63, ADL, .65, 
uncertainty, .71
663 Hope for relief .06 Social support, .07, body, .08
666 Hopeful optimistic .56 Positive feelings, .67
672 Pain affect relationships .64 Anger, .66
6711 Health interferes with 
relationships
.59 Vulnerability, .60, uncertainty, .61, loss, .65, 
anger, .66
684 Satisfied with support 
others
.35 17 other facets, most with uncertainty, .55, 
ADL, .57, work capacity, .59
693 Supported by health 
service
.44 Health and social care, .57
694 Dependent on health 
service
-.10 34 other facets, most with guilt, .33, pain, .32
696 Benefit from 
complementary medicine
.10 Safety, .11, information, .13, relief, .13
695 Satisfied with support 
from HCP
.63 Health and social care, .68
Each item should also correlate at an acceptable level with the G facet, which is 
considered to be the bench mark for which the other facets can be correlated against
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and is regarded as a form o f criterion validity as the WHOQOL G facet is known to 
assess QoL. As shown in table 7.8, correlations with the general facet ranged from - 
.25 (F66.3, hope for relief) and .01 (F69.6, benefit from cm) to .67 (F64.4, diff 
planning). Eighteen items were strongly correlated (r>0.5), 28 were moderately 
correlated (r=0.35-0.5) and 22 were poorly correlated (r=0.20- 0.35). G was least 
related to benefit from CM, access to treatment information, access to information, 
bothered by medication, humour, side effects o f medication, others understand 
condition and dependence o f health service. With the exception o f these items, all 
item- G correlations were >0.24 at p>0.001. The negative correlation between hope 
for relief and QoL suggests that this is inversely related to QoL, that is, the more a 
person hopes for relief from their pain, the poorer their QoL. Consequently, this item 
is problematic.
Table 7.8 Item-G Pearson’s correlations
Item Pearson rlSig. (2-tailed)
Flare-ups
Flare-ups .456 .001
Worry about flare-ups .472 .001
Bothered by flare-ups .456 .001
Pain relief
Treatments offer relief .246 .001
Control over pain .331 .001
Treatment improve QoL .348 .001
Bothered by medication .160 .020
Side effects of medication .212 .002
Cope with pain level .397 .001
Comfortable .431 .001
Satisfied with relief .442 .001
Satisfied with control .517 .001
Anger and frustration
Bothered by anger .444 .001
Anger interfere .505 .001
Anger affect relationships .486 .001
Bothered by frustration .540 .001
Frustration interferes .576 .001
Pain angry .442 .001
Pain irritable .411 .001
Vulnerability/ fear/ worry
Bothered by vulnerable .424 .001
Fear bother .366 .001
Vulnerable interfere .470 .001
Pain a threat .409 .001
Concerned about pain .398 .001
Distressed by pain .532 .001
Feelings of worry .478 .001
Treatment worry .449 .001
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Item Pearson rlSig. (2-tailed)
Uncertainty
Uncertainty interfere .618 .001
Difficulty planning .665 .001
Pain prevent .579 .001
Pain limit life .592 .001
Prevent plans .574 .001
Satisfied with future plans .641 .001
Uncertainty .561 .001
Loss/ loneliness/ feeling alone
Bothered by loss .517 .001
Loss interfere .590 .001
Carry out activities .572 .001
Bothered by loneliness .431 .001




Hope for relief -.252 .001
Feelings of hope .301 .001
Hopeful optimistic .525 .001
Hope and problems .404 .001
Communication
Others cannot see pain .353 .001
Pain affect relationships .469 .001
Pain invisible .305 .001
Communicate feelings to others .368 .001
How others see condition .332 .001
Health interferes with relationships .572 .001
Others appreciate condition .236 .001
Others understand .217 .001
Satisfied with communication .323 .001
Satisfied with express feelings .364 .001
Satisfied with support others .548 .001
Guilt & burdening others
Burden others .327 .001
Worry about effect on others .261 .001
Guilt .444 .001
Resources for others .326 .001
Relationship with HCP
Supported by health service .237 .001
Dependent on health service .199 .004
Benefit from cm .013 .849
Access to information .202 .003
Access to treatment information .148 .031
Satisfied with relationships with HCP .336 .001
Satisfied with supp from HCP .421 .001
Satisfied with info .360 .001
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7.4.11 Item-domain correlations
Each PDM item should correlate more highly with its own domain than with any 
other domain (domain means were calculated without the inclusion o f the new items), 
to ensure that it has been placed in the most appropriate domain. The item-domain 
correlations are shown in table 7.9 and ranged from -0.06- 0.68. Where items failed 
to correlate more highly with the parent domain, the domain that items correlated 
more highly with is shown. O f the 68 items, 40 correlated more highly with other 
domains than with the domain in which they had been placed. Where item-domain 
correlations are unacceptably low, these items are problematic, for example, bothered 
by medication is poorly correlated with domain I and with the other domains that it 
correlates more highly with (<0.23). Other items, for example bothered by frustration 
are strongly related to the parent domain and the other domains that it correlates more 
with (>0.50). Where correlations are unacceptably low items will be considered for 
deletion and where items correlate more highly with other domains, consideration will 
be given to the placing o f that item within the most appropriate facet and domain.
Table 7.9 Item-domain correlations
Item Item-domain
correlation




Worry about flare-ups .537
Bothered by flare-ups .494
Treatments offer relief .214
Control over pain .341
Treatment imp QoL .235 V, .266
Bothered by medication .182 II, .195, m , .205, V, .226
Side effects of medication .277
Cope with pain level .451
Comfortable .569
Satisfied with relief .456
Satisfied with control .516
Domain II
Bothered by anger .492 I, .522
Anger interfere .531
Anger affect relationships .500
Bothered by frustration .499 III, .510,1, .621
Frustration interferes .559 I, .605
Pain angry .415 I, .550
Pain irritable .405 I, .511
Bothered by vulnerable .611
Fear bother .586
Vulnerable interfere .652




Domain that item correlates most highly 
with
Concerned about pain .426 I, .479
Distressed by pain .499 I, .627
Feelings of worry .675
Treatment worry .478 Domain V, .501
Uncertainty interfere .629
Difficulty planning .573 III, .630
Pain prevent .367 V, .431,1, .643,111, .695
Pain limit life .364 V, .419,1, .662, III, .715
Prevent plans .365 IV, .366, V, .434,1, .526, III, .678
Satisfied with future plans .542 I, .588, III, .606
Uncertainty .635
Bothered by loss .572
Loss interfere .599
Carry out activities .437 III, .619,1, .637
Bothered by loneliness .563
Alone bother .485
Lonely .582 IV, .634
Humour .238
Hope for relief -.055 IV ,-.042, VI, .013
Feelings of hope .326
Hopeful optimistic .549
Hope and problems .493 VI, .501
Domain IV
Others cannot see pain .395 I, .478
Pain affect relationships .455 I, .469, V, .477, II, .482
Pain invisible .307 II, .321, V, .355,1, .437
Communicate feelings to 
others
.446 n, .455
How others see condition .319 V, .379, II, .409,1, .437
Health interferes with 
relationships
.562 V, .566, II, .568
Others appreciate condition .358
Others understand .365
Satisfied with communication .470 II, .473
Satisfied with express feelings .493 II, .574
Burden others .279 V, .356, II, .361,1, .419, III, .429
Worry about effect on others .180 V, .231,11, .236,1, .332, III, .351
Guilt .373 III, .374, V, .428,1, .478, II, 528
Resources for others .366 I, .445, V, .470
Satisfied with support others .389 II, .460,1, .475, III, .578
Supported by health service .144 I, .151, V, .226
Dependent on health service .179 V, .225, II, .294,1, .312, III, .364
Benefit from cm .008 I, .016, III, .026, V, .039
Access to information .283 V, .352
Access to treatment 
information
.234 V, .307
Satisfied with relationship 
with HCP
.323 V, .388
Satisfied with support from 
HCP
.357 V, .414
Satisfied with information .377 V, .466
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7.4.12 Facet-domain correlations
Each facet should correlate more highly with its own allocated domain than with any 
other domain, to ensure that it has been placed in the most appropriate domain. Table
7.10 show the facet-domain correlations. Overall, facet-domain correlations ranged 
from 0.10- 0.74. Facet-parent domain correlations ranged from 0.40- 0.71. Of the 10 
PDM facets, 6 correlated more highly with other domains than with their parent 
domain. Anger and frustration with domain I, uncertainty with domain III, positive 
strategies with domain VI, communication with domain II (although the correlation 
between communication and the psychological domain was only marginally higher 
than with its parent social relationships domain), guilt and burdening others with 
domain I, II, III and V and relationship with HCP with domain V. However, given 
that these correlations include the full set of items representing each facet before item 
reduction, these results should be interpreted with caution as certain items might 
artificially inflate or reduce the strength of the relationship between the facets and 
domains.
7.4.13 Scale reliability analysis
Appendix 4 shows the item-total reliability analysis for the 68 items, illustrating the 
contribution of each item to the overall scale. If the scale alpha, with the contribution 
of each item excluded, is higher than or equal to the overall 68 item scale alpha of .96, 
this indicates that the item is not contributing anything to the scale and should be 
deleted. Conversely, items that contribute most to the scale would give the lowest 
scale alpha when that item is excluded and should be retained. A total of 9 items had 
alphas higher or equal to the overall scale alpha, suggesting that they do not contribute 
to the scale. Those below .96 contribute most and should be considered for retention.
Table 7.10 PDM facet-domain correlations

























Flare-ups .585* .001 .430 .001 .490 .001 .348 .001 .398 .001 .161 .018
Pain relief .575* .001 .407 .001 .435 .001 .356 .001 .458 .001 .111 .107
Anger and frustration .6661 .001 .602* .001 .482 .001 .500 .001 .562 .001 .272 .001
Vulnerability/ fear/ worry .621 .001 .710* .001 .519 .001 .507 .001 .613 .001 .228 .001
Uncertainty .732 .001 .617* .001 .7421 .001 .533 .001 .591 .001 .192 .005
Loss/ loneliness/ feeling 
alone
.590 .001 .685* .001 .513 .001 .635 .001 .632 .001 .323 .001
Positive strategies .242 .001 .477* .001 .197 .004 .332 .001 .331 .001 .5151 .001
Communication .564 .001 .5881* .001 .402 .001 .587* .001 .561 .001 .291 .001
Guilt and burdening others .576f .001 .516t .001 .5361 .001 .430* .001 .5031 .001 .107 .119
Relationship with HCP .362 .001 .280 .001 .321 .001 .397* .001 .5051 .001 .118 .084
* Parent domain
t  Domain facet correlates more highly with this facet
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7.4.14 Stepwise multiple regression -  the contribution of each PDM facet item to 
explaining overall QoL and health
The data was analysed by stepwise multiple regression to examine the contribution of 
each item to explaining overall QoL and health. Consideration was given to the 
assumptions underlying regression, including that the relationship between the DV 
and IV is a linear and stable one, that the spread of data around the lull length of the 
regression line is relatively constant (known as the homoscedasticity assumption) and 
finally the multicollinearity assumption, that is that the IV’s are independent of each 
other (Argyrous, 2000). In preparation for analysis, due to the skewed responses to 
items reported previously, items were log transformed to achieve a normal 
distribution.
All items from each facet were regressed against the log transformed G facet. Thus, 
in each case, the facet items were the IV’s and G was the DV. Table 7.11 summarises 
the results from the multiple regression and includes the standardised beta coefficients 
and r square change statistic (shown as %), which can to used to identify items that 
contribute most to explaining G. For the physical domain, for flare-ups, only 2 of the 
3 items were retained in the model explaining the variance observed in G (items 602, 
601). The regression fit for flare-ups was (R 2adj = 27.5%) and the overall relationship 
was significant (F2,213 = 41.48, p < 0.05). For pain relief, 4 of the 9 items were 
retained in the regression model (items 615, 617, 613, 618). The regression fit for 
pain relief was (R  adj = 32.3%) and the overall relationship was significant (F4,209 = 
25.92, p < 0.05).
In the psychological domain, for anger and frustration, 3 of the 7 items were retained 
(items 627, 623, 622). The regression fit for anger and frustration was (R  adj = 37.5%) 
and the overall relationship was significant (F3,211 = 43.15, p < 0.05). For 
Vulnerability/ fear/ worry, 3 of the 8 items were retained (items 636, 633, 638). The 
regression fit for Vulnerability/ fear/ worry was (R 2adj = 39.0%) and the overall 
relationship was significant (F3,207 = 45.21, p < 0.05). For uncertainty, 4 of the 7 
items were retained (items 644, 645, 642, 647). The regression fit for uncertainty was 
(R 2adj = 56.7%) and the overall relationship was significant (F4,207 = 68.73, p < 
0.05). For loss/ loneliness/ feeling alone, 3 of the 6 items were retained (items 652, 
653, 655). The regression fit for loss/ loneliness/ feeling alone was (R 2adj = 44.0%)
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and the overall relationship was significant (F3,207 = 55.23, p < 0.05). For positive 
strategies, 2 of the 5 items were retained (items 666, 663). The regression fit for 
positive strategies was (R 2acij = 31.3%) and the overall relationship was significant 
(F2,207 = 48.08, p < 0.05).
In the social relationships domain, for communication, 3 of the 10 items were retained 
(items 6711, 679, 672). The regression fit for communication was (R  adj = 32.5%) 
and the overall relationship was significant (F3,207 = 34.20, p < 0.05). For guilt and 
burdening others, 3 of the 5 items were retained (items 684, 683, 682). The regression 
fit for guilt and burdening others was (R 2adj = 40.7%) and the overall relationship was 
significant (F3,208 = 48.64, p < 0.05). For relationship with HCP, 3 of the 8 items 
were retained (items 695, 694, 691). The regression fit for relationship with HCP was 
(R 2adj = 19.7%) and the overall relationship was significant (F3,201 = 17.42, p < 
0.05).
On examination of the r square change statistic, shown as % contribution to G, the 
uncertainty item 644 (To what extent do difficulties with planning affect your 
everyday life?) and 652 (How much do feelings of loss interfere with your everyday 
life?) contributed most to explaining G.
Having shown the contribution that each PDM items makes to explaining G in a 
stepwise multiple regression, the following section reports the importance attributed 
to the PDM facets.
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Table 7.11 Facet items, standardised coefficient beta, t, significance levels and 
contribution (r square change statistic shown as %) of the PDM items (log
transformed) to G from the stepwise multiple regression
Facet items|Standardised Coefficients Betat Sig. Contribution %*
Flare-ups
602 .316 4.493 .001 22.6
601 .286 4.071 .001 5.6
Pain relief
615 .308 4.553 .001 23.2
617 .194 2.806 .005 5.5
613 .186 2.768 .0062.6
618 .152 2.660 .008 2.3
Anger and rustration
627 .400 5.745 .001 32.6
623 .188 2.897 .004 4.5
622 .147 1.996 .047 1.2
Vulnerability/ fear/ worry
636 .312 5.119 .001 25.4
633 .266 4.221 .001 1.06
638 .233 3.647 .001 3.9
Uncertainty J
644 .215 2.951 .00443.4
645 .303 4.960 .001 9.3
642 .213 3.356 .001 2.5
647 .193 3.317 .001 2.3
Loss/ loneliness/ feeling alone
652 .333 5.045 .001 34.3
653 .316 4.992 .001 8.3
655 .169 2.852 .005 2.2
Positive strategies
666 .537 9.317 .001 29.2
663 -.165 -2.864 .005 2.7
Communication
6711 .371 4.626 .001 29.9
679 .152 2.400 .017 1.9
672 .171 2.261 .025 1.7
Guilt and burdening others
684 .476 8.547 .001 30.3
683 .404 6.118 .001 10.0
682 -.139 -2.124 .035 1.3
Relationship with HCP
695 .302 3.605 .001 15.2
694 .207 3.259 .001 4.1
691 .166 1.990 .048 1.6
* r square change shown as %
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7.4.15 PDM importance items
Table 7.12 shows the mean and SD o f the items ranked in order o f importance. All 
the new facets had a mean rating o f >3.0 confirming their importance to people with 
pain. The most important was the importance o f obtaining relief (4.43) and o f 
controlling pain (4.43) from the physical domain and the least important was being 
free from guilt (3.63) from the social relationships domain and feeling that you are not 
alone (3.69) from the psychological domain.
Table 7.12 Frequencies for the PDM importance items
Item No. Item Mean importance SD
28 Obtain relief 4.43 0.66
29 Control pain 4.43 0.66
27 Free from flares 4.30 0.79
38 Sense of humour 4.23 0.77
41 Not a burden to others 4.22 0.85
42 Relationship with HCP 4.07 0.75
33 Free from worry 4.02 0.86
31 Free from frustration 4.01 0.91
30 Free from anger 3.95 0.94
37 Feelings of hope 3.89 0.90
39 Communicate feelings 3.88 0.74
32 Free from fear 3.86 0.98
34 Free from uncertainty 3.85 0.92
35 Free from feelings of loss 3.76 1.00
36 Feel that not alone 3.69 1.03
40 Free from feelings of guilt 3.63 1.02
7.4.16 Summary of the tests to determine which items are retained and which are 
excluded
Table 7.13 summarises the performance o f each item on the tests reported above. In 
the selection o f items, priority was given to significant variables in a multiple 
regression. However, if  these items failed other tests, such as correlating highly with 
core WHOQOL facets implying redundancy, they were excluded. The far right 
column gives an explanation for excluding an item or facet. On the basis o f this 
analysis, six o f the ten facets have been excluded. These were flare-ups, loss/ 
loneliness/ feeling alone, positive strategies, communication, guilt and burdening 
others and relationship with HCP. Flare-ups was deleted because it only contained 3 
items, the concept was too unidimensional and it reflected a symptom rather than an 
outcome per se. Loss, loneliness/ feeling alone was also deleted because it was not 
conceptually robust, redundant items did not leave anything left to form a good
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multidimensional facet and the internal consistency reliability was low because the 
facet represented two concepts rather than one coherent one. As with loss/ loneliness/ 
feeling alone, positive strategies represented an unsuccessful attempt to put 2 
concepts together with low internal consistency reliability. Consequently, there was 
not enough for multidimensional facet. Furthermore, the SRPB facet already 
accounts for hope. For communication, only one of the significant variables in the 
multiple regression can be retained, therefore its contribution to explaining overall 
QoL and health is limited. For guilt and burdening others, the items correlated more 
highly with other domains than their own, but not consistently showing that items 
comprising this facet related to different concepts. Relationship with health care 
providers was strongly associated with core facets; in particular the availability and 
quality of health & social care facet and the remaining items did not form a cohesive 
facet. Uncertainty was retained, but was found to be more highly associated with 
level of independence than with the psychological domain and consequently has been 
moved.
Table 7.13 Summary of the performance of each item on the psychometric tests detailed above (facets and items in bold are retained)
No. & item Skew Scale points 





Facet that item 




a with whole 
scale if item 
deleted (scale 
a .96)
Multiple regression by 
facet against G (r 





Reason for deletion of individual 
items or facet
FLARE-UPS a .85
601 Flare-ups .55* 1-3 .68 Flare-ups .506 .96 5.6 X Only 3 items, unidimensional, 
symptom rather than outcome
602 Worry about 
flare-ups
.25 1-4 .68 Flare-ups .537 .96 22.6 X Only 3 items, unidimensional, 
symptom rather than outcome
603 Bothered by 
flare-ups
.45* 1-3 .80 Flare-ups .494 .96 - X Only 3 items, unidimensional, 
symptom rather than outcome
PAIN RELIEF a . 81
611 Treatments 
offer relief
-.02 1-4 .57 Pain relief .214 .96t - X Low inter-item correlation (613 - 
.20 & 6 1 7 -.3 2 )
614 Control over 
pain




-.012 1-4 .58 Pain relief .235* .96 - Y More strongly associated with 
domain V
618 Bothered by 
med
.09 2-5 .15* Numerous facets* .182* .97t 2.3 X Low correlation with own facet, 
scale a improves if  item deleted, 
correlates more highly with other 
facets
619 Side effects o f 
med
.45* 1-4 .35* Vulnerability* .277 .96
'
X Low correlation with own facet, 
correlates more highly with other 
facets
613 Cope with 
pain level
-.04 2-4 .46 Pain & discomfort, 
vulnerability, 
uncertainty' *
.451 .96 2.6 Y Correlates more highly with 
other facets
617 Comfortable .38* 1-3 .52 Uncertainty .569 .96 5.5 Y Correlates more highly with 
other facets
612 Satisfied with 
relief
.19 1-4 .68 Pain relief .456 .96 - X Redundant because high 
correlation with 615 - .80
615 Satisfied with 
control
.20 1-4 .70 Pain relief .516 .96 23.2 Y Retain because significant 
regressor
ANGER & FRUSTRATION a .91 correlates more highly with domain I
621 Bothered by 
anger
-.09 2-5 .76 Anger & frustration .492* ,96+t - X Redundant because high 
correlation with 622 - .79
622 Anger 
interfere
-.55* 2-5 .80 Anger & frustration .531 .96ft 1.2 Y High correlation with 621 - .79 & 
624 - .80
624 Anger affect 
relationships
-.50* 2-5 .77 Anger & frustration .500 •96tt - X Redundant because high 
correlation with 622 - .80
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No. & item Skew Scale points 





Facet that item 




a with whole 
scale if item 
deleted (scale 
a . 96)
Multiple regression by 
facet against G (r 





Reason for deletion o f individual 
items or facet
626 Bothered by 
frustration
.42 * 1-4 .70 Anger & frustration .499* ,96tt - X Redundant because high 
correlation with 627 - .76
627 Frustration 
interferes
.01 2-4 .73 Anger & frustration .559* .96tt 32.6 Y High correlation with 626 - .76, 
retain b/c regressor.
623 Pain angry .14 2-5 .69 Anger & frustration .415* .96++ 4.5 Y High correlation with 625 - .76
625 Pain irritable .11 1-4 .68 Anger & frustration .405* .96 . Y High correlation with 623 - .76.
VULNERABILITY/ FEAR/ WORRY a .90
631 Bothered by 
vulnerable
-.17 2-5 .73 Vulnerability .611 .96++ - X High correlation with 632 - .72 & 
633 - .78




-.47* 2-5 .73 Vulnerability .652 .96++ 10.6 Y High correlation with 631 - .78 &
632 - .75
634 Pain a threat .36* 2-4 .64 Vulnerability .404* .96 - X High correlation with 635 - .70, 
correlates more with other domain
635 Concerned 
about pain
.30 1-3 .70 Vulnerability .426* .96
*
Y High correlation with 634 - .70 & 
636 - .72, correlates more with 
other domain
636 Distressed by 
pain
.32 1-4 .63 Pain & discomfort* .499* .96 25.4 X Redundant because highly 
correlated with 635 - .72, correlates 
more with other facet & domain
637 Feelings of  
worry
.08 2-4 .66 Loss & negative feelings* .675 •96tt - X Correlates more with other facet
638 Treatment 
worry
-.03 2-5 .59 Vulnerability .478* .96tt 3.9 Y Correlates more with other 
domain
UNCERTAINTY a .91 Move to domain III
642 Uncertainty 
interfere
.11 1-4 .66 Negative feelings, 
vulnerability, loss*
.629 .96++ 2.5 Y Regressor, high correlation with 
644 - .70, correlates more with 
other facets & domain
644 Ditf planning -.01 1-4 .78 Uncertainty .573* .96++ 43.4 Y Regressor, high correlation with 
642 - .70, correlates more with 
other domain
646 Pain prevent .79* 1-4 .76 Uncertainty .367* .96ft X Redundant because highly 
correlated with 647 - .87 & 643 - 
.72, correlates more with other 
domain
647 Pain limit life .77* 1-3 .77 Uncertainty .364* .96++ 2 3 Y Regressor, highly correlated with 
646 - .87, correlates more with 
other domain
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No. & item Skew Scale points 





Facet that item 




a with whole 
scale if item 
deleted (scale 
a .96)
Multiple regression by 
facet against G (r 





Reason for deletion o f individual 
items or facet
643 Prevent plans .70* 2-3 .75 Uncertainty .365* .96 X Redundant because highly 
correlated with 646 - .72, 647 - .71 
& 645 - .70, correlates more with 
other domain
645 Satisfied with 
future plans
.06 1-4 .74 Uncertainty .542* .96+t 9.3 Y Regressor, highly correlated with 
643 - .70, correlates more with 
other domain
641 Uncertainty -.07 2-4 .64 Negative feelings & loss* .635 9 6 ft - X Correlates more with other facets 
& domain
LOSS/ LONELINESS/ FEELING ALONE a .88
651 Bothered by 
loss
.34 1-4 .69 Loss .572 •96tt - X ! Highly correlated with 652 - .83
652 Loss interfere -.07 2-5 .70 Loss .599 •96ft 34.3 X Highly correlated with 651 - .83
653 Carry out 
activities
.83* 1-3 .54 Pain & discomfort, 
mobility, ADL, anger, 
vulnerability, uncertainty, 
guilt*
.437* ,9 6 ft 8.3 X Redundant because correlated more 
highly with other facets, correlated 
more with other domain
656 Bothered by 
loneliness
-.32 2-5 .78 Loss .563 .96 - X Highly correlated with 657 - .80, 
& 655 - .80
657 Alone bother -.34 2-5 .66 Loss .485 .96 - X Highly correlated with 656- .80 & 
655 - .72
655 Lonely -.31 2-5 .75 Loss .582* •96ft 2.2 X Highly correlated with 656 - .80 & 
657 - .72, correlates more with 
other domain
POSITIVE STRATEGIES a  .67 correlates more highly with domain VI
662 Humour -.21 3-5 .38* Positive strategies .238 .96f X Low correlation with own facet, 
scale a improves if  item deleted, 
poor facet a, correlates more with 
other domain
663 Hope for relief -.84* 3-5 .06* Body image & social 
support *
-.055* •97f 2.7 X Low correlation with own facet, 
scale a improves if  item deleted, 
poor facet a, correlates more with 
other facets & domain
665 Feelings o f  
hope
.12 2-4 .58 Positive strategies .326 ,97f X Scale a improves if  item deleted, 




.30 2-4 .56 Positive feelings* .549 .96 29.2 X Poor facet a, correlates more with 
other domain
667 Hope & 
problems
-.04 2-4 .64 Positive strategies .493* .96 - X Poor facet a, correlates more with 
other domain
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No. & item Skew Scale points 





Facet that item 




a with whole 
scale if item 
deleted (scale 
a .96)
Multiple regression by 
facet against G (r 





Reason for deletion of individual 
items or facet
COMMUNICATION a .88 correlates more highly with domain II
671 Others cannot 
see
.24 1-4 .69 Communication .395* .96
'
X Redundant because highly 
correlated with 675 - .82, low 
correlation with 674 - .29
672 Pain affect 
relationships
-.07 2-4 .64 Anger & frustration* .455* .96tt 1.7 X Regressor, correlates more with 
anger, therefore redundant, item 
too general at face value
675Pain invisible .08 1-5 .71 Communication .307* .96 - X Highly correlated with 671 - .82
678 Communicate 
feelings to others
-.17 2-5 .76 Communication .446* .96tt - X
6710 How others 
see condition





-.03 1-4 .59 Anger, vulnerability, 
uncertainty, loss*
.562* .96ft 29.9 X Regressor, but correlates more with 









.09 2-4 .42 Communication .365 .96f
-
X Low correlation with other items 
(.19 - .34), scale a improves if  item 
deleted
677 Satisfied with 
comm.
-.34 2-4 .66 Communication .470* .96 - X Redundant because highly 
correlated with 679 - .76
679 Satisfied with 
express feelings
-.23 2-4 .56 Communication .493* .96 1.9 X Regressor, highly correlated with 
677 - .76, low correlation with 674 
- .24
GUILT & BURDENING OTHERS a.81 correlates with 4 other domains
681 Burden others .69* 1-3 .68 Guilt & burdening others .279* .96 - X Correlates most with domain III
682 Worry about 
effect on others
.22 1-4 .65 Guilt & burdening others .180* .96 1.3 X Correlates most with domain III
683 Guilt -.01 1-5 .65 Guilt & burdening others .373* ,96tt 10.0 X Correlates more with domain II
685 Resources for 
others
.20 1-5 .35* Guilt & burdening others .366* .96 - X Correlates more with domain V
684 Satisfied with 
support others
-.15 2-4 .64 Numerous facets* .389* .96 30.3 X Low correlation with other items 
(.23- .35), low correlation with 
own facet, correlates more with 
other facets
RELATIONSHIP WITH HCP a .75 correlates more with domain V
693 Supported by 
health service
.01 2-4 .44 Availability & quality of 
health & social care*
.144* 96t - X Scale a improves if  item deleted, 
correlates more with other facets
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No. & item Skew Scale points 





Facet that item 




a with whole 
scale if item 
deleted (scale 
a .96)
Multiple regression by 
facet against G (r 









-.00 2-5 -.10* Numerous facets* .179* ,97t 4.1 X Scale a improves if  item deleted, 
low correlation with own facet, 
ambiguous scoring, correlates more 
with other facets
696 Benefit from 
cm
.84* 1-4 .10* Physical safety & security, 
information & pain relief*
.008* ,97t X Low correlation with own facet, 
scale a improves if  item deleted, 
correlates more with other facets
699 Access to 
information
.15 2-4 .62 Relationship with HCP .283* .96 - X Highly correlated with other items
698 Access to 
treatment info
.10 1-4 .56 Relationship with HCP .234* .96 - X Highly correlated with other items
691 Satisfied with 
relationships with 
HCP
-.40* 2-5 .60 Relationship with HCP .323* .96 1.6 X
695 Satisfied with 
support from HCP
-.12 2-5 .66 Availability & quality of  
health & social care*
.357* .96 15.2 X Highly correlated with other items, 
correlates more with other facets
6910 Satisfied 
with information
-.16 2-4 .75 Relationship with HCP .377* .96 - X Highly correlated with other items
* Indicates problem with item 
f  Contributes least to overall scale alpha 
t f  Contributes most to overall scale alpha
- Indicates no contribution to G in the stepwise multiple regression
Chapter seven 192
Chapter seven 193
Table 7.14 summarises the 16-item, 4-facet PDM to be used in conjunction with the 
core WHOQOL-lOO, which are represented by pain relief, anger and frustration, 
vulnerability/ fear/ worry and uncertainty. Facet inter-item correlations ranged from 
.33- .76 and Cronbach’s alphas ranged from .77 (pain relief) to .85 (uncertainty), 
demonstrating acceptable internal reliability.
Table 7.14 Summary of retained facets with domain, inter-item correlation range 
and facet Cronbach’s a
Facet Domain Final items Correlation
range
Facet a
61. Pain relief I 616,613,
617,615
.33- .56 .77
62. Anger & frustration II 622, 627,
623, 625
.47- .76 .84
63. Vulnerability/ fear/ worry II 632, 633, 
635,638
.43- .75 .81
64. Uncertainty Move from 






7.5.1 A discursive account of the item reduction
In a cross-sectional survey o f people with CP, 216 completed WHOQOL-lOO and 
PDM were returned, achieving a response rate o f 46%. The aim was to test the 
instrument and reduce the number o f items based on its psychometric properties. The 
highest response rate was gained from the community; that is the general practitioner 
(GP) and charity samples. This could reflect a higher perceived obligation o f being 
invited to take part by their GP and a willingness to take part in research amongst 
people registered with a charity. Reminders were sent to 76 o f the sample, however, 
others were not traceable due to the stipulations o f the clinics or departments who 
distributed the questionnaires that patients would not be identified, to honour their 
anonymity and confidentiality. Given the sensitive nature o f some o f the items 
contained in the instrument and its length, this response rate is considered to be 
acceptable.
The heterogeneous sample consisted o f fewer males than females and approximately 
40% o f the sample was currently employed. In general, the health o f participants was 
neither poor nor good or poor and just over a half o f participants described themselves
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as currently ill, which is an important feature of the data, since despite the fact that all 
respondents had a condition characterised by pain, they did not consider themselves to 
be ill. Amongst those describing themselves as ill, it was common for co-morbid 
conditions to be described rather than the perceived cause of their pain. This has 
implications for the perceptual labels that patients attribute to their health state and for 
the wording of questions relating to people with pain, as illness is not an appropriate 
label for many conditions (for example, back pain). Consequently, an additional 
question asking about the perceived cause of pain was added in order for participants 
to describe what they perceived was causing their pain. Without this, respondents 
were not inclined to include a description of their condition under the question asking 
about illness. Most of the sample described their pain as continuous and 
discomforting. BP, sciatica and arthritis were the most frequently reported conditions, 
mirroring the high prevalence of these in the population.
Analysis of the results from the completed questionnaires allowed the relationship of 
the items in the PDM to be explored systematically to each other and to the core 
WHOQOL items, facets and domains. The results from the psychometric and 
statistical tests conducted were entered into an overall summary table to enable the 
psychometric properties of each of the items to be viewed and compared to each other 
(table 7.13). Items were deleted if they failed to meet the criteria detailed in the 
analysis and results. The decision to delete some items was definitive, that is, they 
were clearly unrelated to the parent concept (correlations <.40) or were redundant 
(highly correlated with other items representing that facet >.70 or more highly 
associated with core facets). However, as highlighted in chapter five, consideration 
must also be given to the fact that high correlations are not necessarily evidence of 
conceptual similarity or redundancy, but might indicate that these variables covary to 
a high degree (Melzack and Katz, 1994). In cases where the decision to select one 
item over another was not definitive, consideration was given to the face value 
heterogeneity of the items comprising a facet in order to select the best item. The 
need for parsimony to avoid patient burden is of central importance, without 
compromising the multidimensional nature of, and conceptual richness of the facets.
Of the 10 facets represented by the items in the PDM, 4 were retained. These were; 
pain relief, anger and frustration, vulnerability/ fear/ worry and uncertainty. These
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represent an elaboration of 3 of the 6 WHOQOL domains, namely, physical, 
psychological and level of independence. A detailed discussion of the item selection 
process follows. Consistent with the core WHOQOL-lOO structure, each facet should 
consist of 4 items. Thus, 16 items representing 4 facets have been derived from an 
original 68 items representing 10 facets. Furthermore, 5 importance items were 
selected from 16, that is, one per facet with the exception of pain relief, which has 2 
items covering its dual components, which are relief and control.
7.5.2 Item reduction by facet
7.5.3 Domain I -  Physical
7.5.4 Flare-ups -  facet deleted
Cognitive interviewing reduced the number of flare-up items from 5 to 3 and despite 
the importance attributed to this facet, three items is not sufficient to make up a 
multidimensional facet in its own right (4 is the standard WHOQOL model). 
Furthermore, high inter-item correlations (>0.71) suggested that the items were too 
unidimensional and conceptually similar and this redundancy further reduced the 
potential of the facet to exist in its own right. Additionally, this facet raises the issue 
of psychometrics versus clinimetrics, whereby the inclusion of items is based on the 
performance in psychometric tests, as opposed to how items perform clinically, in 
terms of the importance and severity ratings given by patients. For example, despite 
the importance attributed to being free from flares, which is consistent with the 
literature described in chapter three, this facet was not elaborate or multidimensional 
enough to hold up to psychometric scrutiny. Indeed, there involves a trade-off 
between these two approaches, which, it is argued can be complementary rather than 
conflicting (Marx et al., 1999). Flare-ups can be viewed as a symptom rather than an 
outcome or consequence of pain and items pertaining to this would therefore be 
considered inappropriate for an instrument measuring subjective QoL relating to pain 
and discomfort. Rather, it is the consequences of such flares that are captured in 
subjective reports of QoL, further justifying its exclusion.
7.5.5 Pain relief
All 9 of the pain relief items were retained during cognitive interviewing, suggesting 
that they were all comprehensive and clearly phrased, which supported their face 
validity. Two of the 9 items (those relating to medication) performed consistently
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poorly across the psychometrics tests and were only weakly associated with the other 
items in their facet (<0.18) and formed a separate cluster in the HCL. Although the 
item about being bothered by medication made a significant contribution to 
explaining G in the stepwise regression analysis, this item was more strongly 
associated with the core pain and discomfort facet, which was evidence of 
redundancy. Of the remaining 7 items, 3 were significant variables in a multiple 
regression and were thus retained given their contribution to G. Selecting one item 
from the remaining 4 involved systematically eliminating those that performed badly 
in relation to each other. Another item was deleted because of its weak association 
with 2 of the selected items, which would mean that those items were not related 
enough to produce a conceptually robust facet. Another deletion occurred due to 
being highly correlated with one of the selected items, which would render that item 
redundant because of its conceptual proximity. There is, of course, a trade off 
between heterogeneity and homogeneity when constructing facets and the final item 
selection ultimately reflects this. A potential problem with this facet is that the final 
item to be selected correlates marginally more with domain V (environment) than it 
does with domain I (physical). However, being able to obtain relief and controlling 
pain received the highest importance ratings of all the 10 facets, providing further 
justification for its retention.
7.5.6 Domain II -  Psychological
7.5.7 Anger and frustration
The face validity of the items representing anger and frustration was also confirmed 
by the cognitive interviewing. Of the 7 items, 3 were found to be significant variables 
in a multiple regression explaining G. These were retained and the process of 
selecting one item from the remaining 4 involved choosing the item that performed 
above the other 3 items. There was some difficultly with redundancy due to items 
being highly correlated (>0.76). Three items were deleted because they were strongly 
associated with selected items and would compromise the heterogeneity of the facet. 
Although the final item to be selected was strongly associated with the 3 selected 
items, it passed more tests than deleted items. This facet correlated more highly with 
domain I rather than its parent domain, domain II. However, given that this 
correlation was only marginally higher (0.67 versus 0.60), that anger and frustration 
explicitly describe psychological features of QoL and not physical aspects and that a
Chapter seven 197
strong correlation with the physical domain would be hypothesised given that anger 
and frustration have been shown to be a consequence of pain, this facet will remain in 
the psychological domain. The high correlation with the physical domain can be 
explained, in part, because of the close relationship between, and the concurrence of, 
the experience of pain and discomfort and its emotional sequalae. In the importance 
ratings, being free from frustration was rated as marginally more important than being 
free from anger, although both were considered important.
7.5.8 Vulnerability/ fear/ worry
All 8 vulnerability/ fear/ worry items were retained remained following cognitive 
interviewing and 3 items were significant variables in a multiple regression explaining 
G. Of these, the item predicting the greatest variance (distressed by pain) was deleted 
because of its strong association with the core pain and discomfort facet, suggesting 
that the core items already account for this aspect of QoL. Of the remaining 5 items, 
feelings or worry was deleted because of being strongly associated with negative 
feelings. A further 2 items were deleted because of their unacceptably high 
correlations with selected items (>0.70). Being free from worry was rated as more 
important than being free from fear, although both were important to the QoL of 
people with CP in this study. The retention of this facet is important given the 
literature supporting the role of fear and worry in patients with CP discussed in 
chapter three.
7.5.9 Uncertainty
Of the 7 uncertainty items, 4 were significant variables in the multiple regression 
explaining G, which supports the importance of uncertainty in explaining overall QoL 
and health. Of the 4 items, 2 were highly associated with each other and another was 
strongly related to negative feelings. Despite the contribution of the 4 items to 
explaining G, freedom from uncertainty was rated as moderately important. 
Furthermore, although being hypothesised to belong to the psychological domain, 
uncertainty was more strongly associated with level of independence.
7.5.10 Loss/ loneliness/ feeling alone
Despite the face validity of 6 of the 7 loss/ loneliness/ feeling alone items confirmed 
by the cognitive interviewing, this facet was deleted following the psychometric tests
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reported here. One item was deleted because it correlated more highly with other 
PDM and core facets than with its own facet. All the remaining items were highly 
correlated, which reflected an unacceptably homogenous concept. Consequently, this 
did not leave enough items to form a coherent multidimensional facet. Furthermore, 
freedom from loss and not feeling alone were given relatively low importance ratings 
compared to other facets (with the exception of freedom from guilt, which received 
the lowest), although they still received ratings > 3.0. This concurs with evidence 
suggesting that loneliness is not a prominent psychological symptom amongst patients 
with pain (VonKorff and Simon, 1996). On conceptual grounds, this facet was 
represented by 2 loosely related concepts illustrated by the weak association between 
the item relating to being alone and the items relating to loss (<.4.0). Consequently, 
there was not scope to retain a facet pertaining to either loss or loneliness/ feeling 
alone.
7.5.11 Positive strategies
Of the 7 items representing positive strategies, 5 were retained following cognitive 
interviewing. However, this facet proved to be particularly problematic and was 
deleted. Two of the 5 items were only weakly associated with the facet mean, which 
was reflected in the low facet Cronbach’s alpha showing only marginal internal 
consistency reliability, which was the lowest and least acceptable of all the new 
facets. The 3 remaining items were not sufficient to create a multidimensional facet. 
Furthermore, the item addressing optimism was more strongly associated with the 
core positive feelings facet. Moreover, positive strategies correlated more highly with 
the spirituality, religion and personal beliefs (SRPB) than with the psychological 
domain, suggesting that SRPB may already account for the concept of hope. As with 
the loss/ loneliness/ feeling alone facet, it appears that positive strategies consisted of 
two related concepts, hope and humour that do not form a conceptually robust, 
internally consistent facet. Moreover, there is insufficient material from either hope 
or humour to create a multidimensional facet. Consequently, it is argued that hope is 
a component of core WHOQOL facets such as positive feelings and SRPB. Despite 
the problems associated with the two concepts include in this facet, having a sense of 
humour was considered important, and indeed more important than feelings of hope. 
However, this is not sufficient to warrant its inclusion because of its 
unidimensionality. The high importance attributed to humour could reflect a social
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desirability bias, that is, the need to convey this desirable attribute. Conversely, it 
could be part of the growing body of evidence showing the co-occurrence of positive 
and negative affectivity despite adversity (for example, Folkman, 1997; Sodergren 
and Hyland, 2000, 2002; Huppert and Whittington, 2003). Although it is likely that 
pain would lead to few positive emotional experiences, given that pain is an 
inherently unpleasant experience, the use of such strategies might be more 
realistically conceptualised as process variables rather than outcomes per se, that is, 
active coping strategies.
7.5.12 Domain IV -  Social relationships
7.5.13 Communication
Of the 12 communication items, cognitive interviewing and expert reading eliminated 
2. This facet was deleted because of the 3 significant variables in a multiple 
regression, the most significant variable was highly associated with the anger and 
vulnerability facets. The least significant variable was also strongly associated with 
the anger facet. Only one item remained G and of the remaining items, 2 were only 
weakly associated with the other items in the facet and 2 were highly associated with 
other items, suggesting that these items were too conceptually homogenous. Of the 4 
remaining items, only one of these was a significant variable in the multiple 
regression and how other people see ones condition was not considered to be 
important by cognitive interviewees. More generally, communication was ranked as 
moderately important by respondents and this facet correlated more highly with the 
psychological domain than with the social relationships domain in which it was 
hypothesised to belong too. Moreover, the face validity of this facet was 
compromised by the fact that it appeared to be addressing quite a general concept.
7.5.14 Guilt and burdening others
This facet was deleted primarily because items were more strongly associated with 
domains other than their own in an inconsistent pattern. Consequently, it was not 
clear which domain this facet would belong to. The conceptual integrity of this facet 
was compromised because perceptions of burdening others related more to the level 
of independence domain, guilt to the psychological domain and resources for others to 
the environment domain. Despite being the most significant regressor, satisfaction 
with support for others was more strongly associated with other facets and only
Chapter seven 200
weakly associated with the other items in the facet. Further justification for the 
deletion of this facet was the relatively low importance attributed to freedom from 
guilt and burdening others (although still > 3.0). Not being a burden to others was 
considered to be more important than being free from guilt (4.22), which suggests that 
these two components are conceptualised differently by people when assessing the 
importance of various aspects of their QoL. Furthermore, evidence suggests that guilt 
is not a prominent psychological symptom amongst people with pain (Vonkorff and 
Simon, 1996). Consequently, guilt and burdening other does not form a cohesive, 
internally consistent, multidimensional facet.
7.5.15 Relationship with HCP
Eight items pertaining to an individual’s relationship with health care providers were 
retained following cognitive interviewing, however, this facet was deleted because 5 
items were more strongly associated with core WHOQOL facets (availability and 
quality of health and social care, physical safety and security and opportunities for 
acquiring new information and skills), suggesting that the core instrument already 
accounts for these aspects of QoL, most notably environment domain. Further 
justification for the deletion of this facet derived from the high inter-item correlations, 
suggesting that the underlying concept was probably too unidimensional. Given the 
range of inter-item correlations (ranging from -.33 to .74), the items do not form a 
cohesive, internally consistent facet. Although this facet has been deleted, 
relationship with HCP’s was considered to be important. However, due to the strong 
association of items with core facets, including availability and quality of health and 
social care it is argued that the concept represented in this facet is already addressed 
by the core instrument.
To summarise, pain relief, anger and frustration, vulnerability/ fear/ worry and 
uncertainty were retained as new facets accounting for the impact of pain on QoL. 
With the exception of pain relief, the other three facets represent psychological 
consequences of pain. However, due to its higher correlation with the level of 
independence domain, uncertainty will be moved from the psychological to the level 
of independence domain. Although the 6 discarded facets were clearly important to 
people with pain, as evidenced by their elicitation by FG and web survey participants 
and by the importance ratings attributed to them, the elimination can be explained by
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a number of factors. Main reasons for the deletion of items and facets were 
unacceptably high correlations with core or other new facets, which suggests that 
those items or facets were adequately accounted for. Moreover, other facets, such as 
positive strategies and loss/ loneliness/ feeling alone did not form coherent 
multidimensional facets in their own right. It is of course possible that concepts vary 
in their degree of multidimensionality, however, the WHOQOL framework does not 
allow for the inclusion of narrow unidimensional aspects of QoL, which may be 
accounted for by other core facets.
7.5.16 Format of the WHOQOL and PDM
Following item reduction, the WHOQOL and PDM was prepared for the longitudinal 
survey reported in chapter eight. Each set of items with the corresponding Likert 
scale was inserted in the appropriate response scale block after the core WHOQOL 
items to ensure a seamless finish and to avoid unnecessary additional text before each 
new section. The 5 importance items will be inserted after the core WHOQOL 
importance items and this will be placed before the ‘About you’ questions as some 
respondents of this survey left these items blank because they believed the ‘About 
you’ questions to signal the end of the questionnaire. It is hoped that this will ensure 
that fewer questions will be left unintentionally blank. This does have implications 
for the psychometric integrity of the WHOQOL-lOO in terms of the ordering and 
structure of the instrument, however, the decision to integrate the new items into the 
existing structure ensures that once validation is complete, the PDM is not used as an 
entity by itself rather than in conjunction with the WHOQOL, which is necessary for 
a holistic and comprehensive assessment of QoL.
7.5.17 Critique
Chapter six considered the face validity and heterogeneity of the items comprising 
each facet. During the analysis of the cross-sectional survey data reported here, items 
were selected based on their performance on each of the tests. When the case for 
retaining or deleting an item was not definitive, for example, when two items 
performed equally as well, but are highly associated with each other, decisions were 
taken on the face validity of the items which involved an element of subjectivity. 
However, decisions taken at this stage are subject to further testing in subsequent 
stages.
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7.5.18 Conclusion and further work
Psychometric analysis was conducted on the core WHOQOL items and the 68 PDM 
items. All new facets received importance ratings of >3.0, underscoring their 
importance to people with CP. Based on the psychometric tests reported here, 6 
facets were deleted, leaving 4 facets in the PDM; pain relief; anger and frustration; 
vulnerability/ fear/ worry; uncertainty. Cronbach’s alphas for the new facets ranged 
from .77 to .85, demonstrating good internal reliability. Further analysis is carried out 
on the data in chapter nine, where the importance of these facets of QoL is examined 
and an abbreviated form is derived to be used in conjunction with the WHOQOL- 
Bref. In the meantime, chapter eight reports a longitudinal survey to examine 




Sensitivity to Change and Test-retest Reliability of the PDM
8.1 Introduction
Psychometric analysis of data from the cross-sectional survey reported in chapter 
seven was utilised to reduce the number of PDM items from 68 to 16. This chapter 
aims to examine the psychometric properties of the 16-item PDM. Specifically, to 
examine internal consistency reliability, construct validity, concurrent validity, 
sensitivity to change when applied to a clinical population undergoing an intervention 
known to be effective and test-retest reliability.
8.1.1 Validity
Validity has been discussed in greater detail in chapter seven. If an instrument is 
strongly correlated with a ‘gold standard’ instrument known to measure the variables 
being assessed, this provides evidence of concurrent or criterion validity (Juniper, 
Guyatt and Jaeschke, 1996). For example, if the WHOQOL and PDM were applied 
concurrently with a generic health status instrument, purporting to measure similar 
concepts, these two instruments would be expected to be highly associated. Although 
this is a central component of psychometric testing, patient burden must be a 
consideration with respect to the length of questionnaire batteries. Consequently, 
selecting a relatively brief, yet validated instrument is an important goal. In general, 
the SF-36 is the most widely used, although as detailed below, the SF-12, derived 
from the parent measure has also been shown to be suitable (Jenkinson and Layte,
1997). Construct validity is conducted in the absence of a gold standard (Juniper, 
Guyatt and Jaeschke, 1996), where for example, a global QoL rating (for example, 
general QoL and Health (G) of the core WHOQOL) is used as a benchmark against 
which to show that the concepts are measuring QoL. Discriminant validity can also 
evaluated by looking at the differences between categories of individuals known to 
differ on the construct being measured (Campbell, 1960), for example, on pain
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intensity or whether respondents define themselves as ill or well. An instrument has 
discriminant validity if it is able to distinguish between such groups.
8.1.2 Sensitivity to change
The ability of an instrument to detect changes over time is essential to determine a 
patient’s response to treatment (Fitzpatrick et al., 1992). In order to test this feature of 
a measure, it needs to be applied to a specified population undergoing an intervention 
known to be effective. The goal is not to examine the effectiveness of the 
intervention per se, but to look at its impact in order to test the measure itself. If the 
instrument is shown to be sensitive to changes in underlying symptoms or condition, 
it can be used in trials to assess the impact of different treatments on QoL. Given 
these issues, an appropriate intervention must be selected that is efficacious, 
accessible and feasible. Furthermore, it is essential to ascertain the most suitable 
interval between baseline and follow up to maximise any potential measure of change. 
The inclusion of questions about whether or not the patient felt satisfied with the 
intervention and so on can be used as a benchmark against which to measure change, 
such questions are known as transition questions (see below).
Longitudinal studies have shown that the WHOQOL is able to detect changes over 
time following pain management for patients with CP (Skevington, Carse and 
Williams, 2001) and following antidepressant medication for patients with depression 
(Skevington and Wright, 2001), suggesting that the WHOQOL can be used as 
evaluative instrument. The purpose of the PDM was to increase its specificity to 
measure change in people with CP and consequently, it is predicted that following an 
intervention, QoL should improve on the facets that are most important in 
understanding the impact of pain on QoL.
8.1.3 Test-retest reliability
Test-retest reliability is about the reproducibility of the measure, that is, whether the 
instrument obtains the same results on repeated applications, when the respondents 
have remained stable. Scores should be comparable across time if no intervention has 
been applied or life-altering events occurred. Streiner and Norman (1995) suggest 
that there should be a time delay of between 2 and 14 days between the first and 
second application of the instrument, preferably so that respondents do not recall their
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previous responses. Although 2 days is probably not a sufficient interval as 
respondents are likely to remember their responses, 14 days is more acceptable as 
forgetting is more likely to occur. In order to check that a person’s health condition 
has remained stable, Streiner and Norman (1995) suggest the addition of a transition 
question to determine whether change has perceived to have taken place, for example, 
‘Is your health better, the same or worse than at the last assessment?’ However, when 
assessing a complex multidimensional phenomenon such as QoL, other life events or 
aspect of life may change despite a relatively stable condition. Consequently, asking 
whether other life events or occurrences have impacted on their QoL in the time that 
has elapsed since the first application is recommended (see below).
To determine test-retest reliability, the population being studied needs to be relatively 
stable, that is, a population not undergoing intervention or experiencing any life 
altering events (The WHOQOL Group, 1998). In practice this is problematic given 
the flares and fluctuations that have been shown to characterise the pain experience 
(Skevington, 1994; Mason, Skevington and Osborn, 2004). To overcome this, the 
measure can be applied to a relatively homogenous patient group who are waiting for 
treatment at baseline and after a 2-week interval with the addition of transition 
questions, to determine whether scores remain stable when there are no underling 
changes. Given the multidimensionality of QoL, scores could change as a function of 
a change in another aspect of a persons’ life. Hence the need for a transition question 
asking respondents about whether there have been any specific life events or 
occurrences that have impacted on their QoL since baseline assessment.
Test-retest reliability is examined using the Pearson product moment correlation 
coefficient or an intra-class correlation coefficient. This later approach assesses how 
much variability in scores is due to differences between individuals or variability in 
measurement, using analysis of variance. Larger sample sizes relate to greater 
confidence in the reliability of a measure (Eliasziw and Donner, 1987). Streiner and 
Norman (1995) propose that to test reliability accurately, sample sizes of less than 200 
are satisfactory, providing a confidence interval of +/- 0.10 is accepted. Although 
minimal standards for reliability coefficient are 0.7, higher is better. Confidence in 
reliability also increases with repeated application of the measure in different 
populations or samples (Williams and Naylor, 1992). In the original field trial
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reported in the WHOQOL manual (WHOQOL Group, 1998) test-retest was assessed 
in four of the centres. Intervals ranged from 2-8 weeks and correlations between 
facets at baseline and follow-up were high, ranging from .68 for safety and security 
and .95 for dependence on medication, demonstrating good test-retest reliability.
8.1.4 Background to the intervention
There are a myriad of interventions to treat and manage pain with varying degrees of 
effectiveness. The best evidence for any intervention is the randomised controlled 
trial (RCT) and subsequent systematic reviews of these trials, which provide an 
evidence base of the effects of health care interventions. However, there is a relative 
dearth of rigorously designed and implemented RCT’s of interventions designed to 
reduce pain. Moreover, very few studies of interventions include QoL as an outcome 
and the authors of systematic reviews and meta-analysis frequently argue for better- 
designed trials for these treatments and interventions (Nelemans et al, 2001; 2003). 
For this study, it was important to select an intervention of known efficacy, that is 
quick acting and feasible in terms of access to required number of patients. Before 
the evidence for lumbar epidural steroid injections (LES) is presented, the evidence 
for other interventions is summarised. It is not possible to review all interventions 
given that they are so numerous, consequently, the summary focuses only on 
randomised trials (RT’s), systematic reviews or meta-analyses of widely used 
interventions. Consideration was not only given to the efficacy of such interventions, 
but also to the feasibility of recruiting patients undergoing such interventions.
8.1.5 Evidence of effectiveness of other interventions to reduce pain
Table 8.1 summarises studies examining the effectiveness of interventions used in the 
management of CP. Despite some compelling evidence for the use of a range of 
treatments for CP, in general, the evidence is inconclusive and the number of patients 
involved in the trials is relatively small. Moreover, the authors of such trials highlight 
the need for more rigorously designed trials before conclusions can be drawn about 
the efficacy of interventions (Ezzo et al., 2000; Verhagen et al., 2002; Brosseau et al., 
2002; Milne et al., 2001). Additionally, given that anticonvulsants such as gabapentin 
are used to patients with neuropathic pain syndromes, compared to patients with 
CLBP, this represents a relatively low prevalence group. Consequently, applying the 
WHOQOL and PDM to patients with a more prevalent condition was a more effective
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form of validation for the instrument. It is also possible that complementary or 
alternative medical practices such as massage and acupuncture might be more subject 
to variability in delivery, which presents a challenge to assessing outcomes reliably. 
This provides further justification for favouring a more systematically delivered and 
extensively used medical treatment.
8.1.6 Evidence for lumbar steroid epidural injections
Having explored the range of treatments for CP, evidence is presented here for the 
efficacy of LES for CLBP. Numerous studies have evaluated the efficacy of LES 
with mixed results, however precedence is give here to key systematic reviews of 
trials given that sample size of individual trials is relatively small. For example, 
Papagelopoulos and colleagues (2001) found that of 50 patients with lumbosacral 
radicular pain, 80% could anticipate early pain relief after LES. More recently, Konig 
and colleagues (2002) found only short duration benefits of LES for LBP in a study of 
74 patients. In another study looking at the effectiveness of LES for 69 patients with 
herniated lumbar discs, 77% had a decrease in symptoms and were able to avoid 
surgery for twelve to twenty-seven months (Wang et al., 2002). A study of 48 
patients with lumbosacral radiculopathy secondary to herniated nucleus pulposus, 
LES injections were compared with saline trigger-point injections and after 1.4 years 
the active treatment group had a success rate of 84% compared with 48% for the 
saline trigger-point group (Vad et al., 2002).
Koes and colleagues (Koes et al., 1995) and Watts and Silagy (1995) conducted 
systematic reviews of the RCT’s published up to 1994. Koes and colleagues found 
that of the 4 studies with the highest methodological quality, 2 had a positive outcome 
and 2 had a negative outcome. McQuay and Moore (1998) are critical of this review 
for failing to report any meta-analytic judgments. In their meta-analysis of epidural 
corticosteroids, Watts and Silagy (1995) found that compared to controls, epidural 
steroids do have an analgesic effect on sciatica. In a re-analysis of this data with 
addition of a subsequent trial by Carette and colleagues (1997), McQuay and Moore 
(1998) used number needed to treat (NNT) as a measure of clinical benefit. NNT 
refers to the number of patients who need to be treated in order to prevent one 
additional bad outcome (NHMRC Acute Pain Management, 1999 p. 159). For 
example, if  LES has a NNT of 12 (e.g. Klenerman et al., 1984), 12 people would need
Table 8.1 Summary of evidence of effectiveness of interventions for CP
Intervention and author Study type Key evidence and conclusions
Acupuncture, Ezzo et al., 2000 Systematic
review
Review of 51 studies for the effectiveness of acupuncture. The results were positive in 21 studies, 
negative in 3 and neutral in 27. Three fourths of the studies were of low methodological quality and a 
significant positive relationship was found between low quality studies and positive results. Limited 
and inconclusive evidence of effectiveness and a need for more rigorously designed trials
Cognitive behaviour therapy (CBT), 
Moore et al., 2000
RT Brief CBT for primary care patients with LBP (n=226) has been shown to have significant effects on 
reducing worry and fear avoidance compared to usual care, but only modest effects on pain ratings and 
interference with activities
Massage, Furlan et al., 2000 Systematic
review
Of 5 RCT’s, 3 were of high methodological quality. Massage was compared to detuned laser therapy 
(placebo), acupuncture and spinal manipulation. Massage was more effective than placebo, relaxation, 
acupuncture and self-care education, less effective than manipulation, shiatsu and TENS and 
comparable to treatment with corsets and exercise. Conclude that massage might benefit those with 
sub-acute and chronic non-specific LBP
Massage, Guthlin et al., 2000 RT Patients with non-inflammatory back pain received 10 sessions of classic massage or usual care for 5 
weeks. Greater pain relief at 3-months follow-up for patients receiving massage therapy
Hydrotherapy, Verhagen et al., 2002 Systematic
review
10 RCT’s examining the effectiveness of balneotherapy for RA and OA (n=607). QoL outcome only 
reported by 2 trials. Although most studies reported positive findings, the quality of the trials was poor. 
Conclude that the evidence for the efficacy of this type of therapy is not presently sufficient
Hydrotherapy, Queneau et al., 2001 Review Review of 20 RT’s assessing CLBP, OA, FMS, RA and psoriasic arthritis, 4 of which were double 
blind. Beneficial and prolonged improvements found for pain, handicap, QoL, consumption of 
analgesics and NSAIDs
Hydrotherapy, Hall et al., 1996 RCT RA patients (n=139) randomly assigned to hydrotherapy, seated immersion, land exercise or 
progressive relaxation. Hydrotherapy produced the greatest improvements, which were maintained at 
3-month follow-up
Anticonvulsants, Wiffen et al., 2000 Systematic
review
Twenty-three trials of 6 anticonvulsants in a range of patient populations (n=1074). Although widely 
used, few trials show analgesic effectiveness and the reviewers conclude that anticonvulsants should be 
withheld except for trigeminal neuralgia until other interventions have been tried
Transcutaneous electrical nerve 
stimulation (TENS), Brosseau et al., 
2002; Milne et al., 2001
Meta­
analysis
Five trials with patients randomised to a placebo group receiving sham TENS (n=170) or active TENS 
(251). There was considerable variability in the course and length of the treatments and the difference 
between active and placebo group were not significant. No evidence for its use or non-use. Better 
trials are needed with standardised outcome measures reporting information on type, site, duration and 
optimal intensity and frequency
Chapter eight 208
Chapter eight 209
to be treated in order to prevent one additional bad outcome. McQuay and Moore 
used the outcome of at least 75% pain relief for short-term outcomes (defined as 1-60 
days) and at least 50% pain relief for long-term outcomes (defined as 12 weeks to one 
year). Of 11 trials reporting short-term relief data, only 3 showed a statistically 
significant benefit although overall there was a significant benefit. The NNT was 7.3 
which means that of 7 patients being treated with epidural steroid, one will obtain 
more than 75% pain relief who would not have done if they had received a placebo or 
control treatment (local anaesthetic). In their analysis of the 6 trials giving long-term 
relief data, McQuay and Moore (1998) found an overall statistically significant 
benefit despite only one study being significant. The NNT was 13 for 50% pain relief 
which means that for 13 patients being treated with epidural steroid, one will obtain 
more pain relief over 12 weeks to one year who would not have done if they had 
received a placebo or control treatment (local anaesthetic).
Despite evidence for the efficacy of LES in patients with LBP (Watts and Silagy, 
1995; McQuay and Moore, 1998), other systematic reviews have shown insufficient 
evidence to enable a conclusion to be drawn (Van Tulder et al., 1997; Koes et al., 
1999). The methodological quality and design of studies has been questioned with the 
best studies showing inconsistent results with benefits being of short-term duration 
only (Koes et al., 1995). Studies not including a placebo arm have also been criticised 
(Nelemans et al., 1999; 2001; 2003) and choice of methods used by the reviewers has 
been shown to alter the strength of the conclusions made about the effectiveness of 
treatment (Hopayian and Mugford, 1999).
In summary, the advantages of using patients undergoing LES were that, despite 
mixed evidence of efficacy, studies have produced positive results and this type of 
intervention is widely used in clinics across the UK. The effects of LES occur 
relatively soon after the intervention which compares favourably to other types of 
intervention such as surgery or a course of CBT where the rehabilitation period may 
be lengthy. Furthermore, the patient group undergoing LES are accessible and 
numerous which satisfies the required sample size. Again this is comparable to the 
smaller number of patients undergoing pain management programmes or hip 
replacement surgery in the region. Given the numerous treatment options for people 
with CP and with respect to the evidence of efficacy, feasibility and access, the
Chapter eight 210
decision to choose LES was a pragmatic one given that it is a relatively quick acting, 
standardised intervention applied to a relatively homogenous group in terms of 
symptomatology and diagnosis.
8.1.7 Acceptance of pain and QoL
In addition to determining the psychometric properties of the PDM as described 
above, an additional aim was to explore the relationship between acceptance of pain 
and QoL, which was identified and reported as a process mediating QoL in the 
qualitative studies reported in chapters three and four. Given that the core WHOQOL 
facet definition for pain and discomfort also encompasses the concept of acceptance, 
this provided further justification for examining the relationship between acceptance 
of pain and QoL. Acceptance describes the acknowledgement that one has pain, 
giving up unproductive attempts to control pain, acting as if pain does not necessarily 
imply disability, and being able to commit to living a satisfying life by focusing on 
life goals and activities in despite pain (Geiser, 1992; Hayes et al., 1994; McCracken,
1998). It has been suggested that changing the self and accepting pain could be a 
more useful coping strategy than attempts to change the pain (Schmitz et al., 1996). 
McCracken (1998) argues that avoidance of pain, through for example, persistent 
unsuccessful attempts to eliminate it, has detrimental consequences and so adjustment 
involves reducing avoidance and attempts to control pain, accepting it and focusing 
on more realistic goals such as functional restoration (McCracken, 1998). This is 
supported by Aldrich and colleagues (2000), who found that an excessive focus on 
eliminating pain resulted in feelings of frustration and distress which brought about 
more suffering and a poorer QoL (Aldrich et al., 2000).
In a study of 160 adults with CP, McCracken (1998) found that acceptance of pain 
was associated with reports of lower pain intensity, less pain-related anxiety, 
avoidance, depression, physical and psychosocial disability, more daily uptime, and 
better work status. However, a relatively low correlation between acceptance and 
pain intensity (r=-0.28) suggested that acceptance is not simply a function of having 
less intense pain. Given that the relationship between acceptance of pain and QoL has 
not previously been elucidated, an additional goal of this study was to test the 
hypothesis that greater acceptance of pain will be related to a better QoL. 
Furthermore, given that acceptance has been characterised by disengaging from pain
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and engaging in activities for their own sake (McCracken, 1999), acceptance might 
also be strongly associated with activities of daily living and mobility.
8.2 Aims
The aim was to examine the psychometric properties of the PDM to be used in 
conjunction with the WHOQOL-IOO. Sensitivity to change will be examined by 
assessing the QoL of people undergoing a LES for CLBP. Concurrently, test-retest 
reliability of the new PDM facets will be determined to find out whether the 
assessment of QoL remains the same when there is no clinical change. The internal 
consistency reliability and criterion, construct and discriminant validity of the PDM 
will also be elucidated and the relationship between acceptance of pain and QoL.
8.3 Method
8.3.1 Sample
Data was collected from the Royal United Hospital (RUH) in Bath and the Salisbury 
District Hospital (SDH). The RUH has an outpatient’s pain clinic, staffed by a 
multidisciplinary team, specialising in chronic pain and its management. Consultant 
anaesthetists conduct LES injections. The SDH runs an epidural clinic in day surgery 
and a consultant rheumatologist carries out LES injections. All new patients with a 
diagnosis of LBP with or without sciatica attending consultant and nurse led clinics at 
the RUH Pain Clinic between April and October 2003 were identified for the 
longitudinal field test. Those not being offered treatment or those waiting for 
treatment were identified opportunistically for test-retest reliability. These patients 
formed the test-retest group as the RUH clinic operates on a ‘see and treat’ basis, that 
is, the decision to administer an LES is taken during the appointment and not before. 
Consequently, as baseline measures are taken before patient appointments, the 
pragmatic decision was taken to include those not having treatment as the test-retest 
group as baseline data had already been collected from them. Patients were excluded 
from the study if they did not have a diagnosis of BP or sciatica. Other exclusion 
criteria included patients with known depressive personality disorder, somatization 
disorder, anxiety or other psychiatric problems such substance addiction or misuse. 
All new patients attending an LES clinic at the SDH for their LBP and or sciatica 
between June and September 2003 were invited to take part.
Chapter eight 212
8.3.2 Sample size calculations
Power calculations for the intervention group gave a sample size of 63 where two- 
tailed a is 0.05, p is 0.20 and the effect size required is .50 (moderate). For the test- 
retest group, if, two-tailed a is 0.05, p is 0.20 and the ra (expected correlation 
coefficient) is .50, a sample size of 29 would be required. The expected positive 
correlation coefficient of .50 was chosen (Hulley and Cummings, 1988) given that the 
strength of the relationship, reflected in the size of the correlation, must be large 
enough to show that the data at follow-up is not dissimilar to the baseline data.
8.3.3 Intervention procedure
LES are administered to people with LBP and or sciatica who have not responded to 
other treatments. A local anaesthetic and cortisone (anti-inflammatory steroid) is 
delivered by injection to the problem area. The injection may be given above the 
tailbone (caudal epidural) or at the lower back (lumbar epidural) (Salisbury Health 
Care NHS Trust, Patient information leaflet, Morgan, 2002). Although it is possible 
that LES may bring about a range of side effects, such as transient headache, transient 
increase in pain, irregular menstrual cycle, puncture of the spinal fluid sac causing 
severe headache, small risk of bruising or infection a the site of injection (McQuay, 
Moore and Justins, 1997; Patient information sheet, Steroid Epidural Injection, 2003), 
this must be balanced against any pain relief or improvement in QoL and may impact 
on measurement. Clearly, no invasive intervention is without potential risks or 
contraindications. However, patients are informed verbally by their consultant and by 
information leaflet of these risks prior to the intervention and give written consent.
8.3.4 Time frame
For the study assessing sensitivity to change, the questionnaire battery was 
administered at baseline prior to the intervention, and 4-weeks following the 
intervention. This time period was based primarily on the known evidence of the 
most suitable interval of measuring change, but also on clinical judgement (Deyo, 
2003, personal communication). For the test-retest group, the interval between 
baseline and follow-up was 2 weeks (recommended by Streiner and Norman, 1995).
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8.3.5 Concurrent measures
In addition to the WHOQOL-lOO (102 items), the PDM (16 items) and the 
corresponding importance items for the core (26 items) and the PDM (5 items) other 
measures were applied concurrently to examine the construct validity of the measure, 
and these are detailed in the following section.
8.3.6 Short-form 12 (SF-12)
The SF-12 is an abbreviated form of the SF-36 Health Status Questionnaire, 
consisting of a 12-item sub-set of questions, which can provide physical and mental 
health component scores. The advantage of using the SF-12 is that it reduces 
respondent burden by only taking 2-3 minutes to complete (as opposed to 10-15 
minutes for the SF-36) (Ware et al., 1994). Precision of the measure is compromised 
because it consists of single items for each health dimension, as opposed to the multi­
item measures in the SF-36 (Ware, Kosinski and Keller, 1996). However, it provides 
a useful compromise between comprehensiveness and precision on the one hand, and 
reducing respondent burden on the other (Sturgis et al., 2001; Jenkinson and Layte,
1997). Its validation with patients with LBP (Deyo et al., 1998), osteoarthritis 
(Theiler et al., 2002) and Ankylosing Spondylitis (Haywood et al., 2002) and its 
brevity provide support for its use.
8.3.7 Short-form McGill Pain Questionnaire (SF-MPQ)
The SF-MPQ was first published in 1987 (Melzack, 1987) and was derived from the 
McGill Pain questionnaire (LF-MPQ, Melzack, 1975). The instrument can be used 
with adults with pain in multiple settings and was based on the earlier work of 
Melzack and Torgerson (1971) in a seminal work on the language of pain. The 
instrument provides a way of capturing all the dimensions of the pain experience, 
including its quality and intensity. It aims to get away from describing pain simply in 
terms of intensity alone using a visual analogue scale (Melzack and Torgerson, 1971; 
Melzack and Katz, 1992) and enables quick assessment when time is limited 
(Melzack and Katz, 1994). The SF-MPQ contains 15 pain words, selected from the 
LF-MPQ on the basis of how frequently they were endorsed by patients from different 
diagnostic groups (Melzack and Katz, 1994). The SF-MPQ has been shown to 
correlate highly with the scores of the LF-MPQ (Melzack, 1987; Dudgeon et al., 
1993), to be sensitive to clinical changes brought about by analgesics (Melzack, 1987;
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Harden et al., 1991) and epidurally or spinally administered agents (Harden et al., 
1991; Serrao et al., 1992) and to distinguish between different pain syndromes 
(Melzack, 1987). It takes 2-5 minutes to complete (Wilkie et al. 1990), and therefore 
minimises respondent burden.
8.3.8 Chronic Pain Acceptance Questionnaire (CPAQ)
The CPAQ (Geiser, 1992) measures acceptance of pain and consists of 34 items rated 
from 0 (never true) to 6 (always true). Of the 34 items, 24 are summed to calculate 
the total score and 9 require reverse scoring (instrument Cronbach’s alpha (a) = .85, 
Geiser, 1992). Recently, McCracken and colleagues (2004) have reduced the number 
of items in the CPAQ to create a short-form, the SF-CPAQ, consisting of 20 items. 
Three separate scores can be derived; a total score (a. 78) and two subscales 
representing the concepts of activities engagement (degree to which life activities are 
engaged in spite of pain) (a. 82) and pain willingness (willingness to experience pain) 
(a. 78) (McCracken, Vowles and Eccleston, 2004). Studies have shown that measures 
of emotional distress and daily functioning correlate with the CPAQ and therefore 
provide support for its use as a measure of acceptance (Geiser, 1992; McCracken, 
1998, McCracken et al., 1999). McCracken and Eccleston have shown that 
acceptance, as measured with the CPAQ, accounts for more variance in explaining 
distress and disability than measures of coping (as measured by the Coping Strategies 
Questionnaire (CSQ) (McCracken and Eccleston, 2003).
8.3.9 Measuring change with transition questions
At follow-up, administering transition questions enables an accurate assessment to be 
made about whether any perceived changes have taken place. This ensures that self- 
reported changes in QoL correspond to self-reported changes in underlying 
symptoms. Thus, such questions can be used as a benchmark to view any changes 
against. For example, a study examining changes in QoL in primary care patients 
receiving antidepressant medication asked about how much general health and 
depression had changed during treatment with five point scales (Skevington and 
Wright, 2001). The use of a single item is cautioned against because they are not 
sensitive enough to change, particularly with respect to detecting deterioration in 
health (Baker, 1998). The follow-up transition questions (see appendix 5) asked 
about whether QoL, health and pain were worse, a little worse, the same, a little better
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or better since they last completed the questionnaire. A question also asked about 
satisfaction with treatment (intervention group only), whether they had begun any 
new treatment since their last assessment and if any significant life events have 
impacted on their QoL since the last assessment (recommended by Streiner and 
Norman, 1995). Including this range of questions avoids the limitations of asking one 
question, by covering numerous dimensions of possible change (Baker, 1998). 
Furthermore, attaching 5-point Likert scales widens the possible response options 
available to respondents.
8.3.10 Procedure
All new patients attending the Pain Clinic at the RUH or LES clinic at SDH who had 
a diagnosis of LBP or sciatica received a letter from the clinic inviting them to attend 
an appointment with the consultant anaesthetist. An additional letter was enclosed 
inviting them to take part in the study and informing them that they should expect to 
receive a questionnaire pack in the post before they attend their appointment. Two 
weeks prior to their appointment, patients were sent a letter, information sheet, 
consent form and questionnaire pack to allow time for completion. Patients were 
asked to bring the completed questionnaire with them to their appointment.
Potential respondents were greeted as they attended their appointment and asked if 
they had had time to complete the questionnaire and if they had any comments or 
questions that they would like to ask relating to filling it in. Consent forms were 
obtained from all those taking part. Following the appointments, those undergoing 
LES formed the intervention group and those who did not have treatment, or who 
were waiting for treatment (such as TENS, acupuncture, physiotherapy and so on) 
were the test-retest group. The intervention group were sent questionnaire packs with 
the additional transition questions 4 weeks after their injection. The test-retest group 
were sent packs with the additional transition questions 2 weeks after their 
appointment. A new cover letter was sent explaining the aims of re-administering the 
questionnaire and inviting potential respondents to complete questionnaire for a 
second time. Stamped addressed envelopes were included and patients were asked to 
complete and return the measures within 2 weeks of receiving them. Reminder phone 
calls were conducted for those not returning packs within the specified time to reduce
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attrition. Patients had the opportunity to decline to take part at any stage and were 
reassured about confidentiality and anonymity.
8.4 Analysis
8.4.1 Scoring the instruments
The WHOQOL-lOO scoring has been described in detail in chapter seven. The core 
syntax file was extended to cover the 16 PDM items, including the reversal of 11 
items and calculation of mean facet ratings. The SF-12 syntax file provides 
instructions for scoring the instrument. Four of the 12 items require reverse scoring 
so that a high score always represents best health. Two summary scores are produced, 
the PCS and MCS. Five scores are derived from the SF-MPQ, these are; Sensory 
Pain Rating Index (S-PRI), Affective Pain Rating Index (A-PRI), Total Pain Rating 
Index (T-PRI), Present Pain Intensity-Visual Analogue Scale (PPI-VAS) and the 
evaluative overall intensity of total pain experience. The S-PRI is calculated by 
summing the first 11 pain adjectives, the A-PRI by summing the 4 last pain 
adjectives, the T-PRI by adding together the S-PRI and the A-PRI. The PPI-VAS is a 
VAS from no pain to worst possible pain and is scored by dividing the line into 10, 
lcm sections, giving a score between 1 and 10. Finally, the evaluative overall pain 
intensity of total pain experience has a score between 0 and 5, where 0 is no pain and 
5 is excruciating. The CPAQ is scored by summing 24 of the 34 items to give a total 
score. Of the 24 items contributing to the total score, 9 require reverse scoring. It is 
also possible to derive a 20-item short-form, which consists of 2 subscales 
representing activities engagement (11 items) and pain willingness (9 items). The 
syntax file for baseline and follow-up measures is given in appendix 6.
8.4.2 Validity of the PDM
Criterion validity can be examined by correlating the PDM facet scores with the core 
WHOQOL facet scores. As these are known to assess QoL, Pearson’s r should be 
between 0.4- 0.8 (Streiner and Norman, 1995). The PDM facets in the physical 
domain (pain relief) should correlate more highly with the PCS of the SF-12 and 
facets in the psychological domain (anger and frustration and vulnerability/ fear/ 
worry) should be more strongly associated with the MCS of the SF-12, so that 
subjective QoL in the physical domain is more highly associated with physical health 
status functioning and psychological aspects of QoL are more strongly associated
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with psychological health status functioning. QoL assessed by the PDM should be 
significantly negatively correlated with the SF-MPQ scores between -0.4- -0.8 
(Streiner and Norman, 1995) so that more severe or intense pain is associated with a 
poorer QoL, demonstrating construct validity. Discriminant validity is shown if the 
instrument is able to distinguish between patients known to differ on certain 
characteristics such as pain intensity or whether respondents define themselves as ill 
or well.
8.4.3 Sensitivity to change of the PDM
To examine the extent of change at following LES, a paired samples t-test can be 
conducted for all facets at baseline and follow-up to see whether there are significant 
differences between the mean facet scores of the PDM. Effect size determines the 
difference between scores gained at baseline and follow-up and is an important 
statistic for looking at sensitivity to change (Kazis et al., 1989). To do this, baseline 
data is subtracted from follow-up data and then the mean change in score is divided 
by the baseline standard deviation. An effect size of 0.2 is small, 0.5 is moderate and 
0.8 is large. Responsiveness can also be examined by using analysis of variance 
(ANOVA) to evaluate differences in change scores between individuals who 
experienced an improvement in QoL and those who did not experience an 
improvement (perceived improvement was assessed by the transition questions). 
Larger average change scores between baseline and follow-up and smaller P  values 
would reflect greater responsiveness.
8.4.4 Test-retest reliability of the PDM
Test-retest reliability examines the stability of scores on repeated applications when 
no underlying change has occurred. To do this Pearson’s correlation between 
baseline and follow-up PDM facet scores should be >0.70.
8.4.5 Hypotheses
It is proposed that the PDM will:
■ Demonstrate good internal consistency reliability (Cronbach’s alpha (a) = 0.70- 
0.90) to show that the facet items represent a different aspect of a cohesive 
construct.
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■ Be significantly positively associated with the general QoL and health facet (G) 
of the core WHOQOL and with health status as measured by the MCS and PCS 
of the SF-12 to demonstrate criterion validity.
■ Be significantly negatively associated with pain severity or intensity assessed by 
the SF-MPQ to demonstrate construct validity.
■ Distinguish between those defining themselves as ill or well and between people 
with different reported levels of health, where higher scores on the PDM (or good 
QoL) should be associated with being well and having good health and vice 
versa.
■ Change in response to LES so that successful treatment is associated with higher 
scores.
■ Be stable when no change in underlying condition or intervention has been 
applied, so that baseline-follow-up facet scores should correlate >0.70.
The results will also elucidate which facets of QoL are poorest, which are most 
important and explore the relationship between acceptance of pain and QoL.
8.4.6 Data cleaning
Data cleaning involved checking that data had been entered correctly and that all 
WHOQOL item data was a numerical value between 1 and 5. Each variable was 
systematically examined to ensure that no incorrect entries had been made. This 
included running descriptive statistics such as means, frequencies and distributions to 
ensure that errors have not been made. Box plots were also examined to view the 
spread of data for each item and check for any outliers (Tabachnick and Fidell, 1996).
8.5 Results
8.5.1 Response rate at baseline and follow-up
Of the 228 questionnaire packs sent out at baseline to patients from the RUH, 118 
were completed and returned achieving a response rate of 52%. Of the 30 packs sent 
to patients attending the LES clinic at the SDH, 15 questionnaires were completed and 
returned at baseline, a response rate of 50% (overall response rate, 52%). Of the 133 
completed baseline assessments, 76 (57.1%) formed the intervention group and 57 
(42.9%) the test-retest group. Of the 76 patients undergoing LES and completing 
baseline measures, 57 successfully completed follow-up measures (75.0%). For the
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no treatment (NT) group, 30 of the 57 patients completed baseline and follow-up 
measures (52.6%).
8.5.2 Socio-demographic composition of the combined LES and NT groups
The sample consisted of 87 (65.4%) females and 46 (34.6%) males. The mean age of 
the 133 baseline participants was 55.9 (SD 16.87, range 17-92); 76 (57.1%) were 
married, 16 (12.0%) living as married, 16 (12.0%) widowed, 14 (10.5%) single, 9 
(6.8%) divorced and 2 (1.5%) separated; 65 (48.9%) had achieved secondary school 
education, 43 (32.3%) further education such as technical/ clerical, 15 (11.3%) were 
university educated, 6 (4.5%) primary school and 2 (1.5%) had no education. Of the 
sample, 43 (32.3%) were currently employed.
8.5.3 Health characteristics of both groups at baseline
Of the sample, 9 (6.8%) described their health as very poor, 45 (33.8%) as poor, 43 
(32.3%) as neither good nor poor, 31 (23.3%) as good, 2 (1.5%) as very good and 3 
(2.3%) failed to answer the question; 68 (51.1%) described themselves as currently ill, 
52 (39.1%) as not currently ill, 13 (9.8%) did not state.
8.5.4 Characteristics relating to pain of both groups at baseline
Mean duration of pain in months was 84.59 (SD 120.86, range 3-720) although 12 
failed to report pain duration; 3 (2.3%) described the temporal characteristics of their 
pain as brief, 94 (70.7%) as continuous and 31 (23.3%) as intermittent; 1 (0.8%) had 
no current pain. Of the sample, 5 (3.8%) described their pain as mild, 44 (33.1%) as 
discomforting, 35 (26.3%) as distressing, 33 (24.8%) as horrible, 10 (7.5%) as 
excruciating. Of the participants, 15 (11.3%) did not describe their condition, 
although all participants had a diagnosis of back pain (BP) and or sciatica and 
substantial co-morbidity was apparent. The most common site of pain was the lower 
back and spine (n=116, 87.2%), followed by the legs (n=93, 69.9%), upper shoulder 
md arms (n=38, 28.6%), pelvis (n=30, 22.6%), middle back or chest (n=29, 21.8%), 
upper back, (n=28, 21.1%), abdomen (n=14, 10.5%) and the head, face and or mouth 
(n=8, 6.0%). Respondents identified 12 more specific pain locations, including ankle, 
feet, bottom, groin, hands, hip, jaw, ear, knee, neck, rectum and stomach.
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8.5.5 Mean facet ratings and missing value analysis at baseline
Analysis was conducted on the 133 completed baseline questionnaire batteries. Mean 
WHOQOL facet ratings are shown in table 8.2. For the 25 core facets, QoL was 
highest for home environment, transport, personal relationships and social support 
facets and lowest for pain and discomfort, mobility, energy and fatigue and ADL. Of 
the PDM facets, QoL was highest for vulnerability/ fear/ worry, followed by anger 
and frustration and then uncertainty and pain relief. Most missing data was about the 
availability and quality of health and social care and the sex facets and from the PDM 
facets, for pain relief due to the question asking about the extent to which having 
treatment has improved QoL. The core facets demonstrated good internal consistency 
reliability with 23 of the 25 facets having a >.70 with the exception of personal 
relationships (a >.69) and the physical environment (a >.65) on account of the low 
inter-item correlations. Of the core facets, financial resources, SRPB, sleep and rest, 
working capacity and mobility had a levels exceeding .90, suggesting that these are 
highly homogenous facets.
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Table 8.2 Ranked mean core and PDM facet ratings, SD, number missing, inter-
item correlation range and Cronbach’s a at baseline (PDM facets in bold)




Home environment 15.73 3.15 1 .52-.72 .88*
Transport 15.26 3.64 1 .58-.88 .88*
Personal relationships 14.68 3.08 0 .23-.48 .69
Social support 14.64 3.35 2 .46-.75 .84*
Physical environment 14.52 2.45 1 .19-.49 .65
Body image and appearance 14.05 3.57 0 .50-.70 .87*
Thinking, learning, memory and concentration 13.49 2.78 2 .31 -.54 .75*
Financial resources 13.42 4.24 1 .69-.81 .93
Safety and security 13.38 2.58 2 .24-.61 .74*
Vulnerability/ fear/ worry 13.14 2.74 1 .10-.64 .67
Negative feelings 12.99 3.51 1 .55-.82 .88*
Information 12.83 2.81 8 .30-.86 .81*
Services 12.70 2.60 15 .44-.77 .83*
Esteem 12.52 3.14 3 .26-.73 .79*
Anger & frustration 12.00 3.26 1 .39-.72 .81*
Positive feelings 11.94 3.00 0 .53-.83 .88*
SRPB 11.80 3.73 1 .60-.83 .91
Leisure activities 11.52 3.26 1 .50-.74 .86*
Overall QoL 11.27 3.21 5 .36-.71 .85*
Uncertainty 11.08 3.19 1 .34-.70 .79*
Sleep and rest 11.06 3.17 0 .65-.84 .91
Sex 11.04 3.84 13 .11-.80 .79*
Work 10.46 3.51 3 .67-.84 .93
Medication 10.38 3.88 5 .53-.82 .90*
Pain relief 10.20 2.44 4 .12-.43 .66
ADL 10.12 3.22 1 .53-.79 .88*
Energy and fatigue 9.90 3.14 1 .46-.71 .83*
Mobility 9.89 3.38 2 .66-.82 .91
Pain and discomfort 8.84 2.53 1 .30-.50 .75*
* Acceptable a  levels
8.5.6 WHOQOL-lOO and Bref domain scores at baseline
For the WHOQOL-lOO domain scores (excluding the PDM facets) shown in table 8.3, 
QoL was highest for the environment and social relationships domains and lowest for 
physical and level o f independence. All WHOQOL-lOO domains demonstrated good 
internal consistency reliability with a  >.70 with the exception o f social relationships 
(a >.67). Excluding the 76 items from the WHOQOL-lOO, the Bref is comprised o f 
26 items; one from each o f the 24 facets o f QoL, and two from the G facet asking 
about overall QoL and health. Four Bref domain scores were calculated from the 
longitudinal data and consistent with the WHOQOL-lOO, these are scaled in a
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positive direction where higher scores represent a better QoL. Domain scores are 
calculated by multiplying the mean score o f items by four (WHOQOL user manual,
1998). WHOQOL Bref scores were calculated using a syntax file to extract the Bref 
items embedded in the WHOQOL-lOO structure. It is acknowledged that this data is 
extracted from the WHOQOL-lOO data and consequently it is possible that the other 
items influence the way that participants respond to the Bref items. For the 
WHOQOL-Bref, the best QoL was reported for the social relationships domain, 
followed by the environment, the psychological and was lowest for the physical 
domain. The WHOQOL-Bref physical, psychological and environment domains 
demonstrated good internal consistency reliability (range a=.77- .82) and the social 
domain demonstrated marginal reliability (a=.63).
Table 8.3 Frequencies and Cronbach’s a for WHOQOL-lOO and Bref domain
scores
Domain WHOQOL-lOOWHOC>OL-Bref
Mean SD a Mean SD a
Physical 9.93 2.33 .70 10.16 2.83 .82
Psychological 13.01 2.49 .84 12.78 2.58 .77
Independence 10.18 2.95 .87 - - -
Social relationships 13.57 2.65 .67 13.96 3.37 .63
Environment 13.73 2.14 .82 13.53 2.39 .78
SRPB 11.80 3.73 .91 - - -
- WHOQOL-Bref is scored in 4 domains
8.5.7 Baseline importance ratings
All facets had a mean rating o f >3.0 reinforcing the importance o f these aspects o f life 
to people with pain (table 8.4). The most important core facets were being able to 
carry out ADL, being pain free, being able to move around and having energy; the 
least important were sex, personal beliefs and body image appearance. The most 
important PDM facets were the being able to control pain, obtaining pain relief, 
followed by being free from fear and worry, anger and frustration and the least 
important was being free from uncertainty.
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Table 8.4 Ranked mean core and PDM importance ratings at baseline
Importance Mean SD
ADL 4.59 .57
Free from pain 4.49 .67
Pain control 4.49 .55




Adequate healthcare 4.34 .59
Hone environment 4.25 .63
Independence from treatment 4.22 .76
Restful sleep 4.20 .83
Relationship with others 4.19 .79
Fear and worry 4.18 .64
Anger & frustration 4.15 .79
Free negative feelings 4.15 .68
Thinking problems 4.13 .63
Overall QOL 4.11 .64
Being able to work 4.08 .97
Safety and security 4.06 .74
Positive about self 4.06 .66
Feel contented 4.05 .64
Uncertainty 4.02 .80
Financial resources 3.98 .73
Adequate transport 3.98 .72
Provide support for others 3.90 .92
Relaxation & leisure 3.89 .78
Physical environment 3.86 .73
Information & knowledge 3.78 .78
Body image appearance 3.52 .88
Personal beliefs 3.50 .98
Sex life 3.07 1.45
8.5.8 Baseline concurrent measures - SF-12, SF-MPQ and CPAQ scores
Table 8.5 shows the mean and SD for the SF-12 PCS, MCS and items. Most missing 
scores were from items pertaining to emotional problems and consequently, PCS and 
MCS scores were calculated for 117 o f the 133 baseline participants. For the SF- 
MPQ, most missing items were from the present pain intensity item assessed with a 
visual analogue scale. Sensory pain rating index scores can range from 0-33, 
affective rating index scores from 0-12, total pain rating scores from 0-45, present 
pain intensity from 0 to 10 and evaluative overall intensity from 0-5. The CPAQ was 
administered to 75 o f the 133 participants. The mean and SD for the CPAQ items and 
the activity engagement, pain willingness, SF-CPAQ total and CPAQ total scores are 
shown. Items are scored on 6-point scales from never true (0) to always true (6).
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Table 8.5 Frequencies, range and % missing for SF-12, SF-MPQ and CPAQ
scores and items
SF-12 score or item Mean SD Missing %
PCS 19.05 10.82 12.03
MCS 41.92 11.55 12.03
General health 2.20 .97 6.02
Moderate activities 1.43 .56 3.76
Climbing stairs 1.52 .69 4.51
Accomplished less physical 1.10 .31 6.77
Limited in work 1.09 .28 6.02
Accomplished less emotional problems 1.48 .50 7.52
Work carefully as usual emotional problems 1.48 .50 8.27
Pain interfere 2.03 .93 4.51
Felt calm peaceful 3.01 1.23 3.01
A lot of energy 2.43 1.33 3.01
Downhearted and low 3.92 1.35 3.01
Physical or emotional interfere social 2.98 1.27 3.01
MPQ Score Mean SD Missing %
MPQ sensory pain rating index 10.46 6.19 4.51
MPQ affective pain rating index 2.93 2.59 4.51
MPQ total pain rating index 13.34 7.83 4.51
MPQ present pain intensity vas 7.33 2.06 12.03
MPQ evaluative overall intensity 2.64 1.16 3.01
CPAQ score and items Mean SD Missing %
Activity engagement 32.74 10.36 12.00
Pain willingness 19.16 8.47 9.33
SF-CPAQ total 52.00 14.88 13.33
CPAQ total 61.11 14.79 14.67
*Getting on no matter 4.13 1.38 0
*Life going well 3.32 1.42 2.67
*Ok to exp pain 1.89 1.60 1.33
Decrease pain level 3.08 1.71 2.67
* Sacrifice important things 3.59 1.76 5.33
*Not necessary to control pain 2.34 1.93 5.33
Hassle of rid pain 1.81 1.73 4.00
Control negative and irrational 2.45 1.61 5.33
*Normal life despite pain 2.68 1.57 5.33
*Concentrate on rid pain 4.01 1.75 4.00
Done best to control pain 3.86 1.77 5.33
Thoughts and feelings 2.11 1.88 6.67
Before I take action 4.65 1.58 5.33
*Activities 4.00 1.78 4.0
*Full life 2.87 1.80 5.33
^Controlling pain less important 2.17 1.69 5.33
Live with idea of pain for life 2.74 1.95 4.0
Fighting pain 5.04 1.24 4.0
“Thoughts and feelings change 2.84 1.78 4.0
* Sticking to certain life course 3.71 1.60 8.0
Disturbing thoughts 3.49 1.77 5.33
♦Keeping pain level under control 4.24 1.59 5.33
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*Before make serious plans 4.06 1.76 5.33
*Responsibilities 3.61 1.68 5.33
*Better control if control negative thoughts 3.17 1.82 5.33
Control feelings assoc with pain 3.06 1.39 6.67
Accept something, feel good 3.80 1.45 5.33
Accept basic pain level 3.04 1.87 5.33
Right beliefs 2.56 1.75 9.33
* Avoid situations 4.65 1.30 5.33
*Worries and fears 3.58 1.66 5.33
*Don’t have to change pain 2.53 1.72 6.67
Control by happy and positive 2.49 1.72 6.67
* Struggle to do things 4.94 1.13 5.33
* Items retained in the SF-CPAQ
8.5.9 Psychometric properties of the WHOQOL and PDM
The psychometric properties o f the PDM were explored using a variety o f statistical 
tests described in chapter seven. Table 8.6 shows the mean, SD, skewness and 
kurtosis o f the 16 items in the PDM for the baseline data. Most missing data was 
from the item asking about the extent to which treatment had improved QoL and the 
full range o f  scores was not used for 4 o f the items. Poorest QoL was reported for the 
extent to which pain limits life and the highest for anger interfering and fear 
bothering.
8.5.10 Baseline distribution of scores
To ensure that ceiling and floor effects are not observed in the items, the whole range 
o f scores must be used, specifically, at least 10% of participants must have used each 
o f the five points o f the scale. Table 8.7 illustrates the percentage for each point on 
the scale for each o f the 16 PDM items. Where there is a low percentage for 5 
(highest QoL), this suggests a floor effect, that is, respondents are treating the scale as 
a 4-point scale and improvements will not be picked up if  they perceive the verbal 
label for the 5-anchor point to be too extreme. The reverse is true for items where 1 
(poorest QoL) has not been used. O f the 16 items, satisfaction with control o f pain, 
comfortable and concern about experiencing pain had no responses at ‘5’ suggesting 
that the anchor point representing the best QoL for these items is not being utilised by 
participants. The item about the extent to which vulnerability interfered had no 
response for ‘1’, suggesting that the anchor point representing the poorest QoL is not 
being used for this item.
Table 8.6 Frequencies, range, skewness and kurtosis for the 16 PDM items
Item Mean SD MissingRangeMinimumMaximum SkewStd. error of skewKurtosisStd. error of Kurtosis
Treatment improved QoL 2.43 .97 11 4 1 5 .21 .22 -.68 .44
Satisfied control of pain 2.42 .90 1 3 1 4 .39 .21 -.63 .42
Cope with level of pain 2.96 .75 3 4 1 5 -.16 .21 1.19 .42
Comfortable 2.40 .82 4 3 1 4 .06 .21 -.51 .42
Anger interfere 3.69 1.11 1 4 1 5 -.59 .21 -.39 .42
Frustration interfere 2.88 1.03 2 4 1 5 .16 .21 -.54 .42
Pain angry 2.95 1.04 0 4 1 5 .07 .21 -.39 .42
Pain irritable 2.49 .88 0 4 1 5 .20 .21 -.06 .42
Vulnerability interfere 3.64 1.00 3 3 5 -.20 .21 - 1.01 .42
Fear bother 3.69 .99 2 4 1 5 -.48 .21 -.38 .42
Worry about treatment 3.33 .99 1 4 1 5 -.00 .21 -.54 .42
Concern exp pain 2.49 .83 1 3 1 4 .23 .21 -.52 .42
Uncertainty interfere 3.02 1.13 1 4 1 5 .12 .21 -.67 .42
Difficulty planning 3.13 1.03 3 4 1 5 -.09 .21 -.39 .42
Pain limit life 2.11 .93 2 4 1 5 .72 .21 .32 .42
Satisfied make future plans 2.82 .96 0 4 1 5 .11 .21 -.80 .42
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Table 8.7 Distribution of scores for the 16 items in the PDM
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Item Responses for each scale point (%)
1 2 3 4 5
Treatment improved QoL 18.0 36.9 30.3 13.9 0.8
Satisfied control of pain 12.1 49.2 22.7 15.9 0
Cope with level of pain 3.8 16.2 62.3 15.4 2.3
Comfortable 13.2 41.9 36.4 8.5 0
Anger interfere 3.8 12.1 22.0 35.6 26.5
Frustration interfere 7.6 30.5 34.4 21.4 6.1
Pain angry 8.3 24.1 39.8 20.3 7.5
Pain irritable 12.8 37.6 39.1 9.0 1.5
Vulnerability interfere 0 16.2 26.2 35.4 22.3
Fear bother 1.5 12.2 23.7 41.2 21.4
Worry about treatment 2.3 17.4 38.6 28.0 13.6
Concern experiencing pain 9.1 45.5 32.6 12.9 0
Uncertainty interfere 8.3 25.0 34.8 19.7 12.1
Difficulty planning 6.2 19.2 39.2 26.2 9.2
Pain limit life 27.5 43.5 21.4 6.1 1.5
Satisfied make future plans 6.0 36.1 30.1 25.6 2.3
8.5.11 Reliability of the W HOQOL and PDM
Internal consistency reliability for the whole PDM scale (excluding the WHOQOL- 
lOO items) was found to be good (standardised item a= .88 ). For the PDM facets, 
a=.81 for anger and frustration and a=.79 for uncertainty, demonstrating good internal 
consistency reliability. Pain relief (a=.66 ) and vulnerability/ fear/ worry (a=.67) were 
only marginally internally consistent (table 8 .8). For pain relief, inter-item 
correlations ranged from .12 to .43 and a was lowest with the removal o f the item 
asking about satisfaction with control o f pain, reflecting the importance o f this item in 
contributing to the reliability o f  this facet. For the anger and frustration facet, inter­
item correlations ranged from .39 to .72 and a  was lowest with the removal o f the 
item asking about how often pain makes a person feel angry, reflecting the importance 
o f this item in contributing to the reliability o f this facet. For vulnerability/ fear/ 
worry, inter-item correlations ranged from .10 to .64 and a  was lowest with the 
removal o f the item asking about how much fear bothers a person, again reflecting the 
importance o f  this item in contributing to the reliability o f this facet. For uncertainty, 
inter-item correlations ranged from .34 to .70 and a  was lowest with the removal o f 
the item asking about difficulty planning. For item-facet correlations, 2 items from 
pain relief and one from vulnerability/ fear/ worry fell below .4 and for item-total 
correlations, one item fell below .4 for both pain relief and vulnerability/ fear/ worry.
Table 8.8 Item-facet, item-total, facet-total correlations and Cronbach’s a for the PDM facets
Domain, facet and item Item-facet
correlation




a if item 
deleted
Physical domain - Pain relief facet a= . 6 6 - _ .52 .80
Treatment improved QoL .38 .64 .28 .89
Satisfied control of pain .57 .49 .45 .88
Cope with level of pain .36 .64 .46 .88
Comfortable .46 .57 .45 .88
Psychological domain - Anger & frustration facet a= .81 - _ . 6 6 .73
Anger interfere .64 .76 .58 .87
Frustration interfere .57 .79 .62 .87
Pain angry .68 .73 .60 .87
Pain irritable .63 .76 .62 .87
Psychological domain - Vulnerability/ fear/ worry facet a= .67 - - .52 .80
Vulnerability interfere .52 .58 .52 .88
Fear bother .62 .50 .55 .87
Worry about treatment .48 .61 .29 .88
Concern experiencing pain .25 .73 .36 .88
Level of independence domain - Uncertainty facet a= .79 _ - .80 .65
Uncertainty interfere .61 .73 .72 .87
Difficulty planning .75 .65 .70 .87
Pain limit life .51 .77 .63 .87
Satisfied make future plans .52 .77 .58 .87
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8.5.12 Inter-item correlations for each PDM facet
Inter-item Pearson’s correlations (2-tailed) for each new facet ranged from .12- .43 for 
pain relief, .39- .72 for anger and frustration, .10- .64 for vulnerability/ fear/ worry 
and .34- .70 for uncertainty. The correlations for anger and frustration and 
uncertainty were acceptable, although the relativity low inter-item correlations for the 
pain relief and vulnerability/ fear/ worry facets reflect the low a levels. The relative 
strength of these correlations reflects the cohesiveness of the underlying constructs 
and pain relief and vulnerability/ fear/ worry are less internally consistent and the 
items are less homogenous than those representing anger and frustration and 
uncertainty.
8.5.13 Item-domain correlations
Table 8.9 shows how the PDM items correlate with each of the core WHOQOL 
domains. Each item should correlate more highly with its parent domain, if it is 
housed under the correct domain. For pain relief, 3 out of 4 items correlated more 
highly with the parent physical domain, where treatment improved QoL correlated 
more highly with the level of independence domain. Only one of the anger and 
frustration items correlated more highly with the parent psychological domain; 2 
correlated more with the physical domain and one with level of independence. For 
vulnerability/ fear/ worry, 2 items correlated more highly with the parent 
psychological domains, for the other two items one correlated more with the 
environment and another with level of independence. For uncertainty, 2 items 
correlated more with the parent level of independence domain and 2 with the 
psychological domain. Although this poses a challenge to the conceptual integrity of 
the facets, it also shows that the items representing these facets might affect QoL in 
different ways, despite belonging to the same concept. In general, the PDM items 
relate most to the physical, psychological and level of independence domains of QoL.
Table 8.9 Item-domain Pearson’s correlations and significance levels (2-tailed)
Item Domain I Domain II Domain III Domain IV Domain V Domain VI
Treatment improved QoL .262 .192 .315*1* .313* .205 .084
Satisfied control of pain .587*1* .303* .527* .349* .330* .188
Cope with level of pain .419*f .296* .418* .267 .237 .087
Comfortable .597*1* .376* .494* .255 .418* .135
Anger interfere .407* .478*1* .289* .347* .438* .156
Frustration interfere .459* .460* .531*1 .349* .405* .099
Pain angry .376*t .311* .374* .102 .190 .022
Pain irritable .486*1* .378* .458* .202 .262 .109
Vulnerability interfere .354* .536* .414* .367* .5581* .045
Fear bother .338* .596*1* .342* .295* .470* .075
Worry about treatment .132 .2331* .192 .121 .239 -.045
Concern experiencing pain .307* .125 .316*1 .126 .187 -.062
Uncertainty interfere .431* .501*1* .450* .302* .455* .144
Difficulty planning .516* .514* .568*1 .341* .449* .043
Pain limit life .605* .371* .740*1 .327* .349* .021
Satisfied make future plans .501* .576*1 .548* .421* .458* .249
* p> .001




Table 8.10 shows the facet-domain correlations. Each facet should correlate more 
highly with its parent domain. With the exception o f anger and frustration, all facets 
correlated more highly with their own domains. Anger and frustration correlated 
marginally more highly with the physical rather than the psychological domain, this 
might be a consequence o f the co-occurrence o f pain and anger and frustration. 
However, given that anger and frustration are clearly a psychological constructs and 
that the correlation is only marginally higher with the physical rather than the 
psychological domain the argument for moving the facet is not strong enough. 
Lowest correlations were found for each o f the facets and the SRPB domain, 
suggesting that QoL relating to pain is least related to spiritual aspects o f QoL.
Table 8.10 Facet-domain Pearson’s correlations (r) and significance levels (2- 
tailed)
Facet Domain IDomain II Domain IIIDomain iV Domain VDomain VI
Pain relief .649*f .401* .616* .418* .408* .190
Anger .534*t .513* .510* .317* .413* .123
Vulnerability/ fear/ worry .387* .533*t .435* .316* .516* .009
Uncertainty .649* .632* .723*f .446* .552* .152
* p> .001
f  Highest facet-domain correlation
8.5.15 Construct validity of the WHOQOL and PDM -  the relationship between 
the PDM facets and pain severity, quality, intensity and subjective QoL relating 
to pain and discomfort
Examining whether the facets are significantly associated with measures o f pain 
intensity or severity tested the construct validity o f the new items. Pearson 
correlations (1-tailed) between baseline scores and MPQ scores showed that all facets 
are significantly negatively correlated with the sensory pain rating index, affective 
pain rating index, total pain rating index, present pain intensity and overall intensity, 
as measured with the SF-MPQ (table 8.11). Pain relief is most associated with 
present pain intensity and anger and frustration with the sensory qualities o f pain, 
reflecting the facets high correlation with the WHOQOL physical domain. 
Vulnerability/ fear/ worry had the lowest correlations with each o f the MPQ scores, 
although the highest was with the sensory aspects. Finally, uncertainty was most 
highly associated with the total pain-rating index. Overall, higher pain intensity and 
severity is associated with poorer QoL assessed by the PDM facets. Each PDM facet
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was also significantly positively correlated ( 1-tailed) with the core pain and 
discomfort facet. Pain relief and uncertainty were most strongly associated, 
demonstrating that subjective QoL relating to pain and discomfort is associated with 
these pain related aspects o f QoL.
Table 8.11 Pearson correlations (1-tailed) between baseline PDM facet scores, 
MPQ scores and the core pain and discomfort facet






Pain relief -.360** -.348 * * -.397 * * -.565 * * -.415 * * .630**
Anger & 
frustration
-.416* -.228’ -.404’ -.315’ -.325’ .482’
Vulnerability/ 
fear/ worry
-.267** -.173= -.265 * * -.234** -.214** .316**
Uncertainty -.447** -.371 -.474’ -.445 * * -.445 * * .611
** Correlation is significant at the 0.01 level (1-tailed)
* Correlation is significant at the 0.05 level (1-tailed)
To explore the relationship between QoL and pain severity, quality and intensity each 
core WHOQOL facets was correlated against the MPQ scores (table 8.12). All 
WHOQOL facets were negatively correlated with MPQ scores, with the exception o f 
affective pain and social support and affective pain and present pain intensity with 
SRPB. MPQ scores were most strongly negatively associated with pain and 
discomfort, energy and fatigue, mobility and ADL (r >-.35). O f these, the highest 
correlation was between pain and discomfort and present pain intensity (r=-.68 ). 
MPQ scores were least associated with social support and SRPB (r<-. 15). O f these, 
the weakest relationship was between social support and the total pain-rating index 
(r=-.004). Although reports o f pain are least associated with social support and 
spiritual aspects o f QoL, in general more reported pain is associated with poorer QoL 
assessed by the WHOQOL facets.
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Table 8.12 Pearson’s correlations (2-tailed) between MPQ scales and core
WHOQOL facets
Facet S-PRI A-PRI T-PRI PPI-VAS Overall pain 
intensity
Pain -.451** -.360** -.477** -.678** -.547**
Energy and fatigue -.369** -.400** -.422** -.472** -.354**
Sleep and rest -.326** -.192* -.321** -.283* -.312**
Positive feelings -.175* -.142 -.181* -.233* -.267*
Thinking, learning -.212* -.168 -.211* -.133 -.188*
Esteem -.064 -.068 -.066 -.149 -.137
Body image -.109 -.084 -.108 -.050 -.014
Negative feelings -.218* -.099 -.199* -.152 -.156
Mobility -.352** -.376** - 393** -.569** -.499**
ADL -.371** -.379** -.413** -.564** -.447**
Medication -.237* -.374** -.307** -.395** _ 4i4**
Work -.297** -.303** -.329** -.486** -.448**
Relationships -.206* -.125 -.200* -.248* -.209*
Social support -.014 .024 -.004 -.152 -.030
Sex -.125 -.133 -.145 -.377** -.292**
Safety -.135 -.037 -.110 -.248* -.076
Home environment -.147 -.131 -.149 -.194* -.085
Financial -.424** -.226* -.403** -.114 -.220*
Services -.316** -.066 -.266* -.080 -.023
Information -.253* -.238* -.274* -.244* L.234*
Leisure -.280** -.276* -.308** -.434** -.314**
Physical environment -.149 -.129 -.156 -.086 .003
Transport -.231* -.084 -.205* -.109 -.162
SRPB r.034 .050 -.007 .021 -.037
Overall QoL -.320** -.290** -.339** -.453** -.364**
** Correlation is significant at the 0.01 level 
* Correlation is significant at the 0.05 level
8.5.16 Concurrent validity of the WHOQOL and PDM -  the relationship 
between health status and QoL
The relationship o f the facets to the MCS and PCS o f the SF-12 and G o f the 
WHOQOL were examined to determine the concurrent validity o f the PDM facets. 
Table 8.13 shows that there are significant associations between the PDM facets and 
these measures. Each new facet was significantly correlated with the PCS and MCS 
o f the SF-12. Pain relief was more highly correlated with the PCS and the anger and 
frustration, vulnerability/ fear/ worry and uncertainty with the MCS. Uncertainty and 
pain relief were most highly associated with G, suggesting that perception o f QoL in 
these areas is strongly associated with rating o f overall QoL. Overall, a higher QoL 
assessed by the PDM facets is associated with a higher QoL as measured by G o f the 
WHOQOL-lOO and with health status as assessed by the SF-12.
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All core WHOQOL facets were positively associated with the PCS and MCS of the 
SF-12, with the exception of availability and quality of health and social care, which 
was negatively associated with the PCS, although this correlation was not significant. 
The MCS was most highly associated with negative feelings, leisure activities and 
overall QoL and health (r>. 61 at P>.001) and least associated with physical 
environment and social support (r<.21 at <.032). The PCS was most strongly 
associated with mobility, work capacity and ADL (r>.62 at P>.001) and least with 
social support and the availability and quality of health and social care (r<.06 at 
P<.88).
Each facet was also correlated with G to see which facets were most related to overall 
QoL and health. Leisure activities, ADL and positive feelings were most highly 
correlated with G (r>.67 at P>.001), suggesting that decisions about global QoL are 
closely associated with the perception of QoL in these areas. Lowest correlations 
with G were found for body image, transport and the physical environment facets 
(r>.28 at P>.001), indicating that overall QoL and health is least related to perception 
of QoL in these facets.
8.5.17 Discriminant validity of the WHOQOL and PDM
Discriminant validity can be examined by dividing respondents into groups known to 
differ on certain characteristics such as those who are ill or well, by those reporting 
different health status or by those undergoing treatment and those who are not. 
Consequently, it is possible to determine whether there are any observable differences 
in QoL assessed by the PDM facets between these groups. Table 8.14 shows the 
mean, standard deviation, F and P values for each of the core and PDM facets for 
those who define themselves as ill or well. With the exception of body image and 
appearance, physical safety and security, the physical environment and SRPB, all 
facets show significant differences between ill and well participants. This provides 
support for the discriminant validity of 25 of the 29 facets (including the PDM) and 
suggests that perception of QoL for the facets not able to discriminate is not closely 
associated with being ill or well.
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Table 8.13 Pearson’s correlations (2-tailed) between core and PDM WHOQOL
facets, PCS, MCS and G
Facet PCS MCS G
Pain 4 7 9 ** .353** .507**
Energy and fatigue 416** .520** .6 6 6 **
Sleep and rest .199* .386** .495**
Positive feelings .337** .557** .670**
Thinking, learning .309** .525** .564**
Esteem .327** .511** .612**
Body image . 1 2 0 .331** .284**
Negative feelings .186* .6 8 8 **.590**
Mobility .706** .481** .661**
ADI. .623** .444** .717**
Medication .600** .269* .466**
Work .685** 4 9 4 **.664**
Relationships .333** .560** .662**
Social support .058 .214* .354**
Sex .341** .301* .435**
Safety .230* .332** .390**
Home environment .155 .367** .424**
Financial .166 .559** .523**
Services -.016 .419** .385**
Information .139 .475** .516**
Leisure .435** .645** .774**
Physical environment .135 .199* .303**
Transport .166 .288* .300**
SRPB .151 .261* .333**
Overall QoL .565** .611** -
Pain relief .461** .369** .604**
Anger & frustration .277* .548** .487**
Vulnerability/ fear/ worry .325** .362** .434**
Uncertainty .438** .573** .643**
** Correlation is significant at t te 0 . 0 level
* Correlation is significant at the 0.05 level
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Table 8.14 Differences between core and PDM facet means for well and ill
groups
Facet Well mean (SD) 111 mean (SD) F p
Pain 9.46 (2.81) 8.07(1.93) 10.08 00
Energy and fatigue 11.35 (3.21) 8.88 (2.67) 21.11 00
Sleep and rest 12.02 (2.97) 10.37(3.24) 8.19 01
Positive feelings 13.10(2.61) 10.88 (2.84) 19.24 00
Thinking, learning 14.68 (2.26) 12.68 (2.77) 17.52 00
Esteem 13.68 (2.79) 11.59 (3.03) 14.56 00
Body image 14.74 (3.43) 13.85 (3.52) 1.92 17
Negative feelings 14.25 (2.77) 12.18(3.62) 11.68 00
Mobility 11.55 (3.44) 8.45 (2.54) 31.82 00
ADL 11.73 (3.43) 8.87 (2.27) 29.96 00
Medication 12.43 (3.83) 8.81 (3.31) 29.39 00
Work 12.17(3.29) 9.09 (3.07) 27.39 00
Relationships 15.97 (2.79) 13.75 (2.88) 18.16 00
Social support 15.40 (2.98) 14.14(3.54) 4.28 04
Sex 12.11 (3.91) 10.15(3.38) 7.83 01
Safety 13.88 (2.60) 13.20 (2.24) 2.33 13
Home environment 16.65 (2.93) 15.34 (2.86) 6.06 02
Financial 14.96 (3.38) 12.22 (4.68) 12.64 00
Services 13.59(2.29) 12.22 (2.77) 7.17 01
Information 13.88 (2.67) 12.23 (2.58) 10.81 00
Leisure 13.04 (3.04) 10.20 (2.93) 26.66 00
Physical environment 15.04 (2.27) 14.29 (2.45) 2.97 09
Transport 16.42 (3.50) 14.55 (3.75) 7.72 01
SRPB 12.50 (3.77) 11.25 (3.82) 3.17 08
Overall QoL 13.18(3.03) 9.80 (2.56) 42.05 00
Pain relief 11.06 (2.75) 9.39 (1.81) 15.41 0 0
Anger & frustration 13.12 (3.07) 11.30 (3.01) 10.50 0 0
Vulnerability/ fear/ worry 13.98 (2.73) 12.82 (2.57) 5.64 0 2
Uncertainty 12.42 (2.97) 10.05 (2.89) 19.20 0 0
When those rating their health from very poor to very good were compared (table 
8.15), significant differences were found for all facets with the exception o f transport 
and SRPB, showing that for most aspects o f QoL, the WHOQOL facets are able to 
distinguish between those reporting different health status as measured by the single 
item enquiring about health.
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Table 8.15 Differences between core and PDM facet means for groups of people
reporting different levels of health
Facet Very poor Poor Neither good 
nor poor
Good Very goodF p
Mean SD MeanSD Mean SD MeanSD Mean SD
Pain 6.89 1.83 7.95 1.528.86 2.52 10.54 2.879.50 4.95 7.41 .00
Energy and fatigue 6.44 2.60 8.82 2.34 10.01 2.46 12.08 3.32 16.00 4.24 13.23 .00
Sleep and rest 10.67 4.27 9.80 3.16 10.98 2.65 12.97 2.63 14.00 4.24 5.74 .00
Positive feelings 10.00 3.08 10.44 2.62 11.98 2.41 14.10 2.48 17.50 3.54 12.98 .00
Thinking, learning 10.89 1.76 13.11 2.61 13.14 2.52 15.29 2.60 16.00 1.41 7.27 .00
Esteem 11.11 3.52 11.27 2.72 12.26 2.77 14.74 2.84 16.00 1.41 8.36 .00
Body image 16.33 3.28 12.59 3.79 13.64 3.19 15.87 2.81 17.00 4.24 6.02 .00
Negative feelings 11.22 3.90 12.27 3.56 12.63 3.19 14.97 2.66 13.00 8.49 3.99 .00
Mobility 6.22 2.05 8.75 2.41 9.66 2.53 13.07 3.64 10.00 7.07 15.14 .00
ADL 7.89 2.42 8.56 2.15 10.08 2.40 13.15 3.26 12.00 8.49 15.78 .00
Medication 6.33 2.06 8.36 2.88 11.09 3.52 13.37 3.64 13.00 . 14.58 .00
Work 6.33 1.94 9.23 2.84 10.18 2.84 13.83 3.12 13.00 4.24 17.48 .00
Relationships 13.67 2.32 13.93 2.46 13.89 3.28 16.91 2.74 17.33 3.77 7.20 .00
Social support 16.22 3.11 14.36 3.42 13.53 3.39 15.91 2.71 17.00 4.24 3.30 .01
Sex 6.80 2.48 10.18 3.10 11.25 3.65 12.77 4.05 20.00 6.99 .00
Safety 12.67 2.74 13.13 2.48 12.81 2.60 14.52 2.08 20.00 4.38 .00
Home environment 15.89 2.98 15.34 2.85 14.68 3.56 17.45 2.32 19.00 4.33 .00
Financial 13.00 6.14 12.56 3.88 12.53 4.20 15.52 3.43 20.00 3.74 .01
Services 12.56 3.47 12.53 2.67 12.03 2.14 13.59 2.53 16.83 3.06 2.80 .03
Information 11.67 3.54 12.59 2.78 12.31 2.64 14.04 2.36 16.00 5.66 2.82 .03
Leisure 8.11 3.10 10.53 2.31 11.24 2.69 14.15 3.23 13.33 9.43 11.45 .00
Physical environment 14.11 1.83 14.14 2.72 14.19 2.66 15.40 1.41 18.00 2.83 2.65 .04
Transport 14.11 3.41 15.07 4.13 14.69 3.05 16.67 3.31 13.50 9.19 1.80 .13
SRPB 11.89 5.56 11.09 3.96 11.35 2.98 13.29 3.68 13.50 3.54 1.88 .12
Overall QoL 6.88 2.03 9.97 1.85 10.71 2.32 14.68 2.86 15.00 4.24 29.02 .00
Pain relief 8.79 2.48 9.51 1.839.54 2 . 0 1 12.29 2.58 1 2 . 0 0 2.83 10.67 . 0 0
Anger & frustration 1 1 . 2 2 t?.38 10.95 3.34 11.79 2.51 13.97 3.02 1 2 . 0 0 9.90 4.50 . 0 0
Vulnerability/ fear/ worry 11.74 2.95 12.83 2 . 6 8 12.59 2.34 14.71 2.60 15.00 5.66 4.35 . 0 0
Uncertainty 8.67 2.55 9.88 2.61 10.53 2.81 14.13 2.17 1 2 . 0 0 8.49 14.57 . 0 0
8.5.18 Are there any differences in QoL between those having a lumbar steroid 
epidural (LES) and those receiving no treatment (NT) at baseline?
In an examination o f  the differences between the LES and NT group, the LES group 
were slightly older (58.26 ± 17.02) than the NT group (52.68 ± 16.28) although this 
difference was not significant (F=3.633, P>.059). There were more women (n=87) 
than men (n=46) in both groups. Approximately equal numbers o f men were in each 
group (LES n=24, NT n=22) but more women had LES than NT (LES n=52, NT 
n=35). There were no significant differences between the LES and NT group for the 
questions asking ‘how is your health’ F  (1,128) o f .001, (P<.991), and although the 
LES group had had pain for slightly longer (86.6  months for LES group, 81.9 for NT 
group) this difference was not significant F {1,119) o f .045, (P<.833).
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QoL was significantly lower in the LES group for the pain, mobility, ADL, pain 
relief, anger and uncertainty facets (table 8.16, only core facets with significance at 
the 0.05 level shown). Perception of QoL relating to vulnerability/ fear/ worry was 
not different for the LES and NT groups. For the WHOQOL-lOO domain scores, QoL 
was significantly lower for the LES group in the level of independence domain and 
for the physical WHOQOL-Bref domain. For the SF-MPQ scores, significant 
differences were only found for present pain intensity and evaluative pain intensity, 
which indicated that patients undergoing LES reported more intense pain than those 
not having treatment. For the SF-12 MCS and PCS and CPAQ scores, no significant 
differences were found between those having an LES and those having NT and these 
are not shown (p>0.05).
8.5.19 Relationship between acceptance of pain and facets and domains of QoL, 
health status and pain severity and intensity
Internal consistency reliability for the subscales and total scores of the CPAQ was 
good with a >.75. The 20-item SF-total score (a= .81) and the 11-item activity 
engagement scale (a= .80) were the most internally consistent, followed by the 9-item 
pain willingness scale (a= .76) and the 24-item CPAQ total score (a= .75). Table 
8.17 shows Pearson’s correlations between acceptance of pain scores and the facets of 
QoL. In general, correlations were greatest for the SF-CPAQ total. Each of the PDM 
facets correlated significantly with each of the dimensions for acceptance. Overall, 
uncertainty and anger were most highly correlated with acceptance. Of the core 
facets, work, mobility, ADL, overall QoL and pain and discomfort were most highly 
correlated with acceptance of pain. Conversely, body image and appearance, social 
support, self-esteem, sleep and rest, the environment, transport and SRPB were least 
related to acceptance of pain. The level of independence domain was most highly 
correlated with acceptance of pain on all but the pain willingness score, which was 
most highly correlated with the physical domain. This provides support for the CPAQ 
given that it measures the extent to which people engage in activity in spite of pain. 
These results also suggest that reporting a good QoL is associated with acceptance of 
pain.
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Table 8.16 Frequencies and significance level for the core facets and domains, 
PDM facets and SF-MPQ scores for the LES and NT groups
Facet, domain or score NT LES
1 tMeanlSD MeanlSD
Core WHOQOL facetsf
Pain 9.63 2.64 8.24 2.28 10.43 .00*
Mobility 11.05 3.83 9.02 2.70 12.71 .00*
ADL 11.17 3.209.35 3.03 11.04 .00*
PDM facets
Pain relief 10.74 2.53 9.81 2.32 4.65 .03*
Anger & frustration 12.88 3.05 11.33 3.277.66 .01*
Vulnerability/ fear/ worry 13.19 2.53 13.10 2.90 .04 .84
Uncertainty 11.74 3.27 10.58 3.05 4.37 .04*
WHOQOL-lOO domains
Physical 10.25 2.549.68 2.14 1.96 .16
Psychological 13.00 2.36 13.02 2.61 .00 .96
Level of independence 11.04 3.25 9.54 2.54 8.73 .00*
Social relationships 13.69 3.02 13.47 2.35 .23 .63
Environment 13.62 2.06 13.81 2.21 .25 .62
SRPB 11.42 3.65 12.09 3.79 1.04 .31
WHOQOL-Bref domains
Physical 10.81 3.149.67 2.48 5.30 .02*
Psychological 12.72 2.39 12.83 2.74 .05 .82
Social 13.93 3.70 13.99 3.12 .01 .92
Environment 13.31 2.32 13.68 2.44 .77 .38
MPQ scores
MPQ sensory pain rating index 9.67 5.22 11.06 6.82 1.56 .21
MPQ affective pain rating index 2.58 2.593.19 2.57 1.76 .19
MPQ total pain rating index 12.22 7.02 14.19 8.34 2.00 .16
MPQ present pain intensity vas 6.83 2.23 7.75 1.836.03 .02*
MPQ evaluative overall intensity 2.35 1.21 2.85 1.086.26 .01*
* Significant at the 0.05 level 
t  Only significant core facets shown
Each o f the acceptance scores was more highly correlated with the MCS than the 
PCS, suggesting a stronger relationship between acceptance o f pain and mental health 
status than with physical health status. Acceptance was negatively correlated with all 
MPQ scores, so that lower acceptance was associated with higher pain scores. 
Acceptance was most highly negatively associated with overall evaluative intensity 
and present pain intensity.
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Table 8.17 Pearson’s correlations (2-tailed) between core WHOQOL facets and
domains, the PDM, PCS, MCS, MPQ scores and the CPAQ scores








Pain .552** .380* .450** .465**
Energy and fatigue .535** 394** .398** .482**
Sleep and rest .263* .097 .140 .334*
Positive feelings 490** .271* .410** .360*
Thinking, learning .335* .184 .355* .172
Esteem .289* .176 .325* .179
Body image .185 .115 .169 .174
Negative feelings .369* .079 .280* .363*
Mobility .631** .504** .604** .380**
ADL .623** .444** .595** .394**
Medication .399** .312* 399** .267*
Work .645** .429** .605** .397**
Relationships .415** .252* .423** .268*
Social support .165 .149 .114 .210
Sex .340* .208 .309* .277*
Safety .362* .180 .302* .289*
Home environment .305* .248* .349* .141
Financial .373* .191 .345* .256*
Services .351* .283* .208 .363*
Information 415** .216 .340* .336*
Leisure .543** .301* .434** .419**
Physical environment .316* .196 .238* .291*
Transport .282* .217 .325* .096
SRPB .173 .122 .228 .089
Overall QoL .582** .376* .455** .493**
Pain relief .427** .322* .396** .324*
Anger & frustration .510** .274* .288* .585**
Vulnerability/ fear/ worry 462** .288* .337* .419**
Uncertainty .656** .453** .532** .528**
Domain I .553** .356* .399** .521**
Domain II .423** .205 .387* .320*
Domain III .662** .481** .628** .412**
Domain IV .419** .270* .376* .341*
Domain V .526** .333* .473** .367*
Domain VI .173 .122 .228 .089
PCS .438** .349* .455** .279*
MCS .597** .438** .456** .469**
MPQ S-PRI -.335* -.234 -.229 -.315*
MPQ A-PRI -.447** -.441** -.346* -.363*
MPQ T-PRI -.396** -.313* r.281* -.358*
MPQ PPI-VAS -.450** -.323* -.327* -.415**
MPQ evaluative overall intensity-.579** -.479** -.451** -.468**
** Correlation is significant at the 0.01 level 
* Correlation is significant at the 0.05 level
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8.5.20 Stepwise multiple regression to determine predictors of overall QoL and 
health
The data was analysed by stepwise multiple regression to examine the contribution of 
each PDM facet to explaining overall QoL and health. Consideration was given to the 
assumptions underlying regression, discussed in chapter seven. PDM facets were 
regressed against the G facet. Thus, in each case, the facets were the IV’s and G was 
the DV. Table 8.18 summarises the results from the multiple regression and includes 
the standardised beta coefficients and r square change statistic (shown as %), which 
can to used to identify facets that contribute most to explaining G. When overall QoL 
was entered as the DV and the PDM facets as IV’s, uncertainty and pain relief facets 
were retained in the model explaining the variance observed in G. The regression fit 
was (R 2adj = 48.2%) and the overall relationship was significant (F=59.16 (2,213) P< 
0.001). On inspection of the r square change statistic, uncertainty explained 41.5% of 
the variance in G and pain relief 7.5%. This indicates that of the PDM facets, pain 
relief and uncertainty are most important in explaining overall QoL and health.
Core and PDM facets were regressed against the G facet and leisure activities 
(61.5%), ADL (9.0%), sleep (2.9%), energy (1.6%), SRPB (1.8%) and mobility 
(1.1%) contributed to explaining overall QoL and health. All other facets, including 
the PDM facets were excluded from the model. The regression fit was (R adj =  
76.4%) and the overall relationship was significant (F=53.34 (6,91), P< 0.001). This 
suggests that the perception of QoL relating to these six facets are most important in 
explaining QoL, to the exclusion of 18 core facets and the 4 PDM facets.
When the 5 MPQ scores were entered as IV’s, present pain intensity was the only IV 
retained in the model, explaining 20.6% of the variance. The regression fit was (R 2adj 
= 19.9%) and the overall relationship was significant (F= 29.00 (1,112) P< 0.001). 
When entering the SF-12 scores as IV’s, the MCS and PCS of the SF-12 accounted 
for 37.3% and 25.9% of the variance respectively in overall QoL. The regression fit 
was (R 2adj = 62.5%) and the overall relationship was significant (F=93.64 (2,109) P< 
0.001). A patient’s present pain intensity and their health status are important to 
explaining overall QoL and health.
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Table 8.18 Standardised coefficient beta, t, significance levels and the 
contribution (r square change statistic shown as %) of facets and scores to G
from the stepwise multiple regression





Uncertainty .441 5.512 .001 41.5
Pain relief .341 4.257 .001 7.5
Core and PDM facets
Leisure .353 4.885 .001 61.5
ADL .220 2.630 .010 9.0
Sleep .140 2.380 .019 2.9
Energy .157 2.277 .025 1.6
SRPB .154 2.881 .005 1.8
Mobility .175 2.163 .033 1.1
MPQ scores
Present pain intensity -.453 -5.384 .001 20.6
SF-12 scores
MCS .562 9.623 .001 37.3
PCS .511 8.755 .001 25.9
* r square change shown as %
8.5.21 Stepwise multiple regression to determine predictors of pain
Given the importance o f present pain intensity in explaining the variance in overall 
QoL, the present pain intensity VAS was entered as the DV and the PDM and core 
facets as IV’s. Pain and discomfort, leisure activities and negative feelings were 
retained in the model explaining the variance observed in PPI (table 8.19). The 
regression fit was (R adj = 53.7%) and the overall relationship was significant 
(F=36.88 (3, 90) P< 0.001). On inspection o f the r square change statistic, pain and 
discomfort explained 45.5% o f the variance in PPI, leisure activities 4.2% and 
negative feelings 5.5%. This result suggests that QoL relating to pain and discomfort, 
leisure activities and negative feelings are most important in explaining present pain 
intensity.
Table 8.19 Standardised coefficient beta, t, significance levels and the 
contribution (r square change statistic shown as %) of facets to present pain





Pain and discomfort -.599 -7.600 .001 45.5
Leisure activities -.410 -4.275 .001 4.2
Negative feelings .304 3.311 .001 5.5
* r square change shown as %
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8.5.22 Stepwise multiple regression to determine predictors of acceptance of pain
In a further analysis, the relationship of facets of QoL to acceptance of pain was 
examined by regressing the core and PDM facets against the CPAQ scores (table 
8.20). Firstly, when the SF-total score was entered as the DV, uncertainty and ADL 
were retained in the model explaining the variance observed in acceptance. The 
regression fit was (R 2adj = 48.0%) and the overall relationship was significant 
(F=24.07 (2,48) P< 0.001). On inspection of the r square change statistic, uncertainty 
explained 44.0% and ADL 6.1% of the variance in acceptance of pain assessed by the 
short-form instrument. This suggests that QoL relating to certainty and ADL are most 
important in explaining acceptance of pain.
For the activity engagement score, only mobility was retained in the model. The 
regression fit was (R adj = 41.3%) and the overall relationship was significant 
(F=36.25 (1, 49) P< 0.001). On inspection of the r square change statistic, mobility 
explained 42.5% of the variance in activity engagement. This confirms the 
relationship between perception of QoL relating to mobility and engaging in activity 
in spite of pain. For pain willingness, anger and frustration and vulnerability/ fear/ 
worry were retained in the model. The regression fit was (R adj = 35.9%) and the 
overall relationship was significant (F=15.29 (2,49) P< 0.001). On inspection of the r 
square change statistic, anger and frustration explained 32.9% and vulnerability/ fear/ 
worry 5.5% of the variance in pain willingness. Overall, the contribution of anger and 
frustration and vulnerability/ fear/ worry to explaining the willingness to experience 
pain and uncertainty to acceptance, supports an important relationship between 
perception of QoL relating to the new facets and acceptance of pain.
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Table 8.20 Standardised coefficient beta, t, significance levels and the 
contribution (r square change statistic shown as %) of facets to CPAQ scores 






Uncertainty .421 2.950 .005 44.0
ADL .346 2.424 .0196.1
Activity engagement
Mobility .652 |6.021 .001 42.5
Pain willingness
Anger & frustration .471 3.854 .001 32.9
Vulnerability/ fear/ worry .256 2.097 .041 5.5
* r square change shown as %
8.5.23 Intervention group
O f the 76 patients undergoing lumbar steroid epidural (LES) injections for their LBP, 
57 successfully completed baseline and follow-up measures. The following analysis 
examines the transition questions, sensitivity to change and the importance items for 
the LES group.
The transition questions assessed the extent to which change was perceived to have 
occurred in QoL, health and pain since baseline by patients undergoing LES. In 
response to these questions, QoL was rated as about the same or better (3.40 ± 1.15) 
as was health (3.31 ± 1.10) and pain (3.36 ± 1.19). Participants were moderately 
satisfied with treatment (3.21 ± 1.22). O f those undergoing LES, 13.8% had begun 
other treatments and 14.0% reported experiencing significant life events.
8.5.24 Sensitivity to change of the PDM facets
The ability of the WHOQOL and PDM to detect changes brought about by the LES 
intervention can be examined by looking at how many o f the 25 core and 4 PDM 
WHOQOL facets show improvements and which have the biggest change scores. To 
examine the extent o f change following LES, a paired-samples t-test was conducted 
for all facets at baseline and follow-up to see whether there are significant differences 
between the mean scores (table 8.21). Following LES, QoL was significantly better 
for 9 o f the core WHOQOL facets (P>0.05) and 3 o f the PDM facets (P>0.01). The 
core facets showing improvement were, pain and discomfort, energy and fatigue, 
sleep and rest, self esteem, mobility, ADL, dependence on medication, work capacity,
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leisure activities, overall QoL. The PDM facets showing improvement were pain 
relief, anger and frustration and uncertainty. Baseline a  ranged from .56 (physical 
environment) to .93 (financial resources). Follow-up a  ranged from .72 (physical 
environment) to .95 (work capacity). With the exception of personal relationships, 
sexual activity, physical environment and pain relief at baseline, all baseline and 
follow-up facets demonstrated good internal consistency reliability (a >.70).
Table 8.21 T-test (2-tailed) showing differences between baseline and follow-up
scores for the PDM facets and Cronbach’s a for the LES group (n= 57)
Facet Base ine Follow-up t P a
Mean SD Mean SD Baseline Follow-
up
Pain 8.23 2.45 9.85 3.07 -4.41 .001* .71 .82
Energy and fatigue 9.96 3.32 10.81 3.63 -2.60 .012* .82 .89
Sleep and rest 11.26 3.06 12.19 3.37 -2.98 .004* .90 .93
Positive feelings 12.04 3.19 12.48 2.92 -1.34 .186 .89 .88
Thinking, learning 13.38 3.19 13.84 3.11 -1.79 .079 .78 .85
Esteem 12.51 3.05 13.11 3.34 -2.11 .040* .76 .87
Body image 13.99 3.82 14.05 3.71 -.24 .814 .90 .91
Negative feelings 12.91 3.42 13.00 3.74 -.23 .818 .88 .92
Mobility 9.08 2.86 10.91 3.76 -4.38 .001* .87 .89
ADL 9.57 3.16 11.46 3.43 -5.18 .001* .86 .88
Medication 10.58 3.53 11.49 4.12 -2.48 .017* .89 .92
Work 10.24 3.06 11.07 3.65 -2.78 .007* .89 .95
Relationships 14.76 3.01 15.08 3.17 -1.07 .290 .64 .74
Social support 14.44 3.29 14.65 3.39 -.78 .440 .79 .87
Sex 10.72 3.47 11.14 3.43 -1.18 .244 .67 .74
Safety 13.84 2.49 14.13 2.38 -1.109 .272 .77 .75
Home environment 16.29 2.50 16.41 2.85 -.52 .605 .87 .91
Financial 13.61 4.50 13.43 4.08 .68 .499 .93 .94
Services 12.65 2.84 12.83 2.83 -.67 .504 .84 .91
Information 12.74 2.74 13.30 2.91 -1.89 .064 .87 .90
Leisure 11.24 3.28 12.21 3.22 -2.73 .008* .82 .88
Physical
environment
14.85 2.21 14.88 2.54 -.09 .928 .56 .72
Transport 15.22 3.90 15.16 4.08 .16 .873 .90 .93
SRPB 11.78 3.74 12.20 3.48 -1.31 .195 .92 .92
Overall QoL 11.25 3.00 12.50 3.46 -3.42 .001* .80 .90
Pain relief 10.08 2.28 11.32 2.95 -3.20 .0 0 2 * .63 .77
Anger & 
frustration
11.58 3.18 12.61 3.54 -2.54 .014* .81 . 8 8
Vulnerability/ fear/ 
worry
13.12 3.07 13.70 3.23 -1.64 .107 .71 .83
Uncertainty 1 0 . 6 8 3.01 12.19 3.62 -4.46 .0 0 1 * .76 .89
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8.5.25 Effect size of the WHOQOL and PDM scores
Effect size determines the difference between scores gained at baseline and follow-up 
and is an important statistic for looking at sensitivity to change (Kazis et al., 1989). 
One method of calculating effect size is to subtract baseline data from follow-up data 
and then divide the mean change in score by the baseline standard deviation. An 
effect size of 0.2 is small, 0.5 is moderate and 0.8 is large (Kazis et al., 1989). As 
table 8.22 illustrates, 16 of the core facets had very low effect sizes below 0.2 (-.04- 
.19) showing that these facets were not responsive to the LES intervention. Of the 
core facets, financial resources and transport had small negative effect sizes (-.02- - 
.04), showing that facet scores had decreased slightly at follow-up. Largest effect 
sizes were found for pain and discomfort, mobility and ADL (.62- .69) showing that 
these facets were most responsive to the LES intervention. Moderate effect sizes 
were found for pain relief and uncertainty (.50- .53), which were the most responsive 
PDM facets. Small effect sizes were found for energy and fatigue, sleep and rest, 
dependence on medication, information, leisure activities, anger and frustration and 
vulnerability/ fear/ worry (.20- .32). Although only modest effect sizes were found, 
overall impressions of change in QoL, health and pain assessed by the transition 
questions was variable. Such findings support the sensitivity of a selection of core 
facets and suggest that facets relating to the physical and level of independence 
domains are more responsive to LES than those representing the psychological, social 
relationship, environment or SRPB domains of QoL.
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Pain 1.57 2.61 .69 1.15
Mobility 1.82 3.09 .68 1.14
ADL 1.89 2.75 .62 .91
Pain relief 1.24 2.90 .53 1.25
Uncertainty 1.51 2.57 .50 .84
Anger & frustration 1.04 3.08 .32 .94
Leisure .97 2.69 .31 .85
Sleep and rest .93 2.36 .30 .77
Medication .91 2.66 .26 .76
Energy and fatigue .85 2.38 .26 .72
Vulnerability/ fear/ worry .57 2.64 . 2 0 .91
Information .57 2.18 .20 .75
Esteem .60 2.11 .19 .67
Thinking, learning .46 1.94 .15 .64
Positive feelings .44 2.51 .14 .81
Sex .42 2.46 .12 .71
SRPB .42 2.40 .11 .63
Relationships .32 2.27 .11 .80
Safety .29 1.93 .11 .74
Work .83 2.21 .08 .22
Social support .20 1.99 .07 .63
Services .18 1.87 .06 .69
Financial -.18 1.96 -.04 .45
Home environment .12 1.71 .04 .59
Negative feelings .09 2.87 .03 .82
Body image .06 2.05 .02 .52
Transport -.06 2.75 -.02 .74
Physical environment .02 1.96 .01 .89
* Mean change divided by the standard deviation o f the change.
8.5.26 Do importance items change in importance following LES?
To examine the stability o f importance scores, baseline and follow-up means were 
compared in a paired-samples t-test to look at the extent o f any changes in the 
importance attributed to core and PDM facets o f QoL from baseline to 4 weeks 
following LES. Table 8.23 shows the baseline and follow-up means and significance 
values for facets that were significantly different at follow-up. With the exception o f 
freedom from pain, all o f the core importance scores remained stable and these have 
not been shown. O f the PDM facets, the importance o f relief, the importance o f 
control and the importance o f being free from fear and worry were significantly less 
important at follow-up (P>0.05). Freedom from anger and frustration and uncertainty 
remained stable from baseline to follow-up. These results suggest that the importance 
attributed to certain facets o f QoL changed following a LES.
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Table 8.23 T-test (2-tailed) showing differences between baseline and follow-up 
importance ratings for the LES group
Importance item Base ine Follow-up t P
Mean SD Mean SD
Free from pain 4.54 .66 4.33 .69 2.12 .038*
Pain relief 4.54 .60 4.32 .69 2.36 .022*
Pain control 4.54 4.38 4.38 .59 2.42 .019*
Anger & frustration 4.25 .74 4.20 .67 .45 .651
Fear & worry 4.30 .60 4.04 .73 2.67 .010*
Uncertainty 4.18 .78 4.04 .71 1.31 .197
* Significant at >0.05
8.5.27 No-treatment group
O f the 57 patients in the no-treatment (NT) group, 30 successfully completed baseline 
and follow-up measures. The following results show the response to the transition 
questions, test-retest reliability and the stability o f importance items.
The transition questions assessed the extent to which change was perceived to have 
occurred in QoL, health and pain since baseline by patients not undergoing treatment. 
In response to these questions, QoL was rated as about the same (3.11 ± .92, versus 
3.40 ± 1.15 for LES), and health (2.89 ± .96, versus 3.31 ± 1.10 for LES) and pain 
(2.93 ± 1.09, versus 3.21 ± 1.22 for LES) as the same or a little worse, reflecting the 
differences greater perceived change amongst patients in the LES groups. O f those in 
the NT group, 50.0% (versus 13.8% LES group) had begun other treatment and 19.2% 
(versus 14.0% LES group) reported experiencing significant life events.
8.5.28 Test-retest reliability
Test-retest reliability refers to the relationship between scores (or score consistency) 
when the patient completes the instrument on two separate occasions. Pearson’s 
correlations (2 -tailed) were conducted between baseline and follow-up facet means. 
Table 8.24 shows the test-retest reliability o f the core and PDM WHOQOL facets. 
Pearson’s correlations for the core facets ranged from .57- .85 and for the PDM facets 
.52- .71 (p>0.01). In general for the NT group, overall QoL and health at baseline and 
follow-up was more highly associated than for the LES group (r=.77 versus r-.65), 
providing support for the stability o f  QoL in those not undergoing treatment.
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Table 8.24 Pearson’s correlations (2-tailed) between baseline and follow-up core
and PDM facets for the NT group
Facet Base ine Follow-up Pearson
r
P
Mean SD Mean SD
Pain 9.63 2.64 9.90 3.01 .60 .00
Energy and fatigue 10.27 2.94 10.38 2.82 .74 .00
Sleep and rest 10.85 3.33 11.60 3.36 .80 .00
Positive feelings 11.81 2.91 12.31 2.92 .78 .00
Thinking, learning 13.57 2.40 12.88 2.33 .57 .00
Esteem 12.21 3.13 12.41 2.97 .65 .00
Body image 14.32 3.06 14.45 3.11 .67 .00
Negative feelings 13.09 3.54 12.92 3.32 .68 .00
Mobility 11.05 3.83 11.43 3.33 .72 .00
ADL 11.17 3.20 11.86 2.84 .83 .00
Medication 10.87 4.32 10.51 3.83 .85 .00
Work 11.03 4.04 11.09 3.82 .85 .00
Relationships 14.51 3.36 14.33 3.27 .75 .00
Social support 14.78 3.66 14.57 3.37 .82 .00
Sex 11.55 4.26 11.00 3.88 .74 .00
Safety 13.31 2.54 13.43 2.45 .61 .00
Home environment 15.25 3.40 14.93 3.34 .76 .00
Financial 13.18 4.02 12.80 3.68 .83 .00
Services 12.88 2.44 13.28 2.45 .80 .00
Information 13.04 2.71 13.17 2.19 .64 .00
Leisure 11.90 3.40 11.73 2.88 .80 .00
Physical environment 14.25 2.73 14.03 2.79 .81 .00
Transport 15.13 3.53 14.89 3.56 .66 .00
SRPB 11.42 3.65 12.07 3.14 .74 .00
Overall QoL 11.28 3.48 11.66 3.20 .77 .00
Pain relief 10.74 2.53 11.46 2.27 .55 .00
Anger & frustration 12.88 3.05 12.82 2.71 .71 .00
Vulnerability/ fear/ worry 13.19 2.53 13.31 2.67 .52 .00
Uncertainty 11.74 3.27 12.62 2.73 .69 .00
8.5.29 Stability of importance items in the NT group
The stability o f importance items was examined by comparing baseline and follow-up 
means in a paired-samples t-test. All baseline to follow-up importance scores were 
non-significant with the exception o f overall QoL and health, which was significantly 
less important at follow-up (values not shown). At baseline, overall QoL was 4.23 ± 
.63, versus 4.03 ± 61 at follow-up (t=2.26, p> .05). This contrasts with the decreased 
importance o f freedom from pain and discomfort, pain relief, pain control and 
vulnerability/ fear/ worry following LES.
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8.6 Discussion
The aim of this chapter was to test the psychometric properties of the PDM, 
specifically the internal consistency reliability, construct validity, discriminant 
validity, sensitivity to change and test-rest reliability of the PDM. Sensitivity to 
change was examined following a lumbar epidural steroid injection (LES) injection 
for low back pain (LBP) and test-retest reliability in a group not undergoing treatment 
(NT). The combined baseline LES and NT groups consisted of more females than 
males, who were mostly married and not currently in employment. The health of 
participants was described as poor (34%) or neither poor nor good (32%) by most, and 
51% described themselves as currently ill. The majority of participants described 
their pain as continuous and discomforting and pain was most often reported in the 
lower back, spine and legs. For both groups at baseline, QoL was highest for the 
home environment, transport, personal relationships and social support and lowest for 
pain and discomfort, mobility, energy and fatigue and ADL. Consistent patterns of 
missing data were found for sexual activity and availability and quality of health and 
social care. That most missing data was found for items representing these facets is 
consistent with the pattern of missing data from the cross-sectional survey reported in 
chapter seven and might be a consequence of the personal nature of these aspects of 
QoL. For the PDM, the question about the extent to which having treatment has 
improved QoL was most frequently missed, which may have been due to the fact that 
patients were attending their first appointment and had not yet received any treatment.
When domain scores were calculated, QoL was highest for the environment and social 
relationships domains and lowest for physical and level of independence. Following 
extraction of Bref items and calculation of Bref domains, QoL was highest for the 
social relationships domain, followed by the environment, the psychological and the 
physical domain. All core and PDM facets were considered important to participants 
(range 3.07- 4.59) and the most important were being able to carry out ADL, being 
pain free, being able to move around and having energy. The least important were 
sexual activity, personal beliefs and body image and appearance. This finding is 
particularly important given that it is these facets that were most compromised by 
living with pain and it is this discrepancy, between perception of QoL and the 
importance attributed to it, that may prove to be key targets for intervention 
(discussed in more detail in chapter nine). Of the PDM facets, the most important was 
being able to control pain and obtaining pain relief, followed by being free from fear
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and worry, anger and frustration and the least important was being free from 
uncertainty (range 4.02- 4.49), reflecting the importance of these aspects of QoL to 
people with CP.
8.6.1 Psychometric properties
In addition to describing the characteristics and QoL of the study sample, the goal of 
this chapter was to look specifically at the psychometric properties of the new module 
when applied to two populations; one undergoing an intervention aimed at reducing 
pain and another not receiving treatment. Firstly, the baseline data was used to 
calculate the internal consistency reliability, construct, concurrent and discriminant 
validity of the module, before going on to examine sensitivity to change and test- 
retest reliability by comparing baseline and follow-up data. Of the 16 items, only 12 
used the full range of scores (1-5) and none of these had 10% at each point in the 
scale. Given that the population is relatively homogenous with respect to diagnosis, 
the distribution of scores reflects this and the items would need to be subject to further 
testing in a more heterogeneous population of people with CP from diverse diagnostic 
groups. Internal consistency reliability for the 16-item module was good (a=.88) and 
for the four facets, a ranged from .66 to .81. Internal consistency was acceptable for 
uncertainty (a=.79) and anger and frustration (a=.81), but only marginal for pain 
relief (a=.66) and vulnerability/ fear/ worry (a=.67). This observation was largely 
due to low inter-item correlations for the pain relief and vulnerability/ fear/ worry 
facets. Item-facet correlations were all above .4, with the exception of 2 pain relief 
items and one vulnerability/ fear/ worry item. The results for the pain relief and 
vulnerability/ fear/ worry facets suggest that, when tested with patients with LBP, 
these facets are less cohesive and the items representing the facets are more 
heterogeneous than those representing the uncertainty and anger and frustration facets 
which have been shown to be internally consistent. Given the structure of the 
WHOQOL framework adopted for the development of the PDM, it is not possible to 
carry out further item deletion, although further testing with item substitution would 
be feasible.
Items should correlate more highly with their parent domain than with other domains 
of QoL. Of the 4 pain relief items, one correlated more highly with level of 
independence. For anger and frustration, 2 items correlated more with the physical 
domain and one with level of independence. For vulnerability/ fear/ worry, one item
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correlated more with the environment and another with level of independence. 
Finally, for uncertainty, 2 items correlated more with the psychological domain. This 
raises issues for the conceptual integrity of the facets, however, also reflects the 
complex relationship and interconnectedness of the concomitants of pain. Each facet 
should also correlate more highly with its parent domain and this was the case for 3 of 
the 4 PDM facets, where anger and frustration correlated marginally more highly with 
the physical domain, highlighting the salience of these emotions for people with pain. 
This finding also mirrors the strong negative association between the sensory qualities 
of pain assessed by the sensory pain-rating index of the McGill Pain Questionnaire 
and the anger and frustration facet.
8.6.2 Construct and concurrent validity
Construct validity was examined by looking at the relationship between the SF-MPQ 
and the new PDM. As predicted, each facet was significantly negatively correlated 
with each MPQ scale so that a higher pain intensity and severity is associated with 
poorer QoL in these aspects of a patient’s life. A higher QoL assessed by the PDM 
was associated with better health status demonstrating concurrent validity. Moreover, 
pain relief correlated more highly with the physical functioning assessed by the SF-12 
and anger and frustration, vulnerability/ fear/ worry and uncertainty with the mental 
health functioning of the SF-12, further demonstrating concurrent validity. When the 
relationship between overall QoL and health and facets and domains of QoL was 
examined, all facets and domains were significantly correlated with overall QoL, 
although highest correlations were found for leisure activities, ADL and positive 
feelings and the level of independence and physical domains of QoL, suggesting that 
for the patients with LBP in this study, perception of overall QoL assessed by the G 
facet is highly associated with these aspects of QoL.
8.6.3 Discriminant validity
The core and PDM WHOQOL facets were able to distinguish between participants 
defining themselves as ill or well, where QoL was significantly lower for ill 
participants (P>0.05), with the exception of body image and appearance, physical 
safety and security, physical environment and SRPB. The instrument also 
distinguished between those reporting different levels of health, with the exception of 
transport and SRPB. The SF-MPQ, SF-12 and CPAQ also demonstrated good
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discriminant validity with significant differences between those defining themselves 
as ill and well.
8.6.4 Acceptance of pain and QoL
This study also examined the relationship between acceptance of pain and QoL in a 
subset of participants. The CPAQ derives a total score and 3 scores based on a 
shortened version with items extracted from the full instrument; activity engagement, 
pain willingness and a short-form total score. Internal consistency was good for the 
total scores and subscales of the CPAQ (>.75). All of the PDM facets were 
significantly correlated with acceptance of pain, with anger and frustration and 
uncertainty being most highly associated, suggesting that patients who are more 
accepting of their pain also report less anger, frustration and uncertainty. Pain relief, 
vulnerability/ fear/ worry and uncertainty were most associated with the SF-CPAQ 
and anger and frustration with pain willingness, which suggests that those who report 
less anger are more accepting of their pain. Of the core facets, working capacity, 
mobility, ADL, overall QoL and pain and discomfort were most highly associated 
with acceptance (r>.55, P>0.01), suggesting that those who are highly accepting of 
their pain report fewer problems with these physical and level of independence 
aspects of QoL than those who are not accepting of their pain. The CPAQ and SF- 
CPAQ total scores and activity engagement were most associated with the level of 
independence domain and pain willingness with the physical domain. Acceptance 
was also significantly associated with health status; however, it was more associated 
with the MCS of the SF-12. Lower acceptance of pain was also associated with 
higher pain scores on the SF-MPQ, with higher negative correlations for present pain 
intensity and evaluative overall intensity. Thus patients reporting a high present pain 
intensity and overall intensity reported being less accepting of their pain. This finding 
contrasts with that of McCracken who found that the correlation between acceptance 
and pain intensity was relatively low (McCracken, 1998). Given that it is not possible 
to elucidate the direction of this relationship, these results raise the question of 
whether those reporting a higher QoL and less pain are consequently more accepting 
of their pain or whether greater acceptance of pain results in a fuller engagement in 
life and consequently reports of a better QoL and less pain. This relationship is 
worthy of further investigation, for example by prospectively testing an intervention 
that specifically targets acceptance of pain.
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8.6.5 What contributes to explaining overall QoL and health, pain intensity and 
acceptance of pain?
Regression analyses showed that of the PDM facets, uncertainty explained most of the 
variance in overall QoL followed by pain relief. Of the core facets, participation in 
and opportunities for recreation and leisure explained most of the variance in overall 
QoL, followed by ADL, sleep and rest, energy and fatigue, SRPB and mobility. Of 
the MPQ scores, present pain intensity explained most of the variance in overall QoL, 
suggesting that of the dimensions of the pain experience, it is the present intensity of 
pain that is most important in explaining observed QoL. Given this finding, core 
facets were regressed against present pain intensity and pain and discomfort, leisure 
activities and negative feelings explained most of the variance. The mental health 
component score of the SF-12 accounted for a greater proportion of variance than the 
physical health component score, reflecting the importance of the psychological 
consequences of pain in explaining and determining the assessment of QoL. 
Uncertainty and ADL explained the variance in acceptance of pain assessed by the 
short-form CPAQ. Mobility accounted for the variance in activity engagement and 
anger and frustration and vulnerability/ fear/ worry explained the variance in pain 
willingness.
8.6.6 LES and NT groups
More women than men made up both samples and the LES group was slightly older 
and had longer pain duration, although these differences were not significant. The 
QoL of people undergoing LES was found to be significantly lower for pain, mobility, 
ADL, pain relief, anger and uncertainty and for the WHOQOL-lOO level of 
independence domain and the WHOQOL-Bref physical domain. Present pain 
intensity and evaluative pain intensity were also significantly higher for the LES 
group.
8.6.7 Sensitivity to change
Responses to the transition questions asked at follow-up suggest that most patients 
undergoing LES reported that their QoL, health and pain had stayed the same or 
improved and that they were moderately satisfied with treatment. A small number of 
patients reported beginning other new treatments and experiencing significant life 
events. The perception of treatment efficacy reported by patients is important in 
understanding the results and shows that the response to LES amongst the patients in
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this study was variable. Following LES, QoL was significantly better for pain and 
discomfort, energy and fatigue, sleep and rest, self esteem, mobility, ADL, 
dependence on medication, work capacity, leisure activities, overall QoL, pain relief, 
anger and frustration and uncertainty. With the exception of personal relationships, 
sexual activity, the environment and pain relief, all baseline facets demonstrated good 
internal consistency reliability and for follow-up facets, all facets demonstrated good 
internal consistency reliability, providing further evidence of the strength of the 
measure to assess QoL. Largest effect sizes were found for pain and discomfort, 
mobility, ADL, moderate effect sizes were found for pain relief and uncertainty and 
small effect sizes were found for energy and fatigue, sleep and rest, dependence on 
medication, information, leisure activities, anger and frustration and vulnerability/ 
fear/ worry demonstrating that these facets are the most sensitive to changes brought 
about by LES.
Such selective improvements to QoL are unremarkable given that LES is a unimodal 
intervention. Consequently, only modest improvements would be expected relative to 
a more multifaceted intervention such as a pain management programme. Enhancing 
QoL across the entire range of facets would be beyond the scope of purely medical 
interventions. Obtaining a global assessment still confers advantages given that it is 
also possible to identify and focus on aspects of QoL that are perceived to be good 
relative to other areas.
8.6.8 Test-retest reliability
Given that an instrument should yield the same score for each participant when it is 
taken on another occasion if that person’s status on that variable has not changed 
(Kline, 1998), a challenge to the assessment of test-retest reliability is the reported 
variability in perceptions of changes in QoL, health and pain over a 2-week period. 
Most of the NT group reported that their QoL had remained the same and that their 
health and pain were the same or a little worse. A larger proportion of the NT group 
than the LES group reported beginning other treatment and experienced significant 
life events. That health and pain were described as the same or worse could reflect 
the fluctuating nature of pain, already identified in previous chapters (Skevington, 
1994; Mason, Skevington and Osbom, 2004) and reveals that despite perceptions of 
changes in pain, QoL can remain stable. It is also possible that this result could be a 
response to not receiving treatment, that is, respondents wished to register that their
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pain had become worse to maximise the chances of receiving treatment at a 
subsequent appointment. Consequently, correlations below 0.7 for pain and 
discomfort, thinking, learning, memory and concentration, self-esteem, body image 
and appearance, negative feelings, physical safety and security, opportunities for 
acquiring new information and skills, transport, pain relief, vulnerability/ fear/ worry 
and uncertainty could reflect changes in pain over the 2-week interval, a bias 
associated with wishing to appear worse to increase the likelihood of receiving 
treatment or that these facets do not meet the criteria for test-retest reliability. 
However, it has already been shown that core WHOQOL facets produce comparable 
scores across time in the absence of significant life occurrences or medical 
interventions, with facet correlations between baseline and follow-up ranging from 
.68- .95 (The WHOQOL Group, 1998). Furthermore, given that patients reported 
other life events occurring during the interval between assessments, this presents a 
methodological challenge because such events or experiences are likely to influence 
the response to a holistic, subjective assessment of QoL.
The drawback of selecting different time intervals for intervention and non­
intervention groups is that the groups will not be comparable at follow-up. However, 
if the NT group baseline-follow-up interval had been lengthened, this would have 
increased the likelihood of changes occurring during this time, for example, 
alternative treatment could have commenced, confounding the results.
8.6.9 Importance items
The stability of the importance attributed to facets of QoL was examined for the LES 
and NT groups. For the LES group, the importance of facets of life remained stable 
over the 4 week interval between baseline and follow-up with the exception of the 
importance of being pain free, the importance of relief, the importance of control and 
the importance of being free from fear and worry, which were significantly less 
important at follow-up. For the NT group, all baseline to follow-up importance scores 
were non-significant with the exception of overall QoL and health, which was 
significantly less important at follow-up. Given the small sample size of the NT 
group, this result should be interpreted with caution and is worthy of further 
investigation. Although perceived importance remained relatively stable for most 
facets, the reported changes suggest that an intervention, such as LES, may mediate 
the importance attributed to these facets of QoL. Given the important relationship
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between a persons’ rating of an aspect of QoL and the perceived importance attributed 
to it (Skevington, O’Connell, The WHOQOL Group, 2004), further work exploring 
these shifts in importance might produce useful insights in the light of contemporary 
theoretical approaches relating to changes to the way that QoL is perceived.
8.6.10 Critique
In any longitudinal test involving an intervention the question arises of the extent to 
which treatment is consistent and equally efficacious across different consultants and 
different clinic sites. This potential source of variability may influence the response 
to treatment and the completion of instruments assessing outcomes. Furthermore, 
improvements were only found for 10 of the core facets and 3 of the PDM facets 
which is unremarkable given that LES is a very specific unimodal medical 
intervention and any reported decrease in pain may not lead to improvements in 
broader aspects of patient functioning, well-being and QoL. Such changes might 
come about through targeted multidisciplinary, multifaceted interventions. Despite 
the multifaceted consequences of pain, a reduction in symptoms (i.e. pain) would not 
necessarily improve QoL in areas not pertaining to health such as aspects of the 
physical environment. Indeed Skevington found that some aspects of QoL are not 
affected by the presence of pain, for example SRPB (Skevington, 1998). This adds 
weight to the argument for developing the PDM to increase the specificity and 
sensitivity of the generic core instrument, because not all core facets are sensitive to 
the influence of CP.
Given the variable response to LES shown by the transition questions, a change in 
QoL may not have taken place, which explains the modest effect sizes. It is also 
possible that the measure may not be sensitive enough to pick up changes, particularly 
as 2 of the 4 PDM facets address the psychological concomitants of pain rather than 
physical ones. However, the instrument did detect selective improvement in QoL 
following LES. A response shift may also have occurred, that is, the processes 
utilised to make decisions about QoL may have changed the way that participants 
evaluate aspects of their life quality (Sprangers and Schwartz, 1999). Indeed, changes 
to the importance attributed to freedom from pain and fear and worry and pain relief 
and control suggest that this is a plausible explanation. However, as such processes 
were not directly assessed during this study, this remains an important issue for
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further research to elucidate the process of adaptation to chronic conditions 
characterised by pain.
It was not feasible or ethical to design and implement a RCT, as this would involve 
denying patients access to treatment to form a control group, consequently, the sample 
was opportunistic. The sample used in this study was also older in age and 
represented a more homogenous diagnostic group than previous chapters have 
reported, however, it was necessary to recruit people with CLBP due to the selected 
intervention. Engaging people at baseline to prevent attrition at follow-up was 
important to maximise the extent to which generalisations can be made about the QoL 
of people with pain. However, some attrition was inevitable and despite follow-up 
telephone reminders. A higher response rate at follow-up was achieved for the LES 
than the NT group. Given the limited resources, the sample had sufficient power to 
enable conclusions to be made on the properties of the measure; which was the goal of 
the research.
8.6.11 Concluding remarks
This chapter reported a longitudinal test to elucidate the psychometric properties of 
the PDM, including sensitivity to change and test-retest reliability and presented a 
summary of its psychometric properties. Chapter nine focuses on the importance of 
facets of QoL and derivation of the WHOQOL-Bref using data derived from the 
cross-sectional survey reported in chapter seven. In the final chapter, all the major 
findings are summarised and discussed.
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Chapter nine 
The Importance of Facets of QoL and Derivation of a Short- 
form PDM
9.1 Introduction
The previous chapter described the longitudinal survey to examine sensitivity to 
change and test-retest reliability of the pain and discomfort module (PDM) and 
summarised its psychometric properties. This chapter makes a preliminary 
assessment of the QoL of people with chronic pain (CP). Specifically, the facet and 
domain scores of the WHOQOL and the PDM are examined, in addition to the 
importance attributed to facets of quality of life (QoL). A particular focus is the 
relationship between facet scores and their corresponding importance item. 
Additionally, an abbreviated form of the PDM is derived from the cross-sectional 
survey data reported in chapter seven.
The relationship between aspects of QoL and the importance attributed to such areas 
has been shown to be important in understanding QoL (Skevington and O’Connell, 
2004) (discussed in chapter five). Indeed, instruments such as the Patient-Generated 
Index is based on patients rating the importance of aspects of their QoL they would 
most like to improve (Haywood et al., 2003). Interpreting the discrepancy between 
the rating of QoL and the importance attributed to that aspect could provide useful 
insights into QoL. For example, where a person reports a low QoL, but attributes 
high importance to a facet, this might be a locus for intervention. Conversely, less 
heed would need to be paid to areas where QoL is good, but importance is low. 
Consequently, examining the relationship between how good or poor an aspect of 
QoL is and the importance attributed to it enables a more detailed assessment of QoL.
The development of short-form instruments represents a trade-off between 
comprehensiveness and brevity. Examples include the MOS health status 
instruments, in particular, the derivation of the SF-12 (discussed in chapter eight) and 
the SF-8 (Tumer-Bowker et al., 2003) from the SF-36 (Ware and Sherboume, 1992) 
and the development of the WHOQOL-Bref (WHOQOL group, 1998). The use of
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such instruments confers advantages both in clinical practice and in research where 
time is limited and where patients are already faced with an extensive battery of 
instruments (Sturgis et al., 2001; Jenkinson and Layte, 1997). However, limitations 
include compromised precision (Ware, Kosinski and Keller, 1996) and reduced 
comprehensiveness. The development and validation of the WHOQOL-Bref was 
described in chapter two and given the brevity of the Bref compared to the core 
WHOQOL-lOO, deriving a short-form PDM to be used in conjunction with the Bref 
would confer further advantages when clinical time is limited or patient burden is high 
(Skevington, Lofty and O’Connell, 2004). An additional goal was therefore to extract 
WHOQOL-Bref items from the core data and to select one item from each of the 
PDM facets to derive an abbreviated form.
9.2 Results
The analysis that follows consists of two parts. The first explores the importance of 
different aspects of QoL and the second on comparing the WHOQOL-lOO and 
WHOQOL-Bref and deriving an abbreviated form. Analysis was conducted on the 
cross-sectional survey data reported in chapter seven using the 16 retained items of 
the PDM, where the characteristics of the study sample and the psychometric analysis 
were reported. The rationale for using the data derived from the cross-sectional study 
rather than the longitudinal study was twofold. Firstly, the sample size was larger 
(n=216) which gives greater confidence in the conclusions drawn and secondly, the 
sample consisted of people from heterogeneous diagnostic groups as opposed to 
relative homogeneity of the low back pain patients participating in the longitudinal 
study.
9.2.1 Part 1 - Facet and domain scores for the WHOQOL and PDM
Table 9.1 shows the mean scores for the 25 WHOQOL facets and 4 retained PDM 
facets. For the core facets, highest QoL was in the home environment, social support 
and transport facets and lowest for the pain and discomfort, energy and fatigue and 
dependence on medication facets. For the PDM facets, QoL was highest for 
vulnerability/ fear and worry, followed by anger and frustration, pain relief and lowest 
for uncertainty. Of the domain scores, QoL is highest in the environment domain 
(13.59 ± 2.34), followed by the social relationships (13.55 ± 2.93), psychological
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(12.74 ± 2.69), SRPB (12.53 ± 4.03), level of independence (10.38 ± 3.30) and is 
lowest in the physical domain (9.99 ± 2.67). This concurs with the results from the 
longitudinal study reported in chapter eight.
9.2.2 Importance of aspects of QoL
As described in chapter two, the original WHOQOL pilot contained 41 importance 
items (Szabo et al., 1997) and this has subsequently been reduced to 26 (Skevington 
and O’Connell, 2004), one representing each facet, one overall QoL and another 
general health. As table 9.1 illustrates, all of the core and PDM importance items 
where rated at >3.0 underscoring their importance to people with CP. The most 
important facets were ADL, mobility and the availability and quality of health and 
social care. The least important were sexual activity, body image and appearance and 
SRPB. Of the PDM facets, the most important was obtaining relief and controlling 
pain (pain relief), followed by freedom from anger, worry and the least important was 
freedom from uncertainty. Such information is important because it provides an 
indication of the relative priority given to different aspects of life.
9.2.3 Relationship between the WHOQOL facets and the importance items
In order to examine the relationship between facets of QoL and the importance 
attributed to them by CP patients, Pearson’s correlations were conducted between 
each facet mean and the importance item representing that facet. Due to the 
inevitably skewed data because of the predetermined importance of these facets of 
QoL (>3.0 on the 5-point Likert scale), the importance scores were log transformed. 
The transformed importance scores were also correlated with G. Table 9.1 shows the 
mean ranked importance items, corresponding facet score, ranked facet score, 
correlation with core facet and with G. Overall, the correlations were relatively weak. 
Ten of the 26 importance-core facet correlations were significant. Significant 
negative correlations between importance ratings and corresponding facet mean were 
found for pain and discomfort, energy and fatigue, sleep, financial resources, negative 
feelings, physical safety and security and body image and appearance. For the PDM 
facets, all importance ratings were significantly negatively correlated with their 
corresponding facet. Working capacity, social support and SRPB were significantly 
positively correlated with their corresponding facet, suggesting that a good QoL in
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these areas is associated with high importance. The largest correlation was found 
between the importance of SRPB and its core facet (r=.61). For correlations with G, 
significant negative correlations were found for pain and discomfort and dependence 
on medication. Of the PDM importance ratings, pain relief, anger and frustration, and 
uncertainty were significantly negatively correlated with G (P> .05). Only SRPB was 
significantly positively correlated with G.
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Table 9.1 Mean ranked importance items with corresponding facet mean, rank,
















12 Care ADL 4.54 (.598) 2.67 (.89) 7 .01 -.04
11 Able to move 
around
4.47 (.590) 2.58 (1.00) 4 -.05 -.11
28 Obtain relief 4.43 (.692) 2.71 (.74) 8 -.17* -.20*
29 Control pain 4.43 (.664) 2.71 (.74) 8 -.18* -.25*
21 Adequate
healthcare
4.35 (.612) 3.24 (.72) 20 .04 -.12
19 Home
environment
4.34 (.610) 3.93 (.84) 29 .11 -.03
15 Relationships 
with others
4.34 (.713) 3.55 (.86) 26 .14 .01
4 Energy 4.32 (.658) 2.46 (.76) 2 -.23* -.15
2 Health 4.31 (.610) 2.80 (.91) 10 -.12 -
3 Pain free 4.28 (.810) 2.25 (.74) 1 -.31* -.21*
5 Restful sleep 4.25 (.708) 2.78 (.91) 9 -.29* -.16
7 Thinking
problems
4.20 (.686) 3.25 (.77) 21 .03 -.03
1 QoL 4.19 (.640) 2.80 (.91) 8 -.12 -
8 Positive re self 4.15 (.804) 3.08 (.83) 15 .08 -.07
10 Free negative 
feelings
4.11 (.817) 3.17 (.93) 18 -.38* -.17
20 Financial
resources
4.11 (.711) 3.15(1.02) 17 -.24* -.11
6 Feel contented 4.05 (.677) 3.03 (.80) 13 .05 -.00




4.01 (1.150) 2.50 (1.01) 3 -.03 -.22*
14 Able to work 4.01 (1.150) 2.63 (1.09) 5 .22* -.14
18 Safe and secure 4.00 (.801) 3.34 (.75) 23 -.26* -.05
25 Adequate
transport
3.98 (.878) 3.69(1.04) 27 -.12 -.12
30 Free from anger 3.95 (.944) 3.04 (.86) 14 -.36* -.22*
23 Relaxation and 
leisure
3.94 (.776) 3.00 (.86) 12 .15 -.02
24 Environment 3.86 (.831) 3.52 (.72) 25 -.08 .02
34 Free from 
uncertainty
3.85 (.922) 2.66 (.89) 6 -.18* -.20*
16 Support others 3.78 (.843) 3.72 (.85) 28 .21* -.00
22 Information and 
knowledge
3.78 (.808) 3.29 (.74) 22 .00 -.08
26 Personal beliefs 3.64 (1.025) 3.13 (1.01) 16 .61* .19*
9 Body image and 
appearance
3.54 (1.060) 3.40 (.97) 24 -.38* -.03
17 Sex life 3.11 (1.345) 2.86(1.05) 11 .03 -.03
* Correlation is significant at the 0.05 level (2-tailed).
t  Highest represents best QoL
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9.2.4 Part 2 - Comparison of the WHOQOL-lOO and the WHOQOL-Bref -  the 
derivation of WHOQOL Bref scores from the WHOQOL-lOO
Analysis was also carried out on the 26 items that form the WHOQOL-Bref, derived 
from the WHOQOL-lOO items, in order to make a preliminary assessment of QoL 
with the WHOQOL-Bref in this population. It is acknowledged that this data is 
extracted from the WHOQOL-lOO data and consequently it is possible that the other 
items influence the way that participants respond to the Bref items. Excluding the 76 
items from the WHOQOL-lOO, the Bref is comprised of 26 items; one from each of 
the 24 facets of QoL, and two from the G facet asking about overall QoL and health. 
Four Bref domain scores were calculated from the cross-sectional data and consistent 
with the WHOQOL-lOO, these are scaled in a positive direction where higher scores 
represent a better QoL. Domain scores are calculated by multiplying the mean score 
of items by four (WHOQOL user manual, 1998). Table 9.2 shows the means, SD and 
missing items for the Bref items. Item means ranged from 2.12 (satisfied with health) 
to 3.95 (conditions of living space), suggesting that QoL was highest for the home 
environment and lowest for satisfaction with health. All items had less than 10% 
missing data, although most missing data was for the item asking about sexual activity 
(6.5%). Satisfaction with health was lower than for overall QoL. The means and SD 
for the four WHOQOL-Bref domains are also shown. Mean domain scores were 
highest for social relationships domain, followed by the environment and 
psychological domains and lowest for the physical domain.
9.2.5 Internal consistency reliability for the four Bref domains
The four Bref domain scores were found to be internally consistent. For social 
relationships a=.66, for psychological a=.79, for the environment a=.81 and for 
physical a=.86, although caution must be applied in interpreting the alpha for the 
social domain as this is based on only three items. For the whole scale, a= .92 and for 
the four domains scores (excluding the 2 items about overall QoL and health) a=.81.
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Table 9.2 Facet and domain scores for the WHOQOL-Bref
Item no. Item content Mean SD Missing
%
General health
G1 Rating of QoL 3.16 1.03 .5
G4 Satisfaction with health 2.12 .95 .5
Physical domain 10.28 3.20 -
F14 Pain prevents you from doing 2.17 1.02 .5
F21 Do you have enough energy 2.85 .97 .5
F33 Satisfaction with sleep 2.64 1.19 .5
F91 Able to get around 2.88 1.14 .5
F103 Ability to perform daily activities 2.67 1.07 .5
FI 12 Need medical treatment 2.33 1.10 .9
F124 Work capacity 2.46 1.20 2.3
Psychological domain 12.81 2.73 -
F41 Enjoy life 3.24 .93 .9
F53 Able to concentrate 3.07 .78 .5
F63 Satisfaction with yourself 3.06 1.06 .9
F71 Accept bodily appearance 3.47 1.07 .9
F81 Negative feelings, despair 3.05 .98 1.4
F242 Feeling life is meaningful 3.31 1.03 0
Social re lationships domain 13.85 3.51 -
F133 Personal relationships 3.73 1.15 1.9
F153 Sex life 2.89 1.27 6.5
F144 Support from friends 3.75 .97 0
Environment domain 13.48 2.56 -
F161 Feeling safe in daily life 3.37 .95 .9
F173 Conditions of living space 3.95 .94 0
F181 Enough money to meet needs 3.08 1.01 .9
F193 Access to health services 3.31 1.01 .5
F201 Availability of information 3.42 .93 1.4
F211 Opportunities for leisure activities 2.75 1.09 .5
F221 Health of physical environment 3.40 .84 1.4
F233 Transportation 3.65 1.03 .5
9.2.6 Selection of Bref items from the PDM facets
In order to select items for an abbreviated version of the PDM, the protocol used to 
derive the WHOQOL-Bref items was followed (WHOQOL Group, 1998). To select 
the ‘best’ item from each new facet, the most general question is selected which is the 
item that correlates most highly with the total score (mean o f all facets). The 
standardised item alpha for the 16 PDM items extracted from the cross-sectional data 
was .91, demonstrating high internal consistency reliability. Table 9.3 shows the 
corrected item-total correlation and the alpha (with the contribution o f  that item 
excluded) for each o f the 16 items. The following items had the highest correlation 
with the total PDM score (with the contribution o f that item deleted) and the lowest 
alpha if  that item was deleted reflecting the importance o f its contribution.
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■ F615i How satisfied are you with the control o f your pain?
■ F627 How much do feelings o f frustration interfere with your everyday life?
■ F633 How much does feeling vulnerable interfere with your everyday life?
■ F642 How much does uncertainty about the future interfere with your everyday life?
Table 9.3 Scale mean, item-total correlation and Cronbach’s a for each PDM
item





a if item 
deleted
Pain relief a= .77
F613I 43.46 .55 .9089
F615I* 43.92 .59 .9076
F616I 43.88 .35 .9152
F617 44.02 .54 .9092
Anger & frustration a= .&
F622 42.83 .629 .9067
F623 43.54 .657 .9057
F625 43.97 .59 .9077
¥627* 43.54 .68 .9048
Vulneraljility/ fear/ worry a= .81
F632 43.06 .53 .9097
F633* 42.81 .633 .9065
F635I 43.98 .58 .9082
F638 43.27 .58 .9082
Uncertainty a -  .85
F642* 43.65 .71 .9039
F644 43.56 .69 .9043
F645 43.83 .67 .9053
F647 44.32 .64 .9062
* Selected items
9.3 Discussion
The data used for the analysis reported in this chapter comes from the cross-sectional 
study o f a heterogeneous sample o f people with CP reported in chapter seven. The 
analysis used the core WHOQOL-lOO data and the 16 items embedded in the pilot 
PDM. For people with CP, QoL was found to be highest for the home environment, 
social support and transport facets and the environment and social relationships 
domain. Conversely, QoL was worse for the pain and discomfort, energy and fatigue 
and dependence on medication facets and for the physical and level o f independence 
domain. For the PDM facets, highest QoL was found for vulnerability/ fear and 
worry, followed by anger and frustration, pain relief and lowest for uncertainty. QoL 
was poorer for overall health than for overall QoL, indicating that when making
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global assessments, people rated their health as lower than QoL confirming the 
importance of holistic measurement.
9.3.1 Importance of facets of QoL to people with pain
In an examination of the importance of different aspects of QoL to people with CP 
reported in part one of the results, a number of facets were found to be significantly 
inversely correlated with their corresponding facet score. The higher the negative 
association, the greater the discrepancy between reported QoL and importance 
attributed to that aspect of life. Such incongruities represent areas of life where QoL 
is poor, but are considered to be most important. Such facets are worthy of attention 
because they could provide potential locus for intervention. Conversely, such 
discrepancies could reflect good aspects of QoL that are considered less important 
relative to other life areas. In general, correlations between importance items and 
their corresponding facet were weak or negative suggesting that they are addressing 
different aspects of the concepts. Significant negative correlations were found for 
pain and discomfort, energy and fatigue, uncertainty, pain relief, sleep and rest, anger 
and frustration, financial resources, negative feelings, vulnerability/ fear and worry 
and physical safety and security, suggesting that these are very important to people 
with CP, yet QoL is worse in these areas. Conversely, body image and appearance 
does not appear to be compromised by living with CP (represented by a higher facet 
score) but is not as important as other facets. Working capacity, social support and 
SRPB were significantly positively associated with their corresponding facet score 
suggesting that there is no discrepancy between perceived QoL and the importance 
attributed to these facets. A therapeutic goal might be to facilitate a convergence of 
perception of QoL in a particular area with the importance attributed to it, that is, to 
target areas where the discrepancy is greatest. In general, the low correlations 
between an importance item and its corresponding facet show that these are tapping 
into quite different aspects of QoL supporting previous work in this area (Skevington 
and O’Connell, 2004).
In general, all core facets were considered to be important by the respondents of the 
cross-sectional survey. The most important were ADL, mobility and availability and 
quality of health and social care, reflecting the centrality and importance of these 
aspects of functioning to people with CP. Of the PDM facets, obtaining relief was the
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most important, followed by pain control, being free from anger, being free from fear 
and the least important was being free from uncertainty. Sex life, body image and 
appearance and SRPB were considered to be the least important of the core 
WHOQOL facets. In explaining such a finding, sex life and body image may not be 
important relative to other facets, or may have declined in importance relative to other 
areas. Such a decline could represent a shift in perceived importance. Given the 
preliminary evidence for a change in the importance attributed to aspects of QoL 
following treatment which was reported in chapter eight, exploring changes in the 
importance attributed to aspects of QoL longitudinally would provide additional 
evidence that, when faced with adverse circumstances, people undergo fundamental 
shifts in internal standards as proposed in the theory of response shift (Sprangers and 
Schwartz, 1999; Schwartz and Sprangers, 1999). Such shifts could mediate the 
importance of different areas of QoL both overtime and in relation to other aspects of 
life.
It is also possible that the low importance attributed to sexual activity and body image 
could indicate that participants gave socially desirable and culturally appropriate 
answers, given that these areas are considered to be private and personal aspects of a 
person’s life. Focus group participants (chapter three) alluded to the problem of 
sexual activity being painful and the impact of pain on relationships with significant 
others, which concurs with research demonstrating a trend towards deterioration in 
sexual activity following the onset of painful conditions (Maruta et al., 1981) and the 
high prevalence of sexual difficulties amongst patients attending inpatient and 
outpatient pain management programmes (Ambler et al., 2001). Consequently, the 
missing data found for items pertaining to sexual activity and the relatively low 
importance attributed to it in the present study suggests that subjective reports of QoL 
relating to sexual activity might be more influenced by biases in reporting than other 
facets. In general, a further examination of the importance attributed to different 
facets of life over time and across groups or individuals who are know to differ on 
certain characteristics, such as underlying condition, is warranted as this provides 
important information about the relative priorities of different areas of life.
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9.3.2 WHOQOL-Bref and a short-form PDM
The second part of the results reported a WHOQOL-Bref analysis by extracting the 26 
items embedded in the WHOQOL-lOO and derived an abbreviated form of the PDM. 
QoL was highest for home environment, social support, personal relationships and 
transportation. Lowest QoL was reported for satisfaction with health, pain and 
discomfort, dependence on medication and work capacity. For the domain scores, 
QoL was highest for the social relationships domain, followed by the environment and 
psychological domains and lowest for the physical domain. These findings reveal the 
way in which pain influences physical well-being, which is also shown by poorer 
satisfaction with health than with ratings of overall QoL. The internal consistency 
reliability for 4 Bref domains and the whole scale was good. Following this analysis, 
a preliminary attempt to derive an abbreviated PDM was undertaken by selecting one 
item from each of the 4 facets that correlated most highly with the total score, which 
could then be used in conjunction with the WHOQOL-Bref. Although detail and 
breadth of coverage is compromised by the selection of a small number of items to 
represent the important consequences of CP, further work should involve checking the 
reliability and validity of the WHOQOL-Bref and the abbreviated PDM to ensure that 
this adequately captures the impact of pain on QoL.
The purpose of the studies reported in this thesis was to describe the development and 
psychometric properties of the PDM. Elucidating the correlates of QoL for people 
with CP is still an important goal to be explored further in subsequent research. For 
example, in depth analysis of the relationship between variables on which participants 
were known to differ and their QoL such as socio-demographic characteristics (age, 
gender, employment status), reported pain intensity, duration, temporal 
characteristics, reported health status, illness and so on. The rationale for excluding 
such an analysis here was because the goal of the cross-sectional survey was to derive 
the PDM from the larger pilot instrument and elucidate its psychometric properties 
(reported in chapter seven) rather than to evaluate QoL per se. Furthermore, the QoL 
of people with CP using the core WHOQOL instrument has been previously described 
(Skevington, 1998; Skevington, Carse and Williams, 2001). The data from chapter 
seven was used for this analysis due to the larger sample size compared to chapter 
eight and the greater heterogeneity of diagnostic groups included in the sample.
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9.3.3 Conclusions
This chapter explored the quantitative data derived from the cross-sectional survey 
reported in chapter seven by examining which facets of QoL were worse for people 
with CP and those that were most important. This work highlights the need to take 
account of the importance that is attributed to different aspects of QoL and the 
potential for targeting interventions at areas where there is an observed discrepancy 
between a rating of QoL and its importance. In particular, if QoL is found to be poor 
for an area such as anger and frustration, yet being free from anger and frustration is 
rated as extremely important, this might provide a useful locus for delivering anger 
management interventions. Conversely, if an area is problematic, yet not rated as 
important, it might be less urgent to intervene to improve this area of QoL, providing 
a way of maximising the usefulness and appropriateness of interventions. Having also 
looked extracted WHOQOL-Bref items from the data, a short-form would clearly be 
advantageous both in clinical and research settings, where patient burden and 
comprehensibility must be balanced. The final chapter draws together and 
summarises the preceding chapters and discusses issues pertaining to pain and its 
consequences for QoL. Furthermore, it provides a critique of the chapters and 





Given the extent of the problem of pain in medicine shown in chapter one and the 
important debates associated with defining and measuring chronic pain (CP) and 
quality of life (QoL), the aim of this thesis was to develop an instrument to assess the 
impact of CP on QoL. Although measures of pain intensity or severity and health 
status are important and necessary, they are limited by their narrow focus. Similarly, 
generic QoL assessments alone tend to be insensitive to the subtleties of the impact of 
pain, hence the need for a pain specific module to be used in conjunction with a 
generic QoL instrument, which takes account of the subjective perception of the 
sufferer. That its impact is so broad is not remarkable given the salience of pain and 
the sense of intrusion and perception of threat that pain represents to the sufferer 
(Price, 1999), which reinforces the multidimensional and all pervasive nature of pain 
due to its chronicity and omnipresence. Pain pervades every aspect of a person’s 
physical, psychological, social and spiritual being (Ahmedzai, 1995) and it is argued 
here that its influence on perceptions of life quality can be measured.
In chronic conditions where patients must learn to live with and accept their pain, its 
impact on QoL becomes even more central than if it was an acute or transient 
symptom. The reason for this is twofold; firstly because of the long-term nature of 
the pain and its consequences, and secondly, because of the uncertainties surrounding 
the trajectory of this long-term situation. Consequently, measuring the QoL of people 
who live with the constant presence of pain was the central goal of this research. 
Measurement was based on a model developed by the WHOQOL Group (WHOQOL 
Group, 1995, 1998) in the development of the WHOQOL instruments. The extension 
of this model to account for the impact of pain introduced novel elements such as the 
web-survey; an innovative approach utilising the World Wide Web and the method of 
cognitive interviewing derived from cognitive aspects of survey methodology, which 
combines cognitive psychology with survey research.
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The experience of persistent pain can be said to impact on the QoL of an individual in 
a complex way through their physical health, psychological state, level of 
independence, social relationships, and their relationship with the environment, 
mirroring the WHOQOL Groups’ definition of QoL (The WHOQOL Group, 1995). 
QoL is both subjectively defined and multidimensional. Above the core elements of 
QoL identified by the WHOQOL Group, additional aspects have been found that 
contribute to, and influence the QoL of people living with physical pain and 
discomfort. These new elements can be conveniently housed under the existing core 
domains and items can be meaningfully constructed that reliably inquire into these in 
such a way as to tap the experience of the individual. Specifically, this thesis has 
shown that QoL is influenced through the presence of flare-ups, the ability to obtain 
relief, through feelings such as anger, frustration, vulnerability, fear and worry, the 
experience of uncertainty, loss loneliness and feeling alone and the ability to draw on 
positive strategies such as hope and humour. Furthermore, an individual’s 
relationship with others also impacts on QoL through the ability to communicate, the 
experience of guilt and perceptions of burdening others and the relationship with 
health care providers. However, of these aspects of QoL, only pain relief, anger and 
frustration, vulnerability/ fear/ worry and uncertainty formed cohesive internally 
consistent facets of QoL. It seems that, over and above general QoL (that is, areas 
important to all individuals regardless of health state), it is the psychological 
concomitants of a person’s reaction to pain that are in need of elaborating to fully 
account for its impact.
10.2 Theoretical framework
The theoretical framework underpinning this work is conceptualised by the 
WHOQOL definition, that QoL is defined by a person’s perception of their life 
position within the context and culture within which they are embedded. 
Furthermore, it is an inherently relational concept and thus varies as a function of a 
person's changing goals, expectations and so on. Consequently, it is an outcome 
affected in complex ways by diverse life domains that are represented and assessed by 
the WHOQOL instruments. The definition itself encapsulates the processes of 
making decisions about QoL and the instruments assess the outcomes of such 
decisions. This is an important conceptual point as the outcomes in themselves do not 
give us insight into the process of making a decision about a particular aspect of QoL
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only the consequence of that decision making. The qualitative studies reported in 
chapters three and four demonstrated that social comparison judgements and 
acceptance contribute to decision making about the way that pain affects QoL, which 
might be utilised to enhance the effectiveness of interventions targeted at improving 
QoL. These and other processes could be further elucidated through in-depth 
qualitative analysis of the narrative accounts of people describing their QoL and 
through co-administration of instruments purporting to measure process orientated 
aspects of decision-making. A challenge for work on QoL and CP is that an 
overarching theory of the consequences of pain has not been elaborated over and 
above cognitive behavioural models (e.g. Sharp, 2001) and the biopsychosocial 
approaches (e.g. Turk and Okifuji, 2002) discussed in chapter one, which represent 
the dominant paradigms and other more narrowly defined theories which aid in 
explaining particular responses to pain such as fear avoidance (Vlaeyen and Linton,
2000), catastrophising (Rosenstiel and Keefe, 1983; Sullivan et al., 2001) and so on. 
In the work presented here, theoretical ideas are also held up in the cognitive 
interviewing based on the protocol analysis of cognitive psychology where verbal 
accounts are said to represent underlying cognitive processes (Ericsson and Simon, 
1980; Loftus, 1984) and by the psychometric approach that is articulated and tested in 
chapters seven and eight.
Embodied in the WHOQOL definition is the notion of the relative nature of QoL, 
which is supported in the narratives of FG participants who drew heavily on social 
comparison in articulating aspects of their experience and understanding of QoL. 
Social comparison theory has been integrated into the theory of response shift, where 
social comparison mediates the relationship between life events, such as the 
experience of ill health and the change in self-perspective or response shift (Gibbons, 
1999) and evidence was found in the verbal accounts of patients describing their 
adaptation to living with CP in chapters three and four. Furthermore, a preliminary 
exploration of the importance attributed to different QoL facets over time during the 
longitudinal survey reported in chapter eight found that being pain free, pain relief, 
control and being free from fear and worry became less important following 
treatment. This suggests that people re-appraise the importance of different aspects of 
life during periods of chronic illness, although this should be tested further with 
follow-up periods of longer duration.
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The theory of response shift explains why scores on a particular dimension do not 
change on repeated applications because people change how they appraise their health 
status and it has been suggested that such re-appraisals confound outcome 
measurement (Rapkin and Schwartz, 2004). Consequently, no detected change could 
reflect true underlying stability or that the same response to a question might have a 
different meaning because the scale has been recalibrated to include ‘worst worlds’ 
(Gibbons, 1999). Conversely, a changed response to an item may occur in the 
absence of any change because a reappraisal of the situation has occurred. In light of 
this, the need for measuring the actual appraisal process as an adjuvant to QoL 
instruments has been proposed (Rapkin and Schwartz, 2004; Schwartz and Rapkin, 
2004).
10.3 Four new facets of QoL
Pain has been shown to have important consequences for QoL. Of the 10 facets 
derived from the FG work and the web survey, 4 were retained following 
psychometric testing. Pain relief, anger and frustration, vulnerability/ fear/ worry and 
uncertainty were retained as comprehensive, multidimensional constructs representing 
aspects of QoL. These can be seen as outcomes or consequences of pain. Pain relief 
relates to the physical aspects of pain and was most highly associated with the 
physical domain. Anger, frustration, vulnerability, fear and worry can be seen as 
emotional components of pain and are strongly associated with the psychological 
domain. Uncertainty was found to be more closely associated with level of 
independence than the psychological domain in which it was originally placed. 
Despite the face validity of the remaining 6 facets, these were deleted due to the 
results of the extensive psychometric testing reported in chapter seven. For example, 
relationship with health care providers was found to be highly associated with core 
facets and was therefore redundant. Flare-ups represented a concept that was poorly 
elaborated, because only 3 items were constructed to represent this aspect of QoL. 
Other facets, most notably positive strategies, failed to reach an acceptable level of 
internal consistency and were therefore deleted. The content and importance of these 
facets was discussed in more detail in chapters three, four and five.
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Pain relief has been shown to be important to QoL. The core WHOQOL pain and 
discomfort facet accounts for the presence of pain but not to pain relief. 
Consequently, including this facet was seen as central to a module pertaining to the 
impact of CP. This study found pain relief and control to be an important aspect of 
QoL for people with CP which concurs with previous studies showing that lower 
average pain ratings are associated with higher functioning and QoL (e.g. Zelman et 
al., 2003) and that control of pain has been associated with improved outcomes 
(Jensen, Karoly and Huger, 1987; Harkapaa, 1991). Alleviating pain or maximising 
relief remains an important goal of biopsychosocial interventions and assessing pain 
relief in a pain specific QoL instrument addresses this.
The experience of anger and frustration was widely reported by study participants and 
became a facet of QoL. An unexpected finding was the close relationship of anger 
and frustration to the pain and discomfort facet and the physical domain, which 
demonstrates that pain and anger co-occur, highlights the salience of these emotions 
to people with CP and demonstrates the anger and frustration are distinct from 
negative feelings. Assessing the impact of anger on QoL is an important goal and 
potential locus for intervention, through anger management and so on. Discussed in 
chapter three, studies have shown that anger is a salient emotional correlate of pain 
(Fernandez and Turk, 1995), that it can exacerbate pain (Suinn, 2001), that the 
differential expression of anger can influence the reported pain intensity of different 
conditions in different ways (Bruehl, Yung Chung and Bums, 2003) and that anger 
has a role in the depression of patient spouses, average pain and level of marital 
satisfaction (Schwartz et al., 1991). Although these studies show that the relationship 
between anger and pain has been elaborated, the present study has shown the 
importance of including such correlates of pain into a CP specific QoL instrument.
The concept of frustration represented part of this multidimensional facet. As well as 
frustration generated through unsatisfactory interaction with the health care system, 
the present study also found that frustration could result from not being able to engage 
in previous activity levels and so on, which illustrates that intrapersonal comparative 
strategies are drawn upon. There is limited evidence for the role of patient frustration 
in CP although it is recognised that competing theories explaining non-specific LBP 
can generate patient frustration because of the consequent competing and conflicting
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treatments offered (Deyo and Phillips, 1996). Assisting patients to manage feelings of 
frustration by presenting realistic alternatives could be an important aspect of 
promoting effective self-management in addition to encouraging active engagement in 
life activities in spite of the pain and a willingness to experience pain, which represent 
acceptance of pain (McCracken, Vowles and Eccleston, 2004).
FG participants spontaneously elicited vulnerability, fear and worry as important 
aspects of the pain experience influencing their QoL, which wrere endorsed by 
subsequent stages. Identifying the variables that mediate the impact of vulnerability 
fear and worry on QoL is an important goal in addition to assessing the extent of its 
impact on QoL. Fear has become a central concept in understanding the response to 
CP and is characterised by the avoidance of activity for fear of irreversible damage 
due to catastrophic interpretations of benign physical sensations (Vlaeyen et al., 
1995). Feelings of vulnerability to injury or re-injury have been described as 
‘kinesiophobia’ (Kori et al., 1990) and although fear and anxiety are closely 
associated, the distinction is said to come from the specificity of the threat (Rachman,
1998), where fear describes a situation where the threat is identifiable, such as in the 
case of pain, whereas in anxiety the source of threat is more elusive. Fear and anxiety 
have also been shown to predict adjustment to pain (McCracken et al., 1993; Waddell 
et al., 1993; Vlaeyen et al., 1995). Worry can be conceptualised as a cognitive 
response and research has shown the distress associated with worry related to somatic 
sensations (Eccleston et al, 2001). Integrating these concepts into an instrument 
assessing QoL has shown to be feasible and acceptable to patients, which concurs 
with the literature demonstrating the importance of these variables in understanding 
the complex response to CP.
Conceptually, uncertainty represents a multifaceted construct. In this study, 
uncertainty was represented as the inverse of life control, that is, in the absence of life 
control, the future is uncertain, which is important because QoL has been shown to 
improve with increased life control (Burton et al., 1998). It can also be viewed within 
the context of diagnostic uncertainty or when physical symptoms are unexplained, 
which is a typical feature when evidence of underlying pathology and reason for the 
persistence of pain is scant. In chapter three, previous studies illuminated the 
uncertain future for people with CP (Thomas, 2000) and the stigmatising
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consequences of medical uncertainty in the absence of a diagnosis (Lillrank, 2003). 
The research reported in this thesis shows that uncertainty was more closely 
associated with the level of independence domain than with the psychological domain 
in which it was hypothesised to belong to, highlighting that living with uncertainty 
compromises a person’s independence and the extent to which they can engage fully 
in life. Where possible, the WHOQOL model conceptualises facets and domains of 
QoL in positive ways, for example, in level of independence rather than dependence 
or mobility rather than immobility and so on. For this reason, the facet title 
uncertainty should be changed to ‘certainty’ to express a more positive aspect of QoL.
Each of the new facets has been described and discussed in light of the literature. 
Pain relief relates to beliefs corresponding to the subjective perception of actual 
nociception and the extent to which one is able to control such sensations. Anger and 
frustration represent emotional consequences of living with CP and vulnerability, fear 
and worry encompass the emotional reaction to beliefs held about pain. Uncertainty 
is characterised as a belief about an uncertain future and trajectory and can be better 
conceptualised as ‘certainty’. These four new facets represent the PDM to be used in 
conjunction with the WHOQOL-lOO.
10.4 The Pain and Discomfort Module
10.4.1 Psychometric properties of the PDM
The psychometric properties of the WHOQOL and PDM were outlined in chapters 
seven and eight. In general, the core WHOQOL facets performed well with 
Cronbach’s alpha ranging from .65 - .93 (19 of 25 facets had Cronbach’s alpha 
between .70 - .90). Similarly the core domain scores were found to be internally 
consistent, although the social relationship domain was only marginally acceptable. 
In the longitudinal survey, the PDM facets performed well and the scale had good 
internal consistency reliability (Cronbach’s alpha = .88). Significant positive 
correlations were found between the PDM facets and health status (physical and 
mental component scores of the SF-12) supporting its concurrent validity, by 
confirming that pain related QoL is poorest amongst those reporting poorer physical 
and mental health functioning. Furthermore, pain relief was most highly related to 
physical functioning, whilst anger and frustration, vulnerability/ fear and worry and 
uncertainty were most highly associated with emotional functioning, demonstrating
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that QoL pertaining to the psychological consequences of pain is more closely 
associated with mental health functioning, and the physical with physical functioning. 
Significant negative correlations were found between the PDM facets and pain 
intensity and severity (assessed by the SF-MPQ) providing evidence of construct 
validity. Furthermore, the PDM was able to distinguish between ill and well patients 
and those reporting different levels of health, demonstrating discriminant validity.
The test-retest reliability (2 week) of pain relief, vulnerability/ fear/ worry and 
uncertainty was lower than acceptable levels (>.70). However, patients reported 
perceived changes in QoL, health and pain, in addition to commencing new treatment 
and experiencing significant life events (assessed by the transition questions), which 
could have influenced mood, pain relief and so on. Given the findings reported in 
chapters three and four that pain fluctuates and flares-up and the consequent 
difficulties reported in the cognitive interviewing in chapter six of the difficulty in 
generalising experience over two weeks (the time period patients are asked to 
consider when answering items) the challenges of assessing test-retest in a clinical 
population with a condition characterised by fluctuations are highlighted. Indeed, 
Skevington (1994) highlights this as a special methodological problem for QoL scale 
development for people with arthritis because the disease itself, characterised by flare- 
ups and periods of relief, affects the stability of measurements over time. It was not 
possible to ensure that patients were not exposed to other treatment modalities in this 
study; however, future work could overcome this by using a waiting list control group 
who were not currently undergoing treatment.
Sensitivity to change of the PDM was examined by investigating whether the QoL of 
patients with LBP improves following lumbar epidural steroid injection (LES). 
Responses to the transition questions indicated that QoL, health and pain was the 
same or better following the intervention, suggesting only modest improvement 4 
weeks after a LES injection. QoL was significantly better for 10 of the 25 core facets 
and 3 of the 4 PDM facets. These were pain and discomfort, energy and fatigue, sleep 
and rest, self esteem, mobility, ADL, dependence on medication, work capacity, 
leisure activities, overall QoL, pain relief, anger and frustration and uncertainty. 
Largest effect sizes were found for pain and discomfort, mobility and ADL (>.62) 
demonstrating that these facets were most sensitive to change. Moderate effect sizes
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were found for pain relief and uncertainty (>.50) and small effect sizes were found for 
energy and fatigue, sleep and rest, dependence on medication, information, leisure 
activities, anger and frustration and vulnerability/ fear/ worry (all >.20). Of the PDM 
facets, pain relief and uncertainty were only moderately responsive to change and 
anger and frustration and vulnerability/ fear/ worry were less responsive. Given that 
LES should bring about pain relief, this provides support for this PDM facet and the 
experience of treatment may have increased certainty. Anger and frustration and 
vulnerability/ fear/ worry may need more targeted psychological intervention, to 
demonstrate greater responsivity.
In general, the WHOQOL-lOO performed well with patients with CP, which concurs 
with previous studies (Skevington, 1998; Skevington, Carse and Williams, 2001). 
The results also supported the concurrent, construct and discriminant validity of the 
PDM. Although test-retest reliability was found to be lower than acceptable, a partial 
explanation can be found in the reported variation in the no treatment group. The 
results also indicate that QoL was selectively enhanced by the LES intervention, and 
given that LES is a unimodal intervention, the selective sensitivity to change of the 
core WHOQOL and PDM is unremarkable.
10.4.2 Structure and scoring of the PDM
The PDM (16 items) should be administered in conjunction with the UK WHOQOL- 
lOO (102 items) as a self-administered questionnaire. In addition, the core WHOQOL 
importance items (26 items) and PDM importance items (5 items) can also be 
administered. The PDM has been designed for use in adults with CP from broad 
diagnostic groups, to assess the impact of CP on QoL. The items that comprise the 4 
facets representing the PDM must be used in conjunction with the core WHOQOL- 
lOO, by integrating them into their appropriate response scale block for ease of 
administration and completion. The importance items corresponding to the PDM 
facets are located after the core importance items. Additional questions addressing 
the duration, location, severity, temporal characteristics and so on are located in the 
‘about you’ section of the core instrument, which asks for socio-demographic 
information. The WHOQOL is scored by summing facets (25) and calculating 
domain scores (6) and the PDM is scored by calculating facet scores (4). The 
development and scoring of the WHOQOL instruments has been extensively reported
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elsewhere (WHOQOL Group User Manual, 1998). The instrument and syntax file are 
given in appendix 7 and 8.
The PDM should be used concurrently with the WHOQOL-lOO to assess the QoL 
people undergoing interventions aimed at improving QoL. To this end, the instrument 
should be used for outcome research, clinical trials, audit and clinical governance. It 
has been has proposed that the instrument might also be used as the basis of a clinical 
interview to explore different areas of QoL and the extent to which it might be 
possible to affect change in those areas (Skevington, 1995). It might also be possible 
to use the instrument as a screening tool to identify those with the poorest QoL and 
target resources at those most in need, or by using it to identify those who would be 
most suitable for interventions such as pain management programmes.
10.4.3 A short-form
Chapter nine reported on the derivation of a 4-item short-form PDM from the 16-item 
PDM. Following the WHOQOL-Bref model, one item from each 4-item facet was 
selected. Such a short-form could be used in conjunction with the WHOQOL-Bref to 
see how this performs when applied to clinical populations. Although this might 
compromise comprehensibility, precision and detail, it would produce an instrument 
with wider applications, which would be favoured over the WHOQOL-lOO in clinical 
situations where time is limited or when patients are being asked to complete 
questionnaires whilst waiting in clinics for their appointment. This trade-off forms 
part of decision-making regarding the selection of instruments and is driven by 
pragmatic factors such as feasibility, length, ease of administration, scoring and so on. 
When a comprehensive assessment is necessary and feasible, the WHOQOL-lOO and 
the 16-item PDM would confer advantages over the abbreviated forms, which would 
be more appropriate when time is limited and respondent burden is high. Given the 
limitations of selecting the 4 items from the large number of items piloted in the 
cross-sectional survey reported in chapter seven, further testing in larger, more diverse 
populations of people with CP would increase confidence in identifying which items 
best explain the variance in overall QoL and which seem to best represent the 
underlying concept.
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10.5 The QoL of people with pain
In general, living with conditions characterised by pain selectively impacted QoL. 
QoL was worst for pain and discomfort, energy and fatigue, dependence on 
medication, mobility and ADL and best for the home environment, social support, 
transport and personal relationships. For the heterogeneous patient groups reported in 
chapters seven and nine, QoL relating to uncertainty was poorest and for the LBP 
patients reported in chapter eight, pain relief. Such a finding suggests that LBP 
patients seeking treatment may report greater dissatisfaction with relief and control of 
pain than the diverse group of patients because they were actively seeking treatment. 
Moreover, uncertainty may have been reduced given that the offer of treatment 
represented a potential source of long-term relief. Overall QoL and health was mostly 
explained by the physical domain, followed by the psychological, level of 
independence and then social relationships, highlighting the importance of physical 
aspects of QoL such as fatigue and sleep and psychological features such as positive 
and negative feelings and so on. The selective impairment of particular aspects of 
QoL provides further support for using the generic core instrument and the PDM to 
obtain a holistic assessment of the impact of pain management interventions on QoL. 
This is important given that people simultaneously reported positive and negative 
perceptions of their QoL across different life domains, which concurs with work in 
the field of positive psychology discussed in chapter three (e.g. Folkman, 1997) and 
with evidence that people are able to derive benefits from adversity (Tennen and 
Affleck, 1996) and from illness (Sodegren and Hyland, 2000; Sodergren et al., 2002).
A range of facets explained most of the variance in overall QoL and health from the 
physical, level of independence, environment and SRPB domains represented by 
participation in and opportunities for recreation and leisure, ADL, sleep and rest, 
energy and fatigue, SRPB and mobility. Of the PDM facets, uncertainty and pain 
relief contributed most to explaining overall QoL and health, confirming the 
importance of pain relief, control and life certainty to people with CP. Of the 
dimensions of pain, present pain intensity was most important in explaining overall 
QoL and health. For health status, mental health explained a larger proportion of 
variance than physical functioning, providing evidence of the importance of the 
psychological concomitants of pain. Thus despite the physical limitations and 
impairment of functioning, psychological consequences remain a key target of
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intervention to moderate the impact of pain. This reiterates the importance of 
multimodal interventions including a psychological component to bring about 
important improvements in QoL given the impairment of psychological functioning, 
compared to a unimodal physical intervention such as the LES reported in chapter 
eight.
In general, more intense and severe pain was shown to be associated with a poorer 
QoL assessed by the PDM. Pain relief was most highly associated with present pain 
intensity; anger and frustration and vulnerability/ fear/ worry with the sensory 
qualities of pain and uncertainty with the total pain-rating index. These findings 
concur with previous work showing that anger is associated with reports of higher 
pain intensity (Bums et al., 1998; Kems, Rosenburg and Jacob, 1994; Bruehl et al., 
2002) and that QoL in patients with CP is improved with increased life control or 
greater certainty (Burton et al., 1998). Designing anger management interventions to 
target reductions in its impact on QoL could affect reports of pain and vice versa. It is 
clear that different dimensions of pain appear to be associated with different aspects 
of QoL. Elucidating the relationship between dimensions of pain and QoL is an 
important goal given that we now have a better understanding of the measurement of 
QoL.
10.5.1 Importance of facets of QoL
The 24 facets of QoL comprising the core WHOQOL are based on empirical research 
confirming their importance to sick and well people (Saxena et al., 2001). The 
inclusion of importance items allows people to rate how important each of the facets 
is to their QoL. Given that no a priori assumptions are made about which items are 
more of less important to people, inclusion of such items allows for individual 
differences to be expressed. This overcomes the assumption that people with CP are a 
homogenous group and challenges what has been described as the patient uniformity 
myth where individual variation is discounted (Turk, 1990). In general, ADL, 
mobility, pain relief and control were shown to be most important to people with pain. 
For the patients in the cross-sectional study, receiving adequate health and social care 
was also very important, and for the patients with LBP reported in chapter eight, 
being pain free. Conversely, body image and appearance, sexual activity and SRPB
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were the least important and freedom from uncertainty. Such findings illustrate the 
relative importance of different facets of QoL.
Furthermore, as Skevington and O’Connell (2004) have demonstrated, exploring the 
discrepancy between a person’s assessment of QoL on a particular facet and the 
importance attributed to that facet allows for better identification of problem areas 
(Skevington, O'Connell and the WHOQOL Group, 2004). Biggest discrepancies were 
found for pain and discomfort, energy and fatigue, sleep, financial resources, negative 
feelings, physical safety and security and body image and appearance, where facet 
means were significantly negatively correlated with their corresponding importance 
item. Discrepancies were also found for the PDM facets and their corresponding 
importance item, suggesting that despite being very important, these aspects of QoL 
are poor. The importance of these aspects of QoL and the size of the discrepancy, 
suggests that priority should be given to targeting interventions at such areas. 
Conversely, the importance of working capacity, social support and SRPB were 
significantly positively correlated with their corresponding facet, suggesting that a 
good QoL in these areas is associated with high importance. Discrepancies between 
the way people rate a particular aspect of QoL and the importance they attribute to it 
also show that these items are measuring quite different aspects of QoL.
Such discrepancies are also important when considering the finding that the 
importance of being pain free, pain relief, pain control and freedom from fear and 
worry were significantly less important following LES. This suggests that the 
importance attributed to certain aspects of QoL changes over time. Such evidence 
provides support for designing interventions to target the relative importance 
attributed to areas of QoL where treatment has had limited success. Further 
investigation of the stability of importance ratings over time would be advantageous 
given that they might reflect important shifts in perception of life quality. These 
changes could provide additional evidence that people re-evaluate aspects of their 
lives or successfully adapt to new experience through acceptance and what has been 
described as response shift (Sprangers and Schwartz, 1999). Inclusion of the 
importance items, although adding to the size of the instrument and thus to patient 
burden, may provide an invaluable way of identifying and prioritising loci for
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intervention, by directing resources at aspects of life where a person reports a poor 
QoL, but attributes a high importance.
10.5.2 Acceptance and QoL
Chapter eight explored the relationship between acceptance of pain and QoL because 
the core WHOQOL pain and discomfort facet embodies the notion of acceptance in its 
definition in the sentence ‘It is acknowledged that people respond to pain differently, 
and differing tolerance and acceptance of pain is likely to affect its impact on QoL’ 
(WHOQOL Group, 1995). Furthermore, chapters three and four highlighted this as a 
possible process mediator of decision making about subjective QoL. Acceptance is 
conceptualised as a process that affects QoL outcomes and this study found that a 
good QoL assessed by the PDM was associated with acceptance of pain, particularly 
less reported anger and uncertainty. Acceptance of pain was also related to good 
mobility and overall QoL, the ability to work, engage in ADL, less pain and 
discomfort and better mental health. This concurs with the assumption underlying 
acceptance that a shift, change or adaptation has occurred for a person to move from 
the unrealistic goal of completely eliminating the pain to one of accepting it and 
focusing on other life goals (Geiser, 1992; McCracken, 1998, McCracken et al., 
1999). This is also consistent with the cognitive processes elaborated in the theory of 
response shift, in explaining the process of adaptation to disease.
Acceptance represents two components; engaging in activity in spite of pain and a 
willingness to experience pain (Geiser, 1992; McCracken, 1998, McCracken et al.,
1999). Engaging in activity in spite of pain was most strongly associated with good 
pain relief, certainty, mobility, the level of independence domain and physical 
functioning. In contrast, patients with a greater willingness to experience pain 
reported less anger, frustration, vulnerability, fear and worry and better QoL in the 
physical domain and better mental health. However, although acceptance was 
associated with better QoL, mental and physical functioning and lower pain scores, 
the direction of this relationship remains to be elucidated. Such outcomes may affect 
willingness to engage in life or conversely, patients who are less willing may report 
more a worse QoL. However, the strong association between acceptance of pain and 
QoL suggests that this might be an important process in making QoL decisions and 
consequently, interventions might be targeted at the facets that are most highly
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associated to facilitate acceptance of pain or vice versa. Further investigation of 
acceptance, along with other theoretical constructs such as response shift and 
comparative strategies may contribute to the explanation of adaptation to chronic 
conditions and how people define their QoL by explaining the processes that mediate 
the response to ill health and the perception of life quality in the face of adversity.
10.6 Strengths
The strengths of the work reported in this thesis include the qualitative exploration of 
the QoL of people with CP, the novel methodological approach of the web survey and 
the application of the WHOQOL methodology to CP with the addition of cognitive 
interviewing as a technique for improving the process of developing and refining 
items before psychometric methods are applied. Moreover, the development of 
patient derived facets is central to this work and contrast with the top down 
development of many patient questionnaires. The work reported here takes 
empirically derived facets, transforms them into a theoretical framework based on 
their semantic and conceptual attributes and tests the relationship between these 
theoretical constructs empirically using statistical techniques. The research adopted a 
holistic approach to QoL and its measurement and made no a priori assumptions 
about the relationship between pain and QoL. Despite the deletion of 6 of the 10 new 
facets identified in chapters three and four, they remain important features of the pain 
experience as evidenced by their spontaneous elicitation by people with CP. Further 
exploration of the factors mediating the response to pain to bring about such 
consequences for QoL is warranted, particularly on the processes that mediate QoL 
outcomes. This work has enabled a preliminary assessment to be made about the QoL 
of people with heterogeneous pain conditions by developing a pain and discomfort 
specific module to be used in conjunction with the WHOQOL-100 that combines the 
advantages of generic QoL assessment with the increased specificity the PDM for a 
holistic assessment that can be used to generate a profile of QoL.
10.7 A critique
Each empirical chapter addressed the potential caveats of the research reported, 
including a critique of the constructs assessed by the PDM. This discussion 
summarises the main methodological issues arising from this work. This research has 
been approached from the point of view of a health psychologist and is therefore
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embedded in the biopsychosocial model, which is the dominant paradigm in the field, 
and the methodology reflects this. The methodology adopted during this research was 
underpinned by a number of assumptions, namely that self-report is a way of tapping 
into the experience and thoughts of people and that certain cognitive processes take 
place and are accessible through this self-report, as illustrated by the use of cognitive 
interviewing.
With regard to the samples used, it must be acknowledged as a limitation that only 1% 
of people with CP reach speciality pain clinics (Smith et al., 1996) and that pain clinic 
samples are a highly selected group (Crombie and Davies, 1998) reporting higher 
levels of disability (Crook et al., 1986). However, at the defence of the sampling 
adopted, any QoL instrument must be appropriate for those attending such clinics and 
therefore this limitation can be said to have a limited impact on the results of the 
study. Furthermore, the inclusion of patients from primary care, a registered charity 
and the Internet minimised the potential for idiosyncratic results. Given the problems 
associated with generalising to others outside of the study sample, a more diverse 
patient group could have been recruited if more centres had been involved. 
Subsequent testing of the instrument would address such a limitation.
Despite extensive validation work on the WHOQOL-100 instrument (Skevington, 
1999; Skevington, Bradshaw and Saxena, 1999; Skevington, Carse and Williams,
2001), the research presented here found that items addressing sexual activity (10%) 
and availability and quality of health and social care (11%) were missed more 
frequently than items addressing other facets of QoL, although the extent of this is 
low. Such a finding could be due to modesty and the perception that some issues are 
private, which does not promote the disclosure of sensitive issues. Although it might 
be possible to minimise this by a more explicit assurance of confidentiality in future 
work, such patterns are likely to reflect cultural values, rather than a methodological 
problem per se.
A potential drawback of using generic instruments is the inevitable inclusion of items 
that may be of little importance or at least unlikely to change during targeted 
intervention such as satisfaction with climate or religion and personal beliefs. Indeed, 
although these aspects might be pertinent to individuals at different times, it could be
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argued that these aspects are not only outside of the control of, but are not within the 
remit of the public health services, consequently, the inclusion of such items reduces 
sensitivity and specificity of the instrument. Thus there is a balance between 
narrowing the concept of QoL (for example with the Rheumatoid Arthritis Quality of 
Life Questionnaire, Whalley et al., 1997) and including items that are relevant, 
acceptable and that relate to the purpose of interventions. Despite this, it is possible to 
predict a priori which facets are likely to change during an intervention and test these 
hypotheses. Moreover, the enduring strength of the WHOQOL instruments is their 
holistic, multidimensional nature and the inclusion of importance items, which 
assesses the relative importance of different aspects of life. Furthermore, the holistic 
view allows for the inclusion of positive areas of QoL such as positive feelings in an 
area that has dominated by the assessment of pain and disability. This concurs with 
research focusing on the positive experiences associated with ill health (Sodergren 
and Hyland, 2000; Sodergren et al., 2002) and that positive and negative affect can 
co-occur (Folkman, 1997), which is described in chapter three.
Losing patients to follow-up is an inevitable feature of longitudinal designs. 
Furthermore, given the limitations of unimodal medical interventions alone, greater 
changes in QoL scores might have been predicted if patients had undergone a 
psychosocial intervention such as a PMP. Such an intervention would have enabled 
further validation of the instrument and allowed more definitive conclusions to be 
drawn about QoL given that the explicit aims of such interventions are to improve 
functioning in different life domains. Further validation of the WHOQOL-100 and 
the PDM in patients involved in a PMP would be advantageous given that such 
interventions target much broader areas of patient functioning than simply reducing 
pain, which would be expected to bring about changes in more diverse aspects of 
QoL.
It should also be acknowledged that factor analytic techniques could have been used 
on the data reported in chapters seven and eight as a method to reduce the number of 
items or for looking at the underlying factor structure of the PDM. For example, a 
principle components analysis could show how many factors are yielded from the 
PDM items. Although this could demonstrate how the items fitted into the 4-item 
facet model of the WHOQOL, this 4-item facet model limits the extent to which
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factor analytic techniques could determine the number of items comprising the facets. 
Furthermore, it is still important to consider the face validity and importance of the 
items representing each facet. Future analyses and studies using the WHOQOL and 
PDM should consider such a method, along with Rasch methodology (e.g. Prieto, 
Alonso and Lamarca, 2003).
10.8 Implications
It has been shown that it is possible to adequately measure QoL in people with CP. 
Consequently, we need to develop interventions that target the important aspects of 
people’s lives that are impacted by their pain. Given that the WHOQOL items 
address the subjective perception and meanings associated with aspects of QoL, all 
aspects of QoL are potentially amenable to intervention or modifiable, although some 
may require change at macro levels, such as through health policy. This thesis has 
made progress in identifying aspects of life that are most important to people with 
pain, although individual differences and priorities should be considered in a clinical 
context. This supports the advantage of using an instrument that gives a profile (i.e. 
facet or domain scores) rather than a single index of QoL, which does not indicate 
which aspects of QoL are best and which are worst. Additionally, including an 
assessment of the importance of various aspects of life offers further advantages as 
described above.
Further implications of this work include the use of the WHOQOL and PDM in 
clinical trials as an outcome of clinical effectiveness and in epidemiological research 
investigating trends in different diagnostic and social or cultural groups. In clinical 
practice, interventions could also be tailored to selectively enhance QoL. Such an 
instrument could also be used in the audit of health and social care through clinical 
governance to monitor the response of patients to treatments to justify the continued 
delivery of such services and to ensure that patients are deriving benefits. 
Furthermore, it provides confidence to the health professionals involved in the 
delivering of health care that the procedures are worthwhile and have measurable 
benefits. Well-validated instruments also have potential to inform and influence 
policy decisions regarding the delivery of health care, although this may be a 
politically sensitive area given that a challenge to the status quo might be necessary 
(Skevington, 1995), however, this should not be a barrier to change.
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10.9 Future research
Given that the work of the WHOQOL Group is firmly rooted in cross-cultural 
research, further work should focus on the cultural context of QoL judgements 
relating to CP, for example, by testing the PDM in diverse cultural groups both within 
and outside of the United Kingdom. It is clear from decades of research that cultural 
differences exist in the expression of pain (for example, Sanders et al., 1992) and 
since this study has relied upon the verbal behaviour of people with pain through self- 
report and therefore rest on the communicative aspects of pain, cultural differences in 
the expression of QoL would be anticipated and should be subject to further study.
Research shows the need to investigate how the presence of a family member with CP 
affects QoL and whether family perceptions of patients QoL could influence treatment 
outcomes (e.g. Williamson, Robinson and Melamed, 1997; Fillingim et al., 2003). 
For proxy assessment, research has shown that the perception of patient QoL by 
family is more consistent with patient report than the perception of friends or health 
care professionals (Andresen, Vahle and Lollar, 2001). Consequently, revealing the 
extent and nature of the observed discrepancies might be an important goal, for 
example by looking at the level of concordance between ratings of QoL in different 
life domains, in addition to exploring the factors or processes that influence the ways 
people make sense of the experience of others, particularly in respect of the more or 
less observable features of that experience. Although proxy assessment might be 
more important in situations when patients are unable to answer questions for 
themselves, exploring proxy-patient similarities and differences could illuminate the 
complexity of the social and communicative aspects of pain.
Much research has focused on gender differences in response to pain, and this clearly 
has implications for management, treatment and potentially QoL. Indeed, many of the 
prevalence studies described in chapter one report differences in the prevalence of 
pain amongst men and women of different age groups and numerous theories have 
been proposed to explain differences in reporting pain (Holdcroft and Power, 2003). 
Conducting large-scale survey work to examine important similarities and differences 
in reports of QoL by men and women could be conducted with the WHOQOL, PDM 
and other concurrent measures. It was also beyond the scope and resources of this
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research to focus on the QoL of children, adolescents and older adults given the 
different issues pertinent to QoL. Other WHOQOL projects have looked at QoL in 
children (For example, Jirojanakul, Skevington and Hudson, 2003). However, future 
research might focus on the impact of pain on the QoL of adolescents and older adults 
using modified and tested instruments derived from the WHOQOL.
Further testing with diverse pain populations will be necessary to complement the 
preliminary psychometric properties reported here to examine whether the instrument 
is able to discriminate between different groups such as people with RA and BP. The 
more frequently the measure is applied to relevant populations, the greater the 
confidence in how it performs (Juniper, Guyatt and Jaeschke, 1996). Consequently, 
the goal is to apply the measure as frequently as possible. Additionally, 
interpretability must also be established to ensure that the scores relate to the 
perceived meanings held by patients about the magnitude of change (Juniper, Guyatt 
and Jaeschke, 1996). Establishment of population norms would be an additional aid 
to interpreting high or low scores, which have been derived for health status measures 
such as the SF-36, providing a way of comparing the health status of particular groups 
with that of the general population (Wright and Harwood, 1992). Establishing 
population norms for the WHOQOL for different cultural groups would be an 
admirable goal enabling researchers and clinicians to compare QoL across conditions. 
In the meantime, calculation of effect sizes, as described in chapter eight, goes some 
way to addressing this issue by showing which facets have changed most following an 
intervention.
10.10 Concluding remarks
In addition to the core facets of QoL assessed by the WHOQOL-100, people from 
diverse diagnostic groups and backgrounds share a common set of factors influencing 
QoL pertaining to pain. These areas relate to different life domains and consequently 
reflect the multidimensional impact of CP, demonstrating that taking a holistic 
approach to QoL allows for the identification of positive as well as negative aspects of 
life for people with CP. Given the importance of a range of facets, although CP 
compromises life quality, it is not synonymous with a poor QoL, but as a salient 
symptom, it impacts on life through its complex, multidimensional consequences by 
comparative processes and acceptance of pain and so on.
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The new PDM will assess the QoL of adults over the age of 16 with CP, as defined by 
the IASP as pain or discomfort that persists continuously or intermittently for longer 
than three months. The PDM should be used in conjunction with the UK WHOQOL- 
100 to provide a comprehensive assessment of the QoL of people with CP. It will 
address subjective assessment of physical, psychological and level of independence 
domains of QoL, be self-administered and address 4 pain and discomfort facets 
represented by 16 items. Following further field-testing, it is likely that the 
instrument will be a discriminative and evaluative instrument for use in clinical trials, 
to examine the effectiveness of pain management interventions and as a clinical tool 
to assess the QoL of patients with CP.
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Coded focus group transcrip t (C hapter three)
The following sample of transcript is taken from focus group (FG) one. The text 
representing a theme is shown in bold, and the theme is highlighted in |rey.
1. Themes were listed from each FG under the facet and domain structure of the 
WHOQOL and new themes were listed under the most appropriate domain.
2. A large table was drawn showing the themes identified from each group.
3. Facets common to all FG’s were identified from this table and re-tabulated.
4. Themes not already addressed by the core WHOQOL were identified.
5. These themes were refined by subsuming related themes into superordinate 
categories and ensuring that they were placed under the most appropriate 
domain heading.
The second rater undertook the same process in a sample of 17% of the FG 
transcripts.
B: Cause even if they understood the pain, they can't understand the restrictions. You go to
do something and you learn not to reach don't you? I suppose it's a bit like Pavlov's dogs.
A: It's like having a bad back for a week, you know, ‘I've got a bad back I can see how you feel’.
C: Yeah
A: I mean my partner said that to me a couple o f months back, he said to me, ‘I dread to think what 
it feels like living like this all day’. A couple o f weeks later he's all better again. ‘Yeah but, you're 
all better now’.
C: Yeah
A: I said, 'I haven't got that nice little sort o f luxury, I've got to do this until whenever, you know, 
for the next twenty, fifty, sixty years I don't know. I said 'you're alright, you rubbed a bit of 
thing in, took a few painkillers, rested up for a few days and you feel wonderful again. You might 
have a little glimpse of how I felt. But that's it, you just have the tiniest little rung at the bottom of 
the ladder, of how I felt', no, you know, I can get out of bed one morning and I'll be fine, but the 
next morning I put my feet on the ground and I fall flat on my face, and I think, 'oh here we 
go, this is a good start to the day'. But I don't know how I'm going to be in the morning. I 
don't know how I'm going to be at the end of the day. Some days I'm in what I call minimal 
pain, and other days, I'm literally, I put my feet on the ground and I've got pain shooting 
down my legs. UNCERTAINTY
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C: I do make an effort though, more so as the time has gone on. When I do get a really good day, 
I'll say to my husband 'today has been a really good pain, it's been the lowest level pain I've 
had for days' and he'll go 'oh, I knew that, but I didn't like to [say]'. He knows.
A: They do though.
C: But my family knows, but on another bad day when I am snapping and horrible and evil 
sometimes. lERSONAL RELATIONSHIPS, LASHING OUT, AN
A: You do, you do feel that, you do get to the point where...
C: You are evil sometimes
A: Anything anyone says anything, it doesn't matter to you 
C: And I'm thinking 'why are you being like this? It's not his fault'
A: That’s it; they can be so nice to you
B: You sometimes think if I didn't have this, I'd be a completely different person, and I 
would have lived a different life, and you almost sort of grieve. Cause mine started when I 
was 22, I was just starting in life, just sort of blossoming, and I feel that I have grieved for 
that person that should have been really. Seeing someone doing something sometimes when it 
was all the aerobics and everything. Cause I was in P.E and English at college, and I think 'well I 
could have done that, I could have walked in this room all gracefully' and, but you can't, you've 




D: Yeah I do, and I seem to put myself in that position all the time. I still go, I still go to the Gym
LAUGHS
B: Do you?
D: I don't do much; I just do what I can 
C: I swim
D: But the trouble is, there's all these people around me that are going (GESTURES 
WEIGHT LIFTING) and doing this, and doing that, and I still keep putting my self there,
but I don't like being there because I don't like feeling as you're describing
B: Coming face to face with it
D: I just still keep doing it for some reason (LAUGHS)
C: I swim because it helps my condition, but I'm still, even though I am still able bodied in 
comparison with a lot of people, and can actually get in that water and swim, but I'm still 
looking at those who have got there goggles on and are bombing up and down, whereas I'm 
like, well when I was, well I've made quite good friends since I've been down there, you 
know, with other people who've got problems and it was a joke - the speed that I swam. I've 
got a little bit better now, but I've learnt to enjoy what I've got, and my friends there. But I still
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find myself thinking 'if only I could go in that fast lane and really get to grips and do some real 
exercise, you know' |iPW A RD  SOCIAL COMPARISON, HUMOUR
A: Come in and do the same in half an hour that I'm doing in an hour and a half 
C: Absolutely
CO-MODERATOR: You talked then about friends and you've all talked about your relationships 
with your families and partners. How does your chronic pain affect your other relationships 
would you say?
D: It certainly affects me working. Because first o f all I found, I had, I don't know how to 
describe this but I think I felt sort of embarrassed about having pains and things, and walking into 
a room and trying to do work and stand there like there was nothing wrong with me. I pretended 
for a long time that there was nothing wrong with me, um, and I think that was sort of an 
embarrassment, and the reason I say that is now I've got this walking stick, and wouldn't come 
out o f the house with it for a long time LAUGHS, and I've only just learnt now to walk into a 
r c n ^ n ^ a y g j j lg ^ w i th ^  but it's hard.
B: Do you find the stick helps though; I used to feel, before my legs were sorted out. I used to 
feel very vulnerable like you about falling over, and I was frightened of being bumped into, 
because if someone knocked me and I was on the floor, I wouldn't be able to get up, I still 
wouldn't be able to get up now. With a stick there, people do just give you a bit more of a wide 
berth or open a door or something, you know, and it helps
D: Well, I am sorry to say, but I do find a lot of people, particularly in shops, don't take any notice 
what so ever, and I've been bumped and almost pushed over ...
A: They look at you and your age or whatever, don't they? And they look at you physically 
and think, you know 'what's ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ m m ^ ^ ^ ^ ^ h e  face doesn't fit
CO-MODERATOR: We've just talked a lot about how relationships with other people, how it 
makes you feel and what you think they're thinking, a lot about how it effects you 
psychologically, but do you think that has any affect on how you behave and your actual, the 
physical relationships or you're behaviour with other people socially?
D: Yeah, it does, it does quite often. Sometimes, because everything's going fine in a room and 
everyone's ok, I can feel more as though I'm not ok, and consequently, I can for no apparent 
reason get a b it...
B: Narky? i B T T i M
D: Yeah, and I know it happens, and I don't mean to do it, but I sometimes I can 't help it and I 
suppose a lot o f the time I tend to shut up now, I'm even finding it a little bit difficult to, um...
B: Does it make you feel a little bit on the edge of things? Cause you feel slightly different 
because you might all be sat down having a meeting and that's what everyone's doing, 
they're all having a meeting and so are you, but you've got this extra thing, you've got this 
pain that you are dealing with all the time as well, just to be, to keep normal and be the 
same as everyone else. PEELING APART FROM OTHERS, SOCIAL RELATIONSHIPS
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D: Yeah, I tried to describe this to my family actually over Christmas, they actually asked me 
about it, which is, I think we’ve got to the point now where we don’t talk about it really, and, 
um, my wife asked me to try and explain how I felt. And the only way I could explain it is, I 
don’t know whether it makes sense to you but, I remember when I was young I was carrying a 
rucksack, you know, when I first put it this rucksack on, I thought ‘oh this is heavy’, but I got on 
with it and I was going where I was going. And I thought, the more I keep walking the heavier it 
gets, and the heavier it gets, the more I start to think about weight that’s on my back, and so it 
gets more and more like that and after a while, because I’m thinking about that I might not hear 
what somebody says to me, because it takes over me some times. That’s the only way I could 
describe it. 1 think she understood what I meant. I said it’s not that I’m not listening 
(interrupted). PERSONAL RELATIONSHIPS, COMMUNICATION, BEING UNDERSTOOD 
A: You do get lost in yourself.
C: You can drown in that feeling
A: It’s like somebody said you can be alone in a room full of people as being in a room by 
yourself. FEELING ALONE, ISOLATED
C: Yeah
A: You can feel just as lonely in a group of people. LONELINESS
C: Your personality definitely does change, doesn’t it?
A: You feel like such a different person, because you do get treated so differently. People do, 
you know, not necessarily always so much in your family, but other people that only know a little 
bit about you, and that, treat you so, like your some kind o f weird person, or you know or there is 
something definitely seriously wrong with you. They can’t cope with it, so they sort o f push you 
away and it starts making you feel outside IBSS, FEELU 
RELATIONSHIPS, BEING TREATED 
B: I was going to say, I don’t know whether it’s always how people treat you, it’s how you see 
yourself
A: Yeah, that’s it, you think that a comment they make, you take it personally, rather than, 
maybe just a comment that, normally you wouldn’t make anything of, but on certain days 
you can make it into such a big thing. fj>ELF ESTEEM
B: I think with the way D is feeling, it’s more like in your head, and it’s getting too big. I 
generally am able to just carry on and try and think about all the good things, and oh god I
sound a bit like... I don’t know, um. H K B I H I 9 B R & K  
D: It’s glass half empty, isn’t it?
B: But when it gets, when the pain is worse, and you’re not coping with it, it does grow in 
your head, and I think you start... you know, I have in the past had quite black thoughts 
about the future and where it’s going to go and how I’m going to end up and how long you 
can sort of keep up this smiley face or whatever. COPING, NEGATIVE FEELINGS, 
UNCERTAINTY, PUTTING ON A BRAVE FACE
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The web survey http://www.bath.ac.uk/~pspvm/painqol.html (Chapter four)
Chronic Pain and Quality of Life Survey 
DO YOU HAVE CHRONIC PAIN?
HAVE YOU BEEN IN PHYSICAL PAIN OR DISCOMFORT CONTINUOUSLY OR 
INTERMITTENTLY FOR 3 OR MORE MONTHS?
We are working on a long-term project on quality of life and health. We would like you to 
tell us how your pain affects your quality of life. We are interested in the ways in which 
YOU think and talk about YOUR quality of life. If you would like to tell us more about how 
quality of life is affected by pain, please fill in the brief questionnaire below. This should 
only take you 10 minutes and your answers will be kept STRICTLY CONFIDENTIAL.
1. What is your date of birth? (please type in the box day/month/year)
2. What is your gender? (Please use your ’mouse' to click one box) Male/ Female
3. What is the highest level of education that you have achieved? (Please use your 
'mouse' to click one box) Primary school/ Secondary school/ Further education/ Sixth 
form college/ Higher education/ University/ Post-graduate
4. What is your current marital status? (Please use your 'mouse' to click one box) 
Single/ Married/ Living as married/ Separated/ Divorced/ Widowed/
5. Do you work? (Please use your 'mouse' to click one) Yes/ No
If yes, what type of work do you do? (Please use your 'mouse' to click the 
appropriate box/ boxes) Voluntary work/ Full-time study/ Part-time study/ Taking 
care of home/ Taking care of children/ Full-time work (paid)/ Full-time work 
(unpaid)/ Part-time work (paid)/ Part-time work (unpaid)/
6. If you do work, briefly describe what you do?
7. Are you in pain? (please use your 'mouse' to click one) Yes/ No
8. What is the nature of your medical condition/ diagnosis if known? (Please
describe)
9. Has a Doctor confirmed your diagnosis?(please use your 'mouse' to click one) 
Yes/No
10. Which parts of your body hurt? (Please describe)
11. How long have you had pain? (please say in months and years)
12. How intense is your present pain level? (Please use your 'mouse' to click one box)
No pain/ Mild/ Discomforting/ Distressing/ Horrible/ Excruciating
13. Is your pain....? (Please use your 'mouse' to click one box) Brief/ Intermittent/ 
Continuous
14. Have you had surgery for your pain? (please use your 'mouse' to click one) Yes/ 
No
If yes, how long ago? (Please describe)
15. Do you take any prescribed medicine for your pain? (please use your 'mouse' to 
click one) Yes/ No
If yes, please tell us which prescribed medications you take for your pain
16. Do you take any other medication for your pain (for example, over the counter 
medicine)? (please use your 'mouse' to click one)Yes/ No
If yes, please tell us which other medications you take for your pain
17. Do you take or use any alternative treatment or herbal medicine for your pain? 
(please use your 'mouse' to click one) Yes/ No
If yes, please list the alternative treatment or herbal medicine that you use for 
your pain
18. In what ways do you think that your pain affects your quality of life?
19. Please could you tell us which country you are from and add any other 
comments related to this issue?
Thank you for your valuable time.
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Cognitive interviewing items and response scales (chapter six)
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This table shows the items, response scale and code for each of the new pain and discomfort 
facets. The column on the right contains an ‘R’ if the item has been retained or an ‘X’ if the 
item has been deleted. If the wording of the item has changed to improve its clarity the words 
are highlighted in the item and the new words are given in the third column. If a more 
appropriate response scale has been attached, this is also indicated in the right hand column.
Response scale ty pe Item
code
Item changed, 




1 .To what extent do flare-ups affect your quality of life? F60.1 R
2.To what extent do you worry about experiencing a flare 
up?
F60.2 R
3.How much are you bothered by flare-ups? F60.3 R
4.To what extent does your pain vary over time? F60.4 X
5.How much do changes in pain bother you? F60.5 X
How important
1 .How important is it to you to be free from flares in your 
pain?
Imp60.1 R





6.To what extent do the treatments available to you offer 
you relief from pain?
F61.1 R
7.How much control do you have over your pain? F61.4i R
8.To what extent has having treatment improved your 
quality of life?
F61.6i R
9.How easy is it for you to get into a comfortable position? F61.7 Changed to 
‘completely’ 
response scale
lO.How much are you bothered by taking medication? F61.8 R




57.How well do you cope with your level of pain? F61.3i R
How satisfied
63.How satisfied are you with your ability to obtain relief 
from pain?
F61.2 R
64.How satisfied are you with the control of your pain? F61.5i R
How important
3.How important is it for you to be able to obtain relief 
from pain?
Imp61.1 R
4.How important is it to be able to control your pain? Imp61.2 R
5.How important is it for you to be able to find a 
comfortable position?
Imp61.4 X





12.How much are you bothered by feelings of anger? F62.1 R
13.How much do feelings of anger interfere with your 
every day life?
F62.2 R
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Response scale type Item
code
Item changed, 
retained (R) or 
deleted (X)
14.To what extent do feelings of anger affect your 
relationships with other people?
F62.4 R
15.How much do feelings of frustration bother you? F62.6 R




74.How often does your pain make you feel angry? F62.3 R
75.How often does your pain make you feel irritable? F62.5 R
How important
7.How important is it for you to be free from anger? Imp62.1 R
8.How important is it for you to be free from frustration? Imp62.2 R
Vulnerability, fear, worry
How much





18.How much do feelings of fear bother you? F63.2 Changed to ‘does 
fear bother you?’
19.How much do feelings of vulnerability interfere with 
your everyday life?
F63.3 Changed to ‘does 
feeling vulnerable’
20.To what extent do you feel threatened by the possibility 
of pain?
F63.4i Changed to ‘how 
much do you feel 
that pain is a 
threat?’
21 .How afraid are you of experiencing pain? F63.5i Changed to 
‘concerned are you 
about’
22. Are you distressed by the fear of pain? F63.6i Changed to ‘how 
much are you 
distressed by 
pain?’
23.How much are you bothered by feelings of worry? F63.7 R
24.How much do you worry about having treatment? F63.8 R
How important
9.How important is it for you to be free from feelings of 
vulnerability?
Imp63.1 X
10.How important is it for you to be free from fear? Imp63.2 R
11 .How important is it for you to be free from worry? Imp63.3 R
Uncertainty
How much
25.How much does uncertainty about the future interfere 
with your everyday life?
F64.2 R
26.To what extent do difficulties with planning affect your 
everyday life?
F64.4 R
27.Does pain prevent you from doing what you want to do? F64.6i R
28.Does pain or discomfort limit your life? F64.7 R
How completely








76.How often do feelings of uncertainty bother you? F64.1 R . . . .
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Response scale type Item
code
Item changed, 
retained (R) or 
deleted (X)
How important
12.How important is it for you to be free from uncertainty? Imp64.1 R
13.How important is it to you to be able to make plans for 
the future?
Imp64.2 X
Loss/ loneliness/ feeling alone
How much
29.How much are you bothered by feelings of loss? F65.1 R
30.How much do feelings of loss interfere with your 
everyday life?
F65.2 R
31 .To what extent are you bothered by not being able to 
carry out the activities that you used to do?
F65.3 R
32.How much are you able to carry out the activities that 
you once could?
F65.4 X
33.To what extent do feelings of loneliness bother you? F65.6 R
34.How much does being alone bother you? F65.7 R
How completely
59.How lonely do you feel? F65.5 R
How important
14.How important is it for you to be free from feelings of 
loss?
Imp65.1 R
15.How important is it for you to be able to continue 
carrying out the activities that you once could?
Imp65.2 X
16.How important to you is it to feel that you are not alone? Imp65.3 R
Positive strategies
How much
35.How much does humour help you to deal with your 
problems?
F66.2 Changed to ‘the 
use of humour 
improve your 
quality of life?’
36.How much do you hope for relief from pain? F66.3 R
37.How much does hope for relief from pain improve your 
quality of life?
F66.4 X
38.How much do you experience feelings of hope? F66.5 R
39.How hopeful and optimistic do you feel about the 
future?
F66.6i R








17.How important to you are feelings of hope? Imp66.1 R
18.How important to you is having a sense of humour? Imp66.2 R
Communication
How much
41.How much are you bothered by the fact that other 
people cannot see the extent of your pain and suffering?
F67.1 R
42 .To what extent does your pain affect your relationships 
with other people?
F67.2 R
43.How much do you feel that other people recognise 
your condition and the consequences it has for you?
F67.5 Changed to ‘does 
it bother you that 
your pain is 
invisible to others’
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Response scale type Item
code
Item changed, 
retained (R) or 
deleted (X)
44.To what extent are you bothered by any difficulties in 
communicating your feelings to others?
F67.8 R
45.How much are you concerned about how other people 
see your condition?
F67.10 R
46.How much do you feel that your health interferes with 
your personal relationships?
F67.11 i R
47.How much are you concerned about society's attitude 
toward how you use health and social care?
F67.12 X
How completely
60.To what extent do you feel that other people appreciate 
the nature of your condition?
F67.3 R




66.How satisfied are you that other people recognise your 
condition? X
F67.6 X
67.How satisfied are you with your ability to communicate 
your needs to other people?
F67.7 R




19.How important is it to you that people cannot see your 
pain?
Imp67.1 X
20.How important is it to you to feel that other people 
understand your pain?
Imp67.2 X
21 .How important is how other people see your condition? Imp67.3 X
22.How important is it to be able to communicate your 
feelings to others?
Imp67.4 R
23.How important are the attitudes of others to your use of 
health and social services?
Imp67.5 X
Guilt and burdening others
How much
48.To what extent are you concerned about burdening 
others?
F68.1 R
49.How much do you worry about the effect your pain has 
on others?
F68.2 R
50.How much are you bothered by feelings of guilt? F68.3 R
51 .How concerned are you that you do not have enough 
resources to provide for others?
F68.5i R
How satisfied




24.How important is it to be free from feelings of guilt? Imp68.1 R
25.How important is it to feel that you are not a burden to 
others?
Imp68.2 R
Relationship with health care providers
How much
52.To what extent do you feel supported by the health 
service?
F69.3 R
53.To what extent do you feel that you are dependent on 
health and social services?
F69.4 R
Appendix 3       339
Response scale type Item
code
Item changed, 
retained (R) or 
deleted (X)
54.How much do you benefit from the use of 
complimentary therapies?





55.To what extent does the use of complimentary therapy 
contribute to your quality of life?
F69.7 X
56.How much access do you have to the information you 
require about your health?
F69.9 R
How completely
62.To what extent do you have access to information about 
the range of available treatments?
F69.8 R
How satisfied
70.To what extent are you satisfied with your relationship 
with your doctor/s?
F69.1 Changed to ‘health 
professionals’
71 .To what extent are you satisfied with your relationship 
with those health professionals that you have regular 
contact with?
F69.2 X
72.How satisfied are you with the support you receive from 
the medical service?
F69.5 Changed to 
‘health’
73.How satisfied are you with the information that is made 
available to you about your health?
F69.10 R
How important
26.How important is it to you to have a good relationship 
with your doctor/s?
Imp69.1 X
27.How important is it to you to have a good relationship 
with your health care professionals?
Imp69.2 R
28.How important is it to you to feel supported by the 
health service?
Imp69.3 X
29.How important is it for you to be free from dependency 
on the health service?
Imp69.4 X
30.How important to you is the availability of non­
prescribed and complimentary therapy?
Imp69.5 X
31 .How important is it to have adequate information 




Item-total reliability analysis for 68-item PDM for cross-sectional survey (over all
scale alpha .96) (Chapter seven)












F601 195.91 1487.30 .50 .96
F602 195.413 1473.34 .59 .96
F603 195.73 1480.02 .54 .96
F611 195.46 1498.84 .33 .96*
F614I 195.59 1497.07 .41 .96
F616I 195.42 1493.62 .37 .96
F618 194.93 1495.51 .28 .97*
F619 195.48 1492.15 .36 .96
F621 194.82 1460.09 .72 .96**
F622 194.34 1468.03 .70 .96**
F624 194.37 1468.29 .66 .96**
F626 195.53 1466.81 .69 96**
F627 195.10 1465.75 .70 .96**
F631 194.72 1469.32 .64 .96**
F632 194.58 1477.72 .56 .96
F633 194.34 1475.24 .66 96**
F634I 195.21 1472.45 .58 .96
F635I 195.52 1483.43 .56 .96
F636I 195.67 1478.78 .62 .96
F637 195.21 1468.72 .66 .96**
F638 194.80 1471.30 .61 .96**
F642 195.17 1463.90 .70 .96**
F644 195.10 1461.67 .71 .96**
F646I 195.89 1467.72 .64 .96**
F647 195.87 1470.47 .65 96**
F651 195.36 1464.43 .64 .96**
F652 194.89 1458.84 .71 .96**
F653 195.88 1467.76 .67 .96**
F656 194.63 1470.92 .57 .96
F657 194.57 1475.29 .52 .96
F662 194.36 1505.77 .26 .96*
F663 193.96 1542.26 -.27 .97*
F665 195.02 1505.52 .23 .97*
F666I 195.15 1489.05 .44 .96
F667 195.03 1488.66 .47 .96
F671 195.27 1471.48 .58 .96
F672 195.04 1470.27 .69 .96**
F675 195.09 1472.46 .53 .96
F678 194.85 1469.35 .62 .96**
F6710 194.79 1470.50 .59 .96
F6711I 195.06 1456.51 .73 .96**
F681 195.79 1479.84 .55 .96
F682 195.48 1483.75 .50 .96
F683 194.95 1458.96 .65 .96**
F685I 195.13 1465.69 .58 .96
F693 195.17 1503.24 .26 .96*
F694 194.91 1497.00 .27 .97*
F696 195.96 1517.46 .05 .97*
F699 195.17 1490.83 .42 .96
F613I 195.01 1490.13 .51 .96
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F617 195.59 1482.37 .53 .96
F643 195.38 1474.37 .60 .96
F655 194.46 1465.82 .63 96**
F673 195.29 1498.28 .35 .96
F674 195.33 1504.28 .27 .96*
F698 195.35 1495.73 .36 .96
F612 195.38 1479.03 .56 .96
F615I 195.48 1480.11 .57 .96
F645 195.36 1468.56 .69 96**
F677 194.78 1481.77 .55 .96
F679I 194.79 1477.27 .56 .96
F684I 195.07 1478.25 .51 .96
F691 194.59 1489.91 .42 .96
F695 194.87 1486.90 .42 .96
F6910 194.95 1479.03 .54 .96
F623 195.07 1464.20 .67 96**
F625 195.53 1480.78 .59 .96




Transition questions for no treatment group (Chapter eight)
/ / When answeringYou last completed this questionnaire o n ___
these questions, please consider how you are NOW compared to when you last 
completed this questionnaire?




A little worse The same A little better
2 3 4
Better
2. Since you last completed this questionnaire, has your health been... {please circle only one 
number).
BetterWorse A little worse The same A little better
1 2 3 4
3. Since you last completed this questionnaire, has your pain been... (please circle 
number).
Worse A little worse The same A little better
1 2 3 4
Better
4a. Since you last completed this questionnaire, have you begun any new treatment or 
medicine? (please tick one box)
Yes No
4b. If YES, please give details of any treatments or medicines you have been taking (please 
include everything, including any herbal remedies, acupuncture etc.)
5a. Since you last completed this questionnaire, have there been any important life events or 
experiences that have affected your quality of life? (please tick one box)
Yes No
5b. If YES, please give details____________________
5c. Please tell us when these occurred (approximate dates)
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Transition questions for lumbar epidural steroid group (Chapter eight)
You last completed this questionnaire o n ______ /______ /____ . When answering
these questions, please consider how you are NOW compared to when you had your 
injection about one month ago.
1. Since your injection, has your quality of life been... {please circle only one number).
Worse A little worse The same A little better Better
1 2 3 4 5
2. Since your injection, has your health been... {please circle only one number).
Worse A little worse The same A little better Better
1 2 3 4 5
3. Since your injection, has your pain been... {please circle only one number).
Worse A little worse The same A little better Better
1 2 3 4 5
4. Overall, how do you feel about the treatment you have received? {please circle only one 
number).




5a. Since you had your injection about one month ago, have you begun any new treatment or 
medicine? (please tick one box)
Yes I No
5b. If YES, please give details of any treatments or medicines you have been taking (please 
include everything, including any herbal remedies, acupuncture etc.)
6a. Since your injection, have there been any important life events or experiences that have 
affected your quality of life? (please tick one box)
Yes No
6b. If yes, please give details
6c. Please tell us when these occurred (approximate dates)
Syntax files and scoring for the WHOQOL- 
100, PDM, SF-12 and CPAQ (Chapter eight)
SUBTITLE 'BASELINE WHOQOL AND PDM SCORING'
RECODE f11t1 f12t1 f13t1 f14t1 f21t1 f22t1 f23t1 f24t1 f31t1
f32t1 f33t1 f34t1 f41t1f42t1 f43t1 f44t1
f51t1 f52t1 f53t1 f54t1 f61t1 f62t1 f63t1 f64t1 f71t1 f72t1 f73t1
f74t1 f81t1 f82t1 f83t1 f84t1 f91t1 f92t1 f93t1 f94t1 f101t1 f102t1
f103t1
f 104t1 f111t1 f112t1 f113t1 f 114t1 f121t1 f122t1 f123t1 f124t1 
f13111 f132t1 f133t1 f134t1 f141t1 f142t1 f143t1 f144t1 f151t1 
f152t1
f153t1 f154t1 f16111 f162t1 f163t1 f164t1 f171t1 f172t1 f173t1
f174t1 f18111 f182t1 f183t1 f184t1 f191t1 f192t1 f193t1 f194t1
f201t1
f202t1 f203t1 f204t1 f211t1 f212t1 f213t1 f214t1 f221t1 f222t1
f223t1 f224t1 f231t1 f232t1 f233t1 f234t1 f241t1 f242t1 f243t1
f244t1 g1t1
g2t1 g3t1 g4t1 f616it1 f622t1 f627t1 f633t1 f632t1 f638t1 f635it1
f642t1 f644t1 f647t1 f613it1
f617t1 f615it1 f645t1 f623t1 f625t1
(1=1) (2=2) (3=3) (4=4) (5=5) (ELSE=SYSMIS).
RECODE f11t1 f12t1 f13t1 f14t1 f22t1 f24t1 f32t1 f34t1 f72t1 
f73t1 f81t1 f82t1 f83t1 f84t1 f93t1 f94t1 f102t1 f104t1 f111t1 
f112t1 f 113t1
f114t1 f13111 f154t1 f163t1 f182t1 f184t1 f222t1 f232t1 f234t1 




SUBTITLE 'COMPUTE BASELINE FACET AND DOMAIN 
SCORES'
COMPUTE pain=(MEAN.3(f11t1 ,f12t1 ,f13t1 ,f14t1 ))*4. 
COMPUTE energy=(ME AN ,3(f2111 ,f22t1 ,f23t1 ,f24t1 ))*4. 
COMPUTE sleep=(MEAN.3(f31t1 ,f32t1 ,f33t1 ,f34t1 ))*4. 
COMPUTE pfeel=(MEAN.3(f41t1 ,f42t1 ,f43t1 ,f44t1)) ‘ 4. 
COMPUTE think=(MEAN.3(f51t1 ,f52t1 ,f53t1 ,f54t1 ))*4. 
COMPUTE esteem=(MEAN.3(f61t1 ,f62t1 ,f63t1 ,f64t1 ))*4.
COMPUTE body=(ME AN ,3(f7111 ,f72t1, f73t1, f74t1))*4. 
COMPUTE neg=(MEAN.3(f81t1, f82t1,f83t1, f84t1))*4. 
COMPUTE mobil=(MEAN.3(f91t1 ,f92t1 ,f93t1 ,f94t1 ))*4. 
COMPUTE activ=(MEAN.3(f 10111 ,f102t1 ,f103t1 ,f104t1 ))*4. 
COMPUTE medic=(MEAN.3(f11111 ,f112t1, f113t1, f114t1 ))*4. 
COMPUTE work=(MEAN.3(f121t1, f122t1. f123t1, f124t1))*4. 
COMPUTE relat=(MEAN.3(f131t1, f132t1, f133t1, f134t1))*4. 
COMPUTE supp=(MEAN.3(f141t1, f142t1, f143t1, f144t1))*4. 
COMPUTE sexx=(MEAN.3(f15111 ,f 152t1 ,f 153t1 ,f 154t1 ))*4. 
COMPUTE safety=(MEAN.3(f16111, f162t1, f163t1, f164t1))*4. 
COMPUTE home=(MEAN.3(f171t1 ,f172t1, f173t1, f174t1))*4. 
COMPUTE finan=(MEAN.3(f181t1, f182t1,f183t1,f184t1))*4. 
COMPUTE servic=(MEAN.3(f19111, f192t1, f193t1,f194t1))*4. 
COMPUTE inform=(MEAN.3(f201t1 ,f202t1 ,f203t1 ,f204t1 ))*4. 
COMPUTE leisur=(MEAN.3(f211t1, f212t1, f213t1, f214t1))*4. 
COMPUTE enviro=(MEAN.3(f221t1, f222t1 ,f223t1 ,f224t1 ))*4. 
COMPUTE transp=(MEAN.3(f231t1,f232t1, f233t1, f234t1))*4. 
COMPUTE spirit=(MEAN.3(f241t1,f242t1, f243t1, f244t1))*4. 
COMPUTE overll=(MEAN.3(g1t1 ,g2t1 ,g3t1 ,g4t1 ))*4.
COMPUTE relief=(MEAN.3(f616it1, f613it1, f615it1, f617t1))*4. 
COMPUTE anger=(MEAN.3(f622t1, f623t1. f625t1. f627t1 ))*4. 
COMPUTE vulner=(MEAN.3(f632t1, f633t1, f635it1, f638t1))*4. 
COMPUTE uncert=(MEAN.3(f642t1. f644t1, f645t1, f647t1 ))*4. 
COMPUTE DOM1 =MEAN.2(pain,energy,sleep).
COMPUTE DOM2=MEAN.4(pfeel,think, esteem, body, neg). 






COUNT TOTAL=f12t1 to f625t1 (1 THRU 5).
FILTER OFF.
EXECUTE.
SUBTITLE 'BASELINE SF12 SCORING'
COMMENT Reverse codes so that high score is always
best health. t1 added to all variable names to 




COMPUTE h6 bt1=7-h6 bt1.
COMMENT Make MCS/PCS with US regression weights 
combining responses 3 & 4 on question h6t1 (some of the time 
& a good bit of the time).
COMPUTE pf02_1=h2_at1=1.
COMPUTE pf02_2=h2_at1 =2.
















COMPUTE vt2_5=h6_ bt1 =5.
COMPUTE sf2_1=h6t1=1.
COMPUTE Sf2_2=h6t1=2.
COMPUTE sf2_3=h6t1=3 OR h6t1=4.
COMPUTE Sf2_4=h6t1=5.












COMPUTE mh4 5=h6 ct1=5.
COMPUTE
rawpcs12=(pf02_1 *-7.23216)+(pf02_2*-3.45555)+(pf04_1*- 







+(vt2_5*-0.42251 )+(sf2_1 *-0.33682)+(sf2_2*-0.94342)+(sf2_3‘ - 
0.18043)+(sf2_4*0.11038)+(re2_1*3.04365)+(re3_1 *2.32091) 
+(mh3_1 *3.46638)+(mh3_2*2.90426)+(mh3_3*2.37241 )+(mh3_ 
4*1.36689)+(mh3_5*0.66514)+(mh4_1 *4.61446)+(mh4_2*3.415 
93)
+(m h4_3*2.34247)+(m h4_4* 1,28044)+(mh4_5*0.41188).
COMPUTE












1.94949)+(mh4_1 *-16.15395)+(mh4_2*-10.77911 )+(mh4_3*- 
8.09914)
+(mh4_4*-4.59055)+(m h4_5*-1.95934).
COMMENT This standardises by OHLSII.
COMPUTE pcsl 2=(((rawpcs12-(-4.7938))/7.6510)*10)+50. 
COMPUTE mcs12=(((rawmcs12-(-11.3215))/9.3733)*10)+50.
EXECUTE.
SUBTITLE 'BASELINE CPAQ SCORING'
RECODE cpaq5t1 cpaq8t1 cpaq10t1 cpaq13t1 cpaq18t1 
cpaq19t1 cpaq22t1 cpaq23t1 cpaq25t1 
cpaq26t1 cpaq27t1 cpaq29t1 cpaq30t1 cpaq31t1 cpaq33t1 
cpaq34t1 (0=6) (1=5) (2=4) (3=3) (4=2)
(5=1) (6=0) INTO rcpaq5t1 rcpaq8t1 rcpa10t1 rcpa13t1 
rcpa18t1 rcpa19t1 rcpa22t1 rcpa23t1 rcpa25t1 
rcpa26t1 rcpa27t1 rcpa29t1 rcpa30t1 rcpa31t1 rcpa33t1 
rcpa34t1 .
COMPUTE
cpaqtot=cpaq111 +cpaq2t1 +cpaq3t1 +cpaq4t1 +rcpaq5t1 +cpaq6t1 
+cpaq7t1 +
cpaq9t 1 +rcpa 10t1 +cpaq 12t1 +cpaq 14t1 +cpaq 16t1 +cpaq 17t1 +rc 
pa19t1+cpaq20t1 +
rcpa22t1 +rcpa23t1 +cpaq24t1 +rcpa27t1 +cpaq28t1 +rcpa30t1 +rc 
pa3111 +cpaq32t1 +rcpa34t1.
EXECUTE.
SUBTITLE 'SCORING FOR SHORT FORM CPAQ’
RECODE cpaq5t1 cpaq10t1 cpaq19t1 cpaq22t1 cpaq23t1 
cpaq25t1
cpaq30t1 cpaq31t1 cpaq34t1 (0=6) (1=5) (2=4) (3=3) (4=2) 
(5=1) (6=0) INTO rsfcpaq5 rsfcpalO rsfcpa19 rsfcpa22 rsfcpa23 
rsfcpa25
rsfcpa30 rsfcpa31 rsfcpa34.
SUBTITLE 'ACTIVITIES ENGAGEMENT SCORE’
COMPUTE activeng=cpaq 111 +cpaq2t1 +cpaq3t1 +cpaq6t1 + 
cpaq9t1 +cpaq14t1 +cpaq15t1 +cpaq16t1 +cpaq20t1 + 
cpaq24t1+cpaq32t1.




SUBTITLE 'SF CPAQ TOTAL’
COMPUTE
sfcpatot=cpaq 111 +cpaq2t1 +cpaq3t1 +rsfcpaq5+cpaq6t1 + 
cpaq9t1 +rsfcpa 10+cpaq 14t 1 +cpaq 15t1 +cpaq 16t 1 +rsfcpa 19+cp 
aq20t1 +
rsfcpa22+rsfcpa23+cpaq24t1 +rsfcpa25+rsfcpa30+rsfcpa31 +cpa 
q32t1 +rsfcpa34.
EXECUTE.
SUBTITLE 'FOLLOW UP WHOQOL AND PDM SCORING'
RECODE f11t2 f12t2 f13t2 f14t2 f21t2 f22t2 f23t2 f24t2 f31t2
f32t2 f33t2 f34t2 f41t2 f42t2 f43t2 f44t2
f51t2 f52t2 f53t2 f54t2 f61t2 f62t2 f63t2 f64t2 f71t2 f72t2 f73t2
f74t2 f81t2 f82t2 f83t2 f84t2 f91t2 f92t2 f93t2 f94t2 f101t2 f102t2
f103t2
f104t2 f 11112 f 112t2 f 113t2 f114t2 f121t2 f122t2 f123t2 f124t2 
f13112 f132t2 f133t2 f134t2 f141t2 f142t2 f143t2 f144t2 f151t2 
f152t2
f 153t2 f154t2 f 16112 f162t2 f 163t2 f 164t2 f17112 f 172t2 f 173t2 
f174t2 f18112 f182t2 f183t2 f184t2 f19112 f192t2 f193t2 f194t2 
f201t2
f202t2 f203t2 f204t2 f211t2 f212t2 f213t2 f214t2 f221t2 f222t2 
f223t2 f224t2 f231t2 f232t2 f233t2 f234t2 f241t2 f242t2 f243t2 
f244t2 g1t2
g2t2 g3t2 g4t2 f616it2 f622t2 f627t2 f633t2 f632t2 f638t2 f635it2
f642t2 f644t2 f647t2 f613it2
f617t2 f615it2 f645t2 f623t2 f625t2
(1=1) (2=2) (3=3) (4=4) (5=5) (ELSE=SYSMIS).
RECODE f11t2 f12t2 f13t2 f14t2 f22t2 f24t2 f32t2 f34t2 f72t2 
f73t2 f81t2 f82t2 f83t2 f84t2 f93t2 f94t2 f102t2 f104t2 f111t2 
f112t2 f 113t2
f114t2 f 13112 f 154t2 f 163t2 f 182t2 f 184t2 f222t2 f232t2 f234t2 










COMPUTE pfeelt2=(MEAN.3(f41t2,f42t2,f43t2,f44t2)) *4. 
COMPUTE thinkt2=(MEAN.3(f51t2,f52t2,f53t2,f54t2))*4. 
COMPUTE esteemt2=(MEAN.3(f61t2,f62t2,f63t2,f64t2))*4. 
COMPUTE bodyt2=(MEAN.3(f71t2,f72t2, f73t2, f74t2))*4. 
COMPUTE negt2=(MEAN.3(f81t2, f82t2,f83t2, f84t2))*4. 
COMPUTE mobilt2=(MEAN.3(f91t2,f92t2,f93t2,f94t2))*4. 
COMPUTE activt2=(MEAN.3(f101 t2,f102t2,f 103t2,f 104t2))*4. 
COMPUTE medict2=(MEAN.3(f111t2.f112t2, f113t2, f114t2))*4. 
COMPUTE workkt2=(MEAN.3(f121t2, f122t2, f123t2. f124t2))*4. 
COMPUTE relatt2=(MEAN.3(f131t2, f132t2, f133t2, f134t2))*4. 
COMPUTE suppt2=(MEAN.3(f141t2, f142t2, f143t2, f144t2))*4. 
COMPUTE sexxt2=(MEAN.3(f151t2,f152t2,f153t2.f154t2))*4. 
COMPUTE safetyt2=(MEAN.3(f16112, f162t2, f163t2, f164t2))‘ 4. 
COMPUTE homet2=(MEAN.3(f 171 t2,f172t2, f173t2, f174t2))*4. 
COMPUTE finant2=(MEAN.3(f181t2, f182t2,f183t2,f184t2))*4. 
COMPUTE servict2=(MEAN.3(f191t2, f192t2, f193t2.f194t2))*4. 
COMPUTE inform t2=(MEAN.3(f201t2,f202t2,f203t2,f204t2))*4. 
COMPUTE leisurt2=(MEAN.3(f211t2, f212t2, f213t2, f214t2))*4. 
COMPUTE envirot2=(MEAN.3(f221t2, f222t2,f223t2,f224t2))*4. 
COMPUTE transpt2=(MEAN.3(f231t2,f232t2, f233t2, f234t2))*4. 
COMPUTE spiritt2=(MEAN.3(f241t2,f242t2, f243t2, f244t2))*4. 
COMPUTE 0verllt2=(MEAN.3(g1t2,g2t2,g3t2,g4t2))*4. 
COMPUTE relieft2=(MEAN.3(f616it2, f613it2, f615it2. 
f617t2))*4.
COMPUTE angert2=(MEAN.3(f622t2, f623t2, f625t2, f627t2))*4. 
COMPUTE vulnert2=(MEAN.3(f632t2, f633t2, f635it2, 
f638t2))*4.
COMPUTE uncertt2=(MEAN.3(f642t2, f644t2, f645t2, 
f647t2))*4.
COMPUTE DOM1t2=MEAN.2(pain,energy,sleep).
COMPUTE DOM2t2=MEAN.4(pfeel,think, esteem, body, neg). 
COMPUTE DOM3t2=MEAN.3 (mobil.activ, medic,work). 
COMPUTE DOM4t2=MEAN.2(relat,supp,sexx).
COMPUTE
DOM5t2=MEAN.6(safety, home, finan.servic, inform, leisur,enviro,t 
ransp).
COMPUTE DOM6t2=spirit.
COUNT TOTAL=f12t2 to f625t2 (1 THRU 5).
FILTER OFF.
EXECUTE.
SUBTITLE 'FOLLOW UP SF12 SCORING'
COMMENT Reverse codes so that high score is always
best health. t2 added to all variable names to 




COMPUTE h6 bt2=7-h6 bt2.
COMMENT Make MCST2/PCST2 with US regression weights 
combining responses 3 & 4 on question h6t2 (some of the time 



















COMPUTE vt2 5t2=h6 bt2=5.
COMPUTE Sf2_1t2=h6t2=1.
COMPUTE Sf2_2t2=h6t2=2.













COMPUTE mh4 5t2=h6 Ct2=5.
COMPUTE

































10.77911 )+(m h4_3t2*-8.09914) 
+(mh4_4t2*-4.59055)+(mh4_5t2*-1.95934).




SUBTITLE 'FOLLOW UP CPAQ SCORING'
RECODE cpaq5t2 cpaq8t2 cpaq10t2 cpaq13t2 cpaq18t2 
cpaq19t2 cpaq22t2 cpaq23t2 cpaq25t2 
cpaq26t2 cpaq27t2 cpaq29t2 cpaq30t2 cpaq31t2 cpaq33t2 
cpaq34t2 (0=6) (1=5) (2=4) (3=3) (4=2)
(5=1) (6=0) INTO rcpaq5t2 rcpaq8t2 rcpa10t2 rcpa13t2 
rcpa18t2 rcpa19t2 rcpa22t2 rcpa23t2 rcpa25t2 










SUBTITLE 'FOLLOW UP SCORING FOR SHORT FORM 
CPAQ'
RECODE cpaq5t2 cpaq10t2 cpaq19t2 cpaq22t2 cpaq23t2 
cpaq25t2
cpaq30t2 cpaq31t2 cpaq34t2 (0=6) (1=5) (2=4) (3=3) (4=2) 
(5=1) (6=0) INTO rsfcp5t2 rsfc10t2 rsfc19t2 rsfc22t2 rsfc23t2 
rsfc25t2
rsfc30t2 rsfc31t2 rsfc34t2.
SUBTITLE 'ACTIVITIES ENGAGEMENT SCORE'
COMPUTE activeng=cpaq1t2+cpaq2t2+cpaq3t2+cpaq6t2+ 
cpaq9t2+cpaq 14t2+cpaq 15t2+cpaq 16t2+cpaq20t2+ 
cpaq24t2+cpaq32t2.














The UK WHOQOL-lOO and PDM
ID
**Please remember to bring this pack with you when you attend your appointment*** 
IMPORTANT - What is today’s d a te ?  d a y  m o n th ________Year
WHOQOL
UK VERSION with WHOQOL-based pain and discomfort
module
Department of Mental Health
World Health Organisation
Geneva
This document is not issued to the general public and all rights are reserved by the World Health Organisation (WHO). This 
document may not be reviewed, abstracted, quoted, reproduced, translated, referred to in bibliographic matter or cited in part 
or in whole without prior written permission of the WHO. No part of this document may be stored in a retrieval system or 
transmitted in any form by any means -  electronic, mechanical or other -  without the prior written permission of the WHO. 
The WHOQOL Group, Department of Mental Health, WHO, CH-1211, Geneva 27, Switzerland.
Permission to use the UK instrument must be obtained from Professor Suzanne Skevington, WHO Centre for the Study of 
Quality of Life, University of Bath, Bath, BA2 7AY, UK (s.m.skevington@bath.ac.uk)
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The UK WHOQOL and Pain and Discomfort Module 
Instructions 
Please read this carefully
This questionnaire asks how you feel about your quality of life, health and other areas of your life. 
Please answer all the questions. If you are unsure about which response to give to a question, 
please choose the best one you can. There are no right or wrong answers. Your answer will be kept 
strictly confidential. Please keep in mind your standards, hopes, pleasures and concerns. We ask 
that you think about your life in the last two weeks.
For example, thinking about the last two weeks, a question might ask:
How much do you worry about your health?
Not at all Not much A moderate Very much An extreme
amount amount
1 2 3 4 5
You should circle the number that best fits how much you have worries about your health over the 
last two weeks. So you would circle the number 4 if you worried about your health “very much”, or 
circle number 1 if you have worried “not at all” about your health. Please read each question, assess  
your feelings, and circle the number on the scale for each question that gives the best answer for 
you.
Thank you for your help, please turn over page
The following questions ask about how much you have experienced certain things in the last two 
weeks, for example, positive feelings such as happiness or contentment. If you have experienced 
these things an extreme amount, circle the number next to "An extreme amount". If you have not 
experienced these things at all, circle the number next to "Not at all". You should circle one of the 
numbers in between if you wish to show that your answer lies somewhere between "Not at all" and 
"Extremely". Questions refer to the last two weeks.
1. How much do you worry about pain or discomfort?(F1.2)
Not at all Not much A moderate Very much An extreme
amount amount
1 2 3 4 5
2. How difficult is it for you to handle pain or discomfort? (F1.3)
Not at all Not much Moderately Very much Extremely
1 2 3 4 5
3. How much do you feel that pain prevents you from doing what you need to do? (F1.4)
Not at all Not much A moderate Very much An extreme
amount amount
1 2 3 4 5
How easily do you get tired? (F2.2)
Not at all Not much Moderately Very much Extremely
1 2 3 4 5
5. How much are you bothered by fatigue? (F2.4)
Not at all Not much A moderate Very much An extreme
amount amount
1 2 3 4 5





Not much A moderate Very much An extreme
amount amount
2 3 4 5
7. How much do sleep problems worry you? (F3.4)
How much do you enjoy life? (F4.1)
9. How positive do you feel about the future? (F4.3)
10 . How much do you feel positive about your life? (F4.4)
11. How well are you able to concentrate? (F5.3)
12 . How much do you value yourself? (F6.1)
13. How much confidence do you have in yourself? (F6.2)
14.
Not at all Not much A moderate Very much
amount
1 2 3 4
Not at all Not much A moderate Very much
amount
1 2 3 4
Not at all Not much Moderately Very much









Not at all Not much A moderate Very much An extreme
amount amount
1 2 3 4 5
Not at all Not much Moderately Very well
1 2 3 4
Not at all Not much A moderate Very much
amount










How much do you feel inhibited by your looks? (F7.2)
Extremely 
5
Is there any part of your appearance which makes you feel uncomfortable? (F7.3)
Not at all Not much A moderate Very much
amount
1 2 3 4
Not at all Not much Moderately Very much
1 2 3 4
16.
Not at all Not much A moderate Very much An extreme
amount amount
1 2 3 4 5
How worried do you feel? (F8.2)
Not at all Not much Moderately Very much Extremely
1 2 3 4 5
Appendix 7




Not at all Not much A moderate Very much An extreme
amount amount
1 2 3 4 5
How much do feelings of depression bother you? (F8.4)
Not at all Not much A moderate Very much
amount




19. To what extent do you have difficulty in performing your routine activities? (F10.2)
Not at all Not much A moderate Very much An extreme
amount amount
1 2 3 4 5
20 . How much are you bothered by limitations in performing everyday living 
activities?(F10.4)
Not at all Not much A moderate Very much An extreme
amount amount
1 2 3 4 5
21 . How much do you need medication to function in your daily life? (F11.2)
Not at all Not much A moderate Very much
amount






How much do you need medical treatment to function in your daily life? (F11.3)
Not at all Not much A moderate Very much
amount









Not at all Not much A moderate Very much
amount
1 2 3 4
24. How alone do you feel? (F13.1)
Not at all Not much Moderately Very much
1 2 3 4
25. How well are your sexual needs fulfilled? (F15.2)
Not at all Not much Moderately Very much





26. How bothered are you by difficulties in your sex life? (F15.4)
Not at all Not much Moderately Very much
1 2 3 4
Extremely
5





Not at all Not much Moderately Very much Extremely
1 2 3 4 5
To what extent do you feel you are living in a safe and secure environment? (F16.2)
Not at all Not much Moderately Very much Extremely
1 2 3 4 5
How much do you worry about safety and security? (F16.3)
Not at all Not much A moderate Very much An extreme
amount amount
1 2 3 4 5
30. How comfortable is the place where you live? (F17.1)
31. How much do you like where you live? (F17.4)
32. To what extent do you have financial difficulties? (F18.2)
33. How much do you worry about money? (F18.4)
34. How easily are you able to get good medical care? (F19.1)
35. How much do you enjoy your free time? (F21.3)
Not at all 
1
36. How healthy is your physical environment? (F22.1)
Not at all Not much Moderately Very much
1 2 3 4
Not at all Not much A moderate Very much
amount
1 2 3 4
Not at all Not much A moderate Very much
amount
1 2 3 4
Not at all Not much Moderately Very much
1 2 3 4
Not at all Not much Moderately Very much
1 2 3 4
37. How concerned are you with the noise in the area where you live? (F22.2)
Not at all Not much Moderately Very much









Not at all Not much A moderate Very much An extreme
amount amount
1 2 3 4 5
Extremely
5









38. To what extent do you have problems with transport? (F23.2)
48.
Not at all Not much A moderate Very much
amount
1 2 3 4
39. How much do difficulties with transport restrict your life? (F23.4)
Not at all A little A moderate Very much
amount








40. How fed up do you feel? (F8N)
Not at all
1
41. To what extent has having treatment improved your quality of life? (F61.6i)
A little A moderate Very much An extreme
amount amount
2 3 4 5
Not at all Not much A moderate Very much An extreme
amount amount
1 2 3 4 5
42. How much do feelings of anger interfere with your every day life? (F62.2)
Not at all Not much A moderate Very much
amount
1 2 3 4
43. How much do feelings of frustration interfere with your everyday life? (F62.7)
Not at all Not much A moderate Very much
amount







44. How much does feeling vulnerable interfere with your everyday life? (F63.3)
Not at all Not much A moderate Very much
amount
1 2 3 4
45. How much does fear bother you? (F63.2)
Not at all Not much A moderate Very much
amount
1 2 3 4
46. How much do you worry about treatment? (F63.8)
Not at all Not much A moderate Very much
amount
1 2 3 4
47. How concerned are you about experiencing pain? (F63.5i)
Not at all Not much A moderate Very much
amount













How much does uncertainty about the future interfere with your everyday life? (F64.2)





1 2 3 4 5
To what extent do difficulties with planning affect your everyday life? (F64.4)
Not at all Not much A moderate Very much An extreme
amount amount
1 2 3 4 5
Not at all Not much A moderate Very much
amount
1 2 3 4




The following questions ask about how completely you experienced, or were able to do certain 
things in the last two weeks, for example activities of daily living like washing, dressing or eating. If 
you have been able to do these things completely, circle the number next to "Completely". If you 
have not been able to do these things at all, circle the number next to "Not at all". You should circle 
one of the numbers in between if you wish to show that your answer lies somewhere between "Not at 
all" and "Completely”. Questions refer to the last two weeks.
51. Do you have enough energy for everyday life? (F2.1)
Not at all Not much Moderately A great deal Completely
1 2 3 4 5
52. How much are you able to accept your bodily appearance? (F7.1)
Not at all Not much Moderately A great deal Completely
1 2 3 4 5
53.
Not at all Not much Moderately A great deal
1 2 3 4
54.
Not at all Not much Moderately A great deal




To what extent are you able to carry out your daily activities? (F10.1)
Completely 
5
How dependent are you on medications? (F11.1)
Completely 
5
To what extent do you get the kind of support from others that you need? (F14.1)
Completely 
5
How much can you count on your friends when you need them? (F14.2)
Completely 
5
To what degree does the quality of your home meet your needs? (F17.2)
Not at all Not much Moderately A great deal
1 2 3 4
Not at all Not much Moderately A great deal
1 2 3 4
Not at all Not much Moderately A great deal Completely
1 2 3 4 5
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58. To what extent do you have enough money to meet your needs? (F18.1)
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Not at all Not much Moderately A great deal Completely
1 2 3 4 5
59. How available to you is the information that you need in your day-to-day life? (F20.1)
Completely
5
60. To what extent do you have the opportunities for acquiring the information that you need? 
(F20.2)
Not at all Not much Moderately A great deal
1 2 3 4
Not at all Not much Moderately A great deal Completely
1 2 3 4 5
61. To what extent do you have the opportunity for leisure activities? (F21.1)
Not at all Not much Moderately A great deal
1 2 3 4
62. How much are you able to relax and enjoy yourself? (F21.2)
Not at all Not much Moderately A great deal
1 2 3 4
63. To what extent do you have adequate m eans of transport? (F23.1)
Not at all Not much Moderately A great deal











The following questions ask you to say how satisfied, happy or good you have felt about various 
aspects of your life over the last two weeks, for example, about your family life or you energy level. 
Decide how satisfied or dissatisfied you are with each aspect of your life and then circle the number 
that best fits how you feel about this. Questions refer to the last two weeks.
64. How well do you cope with your level of pain? (F61.3i)
Not at all Not much Moderately A great deal
1 2 3 4
65. How easy is it for you to get into a comfortable position? (F61.7)
Not at all Not much Moderately A great deal
1 2 3 4
66 . How satisfied are you with the quality of your life? (G2)
Very dissatisfied Dissatisfied Neither satisfied Satisfied
nor dissatisfied
1 2 3 4
Very satisfied
67. In general, how satisfied are you with your life? (G3)
Very dissatisfied | Dissatisfied | Neither satisfied | Satisfied Very satisfied
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69. How satisfied are you with your energy? (F2.3)
70. How satisfied are you with your sleep? (F3.3)
71. How satisfied are you with your ability to learn new information? (F5.2)
72. How satisfied are you with your ability to make decisions? (F5.4)
73. How satisfied are you with yourself? (F6.3)
74. How satisfied are you with your abilities? (F6.4)
75. How satisfied are you with the way your body looks? (F7.4)
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nor dissatisfied
1 2 3 4 5
68. How satisfied are you with your health? (G4)
Very dissatisfied Dissatisfied Neither satisfied 
nor dissatisfied
Satisfied Very satisfied
1 2 3 4 5
Very dissatisfied Dissatisfied Neither satisfied Satisfied
nor dissatisfied
1 2 3 4
Very dissatisfied Dissatisfied Neither satisfied Satisfied
nor dissatisfied




Very dissatisfied Dissatisfied Neither satisfied Satisfied
nor dissatisfied
1 2 3 4
Very dissatisfied Dissatisfied Neither satisfied Satisfied
nor dissatisfied




Very dissatisfied Dissatisfied Neither satisfied Satisfied
nor dissatisfied
1 2 3 4
Very satisfied
Very dissatisfied Dissatisfied Neither satisfied Satisfied
nor dissatisfied
1 2 3 4
Very satisfied
Very dissatisfied Dissatisfied Neither satisfied Satisfied
nor dissatisfied
1 2 3 4
Very satisfied
76. How satisfied are you with your ability to perform daily living activities?(F10.3)
Very dissatisfied Dissatisfied Neither satisfied Satisfied Very satisfied
nor dissatisfied
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Dissatisfied Neither satisfied Satisfied Very satisfied
nor dissatisfied
2 3 4 5
78. How satisfied are you with your sex life? (F15.3)
Very dissatisfied Dissatisfied Neither satisfied Satisfied
nor dissatisfied
1 2 3 4
79. How satisfied are you with the support you get from your family? (F14.3)
Very dissatisfied Dissatisfied Neither satisfied Satisfied
nor dissatisfied




80. How satisfied are you with the support you get from your friends?(F14.4)
Very dissatisfied Dissatisfied Neither satisfied Satisfied
nor dissatisfied
1 2 3 4
Very satisfied 
5
81, How satisfied are you with your ability to provide for, or support others? (F13.4)
Very dissatisfied Dissatisfied Neither satisfied Satisfied
nor dissatisfied
1 2 3 4
82. How satisfied are you with your physical safety and security? (F16.4)
Very dissatisfied Dissatisfied Neither satisfied Satisfied
nor dissatisfied




83. How satisfied are you with the conditions of your living place? (F17.3)
Very dissatisfied Dissatisfied Neither satisfied Satisfied
nor dissatisfied
1 2 3 4
Very satisfied
84. How satisfied are you with your financial situation? (F18.3)
Very dissatisfied Dissatisfied Neither satisfied Satisfied
nor dissatisfied
1 2 3 4
85. How satisfied are you with your access to health services? (F19.3)






1 | 2 | 3 | 4 | 5
86. How satisfied are you with the social care services? (F19.4)
Very satisfied 
5
87. How satisfied are you with your opportunities for acquiring new skills? (F20.3)
Very satisfied
Very dissatisfied Dissatisfied Neither satisfied Satisfied
nor dissatisfied
1 2 3 4
Very dissatisfied Dissatisfied Neither satisfied Satisfied
nor dissatisfied
1 2 3 4
88. How satisfied are you with your opportunities to learn new information? (F20.4)
Very satisfied
89.
Very dissatisfied Dissatisfied Neither satisfied Satisfied
nor dissatisfied
1 2 3 4
How satisfied are you with the way you spend your spare time? (F21.4)
Very dissatisfied Dissatisfied Neither satisfied Satisfied
nor dissatisfied
1 2 3 4
Very satisfied 
5
90. How satisfied are you with your physical environment e.g. pollution, climate, noise,
attractiveness? (F22.3)
Very satisfiedVery dissatisfied Dissatisfied Neither satisfied Satisfied
nor dissatisfied
1 2 3 4
91. How satisfied are you with the climate of the place where you live? (F22.4)
Very dissatisfied Dissatisfied Neither satisfied Satisfied
nor dissatisfied
1 2 3 4
92. How satisfied are you with your transport? (F23.3)
Very dissatisfied Dissatisfied Neither satisfied Satisfied
nor dissatisfied





93. How happy do you feel about your relationships with your family? (F13.2)
94.
Very unhappy Unhappy Neither happy nor 
unhappy
Happy Very happy
1 2 3 4 5
How would you rate your quality of life? (G1)






I 2 | 3
How would you rate your sex life? (F15.1)
Very poor Poor Neither poor nor Good
good
1 2 3 4
96. How well do you sleep? (F3.1)
Very poor Poor Neither poor nor Good
good
1 2 3 4
97. How would you rate your memory? (F5.1)
Very poor Poor Neither poor nor Good
good
1 2 3 4
98. How would you rate the quality of social services available to you? (F19.2)
Very poor Poor Neither poor nor Good
good
1 2 3 4
99. How satisfied are you with your level of happiness (F4N)
Very dissatisfied Dissatisfied Neither satisfied Satisfied
nor dissatisfied
1 2 3 4
100. How satisfied are you with the control of your pain? (F61.5i)




101. How satisfied are you with your ability to make future plans?(F64.5)

















The following questions refer to how often you have felt or experienced certain things, for example 
the support of your family or friends, or negative experiences such as feeling unsafe. If you have not 
experienced these things at all in the last two weeks, circle the response "never". If you have 
experienced these things, decide how often and circle the appropriate number. So for example if you 
have experienced pain all the time in the last two weeks, circle the number next to "Always". 
Questions refer to the last two weeks.
102. How often do you suffer pain? (F1.1)
Never Seldom Quite often Very often Always
1 2 3 4 5
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103. Do you generally feel content? (F4.2)
Never Seldom Quite often Very often
1 2 3 4
104. How often do you have negative feelings, such as blue mood, despair, anxiety,
depression? (F8.1)
Never Seldom Quite often Very often
1 2 3 4
105. How often does your pain make you feel angry? (F62.3)
Never Seldom Quite often Very often
1 2 3 4
106. How often does your pain make you feel irritable? (F62.5)
Never Seldom Quite often Very often









The following questions refer to any work that you do. Work here means any major activity that 
you do. This includes voluntary work, studying full-time, taking care of the home, taking care 
of children, paid work, or unpaid work. So work, as it is used here, means the activities you 
feel take up a major part of your time and energy. Questions refer to the last two weeks.
107. How much are you able to work? (F12.1)
108.
Not at all Not much Moderately A great deal Completely
1 2 3 4 5
To what extent do you feel able to carry out your duties? (F12.2)
Not at all Not much Moderately A great deal Completely
1 2 3 4 5
109. How satisfied are you with your capacity for work? (F12.4)
Very dissatisfied Dissatisfied Neither satisfied Satisfied
nor dissatisfied
1 2 3 4





The next few questions ask about how well you were able to move around in the last two weeks. 
This refers to your physical ability to move your body in such a way as to allow you to move about 
and do the things you would like to do, as well as the things that you need to do. Questions refer to 
the last two weeks.
Very poor Poor Neither poor nor Good
good
1 2 3 4
111 . How well are you able to get around? (F9.1)
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Very poor
112 . How much do any difficulties in mobility bother you? (F9.3)
Not at all Not much A moderate Very much
amount
1 2 3 4
113. To what extent do difficulties in movement affect your way of life? (F9.4)
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Poor Neither good nor Good Very good
poor
2 3 4 5
An extreme 
amount
Not at all Not much A moderate Very much An extreme
amount amount
1 2 3 4 5
114. How satisfied are you with your ability to move around? (F9.2)
Very satisfied 
5
The following questions are concerned with your personal beliefs and how these affect your quality 
of life. These questions refer to religion, spirituality and any other personal beliefs you may hold. 
Once again these questions refer to the last two weeks.
Very dissatisfied Dissatisfied Neither satisfied Satisfied
nor dissatisfied
1 2 3 4
115. How much do personal beliefs give meaning to your life? (F24.1)
Not at all Not much A moderate Very much An extreme
amount amount
1 2 3 4 5
116.
117.
To what extent do you feel life to be meaningful? (F24.2)
Extremely 
5
How much do your personal beliefs give you the strength to face difficulties? (F24.3)
Not at all Not much Moderately Very much
1 2 3 4
118.
Not at all Not much A moderate 
amount
Very much An extreme 
amount
1 2 3 4 5
To what extent do your personal beliefs help you to understand the difficulties in life? 
(F24.4)
Not at all Not much A moderate 
amount
Very much An extreme 
amount
1 2 3 4 5
IMPORTANCE QUESTIONS
The following questions ask about how important various aspects of your life are to you. We ask that 
you think about how much these affect your quality of life. For example one question asks about how 
important sleep is to you. If sleep is not important to you, circle the number next to "not important". If
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sleep is "very important" to you, but not "most important", you should circle the number next to 
"Very important". Unlike earlier questions, these questions do not refer only to the last two weeks.
1. How important to you is your overall quality of life? lmpG.1




1 2 3 4 5
How important to you is your health? lmpG.2




1 2 3 4 5
3. How important to you is it to be free of any pain? Imp1.1




1 2 3 4 5
How important to you is having energy? Imp2.1




1 2 3 4 5
How important to you is restful sleep? Imp3.1




1 2 3 4 5
How important to you is it to feel contented? Imp4.1 (Imp4.2)




1 2 3 4 5
7. How important to you is being able to think through everyday problems and make
decisions? Imp5.1 (Imp5.2)




1 2 3 4 5
8. How important to you is feeling positive about yourself? Imp6.1




1 2 3 4 5
9. How important to you is your body image and appearance? Imp7.1








How important to you is it to be free of negative feelings like sadness, depression, 
anxiety, worry...? Imp8.1
Not important A little important Moderately Very important
important
1 2 3 4
Extremely
important
11 , How important to you is it to be able to move around? Imp9.1
Not important A little important Moderately Very important
important
1 2 3 4
Extremely
important
12. How important to you is being able to take care of your daily living activities e.g.
washing, dressing, eating? Imp10.1
Not important A little important Moderately Very important
important




How important to you is it to be free of dependence on medicines or treatments? Imp11.1
Extremely 
important
Not important A little important Moderately Very important
important
1 2 3 4
14. How important to you is being able to work? Imp12.1
Not important A little important Moderately Very important
important
1 2 3 4
Extremely
important
15. How important to you are relationships with other people? Imp13.1
Not important A little important Moderately Very important
important
1 2 3 4
Extremely
important
16. How important to you is support from others? Imp14.1




1 2 3 4 5
17. How important to you is your sex life? Imp15.1




1 2 3 4 5
18. How important to you is feeling physically safe and secure? Imp16.1




1 2 3 4
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important
How important to you is your home environment? Imp17.1
Not important A little important Moderately Very important
important
1 2 3 4
Extremely
important
20. How important to you are your financial resources? Imp18.1
Not important A little important Moderately Very important
important
1 2 3 4
Extremely
important
21 . How important to you is being able to get adequate health care? Imp19.1
Not important A little important Moderately Very important
important
1 2 3 4
Extremely
important
22 . How important to you are the chances for getting new information or knowledge? 
Imp20.1
Not important A little important Moderately Very important
important
1 2 3 4
Extremely
important
23. How important to you is relaxation and leisure? Imp21.1
Not important A little important Moderately Very important
important
1 2 3 4
Extremely
important
24. How important to you is your environment e.g. pollution, climate, noise,
attractiveness? Imp22.1
Not important A little important Moderately Very important Extremely
important important
1 2 3 4 5
25. How important to you is adequate transport in your everyday life? Imp23.1
Not important A little important Moderately Very important
important
1 2 3 4
Extremely
important
26. How important to you are your personal beliefs? Imp24.1
Not important A little important Moderately Very important
important
1 2 3 4
Extremely
important
27. How important is it for you to be able to obtain relief from pain? (Imp61.1)
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Not important
28. How important is it to be able to control your pain? (Imp61.2)
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How important is it for you to be free from anger and frustration? (Imp62.1)









30. How important is it for you to be free from fear and worry? (Imp63.1)






31. How important is it for you to be free from uncertainty? (Imp64.1)











We would like you to answer a few general questions about yourself: by circling the correct answer 
or by filling in the space provided.
What is your gender? 
What is your date of birth?
MALE / FEMALE
/ / (day / month / year)
What is the highest education you have received? None at all
Primary School 
Secondary School
Further Education e.g. Technical/Clerical 
University
What is your marital status? Single Separated
Married Divorced
Living as married Widowed
How is your health?
Very poor Poor Neither good nor Good
poor




Are you currently ill? YES I NO
If something is wrong with your health, what do you think it is? Please write your illness(s) or 
problems here______________________________________________________________________
How long have you been in pain?____________________m onths______________________ years
What do you think is causing your pain?_______________________________________________
Which parts of your body hurt? (Please tick aM those that apply to you)
Head, face and/ or mouth
Upper back
Upper shoulder and/ or arms
Middle back or chest
Abdomen















Are you currently in paid work? YES I NO 
What is your occupation?_______________
Syntax files and scoring for the WHOQOL- 
100 and PDM
SUBTITLE ’WHOQOL AND PDM SCORING’
RECODE f11 f12 f13 f14 f21 f22 f23 f24 f31 f32 f33 f34 f41 f42 
f43 f44
f51 f52 f53 f54 f61 f62 f63 f64 f71 f72 f73 f74 f81 f82 f83 f84 f91 
f92 f93 f94 f101 f102 f 103
f104 f 111 f 112 f 113 f114 f121 f122 f123 f124 f131 f 132 f 133
f134 f141 f142 f143 f144 f151 f152
f153 f154 f 161 f162 f163 f164f171 f172 f 173 f174 f181 f182
f 183 f184 f191 f192 f193 f194 f201
f202 f203 f204 f211 f212 f213 f214 f221 f222 f223 f224 f231
f232 f233 f234 f241 f242 f243 f244 g1
g2 g3 g4 f616i f622 f627 f633 f632 f638 f635i f642 f644 f647
f613i
f617f615if645f623f625
(1=1) (2=2) (3=3) (4=4) (5=5) (ELSE=SYSMIS).
RECODE f11 f12 f13 f14 f22 f24 f32 f34 f72 f73 f81 f82 f83 f84 
f93 f94 f102 f104 f 111 f 112 f 113
f114 f131 f154 f163 f182 f 184 f222 f232 f234 f622 f623 f625
f627 f632 f633 f635i f638 f642 f644
f647
(1=5X2=4)(3=3)(4=2)(5=1).
SUBTITLE ’COMPUTE FACET AND DOMAIN SCORES'
COMPUTE pain=(MEAN.3(f11 ,f 12,f13,f 14))*4.





COMPUTE body=(MEAN.3(f71 ,f72, f73, f74))*4.
COMPUTE neg=(MEAN.3(f81, f82,f83, f84))*4.
COMPUTE mobil=(MEAN.3(f91 ,f92,f93,f94))*4.
COMPUTE activ=(MEAN.3(f101 ,f102,f103,f 104))*4.
COMPUTE medic=(MEAN.3(f111 ,f112, f113, f114))*4. 
COMPUTE work=(MEAN.3(f121, f122, f123, f124))*4. 
COMPUTE relat=(MEAN.3(f131, f132, f133, f134))*4. 
COMPUTE supp=(MEAN.3(f141, f142, f143, f144))*4.
Appendix 8
COMPUTE sexx=(MEAN.3(f151 ,f152,f153,f 154))*4. 
COMPUTE safety=(MEAN.3(f161, f162, f163, f164))*4. 
COMPUTE hom e=( ME AN. 3(f 171 ,f172, f173, f174))*4. 
COMPUTE finan=(MEAN.3(f181, f182,f183,f184))*4. 
COMPUTE servic=(MEAN.3(f191, f192, f193,f194))*4. 
COMPUTE inform =(MEAN.3(f201 ,f202,f203,f204))M. 
COMPUTE leisur=(MEAN.3(f211, f212, f213, f214))*4. 
COMPUTE enviro=(MEAN.3(f221, f222,f223,f224))*4. 
COMPUTE transp=(MEAN.3(f231 ,f232, f233, f234))*4. 
COMPUTE spirit=(MEAN.3(f241,f242, f243, f244))*4. 
COMPUTE overll=(MEAN.3(g1 ,g2,g3,g4))*4.
COMPUTE relief=(MEAN.3(f616i, f613i, f615i, f617))*4. 
COMPUTE anger=(MEAN.3(f622, f623, f625, f627))*4. 
COMPUTE vulner=( ME AN. 3(f632, f633, f635i, f638))*4. 
COMPUTE uncert=(MEAN.3(f642, f644, f645, f647))*4. 
COMPUTE DOM1 =MEAN.2(pain,energy,sleep).
COMPUTE DOM2=MEAN.4(pfeel,think, esteem, body, neg). 







COMPUTE ttransp=(transp-4)*( 100/16). 
COMPUTE tspirit=(spirit-4)*(100/16). 
COMPUTE toverl=(overll-4)*(100/16). 
COMPUTE trelief=(relief-4)*( 100/16). 
COMPUTE tanger=(anger-4)*( 100/16). 
COMPUTE tvulner=(vulner-4)*(100/16). 
COMPUTE tuncert=(uncert-4)*( 100/16). 
COMPUTE TPHYS=(dom 1 -4)*(100/16). 
COMPUTE TPSYCH=(dom2-4)*(100/16). 
COMPUTE TIND=(dom3-4)*(100/16). 
COMPUTE TSOCIAL=(dom4-4)‘ (100/16). 
COMPUTE TENVIR=(dom5-4)*( 100/16). 
COMPUTE TSPIR=(dom6-4)*(100/16).
COUNT TOTAL=f12 to f625 (1 THRU 5). 
FILTER OFF.
EXECUTE
SUBTITLE 'TRANSFORM SCORES TO A 0-100 SCALE'
COMPUTE tpain =(pain-4)*(100/16). 
COMPUTE tenergy=(energy-4)*( 100/16). 
COMPUTE tsleep=(sleep-4)*(100/16). 
COMPUTE tpfeel=(pfeel-4)*(100/16). 
COMPUTE tthink=(think-4)*( 100/16). 
COMPUTE testeem=(esteem-4)*(100/16). 
COMPUTE tbody=(body-4)*(100/16). 
COMPUTE tneg=(neg-4)*( 100/16). 
COMPUTE tmobil=(mobil-4)*( 100/16). 
COMPUTE tactiv=(activ-4)*(100/16). 
COMPUTE tmedic=(medic-4)*( 100/16). 
COMPUTE twork=(work-4)*(100/16). 
COMPUTE trelat=(relat-4)*( 100/16). 
COMPUTE tsupp=(supp-4)*(100/16). 
COMPUTE tsexx=(sexx-4)*(100/16). 
COMPUTE tsafety=(safety-4)*( 100/16). 
COMPUTE thome=(home-4)*(100/16). 
COMPUTE tfinan=(finan-4)*(100/16). 
COMPUTE tservic=(servic-4)*(100/16). 
COMPUTE tinform=(inform-4)*(100/16).
367
